%PDF-1.3 %âãÏÓ 70 0 obj << >> endobj 132 0 obj << /Length 475 /S 517 /L 656 /I 672 /Filter /FlateDecode >> stream xÚc```a``çd`c`àžÀ À€@1v ,ǃ‡ L ‡˜ö6òƲÌç’ä|#¢Ã'ÂÀðñû“ÚŸR5 ,�Îì*›Ýù\&µz‹¤\ÜÜî/ïÐ*dÒ¬°4hkw¸~ÂÑÉf½ÑæO/oï�·o�°©´ªøÅ¢yE3dmÒÕÓ7 Ó.®HxrJT'æåã‹Ü&j¥¼Y¶1ëé‰ÍW_?ÿ€�Ï¢’I¥sŠVÄÎËÇ/(ú-ôZš-¶.î`·Y¯3»ZÀʤg<³Ì Q­�í¶°y²FÈÆb6_i‹N)—•“W­Œ:ºzú†¤³‹‡¹ä�‰K¼fZµjM]µ³šMç–)�ÌL§¥Ýsmj™D�ÜrÅ ðð AŸ…AGÏHšä> /Type /Annot /Subtype /Link /Rect [ 522.486 484.415 558.5 493.747 ] /Border [ 0 0 0 ] >> endobj 74 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 410.418 464.915 447.088 474.247 ] /Border [ 0 0 0 ] >> endobj 75 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/guidelines/CD/lipids) >> /Type /Annot /Subtype /Link /Rect [ 93.937 345.082 291.835 357.747 ] /Border [ 0 0 0 ] >> endobj 76 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 349.696 301.082 398.761 313.747 ] /Border [ 0 0 0 ] >> endobj 77 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 52.5 33.415 89.741 42.747 ] /Border [ 0 0 0 ] >> endobj 78 0 obj [ /Separation /PANTONE#20322#20C /DeviceCMYK 79 0 R ] endobj 79 0 obj << /FunctionType 0 /Domain [ 0 1 ] /Range [ 0 1 0 1 0 1 0 1 ] /BitsPerSample 8 /Size [ 255 ] /Encode [ 0 254 ] /Decode [ 0 1 0 1 0 1 0 1 ] /Length 718 /Filter /FlateDecode >> stream H‰ ÃT †ÑOPQPP00PAA Ì©›nÓm¾îî:¯»»»»»»»»»»ßûï9 Cdd5CFC¶š0r4£1�L£Y-deZ5_ ÈÎ*Ô"-Æ”U‚)»”œl›–‘c*'×T¡•äåØÕ¡U˜sª1ç:Õ…%×�%¯k^­z°š½ä›ë´^}XüÚ@¡¥‘Bk“6SdP”ßBq~«¶i;%AíÐNJ »4„­0Œ­¨[{(+Šh”òâ^íÓ~*Jbו¥:ˆ½4©)ì¶!¶aÁQ6JUYZǨ.× �ÄY>…³bWÅ �ÁU9‹»rNW⶯¢Æ>¯ Ô:Vë]‹Ç±ˆ§jI×á­Z�·zuÕ˺uÎ�©wn¢›âsn†Ïµ¹n�ßµ%~÷Vº5îmh¨Ù–Æšít{Ý�¦Úu'Ý™fÏ.º+Ïn¼»ë´x÷Ô½h­Û[÷Ñ}i«ßO÷×h÷¨ô¬‡ôJ‡ÿ0=œÎ†#ôH=Š®Æ£õ=–Pãq„šŽ'Üt‚žH¸ù$º›OÖSèœJOà4=�Hà "-gêYD[Î&Úz½­çêyô¶�O_Ûz¡^DûÅz ±öK‰/Óˉ¯ Þq¥^E¢ãj�×0Ðy­^§×3ØuƒÞH²ë&’¡›õR¡[I…oÓÛ ß¡w2Ü}—Þ­÷0Òs¯Þ§÷3y@$yH&}„±è£úã½�ëú$}OéÓú “}Ï2ÙÿSýÏë LÅ^d:ö’¾ÌtüVÄ_Õט‰¿ÎLâ}“ÙÄ[̼ÍÜÀ;ú.sƒï±rð}ý@?dUò#ý˜ùä'̧>ÕÏXH}ÎÂЬúR¿Ò¯Y3ü�~«ß±vä{ý�Å‘YýIfiôý•¥ôo¬Kÿ®°~ìOýKÿfÃø?ú/Ëãÿ±<ñ¿—–Õ` endstream endobj 80 0 obj << /ProcSet [ /PDF /Text ] /Font << /F1 81 0 R /F2 86 0 R /F3 91 0 R /F4 96 0 R /F5 123 0 R /F6 101 0 R /F7 106 0 R /F8 126 0 R /F9 129 0 R /F10 111 0 R /F11 116 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 81 0 obj << /Type /Font /Subtype /Type1 /FirstChar 46 /LastChar 121 /Widths [ 245 512 500 512 500 512 512 512 512 512 512 512 280 512 512 512 512 512 512 506 512 496 569 512 512 549 512 512 512 512 512 746 512 512 495 512 513 449 512 567 507 512 512 512 512 512 512 512 512 512 512 435 512 351 496 448 269 493 503 248 512 453 250 757 505 468 496 512 307 371 284 505 425 512 512 427 ] /Encoding 82 0 R /BaseFont /FNDNDJ+AvenirNextLTPro-DemiCn /FontDescriptor 83 0 R /ToUnicode 85 0 R >> endobj 82 0 obj << /Type /Encoding /Differences [ 46 /period 48 /zero 50 /two 58 /colon 65 /A 67 /C /D 71 /G 77 /M 80 /P 82 /R /S 85 /U /V 97 /a 99 /c /d /e /f /g /h /i 107 /k /l /m /n /o /p 114 /r /s /t /u /v 121 /y ] >> endobj 83 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -240 /Flags 4 /FontBBox [ -121 -250 912 959 ] /FontName /FNDNDJ+AvenirNextLTPro-DemiCn /ItalicAngle 0 /StemV 0 /XHeight 510 /CharSet (/space/M/a/n/g/e/m/t/o/f/D/y/s/l/i/p/d/r/C/v/c/u/R/k/colon/S/h/two/zero/U/period/V/A/P/G) /FontFile3 84 0 R >> endobj 84 0 obj << /Filter /FlateDecode /Length 2830 /Subtype /Type1C >> stream H‰|TkTçžÙÙ™]Ö„uÈ «3 1 "ÄÅzCñRD¢b#*{™uG–Ýuv—å¢1–㥭˜T‚�w°(,B”ªPEmì‘à5õ5¶FO¼E¬Ôw6žÓoIò£=§=óã›ï›÷}ÞçyÎ3I¨UI’Ü´œÌœÌ¬áÅ¢S’sÄoö¼Ù²kD¦X$Mq†*â© V+C"¢Q$ÚôCì¹ô‚É©�Tž ƽÚ88biA…о#«TS\îRYZf÷ û…QÉɩˆВ&dKN—·Ô- Ó‹Ì3¿ßŸäøé(Éâ*J2¡¿Ñ#È¢G”‹Ek’0Ï.y›Ëé<.›×o’E¡ÈT*à>Á,â:·ì²ú,¢5Q(rY%›z³J‹Ãå­‚K¼²É鱉²Œ·~Ékwù¼‚×. b‰Oñ~YòzE§`rc¨b“CpÙþ“*&Öï�€‰˜BpV±È$†êfˆ’Ut˜Ey™( ™²ÏRXdòXì’ãeLOÄ3,ŸG*¥‚C²ˆÎ'¯]vù–ÙÿÛ“ÓÚ¯¬_Õ2ÉãCŒ%§`e¯ ¯Ë}²ä±J¯ärz~2&Ôo3YÄ7öNrb&ÙëwýH0Ã*K&§0Möy¥ÇÐ�ŒBI6 3]fS©Éc—BH¢`=Ò2çϰ^Ñâý¿óCù¡!Hü âU‚Є� †D,I¼EI‘Bo“DIL&ˆL†È¦‰\5ñ.À "ЉRbq—IÚÉÝ8M‰ª ÕY*œz—j¥zÔCÕ•êt]Aw0o1&fs–¹©«ñhŽj5Ú‰Ú­ÚkalXFد¶ww·+Î�í_Á'7(�!Œí>5C3¯Uµt`ó¾êZ®º¶æ³�;µ‡[W»'æ˜=`6/wO¯àn¡VŸüü²áÒ‰ã Vååó²oUÙº÷µëÞ¯òØc e³Ê˾侗ÅLf_šûªƒf�5éЪ Fž„!äv±-΃‹K²˜ë [ZêZ9ÝÎU/”?¼ › r ’R¬ð‚…4˜ÑT”)"3JCiÍÈ ™05fHãPdtÂd4×€ññ£­�~ûöV”>#}Ô«T÷’p"(%[Ù΂vê¤Cªq3Р2èè®ê†¦£†?ïY2oÑŠE–ù<2¡OhD*Q½¨RoÂ;ôé¯ÚÏÝ�Ñ¡÷ª€ƒ50„¼ ƒ((PrØ€û�6q…ÃfÙëlnª«oáú¨î|Vh³î-ÂgûqººÅ�ðžMnTÖSʆh”Ì£Ñe¾Ì£!‚i‚r˜F”@/„J%3×à9½™Ñ•­| j²^¡ÿUvÚMZòÙ]‹ñ‹ †Bì1Ð>:Òè·îã/|CwŠÙchT,‰ŠPaJ�Ôœ>Ôàu÷±k{ÉËØÒå!/vÿXð&Âk(‹CÓ^æÁT²A4xx„o°ô_“¹¹ÊÚÓÌý/ÓÑ8^wi%¨`és°÷“‰ÄQ!)eÍaZð‹¿£™šÕåîŠBð|Ð@ðG!âû#�’i�´Îj0Pê0LË�VÅZᔲ:éáݾíì)PÅÀc΢0-ÁXZèìf@…:é ¥’�\`›ƒ¡œç™c'|£y�³Hì.AÅN¼a”’ŒcÛÄÙ»3ñ±YèM¤ýrÑU‘ÿ«ãˆ#'f–h[¸dñ®€ƒËz›Îo¹$]7€ê»k8géSù9õ–}_Ä\l«ok>XîØËé¾%"è'ÏBNþJÙ›Ye1Ð7W3ªx|zzñõo9e.Šè[¬AñgPŒ�1¡âxNWÿh@q0ϵI©Ò»•Á<bôÞ×EW2(\é¢Q ¡X&2º‚÷ïL¹ ¿üÔ�¢ôÀ°ú•P66Ç7!ÇáÞsâʉO;¹ŒþøoÑV¿râ8¥�¡·PTn¶;߯�̤ëwø¬Ùжß9ƒ/wi#¡X^Ñ—ÌgÎ:ع�Ó!}Y/Ü{¶ÄÕ j}zö³ùwé’•%¸ ï8»{xý…žýç;붯.¯áô�Ž;´þÂ.¯eç»ôÊt¤B£Qj¢!ŠÇßZ¶××ñº²ïÓoÁÓ'�†±@éK”IÑÁJD¡s•š£«Ì�¹DÌE4Jâõm(å ÑÛÝÐÒ^Ãmdô%“5a ;Ü5aÎlùÚ£'{®þåtýDì^QÙˆ»ƒî“Í@A ”2 ŠÙÃøŽXjôÒŽC$2¢Œñ~ûäŸ.ÖsÆc´}¥×a6Ìqt}½ž‡”[¡_ûø†]7Î:vÍÇÁC"οñLzHþT‚[Ù߬ôm*7 º |ÆÌ”s}FP)Æ›÷Ò/k:~¼ýã�«*·pºôáSÐ?Ä2É@¿L¥LØÆ*"bJ¥¦£¼°9ËðÆl¤A)hä)lÙùyS[¿q“î™9)ß²»ÁÉ匥—´^(ºh€øÓÿ„á¼kÙç„\¬üñã�òº‰ œnæ˜ñ„<�§ÄM)3£áЦ×ÿ ©³—.]PÆUÁõÓUm!QDa8YÏŒ¥Là:[80›�’V$¦h šú^’Õð†•[^-”MDWÍ4S'qT¢‹²UKËËR!&&ºú ’b†f!YØíœ8+õ�[ÐK�3ç›ï|ÿÿ}ÿ?mÖÀñ0óªwbd¬1.Q¤ó°ê�ðå vs¶àÝ”ogÕ+8î§?˜Û“‘‘›“žÖua ¿û¾YTÏ–ozðD¦öV™å ív³ÊMI�óÅeˆîb¨†æ ‰œùs™TÇ`�Jˆ£…€Ÿ�±Ç‘ŠËÌfËá›è9lkRµ%G‘P^Z¦*« oŸ1‹&FžÛ´b˜ýG;ÐÛJT…ê“S Df´4{(\ˆHM�/Õr�Ém™#2œèѧRã‹Di™áÊ�ŸÔ\a{ Ã2�ýCa›ptgdÙŸú.Pæ0·š|Ej�÷2„èb‹!‹‹IÉ¢�e�J›Nã&Òa·ÈœŒ$Pû’ÚmVÀé‹:æäMs¦Eøa�ß…·–"�—!X— öv-NLÞSì¥!P�7f¡Vé‘7/­oõˆÅMÌRïÒd³|M’Åì€ê®V×V ÉiiG�Zn�q�l{g7øuí› ¯“,þQVrGŒ»ïàDöh‘v´ðaIŠëÙüÜLýù»]Řp¤˜Ì›V^�aôþ¸YצMlÍ¿av0™zûºŠ ­ &áÒ] \u^ü®ÎÃ$ˆ_õÁ7ª‰ò�¦fVÝ /þ�¨Îëình¼#/½EU¥5eBVqǸßb¹Neü�§mæÀš;¦�`!:ÌgŸHŽ¿2>*âyxž®½mîX55ôt¬E™ý¼@–K¨ÅŽžÎÍÄS­'‡ÁXÊ2êö«€$Æ�ˆ:Bê¬2ÂÃ%ÑÊ/vÍd¿ŠøÙ€�VX£>Äe æim-‰FéÆüsBIq}ýem©;ªºmªî>?™Ù0i¹¢"ßÁ- ­¬eÅö#i¿œ¶oìÀÈq㱓©t!þ·vêÑ endstream endobj 85 0 obj << /Filter /FlateDecode /Length 320 >> stream H‰T‘MOÃ0 †ïù>qH?S!U•`i>Ä÷.qG%šFiwؿǮLJ6Oûõ[[¯·›­ïgÐoq´;œ¡ë½‹8�§hxì=¤¸ÞΗ¯åm‡6€¦âÝyšqØún„ºVú�.§9žaõ”Þ&7 _£ÃØû#¬öéÇ'v§¾q@?CM;¥×ÏmxiÍe±ý9 dËwzi<:œBk1¶þˆPgØ@]Ý5€Þý¿Si"%‡Î~µQIj’d��ªóda:ˆ3ጹ¾'.Ò…é ®„+f'¼!.E§d#ù†óÙ1ŠŒ]˜_?â¯.rJ* QËY��”¹H²�²ä€‘@É=øÒˆ¸ásàÿæ�;³F%%ÄÒ^òˆxo×iÛSŒ´ˆe¹Ë¼yÒ½ÇëþÃx°ü¨h$›± endstream endobj 86 0 obj << /Type /Font /Subtype /Type1 /FirstChar 44 /LastChar 144 /Widths [ 300 326 300 512 512 512 512 512 512 512 512 512 512 512 332 332 512 512 512 512 512 729 665 696 774 607 576 769 764 512 529 711 526 955 790 851 640 512 663 591 581 512 682 512 512 512 512 512 512 512 512 512 512 566 659 503 658 596 364 658 617 296 299 595 298 924 616 632 657 512 396 472 372 614 567 871 512 567 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 300 ] /Encoding 87 0 R /BaseFont /FNDNEA+AvenirNextLTPro-Bold /FontDescriptor 88 0 R /ToUnicode 90 0 R >> endobj 87 0 obj << /Type /Encoding /Differences [ 44 /comma /hyphen /period 58 /colon /semicolon 65 /A /B /C /D /E /F /G /H 74 /J /K /L /M /N /O /P 82 /R /S /T 86 /V 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p 114 /r /s /t /u /v /w 121 /y /z 144 /quoteright ] >> endobj 88 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -240 /Flags 262148 /FontBBox [ -194 -250 1210 963 ] /FontName /FNDNEA+AvenirNextLTPro-Bold /ItalicAngle 0 /StemV 167 /XHeight 498 /StemH 122 /CharSet (/space/P/a/t/r/i/c/k/G/period/O/quoteright/M/l/e/y/comma/D/H/semicolon/h/J/A/n/o/d/C/K/m/L/S/p/w/B/u/N/j/E/V/g/v/f/hyphen/z/F/R/T/s/b/colon) /FontFile3 89 0 R >> endobj 89 0 obj << /Filter /FlateDecode /Length 3214 /Subtype /Type1C >> stream H‰lT{T÷žÙaf�%#QgÓ°83&Bä!/ b±ˆ<%GED,’¸Ñrº©Òl«©2È«*ŠRBe‡ÃVþŸ£°bsE˜œX^.O'Ze‹Áj°Ø%arV™É*Í•6Ùj6Úz‹A®Ð×È$O.2�¸*‹¹dk±¡$T®0—˜Œ&÷[‰ÉZ\n¶Jd³E¶Yô•V£Áb!Ÿ“­Ì¼Õ&ÛÊ ²¡ºŠT±Ê‹Éf3TÊú*e×—ËfãÏ©bÓÚÈ„ˆÞWb¨Ð[~ý?q„L©Éúu$ÂÐõšŠÒÑÔ[j*„£ª¨hŠZ1ƒÊd©4åIÑ™ UÅÒ‰êTn�*‡Òϰ°5ôÊISvª†:@�¦¾$‡Ó&z\5WU¦:¨êeD&ƒÙÍt2_{h=Ò=>óxÌ.f³=ì#.™;ÄÝS‡ª?Téí¹Å³ÙóŸ^þ^^õ^CÞ>ÞÞ¼Ÿi¢4ešF͘ÏlŸŸ¼ Þ[·zÍuº÷|<ÉÀiðne¦¨{Èó|Ãñ¦CbÓ¡OŽœøÌój÷ǧ:ý&súV&eëCw‰½°c�méÐuœ7¾gÙ½­°HÚºu»c×6Ï]Ûꪌ~ÛXLÂtA™R"\SjW‘3B˜*R:‹Ô<ºxô…6ú(lgà·°HÀH.ÛXÐq<¶ÁzÐÒà�°^-@­šÿ½�î�šù�Ù™ùÙYÝú�k]�"�§ÛaÖÑc�ÇÀ%Lè+¸”›]P˜“ÓUÔßw¥³_Ä;ý?;»Ôï΃1’5¹/³¦#6MGôõ_&¿ÁF½$'rãCfÃY (˜Á­�׆Ì›·’æƒÁôÓÆIóa„J̃fa­nÏVi�y�ÍØJDˆ'œâIH+ö¨ùØjWÆ4t@£‡‚bÄW©:cgafé–m»D Écƒÿx?4:Èn‡ ð�øgÍvgž»@ã¬Ðâ7ÊL¸“,næðwØÁî…Œ#eâ`²�ƒOq’å£ë!Ht§�:Ÿj![”ALp‹?¼B[¨Ô�_pnºõj sm`ë8\¬l`±ŽÀ-æê”}l#«\ûXðá }ú³Ž|ñ�ò $†XÃ8õn�Xu“«ˆÝËa›RÄb.Áˆ%ÅnŒÏ]Å$kO5D()F¬HS‚ �qö�SÆ�©¶àŒÁ·‰È6ˆ!¶,=l"¦iqvt8jPófƒï½Gà> G_‘?E8 þdöÄi r‰Ê�ÊN– ?ˆá"š¶à(¶ùðæ0ÄH¿_HY[�&&Á²?sÞ¹Jâû Ì9ð%{熉ƒB2WNY‹0È><98öÔ�àéúÐ_ÄcÓZŸ»ÎÁ<ÇîVÞ’’wd‰±°ô!wõÆÎÕ_]s•"˜K÷BD@"£ô;g C‘§–éðøV*Fâì‡ùßWJ�+®mËö[—ïÈÍL?ÓiÑ96õ«çÆg:�á� ˆ&³ìÛrZJiÖîö8|ùr¿ÕØ*ò•Íve˜lèÝO¼\�1 „�®aˆW†Õüí—&mwndœÎ<ßå0ÚµßírŒ²ŸÅ,šÝwR<ÇozT yúàé³+ ˜�°QÈ0¯Þl8ôùð_Þ›9¬_áä©®cݺ«m¤Ôd+’¬8½ž—Lï8!5æ��kâ`uÆ=\S™õ®È÷ÔÁ�¾I,­…(Fù š�"�Ç€y¦ÍfqŒ`ÌÔ^màÖŸ­¼©ƒàïÈu(I¥M-N[ž˜côF×è�»íéi"/×’­þæÐ!–Qö+™B{IBËJ†ãŒy¸—ÿDN|}¼½CІµ:JwnÖ%\ï?{¡Öú‰ÿ⭋䂨%s¬üCëÜK¦pdŸú¬9ïÜ D"�JßáL¾9ÚÚ{FjHåö@£�šŸž¸¼xdt¤ýÆÝ;]©é"¿£f>yþX‚ ¥òo6«?(Š:ŠÏµíníÕåj²ã®I Åi0€f¤XšF‡ãqœ?t„QQ3³1ÉóŽ¢â(¨9žhéYÎÃ*�ç�€Ø(£M5ÍXc5Õ¨Ñô–yGõ¾÷OüÑŸßÙ÷yû~}>ïqPAùbCgÇ5eàS‡Uó›2d=ûÐŒQq˜Žsà‰�øàëÖ¡€ŠÂM¾ÌYâ´*yKÚ¾tk0&ÔªmnŠ•°†šFRš)†{,Љ£ûäýÎ{6*8Û>%ÍžŒÆ{áhÈ ;ŒÈu‹�M]W�õì>¤J]ø!<ý ܾH¶©PI”m@Ö­˜´Ð+^.]tr‘‚‰ihDÕ»æÁžSí~mO™�±"ßœ¿øø»š‰xÛõ‡ï*��ýV“¡Hž¿‚±¹–Õ+·¨ãõ�é¾LÕEWC¢h‹˜¦}®çëyrgaVËjÇè™·Ko¸´!—ÿƒõ±ëÖíØd_Ñrvƒš”ÈÛ.}¿é[å!p`ú-£õ•£ÚÂæM�ŸÄžöô··nÝ|Š¼ï¬‚§  Œ†ï �Ô£e"Ó˜Œ³pò4~ƒkÄg:^ƒ)çZ÷7úhŒcxwÕV�KYVÑÒ©�E”HT ÁH�(§À$6©è-ëm–·*»{U8�™qûU_[Ç µ>W�4J5ú §èn³…éx›6ét¸Íã„Ý<äÐyÙLfµ£È�"3ËÒpˆ÷ I0Äc¦�B�0‹=r˜Ë0™Â¯p�¯~Çkì!9[ÆýèUá9¼ÅV6·x\ ÀêðvW1ïxßõn�â*oØëÒ¶¡Êïj9çö+ðdOh¤]“ž¯¥yÁdøLÏãôÍt5aƒ» ŽcøeJ§ˆÛÑÃãDQb è<”qp�- x!0 Ò{Çt÷XzLÀ]õ¢zܲJÞöOÌ�¢à¥h�|11u1\ž¨ÿ%ÿ+À/¡)• endstream endobj 90 0 obj << /Filter /FlateDecode /Length 299 >> stream H‰T‘Ënà E÷|Å,SuÆIK–¥ÊU¥,úP“fOð8µTc„�Eþ¾3�¤ê÷ò¸Èfû¼uý ò#Œv‡3t½kNã9X„#žz™†¶·óu{;’Ì»Ë4ã°uÝU%ä'-Ns¸ÀâE?ª�ï¡Åл,öÙ×�ÀîìýèfPP×Ðb'dójü›$ÛþØþâtœg׃Ç'o,ãN•¶5T¥ª]ûMèä8vöÛQ­Ö¤TŠ•VYY ò]››>ÙÓÖ£K7äÊÕù1‚ü‰À2£z¹‰€j¬X©X±Ò –édM`Í–")Öl)XQ¬(J&�ÛÓ•ø�ü=.{�’Œ¿ã¨z‡÷ô£çd¸‰_Š¥�ÿ endstream endobj 91 0 obj << /Type /Font /Subtype /Type1 /FirstChar 2 /LastChar 148 /Widths [ 666 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 833 704 260 300 300 444 512 260 320 260 370 580 580 580 580 580 580 580 580 580 580 300 300 512 666 666 482 800 700 636 720 757 592 562 779 718 260 492 628 510 886 764 850 580 843 599 564 570 710 623 972 649 602 572 300 512 300 512 512 512 534 637 500 637 572 295 632 583 250 251 510 252 883 581 611 635 635 360 444 317 581 488 746 484 488 442 512 512 512 512 512 512 556 512 512 512 400 512 512 512 512 512 512 512 387 387 512 222 512 512 544 544 ] /Encoding 92 0 R /BaseFont /FNDNEH+AvenirNextLTPro-Regular /FontDescriptor 93 0 R /ToUnicode 95 0 R >> endobj 92 0 obj << /Type /Encoding /Differences [ 2 /greaterequal 37 /percent /ampersand /quotesingle /parenleft /parenright /asterisk 44 /comma /hyphen /period /slash /zero /one /two /three /four /five /six /seven /eight /nine /colon /semicolon 61 /equal /greater /question /at /A /B /C /D /E /F /G /H /I /J /K /L /M /N /O /P /Q /R /S /T /U /V /W /X /Y /Z /bracketleft 93 /bracketright 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p /q /r /s /t /u /v /w /x /y /z 129 /dagger 133 /endash 141 /quotedblleft /quotedblright 144 /quoteright 147 /fi /fl ] >> endobj 93 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -240 /Flags 4 /FontBBox [ -205 -250 975 945 ] /FontName /FNDNEH+AvenirNextLTPro-Regular /ItalicAngle 0 /StemV 0 /XHeight 468 /CharSet (/space/I/n/J/u/e/two/zero/comma/t/h/U/period/S/D/p/a/r/m/o/f/V/s/A/hyphen/i/parenleft/parenright/d/l/j/c/g/y/v/k/T/b/O/six/nine/one/slash/E/B/P/W/G/M/quotesingle/w/q/three/seven/R/z/colon/four/eight/F/x/C/L/fi/endash/fl/ampersand/K/Q/H/bracketleft/bracketright/semicolon/N/five/quotedblleft/quotedblright/percent/greater/greaterequal/asterisk/dagger/equal/Y/question/quoteright/at/Z/X) /FontFile3 94 0 R >> endobj 94 0 obj << /Filter /FlateDecode /Length 5310 /Subtype /Type1C >> stream H‰ŒS{P÷ß½cï@¸îX ‡,‹1£"D“”XA^“¢÷XîŽ;Ü{IÒH5VÇ!fÒ&ʘ¨ÕŒŠ„ÁÇÄã!„§ 8iÒ©È(Fku¾‹¿£íÚ™¶™fúÇîï·¿ß÷óø~÷ûÅ1?†ãxtf~z~Fö¢T'ca¹|f«]³æmκ¸�1:ÌZÎò*?çÃýø¨ ÙH‹ö?×?Ï ¢0Iþoe< žR…ž™±L�‰:L†?9Fkg8f‹Ck^i­¬âX£ÉNÿ�^’�ð:½Ø·¼IkX‹Õ^UÉÐYºì8Úår©Í/�Ôzk…šN5›é �æÃ9ƒš^cbmt©Õb§mÖR»KË1t…¶Šp´Žâ*9«Á¡g qt…ÕÀ–²¾��µéÍVc ­mç´[)Ãq§‹µ›¬;m714³µRP±Ñ.޵Û ­­¨œZ3m-ýO«‚±™BÑ‚­�ÎÀTh¹r_\6óŽáŒ G§s}y…Ö¦7±�/5+NÐЛ6Öɘ«h3«g,>OvguMÿ]­Å0“ÙLVFÖæ+§�f-´žáìZa-sp¬ÍÀêí¬Õb{Y¾T«g|Þ¬BíX‹�€–³»¬/ ¦8Vk¡39‡�õyô‰¤–³œ–εê´UZ›‰õ11´�±±FË¿ •°3zûOêÿ¯îZÇ0 �É‚1ŠÂ’1,-3áX…saøn Ûèë'V…=Çwâµø€(@´\´VT.Ú+:.z&þ™¸D|Mìõ{Ûï˜ßu"›ø=ÑGx%s$i’Ò5ÒéSÿTÿíþ'ý»^Ðè¸nÍRÌÊœõù¬±À¤ÀÝ�wƒDA+‚ÌA-AOd”,S¦“m“=�§ÊwÈo«ƒ+‚‡Cd!ËCv†4†t„Æ…ZBëCÿ®ÈUìUüY¥4(÷+o‡ÉÂòÂaûÃ.�4YNn'�“}¤·ôRoï%>°¿4 ŸÞdo[¶´XX÷Ôç?TKª=|¤®Î¿©¡¦ö U«éœNWV™õµácâþ¡«�ƒ‘îuI›«+Ö¿Í9Þw÷6ÿÝÛöØL*(B’Ÿö&x§¥¼n*�œÖyMé¤rtEçª=f'œñœöÀ»ž\ŠzüÊãö½”­n^Å7’“G,HN^¸p4ù‡FGR³WoÔhŠ/öô¸/vu¹7®¢xÆ«ø¿•.wßB®?î]7ýÞ•JBñÕžJçTüuÅÅáý ïW6LÍç•ä2ÉB´½ÉÄíócW'T�“ÛSʯb“òcršŠš6E+Ôºô™–­ÓX¨Êº—U=ÍM�ך´«©³Þ¥¤²!³äSrä²ì¯ÇFš/W-GcSë]x#PbÈžZO¦K²Q5qM"GKŸ+ðÓ°QüH߆âFhj]ñsçA"¬PÁŠNHüˆ©+eD ]„âP¼ê JzÄP2ŽSh_„Øù&À×Ýö6×çÖxÄpPðP€^‘ ºÙY1%¯!Y«ñ„ÜC!­g_Ä4;Û]BÈQ#¢¡oö9ϽÿoÆ« ìÞ v1|ÇHd/»pÚøÀðÀÄ i%O8¾,/wl±Zë¶œ>]÷å J޲êœS¬ ?^1�O“…GPÛ4Û¾•�ŸªêœÂ;ðö!CÓT‰2×¢ÕHƒ4WQdBz€4E°¥GçûAÈ”‚bPŒ %¡¤(ƒ$ˆ�˜¯ ÑòSG�3ÙžÃs!Û\ ÊF .l€0À ï?¥òS{»ù‡8Ÿ<$æ?ì&½�ø>":;Ýã* ô ¿‘6ßE¼O þÚ=9Ò]üV޶xó¦hÔ„Zˆü©Ï7\ì„Ï:¼z`Ý rÊ`‚<%™/¥ãV.[YÐÐk‹Îâõï¬{ ÁOoCäý¼îeµÑû¤ÊÇýŸ»=ߪ xQ¯ –aLÙDu”WO´ž¼.¨­MZœjLˆ6K|é@Jug¯KÁ‹ú•£¼¯�K�Ûk$2`¥ôCÊߺ^‘fÌFû$‚‰½|±O2ãnü:lêÆAÔ  ©Zš–ìôâıæË‡/G>¾™3wQÆÊEyEõí\tŽ…X~~`ý_#�¾ÿ¢ <ö.Š(7îúuEôA°Ðêã쀛íPïÂ=ƒÐ7(æç ”‰´u¦BK^š …O&@DLŽC8�ê¿ `ã¦íï9©=ûˆLTLŽwôMNvd&Äçd¨Õ9ý÷¨™¿Þ�ßâÅü.�Í›˜ ¨µL‡w$P?5›˜Q½ÒŸv(ºKúáwý%ƒÊ'¼’$…2Nv½Ð3¤iü0ÂŸŠ¤iVu ŠRå“d{azœ …<û…ÐØ²gcr¿p0¹ŽRN",!GÚÚ†‡ÛŠRRW¯\¹Ú=L)Ÿpèù]g×ÄD§æÍ7òrÔê¼ßϘ„úv¸Ù�wÎä9³¿•ÀZè&Î\;Ù)¨‡ÇŽ£›€Â9±‚Ï^øä³£Ô¾=D“ ù™±±ù}ã÷nôOLÜȈ§ä¬@­0/|ó²™OüñÀxýý~Ž,àkPPD·\)K]�Š¥"–AD’”Q´tU\5®¯U6¾¢(/FqQLÈÝñ±*pîä4Ù==$•ÚJêþ¸ÓÓ}oçÜï|çë…çd¥˜)gd ‹S’üg4è Ï£ßohe×€[5ª]­æTcÇ]˜_#ëµ<�¯o�60 fÝÍ3ÎÛÊp ÿ-FG…$¡›ãÐzÁLR‰>Ðb�NzN2-½ð¯GJöþUÑ>¹â„é,w�°…�XŸt$Áˆ}ÂP‹‚ÅÛ­‹ŽËE,ùhêõ·O[a¤ãÄŒÁ’˜‘˜†Ë`(ƒl0€æì£ÖŸÈw‹»?¢‚üÂ1Ž2 q"wa0Nxİʑ D2¼Þ• #ä4ºþ ¾ýiÉÅ&¬˜;Æ`º.sqäš±Ý9ðuæ@ÍEL›eÙœËãxõí· fµ¦—•´B÷Â6«#!k/¨ W\w_q"$¡ wš•]çð§fóĪý;xˆ!{ïÌ 8 ^ßË|[¸²E¼|Üài‹ÏWl”ô½ï½�A§Ò[è`Joþ{pÀ=Á�¡ï[™ž²ïè÷ ¸ÉŒ-”Û�UŸ©€ËèæBUÙ]Ôí¨À…34q ¤ Ð…a®Ò¢îéí!«xÇ+"/-ްæÁ4Z=\�ư”wêx Ò!Ø(tfØ«¼Î'¥(Ï6ó.gÞ[ˆT§ S¤"Ã)í¿$žfH¡AÿCºæ…c¨Ä|)ç1¨ý)ë*óbhh‰cºUõñØQ«qÖ‚3ï�Áƒ�ß‹:*7õè'ã<'ñõ 4æÄ‘!q ÐUF=r‰˜iw‚ª½§¥fó_‚:ÈDÀdÐ�9¢¡Î“1‚¼IŽp¼*⇔ —ºJp�ßyÃJÕ½�>‡ÒX‚Kèj(,’ø¦¿BèZká3'ºëNZ¶ŠàÎ […6†‰`Þî|p«Ý¤�e8@Â$5‡oWðd�wÒ†…D/B�Œ}™~O·Á±Xá<µáMOñbZDéF_ÔÏÄ÷ÐÓ¾øùG²-£%k°w`ÈüÉ“f�½²Tš>_ˆ,û&õ#‘µW-ø�¸tBwxb‰ÍûióWõ—3“ôº;(Æ{Ž~"äš•s±�ÛÕO-›QÙfÇû«56'³²EH½F>ÑMæñáÊT²¹èJÇá7—^Ã$>5\‰×¡Û5©’þ^Á³p•²Ûy—!³™x2žA Û}‡Hæ&0Ã?q-Ñ-ŸéùØ‚WãWñö×ĬÝ?DˆBbƒdz¼•Ra o'_S”vº†dZÆ Å8‰Ø–Ï0’w£hr^é_wWÊß8q¦ŸJO¹ø+=ƒt°ÂR´ÒO,æ:È¡“¥š�³‚þÚOæokƒjöñAB#†Ú1ìm´O$`5ÙÀ’nmûµ@~\µ¹±|SF(͵H³¢ãÃy3áÀrÇ�rM5™îLG¦ˆÁ?ºCp¹¿ã€�ý|"nia Á?¸cðl{צ_—S¹rl¸ý«<*È·˜—¹¥"5– èçû4ùNãÕõçd²më²¶g­”n°Oç�;í‹tÀB+Mc£?JN–Î,Nœ(;Xal>Ÿ*G¹¦ê —GÏ÷ÿó¬ƒõß�¸‹Ì¾¾-§:k[åñ½ÞX ø¡_Ú�^o9�@ò‡hš™—(çs!ŠÖtåYt† uðDߨ|&6wv6>nÁì+éçæTóÞUšJ²z+¹¯Xžqdšýû¨îû•ø7W¿\*'œR2gÅQ3åqGgÃcД]ZžrPþV¥ÞX xÆC‘Â]3ÎâÈ‹R„|Ý�ÄÈãS�hò'÷&Ɇ (Ù±˜êŽ_/•ð5ázg~B{ã˜&†ú ÛúNÒ—äTÄrªBëm-yûñÑgõwŸ_”ÇÉ·?ÁsÂ;„ðs‚}ërÓí/*¤„RaÑòÙI‘FÿÉ÷Ÿç˼Û¶«`çú¶úœD5  6×�e¶há_<•T•JÞ²çêÝ}{ò¶ì–vÕŸ®ý¸p­qÀœè?Êè9dÖK%ÀÂÀE§oÁÍ50µškœ ÞX´·Ð$άhM¡N¼>odžš¯«Y~"ʱ†<ã{v˜,wOVŸ– ƒ˜iîhôŽˆ8óõ©¾_v‡<{LœäŒý¥¤?y@M¨†Îù �É�"×DÑIÂfôm¨¶¾ü2zˆ„»,PªƒžñMØ+::uv}�]¥…/ìMö1Ãm¢è¢”T 3<Ùíè/]±ÅŠ«32­>tèÐ~õ‹­ 7W;JìÔŸfâzñ“½%ù»�G¬�2¯ŽR.éâ7-žµamaÑÉðþä¸ùÛ$‘ŽnÝIp «#Ot"ݺ�Á&üåÕÓV…­õ¾:G¬Ý#MÞcL–aft‹nÅ?ˆmP©Ê’†YÙÍÊXÆš(›m8q ÆaŽÆ8È"sCgXZZu@Uÿè˜KÙP’‰ÓŒxîrß2ϳÒlýïÞÜsï=ï»çûÎ÷¼�þûÐ�^¢†dq¬–í n¤*ï=á¨b3ñožC[:pm#Õ ®ÛsÒÓ+pí;m#MVÅ1˜ûùXñã"óc¸fæäÌüÕþ%�<]b~§x©vÛ‡VC^QuiƒÄ÷%®@Xcν‡. ¬¹ºt—¸˜ÿí"Y�/ð_€5kÐe®ý»of@&¬»¹kÄÜÔ “ßÿ>ÓO ¯ ?U·dˆ|,~ĬÂa5lŠ íœåÔdÍr$®’ÜÓæÛÖ0ÐúeÉKäƒÅHwE ß²šŸrk¾©º‹t Æõ�ž’ØoÿÂ8fA|žüSSÏR•°ËØp¤ë˜Ûýžxäy§¹ùÐ^C¾A‘–¾ŸO&4•èë4]8_g:Q`Øœ]±aSÔñÕ~éšs¨ñÕ´Â2§å%kßi‡XZI^œz}Ê›øóû²Óìþ�¤Ÿ½ûó´ás=CÃUݘ־£Àªß±&F¾êAofúGJ~e_pOî>w¢÷ð‘ã¢;HÞlÚ}`�¡¢Þ7)�ô¾Ïp8µ1å½uŸêè[©î>ïÙÞ4dkÑ`c[õœ%7«~|^„N3ûLà æÀÊñðÀˆ_D khl³·!­ [#V§ÖGËu6Z‹<ÃézØ£rºÒÔ6Ðtlrð¢l'?b¿Òz5ÏI“¯iý· t~ †õ¸ôÉ4Yé�«äde¶žÚI®ÒZ�S”cVÓ’Ï1m|FpÆ G|Ôªö¥^æÐ]•�ÄÊWRÈÉÆ]Ì„ÿF&ò[™“ð…¨O¸§\ý ^ŒY•Ë;ª³ÈË�Žºí†¦½í‡÷I-ÛÈÛÝ=žnÃôÀ—‘�%h¦1²•c™²¤ôäôÖ ,°]¦¨i¦5-�.Žõ±;ä5šdƒè‡ÛØ.ÏÐ:p¡ ¸ÒÙt=7h�W{ó? gàkeã„)n\¤„»Â\‰10®Ãúë�!-*1”^7†uQjM(–üÁrŠÅÌ,/.غè“ìƒw >T K¬‹šÃŒÿOýYÔTŸÀœš¢7Ø\ Ìq|-�ýˆÍÃôùè6mE`“'ÆéØB̶˜Ç°g±ˆò˜‹¸-àÂY|ÌÊwƒªËÔ«¦Ó0$Œid/XH�†ÙFÙÈS†ÞL!({‹5|SµwÂ|¡–V�Ø“]y'iÅÈC‘•#G/%%ÁùÕô¬ð—�áœh endstream endobj 95 0 obj << /Filter /FlateDecode /Length 300 >> stream H‰TQ=oà ÜùoLÕŒë4–�‡&Š”¡jÒîžSK5FØòïË7Uнƒ»ßv×ÏÀßÂhŽ8C×;p/Á ´xîloæeJ»´ÅÇë4ãppÝJ1þ§9\aµ/ïÅð×`1ôî «Sññ‰ãÅûoÐÍ  iÀbÇøöYû= p’ýq§«G�i.–àÑâäµÁ ÝA Ù€ª@gÿŸ±*+ÚÎ|éÀòM)×UÃTe#¢ÚE¼)ˆR®.ʈk‘qݰ轸¬=s„’I “›$gi".ÛLl#QRT•‰’òÖ”÷˜%ÇPº±ÁœF’º\Þ¤öO¢Xâs ½’ª¿f.!Ä.Óÿ¤Ê¨¬Þáí ýè©ZìG€æ�ß endstream endobj 96 0 obj << /Type /Font /Subtype /Type1 /FirstChar 45 /LastChar 121 /Widths [ 320 260 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 512 695 512 720 757 512 512 770 512 260 512 512 512 886 512 512 580 512 512 512 512 512 600 512 512 512 512 512 512 512 512 512 512 534 512 500 622 566 295 512 577 250 512 512 252 874 577 596 512 512 348 444 307 577 478 512 512 483 ] /Encoding 97 0 R /BaseFont /FNDNFD+AvenirNextLTPro-It /FontDescriptor 98 0 R /ToUnicode 100 0 R >> endobj 97 0 obj << /Type /Encoding /Differences [ 45 /hyphen /period 65 /A 67 /C /D 71 /G 73 /I 77 /M 80 /P 86 /V 97 /a 99 /c /d /e /f 104 /h /i 108 /l /m /n /o 114 /r /s /t /u /v 121 /y ] >> endobj 98 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -240 /Flags 68 /FontBBox [ -260 -250 1029 946 ] /FontName /FNDNFD+AvenirNextLTPro-It /ItalicAngle -12 /StemV 0 /XHeight 468 /CharSet (/space/A/n/I/t/e/r/M/d/period/P/h/y/s/i/c/a/l/v/G/u/f/o/m/V/C/hyphen/D) /FontFile3 99 0 R >> endobj 99 0 obj << /Filter /FlateDecode /Length 2368 /Subtype /Type1C >> stream H‰”• PT×Çïe¹Œ¸(Ûëc7î½cZE† A��ˆP¥È#©¨1º� {yìâÝË®‹ÄhµÊ„D$ €…X#ŠŠQÐ’E�GP ø _ÓMµ“´ö»ëY:=+6�f:ÎtvfÏž=ç|ßïÿ¿ÿ=KÞ^I’꨸ȸ¨Èá6Þ,ˆqü)ö½xÑ23Fò¬N“5¤<Ñ;×ÏK~Õo<úí~öé³(j2AÇ�‘ÿäïúÙ¸úW_9@xyŠ‘Ï",YQH5I\ÊÍô a\¬`¶HŽ,ž[’©�äìv{PÆ‹¯‚ –Ì .<#ƒ{~Ðʉ¼•m¼1ˆ{Ï$X¹‹Y⬖É®y.Sçàð9NÏã}Y¢Å˜mà��\¦Å(¤žOFÁjȰXy#g9IÔ™­)¼(â©]�L–l‰“L<ÇoÈÂ]¬œ]$‰7sº,\ʦËà,)ÿ�ŠÁžÃa�§œ‘ÏÔ‰éž}Ѽ`ä3ô¼˜Ê‹\¤˜mHÏÔY&ÁŒë…/ Ä= ÙVÁÆg8¸ ÁÀ›=L’I´d§š~ê‡Îl|®ì¹ªTÁ*ñbÁÌxQÒá1-[¬FÁ ³õ…1žó):ïa³`ï3 %»e0Ü( :3%fK‚‡ÑÓ$<]uÜ2‹^çÐYM‚§Ïy«�jþ7vBâÒKûÿ�´$~J’˜B¯“Ä4‚˜NAñAÌ&ˆÅ© bHâ— "É›XE“qba'ö�ÄßÉEäò ^ ½6zÕ*~®ÈPtx¿á-y·zÿ@½BQ�é0z}Ï'Ôg�O£Ï3csOO³<úÙ<¥ƒ aÓãŒöù Rõ{Ž”Ô–ÜøA¥M–¿#\—Pƒ—1²ÖK!ËT1ÓÜ2u‚–GfˆÀ³>Æa[I£ïÜßR;ie-~ ·Û ô2)ôcý}ô%¸M�š†Pôût^Ò²(�nÇÏÆŸjË ŠX…F³h<­lÚ5áá ¸!?UeÁLLñ.4† å¹¸Ñ|ZU�ÜnDÒÊœm-Vl½“�‡{¡¸}s§êœ¬‚-Bñ"š<˜Ùɪšn6îha‹iÕ¦|±Ð"©Ûéš½g~s\«:w ©âOŠ«KÕ�6„,]œeøP[÷!U÷…³æ+ÍÕSë£óvnÍ—ØmÉÌv#5gStÔ ÍêÕem�áÍrÍ*“s[e'y²O!;ä7˜–Ìèê(Z€h E~wÞ�IƒmG›Î³ëê©Ô´5b¼&0©ëŒ»÷7sáôúÔ2VÙ—ÛjµÉó�ÇzUõ‡ÁÇæ‚êZÏ©óuZŒœµy!ÕCƒÚU@EÓKÝ ¬»-3æh´Û‚F¡ñ(”íÝË€êÖ÷àÿç¶ØYhlðkhTàŠ¯ïh•r[áÝfq’Ç®À�…œ ̾#Å'ÊÔ@,¹†T(�Fjü>ahøÝºv¬»E«k Ö¦%ñ‹5a1÷÷í+ÚÏ–43w+úþðDs÷lrDÞÎM;óX%*Ái vÂöv²Ü è•M ò¦+Á�ºRZu±[S~ 0ÿS¶¬�Úë°çh¸ó‚6²ÙHEM§·&QOèw0VÖ/SàE+k*=.�òÜ>Ü•%fY¼é}[HwÉ$Ž&àͧa;ã]oë× Ñ/uÚómìTŠ—.@µ»¼¸¬Lý`ùWSµJ\îñCÔC XŽÉ¢é9n“ÇH×dæ·örQ”lKeNuMå¡­]¬´‘'`�>r0KFú]Á?‰ë#XàÓ%ïS¸|1YdBjl*ûÍÆeŸ%k¢M‰<¦ÜS±ç‹ÝÕ¾Ëè‚ôík~-.s“¤lëÖ\­2%9 mùÙì*T�1¡˜º áÁÍ�—éxS;âKãZgøtÃŽ>U-¾Õ|° Ÿ6R�Å­nbc^^06Δ˜ª-¤U7^ +ÏŽdøX<íUÀî\_T>0BÁ/ä6NHòÅÔ[Èï�s €#œdÐØ°)ht�'Êþ÷žÂ¨‡Î¥aØÃµõí É�Çá>ÚߥªWÕþU&ÌøŸGwõb¿¦¼² `[ÖEíÙ¼¥(G“Ä¿/`U—tQU;"ÏWÉ�Ð]í†y8¾3ä©Ì—bÜçšÙ3ô3tXœvÀÚ`_©NŒ—âW=‘­Mà©å'Ì75·Ÿœþ~`e}p›pÐTÚ¬vvVœ¿xÒj*Ǩ;ZaØI¶`Å=žÜ2ôa˜ˆs&¡‰T 'ž¡W /©ÂÜ�yyêENGãçµ{ñ_ÞþKÔ¶Üõ;6hëÇ�%E—²ÿÒžïËX¿ Ó/( í¿ô½õŒðႎb}«'휰˜~%<ØchÃoÁRÛ@gi»‚ÍgæöÎï_ ¿óût ¥¿7³vTvVWKùpêĺ#ëÁ9¿½¼=£NÝ—#Ê„ÖýˆNøQt­›ð‚ßµ€E�ÃV7¶·À¤}™�ÏýwËñïqeŒÎ?N1g*tʤj²†åäå&J×V÷M¨•oôemŸ7·s¾ô…­».o—ÿþíÇCV¶ßä@%jåÜÓ¿WÌeûÝÒÍ.·À2Ÿ‡ó0×eîÃ�yx./æáýÞ'òc·(@€~Ïê* endstream endobj 100 0 obj << /Filter /FlateDecode /Length 305 >> stream H‰T‘Moƒ0 †ïü ;í ,´âÒj‡}hív§‰i‘FˆúïgÇ]§ˆŸ¼‰ý[íš}ãúÔ{ÍgèzgNã  Ͻƒ,Û›ù¶‹«ZŠ’×iÆ¡qÝU•¨:œæp…Õsñ˜>€z Cïΰ:fŸ_$ï¿q@7C u»Dí^ZÿÚŠÓþ´ãÕ#äqŸÝŒG‹“o†Ö�ªÜÖP•ÛÐÙÿgÉF2N�¹´!©ŠŒn¦)âR¸dÞ o™­ðžø)�L�X kb-u4×)%—BBþ7'ýë+Ï�'æoæ\¹X…X­¹$ Z> endobj 102 0 obj << /Type /Encoding /Differences [ 39 /quotesingle /parenleft /parenright 44 /comma /hyphen /period /slash 59 /semicolon 65 /A /B /C /D /E /F /G /H /I /J /K /L /M /N /O /P /Q /R /S /T /U /V /W /X /Y /Z 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p 114 /r /s /t /u /v /w /x /y /z 144 /quoteright 147 /fi 154 /dotlessi 168 /dieresis 180 /acute 248 /oslash ] >> endobj 103 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -240 /Flags 4 /FontBBox [ -210 -250 1015 951 ] /FontName /FNDNGG+AvenirNextLTPro-Medium /ItalicAngle 0 /StemV 0 /XHeight 474 /CharSet (/space/F/i/g/u/r/e/A/p/n/d/x/l/o/t/h/m/f/V/slash/D/c/a/y/s/C/k/period/T/b/L/R/M/S/comma/B/j/E/J/semicolon/H/hyphen/P/v/w/O/quoteright/G/U/dieresis/N/z/I/dotlessi/acute/Q/W/oslash/Z/Y/K/fi/X/quotesingle/parenleft/parenright) /FontFile3 104 0 R >> endobj 104 0 obj << /Filter /FlateDecode /Length 4080 /Subtype /Type1C >> stream H‰|”{T÷ÇgØ�Yä±ë]twĈTP0ÄxP+b‹zâjcpÙØ‘}9»°nëëĦ–R UO='‡6˜S‰/lµæœ�µjã |`!æ ìbó0.i|ÜYîÒô7¨'M{Ú³üvæ÷ûÞû¹ß¹÷GSê(ЦiÃ’ÒÅ¥EE3 k§(• ›½%« ¹f-¬b�C91MN¦åçÔò¤¸ñX‰»‡ë‡_f&Slé/âå{ a]b뤤î$*J‰öýÏE.·_«l^¾…Ÿ“••ÃÏR–\¾Dtº¼~·À9*–¦ó>Ÿ/ÃþôU†ÅåÈà ív~Tèá%Á#Hµ‚5ƒ_m=|¥Ëéå=®J¯Ï, ¼Ãì牎¯È9·ä²ÖXk:ïpYÅJQùg=»Ë#Xy—Ä{%³ÓS)Hyô‰^›«ÆË{m/lv“,Þ'‰^¯àäÍnªÖlç]•ßE%`£ÎðĬ„³ ³T­œ[*ˆVÁ^!HU‚Ä/–j,Õ³Çb�$^aQ:Éa±×xÄZÁîçí¢Ep*L^›äª©²ý§f§u´²ÑªªD�WPˆE'o$¯™¬k$Ñc-^Ñåô<5FÑWš-‚Âæ"Þ‰NR€Yòú\O ­’hvòK¤¯¨0*I «EÉÌ¿ìª0ûÍ›¨Dx«à«œÏˆ^Áâý¿ùÿG»P4ùQÑQT¼ŠšDQ)©… ÔªhÊFQds+Eí¤¨_RÔ^ŠZDú…ª¥üÔ~êGO¥çÑkh‰n¦oGDíŠ:u_5V%ªUïªnª5j^½N½Wý)3…y�¹Â¦³ÅìNöwµ¦PãÒì�VG›£ß‰³rLã˜obæÆØbNÄ Æ<Š}-ö½Ø/âæÇÕÅÄOŠ·Ä7Ä÷jÇjË´~ííp¸„’„ò„Ë+Û¯^m—cÏÑíݰÿcH0†»zv©æ²Ö51­o¾»¯É°¯é­·ˆþÃÉ=M¿ÕÿÑÖZQ±Ñ]´Ó°v/óž3§n$_ÿpÍ‹¶;L¯¥š­?Úµ-z×¶:�M«°„“G"Y‘�\ÎâF*"ûÂ-ÞÐâßä×`w½/éäê6À†°‰Ë`uÍKp7ó1«Å=8{XKíWA,œä µR{�6�f²1¦ s°@�ç0'ˆ1†ÎÓÌ| M� ©úgJ0©‰H1Õ„©ó‘6t–3Aˆ99P ‡‚2ÈɆCQ9Ó‹t¦¢"�»é£�§‚µ¤øY¬Âr›°4À†ÛôiØ¢‚CÐÊá–ØÂj߀çè‹ 'g/pÇ�‡Á騲µ8ZOzÿ˜A‹eûkâ�®“µ*9.¼�[|/Œì¼îa´xþA´}ŠÖ!gsÇœ-Dl·Uµ8‰¸å¸av|›Rškaa@^å£Ãe*(…… ²7p!jÿ61³YÚÄ@ ;å»LÀ~ÍjoÖß�7/i Í¡¥Cº‡ãa+ is&…Š?Êú•±A£“»ßn?Û«‡dÔœæø36”ÏÃ~þWÇ‚—J6.0"Çæ©a"«{Ôùªü™™›òŒ8– ýAùJ€nJ%C>Wj^²ñÅdÌ{’ 2ù7»l?&~Œ¢®ÂŽ~°H,‡ý@ ²nÄ$‹ÁËjN¼ìê÷³c]t÷c7¸á^ R:b ‘¢ÿ l¹�£uÉËî«Âßk¹³e™ÇQýïø³ þ¦Á¿ï6Â=Ü›G^¬ÕÔT”m+NÆùS‰s óqà…OºìëO‘ sHòž ´ùHr"E† †±g(lšŽm8 mi¤Ù:škÃ&ß@2i£T…þ`8ÉGCWHõLಛ¯-*^8“ïåíi‘kòkŠr_Z;v´wÿ;„ÕÀB$Š�6BËãàKèap2‹]x™©cµeõÁ0õ‰œÄ.âG ¹V„hzàž|„ìþ„ìbƈéžæ=@3ÚƒÄüKwÀG1ÿ�'æ_"ÓAuRÀ0ý<Î2¢�åq�ÙÏ®¹róŠªgSH-õ}ù¹-�Dx~óH÷AøV‡kØÀ™ó÷!I"f´J´ál‚&¢Òq*Ør«Û<2¾á`æ×�H&"gq&fW0 ³§A<´ZgÔŽ¢Rú²“{ÄÂRìd ŽÅuÐË|ÕtýÊ=<�š?ádúûÂj5ij7ݹ¹ �F$ý]ïï—oöÑAãW*¹1<‘k+éð¼dƒI¥8Ç^q×e¼ëêõÎÕç-¨,^¶âhÛFÃK˘¢3wmƒÉĸØNâÈdާ· .kîÑßî>vé|‡ÛúžA[OúŠа�ôA Lsà DÚsÀ7B+ƒ3Õ?NôÑŸ„à!Ù—ý¬B2L3Ê+Ó"%šåÓqN(úÒ —¤EVjpZ“a…�ÜS0ŽW:6©.¬×¹�R:„\f‡È¥ö) ï“+Žgu­(Fz˜Q^­AQ\Y8ÃØÝ Ø§ÓîcuƒÂˆ1ã± P—Åׂø"ˆÅŠ#,DBaʸqI"Š âkA¢Æ€Ö"á1 ƒQŠÔHâžËÞÑÚÛC*‰•Ú[óëN÷ùîwÏ=ßwNëiùf‘Dü!5€Hê*÷?‘Ü p"1®4D“�AšÛ �¨�"õhk kˆ&ãi.{Ùn’ÒÄþè&…4žf_²Ï†õR84J ~òæ£iHÅñg¶Q°4„A,Ãu¤Jiœ‹œ QØ‘Æ3pÅ^†|rs¯á…HCa†Æ¸¯€ „BùïÆs†-Éz„Nw+Π%ª%[ÙLEjÚ6ÁVJME%�lï2È�¦Ø„�­ëS å.8µ«ªû!£‡«AÎp‰'�/ OÀŠ�MmÍWŒuå¢�æÒ“I9)ÂúÓ’Ìse.°�ùi¡� ˜“µZ¨]L••Õ–\Vß»¤›+N‘Äp5ÓW†¾Qx­Fæö lc†e^Ú¤íPÝ—À4ÀÍà `NVÙרM±a\'ƒ»ý%tãêXQ/µ47㕾—á Ú¸ ¾<éîç>y~goïk¿À ^õ÷ÙÀ <±(jŸ)Q2ÒòuѳO«±~Kƒ'aé šö›§ªÏ‹ ê©Ø¤õÛW©=ì=½õ�O«¾ÞW$²¿²«y w$™Šjã³ �ÀÞ!½¿Ìdª·„~ Æã'cv¹,öá i¼[ZVà"±‰||¥k°ÿÎ4/¯ùÓ'»/½ÿX`÷gt€û=piUÔöCÅ%™ ÊøÖÏn}kUw˜->ÙHÄûþìŠE7wì‰'½œîß7•6Ô ó.S"cç«ý‚n[õ"r¦÷Ì:˜K¦ˆCÄ1ÝÌ ³*žKJ¨Gñ¤šŸÑ×ó®5æë÷Z©œ©ÙÉjüÎJ_¬=µ’ÍMBnàÀ°·ñî.˜b�nSH‡ªv@>¯õ:žÂ/½ÑÛ¥†© rh™ÃYÿšÉ܈ >D:+ñ8JÞ“¦ŽÜ^R/B¨6oØyTfûåù¡}cõ¥{«�» G-&7·B»|aàÔ”»äkñ%†Ës»:ئ[j� Ä�ü¶gë²?Ø�¬¦§¨ ÜZ´‹0˜H>s°«ÍIîD"r¢&аÔO½ u¹6 Fx¥‚‘ªÃC\Âaò:ø�‡Oip$·4'Œä•7ЧÈÄTéŠ_Ë8 ¼&KLÙW®dÁ~@ªþs´[ùùX2˃ ™*þ„RàDã%` #ô6ŠôX2øbGð•ÛÌÄÉBüGA¸*�&{�§!Êÿ÷ÔŠí©[WªÓÓ 9éâ.?êÓââÌ"ußùK©iè>5‘Æ´9ÊÍÔ5ËÍfÒáܔȗ@Øœà ã*¹Yp9%ÐL>ƒ¾ýùû¯§‹[Ë÷ 5|üi6gØ>•0:Õªz.Aè°ÇXþO'…ÅæŸià8Òwè&¸+šA§„J¹ëSôDìN™iù 17…Þ¾o+u$:îDüÙŠ“'Ï”'œÜ“+À²±¿ûÏn‹Š.â4¿¸!Ñm;¼hSÔJÐ.)‘ Åò›*‚æRgÖ….’» Ã¬ )^R¹Vœt6ænûÕÕÔ[jYÇ?‚Æ´­~ÓW"îÂ…|êñ]ç*]zêüxîËŒäcBY4ÿϤÜè¯0_·è˜¼£‰»£ÅçAb!�wg1B±ÿVg'ËÈþQ“³sÿ)çÑ�÷jàÿ+Àµ‡Xd endstream endobj 105 0 obj << /Filter /FlateDecode /Length 307 >> stream H‰T‘Moƒ0 †ïü 7í�hi%„´vªÔÃ>´v»‡àtH#D�úïg']§@OžØyÁÛýÓÞõ3ˆ·0šÎ`{לÆs0-žz*‡®7óußfÐ5.ÓŒÃÞÙê:ï´9Íáw»åƒ¼ñ: ½;ÁÝQ}|’8œ½ÿÆÝ š:´™Ø>kÿ¢Ámîxñy\«kðØáäµÁ Ý ¡Î«j»j]÷/«RGkÍ—Y]´T)e±i²z-‰s©ÖÌñn#³æU0ëU¬\·eäMIl“ß‘§Ìëé‹ß¬�>+_ÇJb†…MbK¢TÄ‹˜'KÎ[²¨dKUÎ"U§´t>ÿ,ßÀmnæ�4^SœϬwx»I?z?Ù�Úþ’y endstream endobj 106 0 obj << /Type /Font /Subtype /Type1 /FirstChar 44 /LastChar 147 /Widths [ 328 379 328 472 1000 651 651 651 651 651 651 651 1000 651 367 367 1000 1000 1000 1000 1000 758 757 715 834 721 671 807 913 446 1000 817 686 1023 839 820 701 1000 797 649 684 833 762 1126 809 1000 1000 1000 1000 1000 1000 1000 1000 596 646 531 663 572 393 577 680 354 1000 632 344 1016 690 636 658 1000 520 513 397 677 567 1000 588 562 525 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 695 ] /Encoding 107 0 R /BaseFont /FNDNGO+GeorgiaPro-Bold /FontDescriptor 108 0 R /ToUnicode 110 0 R >> endobj 107 0 obj << /Type /Encoding /Differences [ 44 /comma /hyphen /period /slash 49 /one /two /three /four /five /six /seven 57 /nine /colon /semicolon 65 /A /B /C /D /E /F /G /H /I 75 /K /L /M /N /O /P 82 /R /S /T /U /V /W /X 97 /a /b /c /d /e /f /g /h /i 107 /k /l /m /n /o /p 114 /r /s /t /u /v 120 /x /y /z 147 /fi ] >> endobj 108 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 693 /Descent -217 /Flags 6 /FontBBox [ -190 -303 1295 917 ] /FontName /FNDNGO+GeorgiaPro-Bold /ItalicAngle 0 /StemV 0 /XHeight 484 /CharSet (/space/G/U/I/D/E/L/N/V/O/P/M/T/R/C/S/A/one/period/o/n/t/i/u/e/r/a/g/s/hyphen/v/l/two/f/d/fi/k/c/colon/three/m/y/h/p/z/semicolon/b/slash/K/x/nine/four/comma/H/five/F/six/seven/X/B/W) /FontFile3 109 0 R >> endobj 109 0 obj << /Filter /FlateDecode /Length 5831 /Subtype /Type1C >> stream H‰tTiPéî�éÄF�F2CzРFqUÄu1‹¨ˆ °¨…P.q9˜˜á¹u嘹äTnÜuµÔ]7k,-WS¬Z1Y“¬TÞ¿1IS•TêýÓÕß{<ßó>Ï'À„˜@ Xà·Ãw‡ÿN7irZ\Â�]iÉù$'Ř�\8±€srÎ6Ž(}åŒÛ¾Y†ƒ‹-l�?î,²´Ã,Ÿ3.kV»»»%JK–%Ǧ»lINKIN;�ž�üùJ—ÍII.Á qñé2—`©Lš–)�Yùߣ0Ø\KÌŽÀDØ" [�cæCaŸáØn!¶×;‚aÞ<^L‚-Âvb‡0v{(X+¼´ØaqÎâ±¥·¥ÌrL¸B8ˆÛâ©øÏD ñ3YC>¡dÔM«CVSÖnÖÇæ0sšç¼µI±y<7‚Æé[¡í^Ûïç-™W<ßsþ%;‘�Þî¹}§ƒ›C’ÇÄ0wiÇ<ÇéY fœ68Ý�“å7�ø�ñŸŽÆü·|�7�¾ŒËA›”´iÚ� Áðœjc¦®mKŒŽ9Øýˆí ½Ã"õñN¾÷|JD#Ä&€gφÆFòr`·NN1Qá{¢£BC‡¢¯L M°4jA;2ßÊ\€1›ñ гâÓ]ÞÏõ�ýA.kG.°Ÿˆ­Ü[›UG)êóš "n/9Zu«òû1q$=j7"Ä#€5¥©j•¢ˆUû&—Qt9¸Â4(#Gìì'¹çŽàjò«!‡F¯|–zòŘ'çe��ZºÚÇkÿ™¤K—û;Çz5ù­¬½N{R_£uù ¢WnÝü™Ä'È32vµŒ¤sF"At_üµ§ 0÷ïä¦!œ{Dž_«eëHpîì¿wSôuÄk´-wóÝ´¿+îâD_çh¯æl~;k__{ÊPmßoõ_š°o½$j×â'ÃÎ�ÈÆ?|CbFµV-©o?Ñß#²�‹ë OŒÛïõÓ6�Àøåp`i]&ÿ‰skä£%la_Ä­AÎ$zmÚˆ/…ûh xÂyΠJà>‹Z›¯¾†ÅvöýÜ}P1à‰–\D˜WXjfÛn87›Ü‰„Ôx_WO×mñÃÉ€UH´5pSVj•6ÇŒël¯È>e4î �+6òÓW /pøüš¥UCß@3¿ÎÈd`�Ç�H¢ f›Áz ,Ácx¢Þ)wG]‡ÑF´Š�?X ¼a=1‹¶«d³5xç�§àÎê*ºkE:º�ˆ¯Ÿ p•ЙÜX,0’FšùÚtÕ�%믜êӣ޵tUœÃ¯"Óü.A×fBãM€!÷Šû˜�mH?v"…ÄÈqzoM6\¾Ê*Мˆ…È#*4ß©a=ý°VA�ùÕ3eIe…ìÁ”$�T¼#æök°:ûêõ ë�»„6Q¼´ÁÚ,ïNÄLD‡„DñúŽžœâõ�nÿç_ôÞPÀüßÂ*ÆLÅ_óKà­¦ã­ÖNy‡F&êâ�^¾³Z3/‚ìqîS^펤¼2µZÑ ;™ûE~KÔkÈ@` –¨Àt_}X•‘’ý UÞá"E%…þ2®z[]—¨¶âøñ~¶¾ýÔ…†v ˆkȯΫ(*eåÅ•²Rò$ô0(‚xÕ8ÝT>—Ç aD`Œ†] X!bÂ¥�­'_�~ráÏ".D^¬ÉFJ4•vé ¨¶ÜU†È”M¦)ÓòØœbi‰ò(?ßDBУ°H‚ðœñܲ�Mƒz¢âx[EƒøÁDüZI/zʬÙã•ØÔZÄ‚–¬¨ëàÏþ~-t¹„–)~ǽSÊygƒÁ‡9Њ»ï ܵDŒæy<ƒ$Øû/5ÛWßú¢�Æ%C„½®´øâH n?iˆÔo£#¼íÝP J…Õˆ…ƒðÉ‹é™Kúeù0÷Wþ~çá%]¨ô.ZÉš„R¢ñè™ÒÓyÔéÜZ!™^¨’屚bi©ÜLèßH8 ûg O‚BQÀD!·í²î–Ó“�}Íbp}„æ¢ ­,†ÑaÐ ŒA�ÄÄš#ŸN¤di›ËÂÅ+åÇ~�@ÄòK�*ç„äDNKXõçT? Æ%)ʈìlJ£ÉTìû‚î/DGOy±Ar1o·1‚ÏÙjzÃ3´»°¥€jÕh³x 9<ó*žyuqL±’jdIÚŸ×ÍÓ°‘Ã&ƒ+WÃ@Ð[ )Ùx´g¶2W«zWY¨”å›+gwÆY�UI59Z*ýXA“^ªïþR­©2ƒæA¦*Ã³Ì åÊ`±?´Ftw-5HÆ‹¾\w*’¢¿S\4ÒïW7 }Ì2II}iOaseÈ­ãG£…¤J“ê'FvÛÁÂá·ßv3ßnFË/Jùm–Ìn3ɼM}”ŸÁKŒÔh9©HÍ¿hóaß ¸ž»%)k+Ówˆ¦HCmK[=Û¢m®j¬¤hðá ˜¾ ×å‚7–¼q”•ÒšœZJÖPبqR¯mn­g›´½ÕM•Ô€ÉÚÌLoAã,<žS‰ÆáЇ¬îYM|VS�Y"fæÕ< Y¯ùC%Y<óœõì$­æ90Žòg�af9¶Ô¼’F£ºLãvþõ˜…õŸ3´šfþ"ÍÚþwCÌÐÎ4š‡ªÞéò}»è÷í¼ëfü‘寧�W)ëâ¾HiËh_v�?l|ñà¡Îpïöèàxã�:j]‘’#ÿ¢º\¼šº²0.–äÞjWpˆ±x£7c}ÓE|ŽŒ@[QkkÅÈKOAˆ � �¯�ðJ &¼†‡&€ E@lÕÚYà¬Z•±hí,míšV÷ÍœtÍœ€í8À½ßùöþöoŸ£jTæQè-œV7äJg‚Œ=íµ®ìÜ´ì§×6¥éä¯)“ÿ–•è)YÆÕFˆ‹“Kñѧ« )Ä�ÈýZà=äFröŸºh_ˆÏä"ÿŒPa@B"™‘¾¯p?i–vBÀ~eÔXfûM±åÿr=¥(ÇéãtÚÝ X§½þ;{ÍÖÄ”ÉpåôŠ×›ZWÖ\R‡ˆ>#Šrså‰Ðé�ü˜pº-d7©[ ,bÒ$Õ¥FQèbƒB(Ê¢E’¨‚)j8]¬’T“éFù¹ ŠÙH@€#µ2±Í§,}þçlP0/XŽjBtÒ ;©2¶0CíìÁsCFƒódîÜHû˜}1Žü€�0öÊ�9¤%SŸàK¡ÂáÆ$°Pu Ûšß*?“Nš2tɉ'6œŸ:D¡D5}ˆ%azqÍ«CÀ]‚kbí¬‡Œ‚ý�Îj1ÒcOi-Nú¸¸ÏîÖçbo„Ÿxpý¢‹·î$A)°ýÂA ñ&ФÑí8„¢yhÞ!|ׄÈëxðf� y¡u4Gˆçf †1ýÆÿÚ!ôíp²kÕNt¼Â}!Ê—¾ŽŽÙ6Bª‰.—•:û�/p°ˆ€°à&x Ð'"žWøGh6NÚpû…íàRgwr–Å�Ì=�Zœ]š¤?Ú)úËû�‚ÇÂGÈŸÛnöÿDÁÌÕW�?íðÀúªö×ÖÍkЛÖgáìkÊþǸFâÑ¢ÞÝߣedSÉC3ö†ü�Ž… 6ö÷W�¬pÖˆûó2ìïö91ebç½øphC;[³Ç^Knl¶Q×.õŒ�k¿'r9Oc*•B®sǤ°¸&“0 q+mð\‰fúöø?‰œÍ‘|šM~“Ú¿� õFÜmàöC ÅæF–£bV7»£™ÙõEâ >¼oüæ8Á¦ F!¡}N\nb<ùe ±áž×ö L^('5­3ÿŒ£‡�®Ìœ21mzž3­Qå˜×ÇuùuøÖÜe&›Ôê÷ò…üAÏš0’óT|ËNáIüÛT*ñôU—e8•f±>§RN ùï"WDìº4ÿÂcTߨÅcÔäœK+úO,Q«nQÖbêɧÐZ®«0´½àw�a=zb¢ÂÚ` Mµ}åNúš«2ìž�.v³ý^'êˆ!®žL¡Ä²#Ù1t¼wÌ’ ä»$€·d€,Ô«tå”N«ÿ»Ž¶:f ‹ª^Y—Û"ÕçÔ$uýñ;” .¨žœd�C¸ÁEÛÃê¶ªÚæÚºJsžsóö´ÚWÉ”\[ 1P8â”Ë‹–ÇЩ^Ç×ïC›ÑNÆè±˜�¼?ÈŠ·¬¡ù*�º¢‚Ò•N+³�ʦƒ¼YR%×'Aˆã®Ç$62•°ÓQÉšdéÿCÛc}›ÞÐTS§7•×cùÑS6曋}÷"I#-—ÇUkMoÛ{/âÆfx V‚ŸÇY›¹Áf0jkJNc0™…ƲŠîr¾•èxçIÊ©Ò\�X§¨ié(�Yw)X´ÌŒÜV!÷ˆ€xSÜõ/M-r‹ª?•Êuõúþ­Ò�1‚0"2smÆŽãäÞÌý‰¾Ô¶ÏBï|{±ýœ•.fGVµ§�ómýÕz‹€–§F›XéâLi?!Í4pØ|¿EÀY%í:–Áz<{© ÎüÚõÏÑÂÀCGÒRiŒ²Z¤”±â‰º¢–üJiÈÕŸQŽ0b“j»*ŠnɽÉâZ³Ì=B øàùò%¬ %Í?â·}íy4X‰†:KU7¢yÍrÅHoƒ"�öML¸ñbX'Ä%úó·î¾ošÁËWÏè•ò2�*3c™{9ü’ÄzÍÒÖ;ºs½�ü¡9È­ø½»~¾wýëNšã';0Èú¦ŒXí+œEŸNÖähII…ÂÐ@ÙçùZdp:iU·+ësÈZ™>CD¡u„Ni 䣹ˆ\Œ–#ŸÉ¥0÷¯W»,‚’"75œ(Ïg)~ä¥Ï”Fñ}“N‚¾¯nŒœ‰HÔa3›¥cy¼»\˜~x“ÛÄ:X¸‹�\CÆ`¾´±aæ®I€þ´¯x´ô" fL ßé¥Ñnø�‡Ö¨Yà¢iï¿Äÿ¼2Ðÿô‘ÿ °Ö…‘Ù}xã:½PÐü5]D®8ð =Å+Yš™�/<²"üȈƒد&¥$«ŒÌÔÊ+(ø¨AÄï$`Fé�N½µÝ3Ì¿fì>‹ÿï‹’»¢á¨X÷ÎAÜ`ú™t›;·‡òžøô¾WL§�ÞYwšÜ­9¬î¢jôº -}Ÿœç#O:d¢fÁËA´‡ÍíÔ¦ÑFá½óɲíÝa“J":w·8˜Ú3’b•Ó܃Jb¹*4ö µíöAü‹|zÿ�–Åñ¸ÝaG7¬Llï±Xj«éñ/ÕªzÁyY…(�ÚȬâíïÛžÖ?v«úÊаaOÍùÄg7×Åþî<<.šœbŒZq…²ï·|âÙþ[‹V ÇDÐjxÌÆ}.tö¹¾¨EY¥ �r]jåè~U±ìùtÅúÏ9𬼧²uʪÿò]­1MžQx„µßç„îâê\«_en^`‰�ÜŒq*Å1&(¡J)2(¥ôkKK¯Øri¡µå"BÊ¥”û�UÀ wѧ›Ùç¶lÓ¸lú¶{Y²÷£¨[Föÿä¼çyÎsžs^”dž�²öM³ÇÚó¢ÑW +Öˆ%Jtôˆ+I�1昨Š/@´hö†2Ý郉‰Ṳ̈¤‘¬ÉÉÑ7qí¯P$:±�¬&kq‘IÞ€¶À ¬Â+d´l¬Y×QárnV¬øgû0Æj”»T>@× „ùUyµ%]ûoe\Ú ü;ì§»[Ú;­3MxÔç`v�KE²´zYI ‘”´ÿ@2÷è±'À*Ë<ðB�x™PE�™nøy\OVQU•¨Ê˜Ã~6z$n*äeÆZ¡˜�§YV%6"š+l­,o•¿Ò—¿[nQàMåõdý�¥([À'ú<϶û¿?Å(�¥¡ºeR¡4@�ÝK¹œ‘zø¡¡O ’�ÛØxiY\Žî*±%ñ±Õ¢¦Ø’YÂy¶*þ%ö1ªuÒùÖÕ©­¾ÖYœCçÙ£öc»æ[§{Ô: ßÕ‡I_¼fñø2‰êq<ÆH¦ôFðF.§KF±õDn>]œ•šÅ%t×þ§dŠt‰Fª{¤6é‚Ú|iP '}j[(A#&•„\]¶ ¶WŃžhä*w�Ž Ö­ywÃAAðu´òƒA8xç>:_#à.=>'ذ9Bt<{ï$xúÇÛ�¯À§FÌúôQÏÊÈg½þ@Á7ÿÙ;fð �ž6…)k¡ÂW{;š”F™IlàsZL ,¥£.Ò u¨ö\£˜’u9uQ®ªÆ–qEí}äe6Xüÿk‘çë˜�uxG òüîr80û©6ë åùÁÈq Ð5{$úy,ó£Ì¡}ñ‡òR篴xþ¾FüéÓk¤F\lRR:jÁê­®�Q=®•k$BVª«hÜÝ;â&°¤lHQâɦ֋„0¿ß3üÆ"Ì~Äâf¹ºZ?üäR|ôiÂI¯[hGér>Íš›d‹e×ފŽ\÷UÖMçVÑ„ô +…_üîÆè;3%��µ0†ÖO·õ ³‘´Ì¿Î/ÜŸþÛÏÒÏ=K&Àzô�\yš9„é¤G4¥ìXùÀM0ö\ ÖÃMp}ø�Ûp ?øÛÅ Í.‚KÞˆŸöl§Î^o(µ±„ú½´/3ËÐ?*S¡œâ¦­²UkV"ó0QæÑ€••ó2ßc§t^å ‰j!ªYתµÈñ™™D{í8<¶ýÁÝ¡áÁt,ãîÁLJnk,ñ�¨Ò[ž¦¦ñПvJVÄÒž�©$Ä‘pÞæ‚}i÷’ ÇqµEg2°l®:»žpÂ)´75]"ë±›ðM{Ê,܋ߡ›{›Æ­�nà×7;öKc—­³gÀ4üáNôšœ”qƒÈž7–¼ß h`é ›­­cÊŒ;a"zºÒ©²´¹BFd ó ]¼©ò&\]§1Õ°Œg -èå :�êÖ¼nî•�žCû㊠S“%$ŸŸ(GºHAV�YuÊPU_oát·ut»ÚrãëËp£Ì$U±ä|ÍñJÍ܉æ!ÂÓ�°ù{“nr{¹Š$²#eùikS~MùIpW›uu{_]›ÞWA—Æ!j8ö-ÜÒwÆŠS³Ó‹‹ñ�Ü‚.;N”žÇʘ™¼Þ¶ÎrÐTVYœÓ °©ßá#$÷Ĉ'hÔÏS¹Äð0e�8UQªJÊ ´¸¶0W—S|T/b§'”æ˜K†›z1óÙv·¥7wL.°é°w.˜–ƒ1Ò‘)½}îØ{Iûª7jù·L`æõÑAøeçL5±ì»°úޤkì ÇPïÅ7\¶�ÏËäÄ$îŽbU,zIœ£ÌU´àTftIü6bmrÃq’G°b5å¬åjÑ‚M‘6�Àj·€ÈW=æ×b£Ï€ˆ¥ƒÕC•# D˜j«�õ�ú†—ó¢WÈü[€¾Ï ß endstream endobj 110 0 obj << /Filter /FlateDecode /Length 306 >> stream H‰T‘=oà @w~Å�©:€ÇÄò�T‘2ôCMš�àsj©Æ;Cþ}9pRuïîÙpÇ·û—½í&à~0œ ílãq®Þ œñÒYÈrh:3ͧ¸›^;àA>ÜÆ û½mPŠñÏ�'ƒÅN>‹'àï¾AßÙ ,ŽÙ×)€ÃÕ¹ìÑN  ®¡Á–ñí«voºGà¤ý±ãÍ!äñœÍ?�6èµ½ ¨ÜÔ ªeh›ÿ¹»qnÍ·ö,©ÝFd5 µ3ÍĽ(9é{y6!òmÍÔ2 ñRFâ*çª ª(ª ª((¹ lXåÖ„˜©’”2)%)%)2)%)’YF I‘¤K�Àz~Cº4=�æñ袹z‡ûHì,>æêG£Å~é=”¶ endstream endobj 111 0 obj << /Type /Font /Subtype /Type1 /FirstChar 47 /LastChar 117 /Widths [ 413 594 546 512 546 546 546 546 546 546 546 546 546 546 546 546 546 546 693 546 645 742 599 546 711 546 337 546 546 567 869 723 546 546 546 546 546 546 755 675 546 546 546 546 546 546 546 546 546 546 511 546 484 583 497 340 546 618 299 546 546 299 546 618 552 592 546 420 426 360 609 ] /Encoding 112 0 R /BaseFont /FNDNIO+Acta-Book /FontDescriptor 113 0 R /ToUnicode 115 0 R >> endobj 112 0 obj << /Type /Encoding /Differences [ 47 /slash /zero 50 /two 65 /A 67 /C /D /E 71 /G 73 /I 76 /L /M /N 85 /U /V 97 /a 99 /c /d /e /f 104 /h /i 108 /l 110 /n /o /p 114 /r /s /t /u ] >> endobj 113 0 obj << /Type /FontDescriptor /Ascent 730 /CapHeight 700 /Descent -210 /Flags 6 /FontBBox [ -23 -260 1660 933 ] /FontName /FNDNIO+Acta-Book /ItalicAngle 0 /StemV 0 /XHeight 500 /CharSet (/space/C/L/I/N/A/G/U/D/E/n/a/l/s/o/f/t/e/r/M/d/i/c/p/V/slash/two/zero/h/u) /FontFile3 114 0 R >> endobj 114 0 obj << /Filter /FlateDecode /Length 2323 /Subtype /Type1C >> stream H‰¬UkPWîž¡»EØŽLWcœÁîÑðP(‰®(*�`*"A³»ˆ ¼„d "80ŠVp� ¬"0ÍKqf  ²‚客øŠåMt‚)D̺¥neëôìÅÊö€FRš­ý±uœª¾}¾ï;ß=ç^³“a8Ž;½·*xUh¸W`|ÖFï ôô�myQ…‹¬�èâ蜅ª\ȼ/$Àõ5øÀÉàâ°K�Ép<8ìÝôŒÜÌ”MÉYêYñ³ÕoÍõ�«ŽËU§¤¥«Ò5êÈ�iYRˆŽ\“›‘è£LMU�ý®Qg&j3³|^�b¸´°)8Æ`ØL s•a³0ÌüeØoq,ÂåX(Ž…aX¸ ‹”c¼$Ë´X6€{áŸáÙ"Ù!9/_+ÿÂNn·Áî$AÄu2”4ST6už'ÅNj²w·/²šµ&ôM�YüÁŒŸ†îaù9ècQÀ=ä³aö=ðƒð?4ÍöE~(€§:£¨5î>>kCD�y<2rÆEqtQé±ËŒ_»¹Cr(²Ú±wÍï ùGÚ€æñ±â[7Ði0÷!È@¥Æ÷¼;®X”Ø\RS#T¸ÆÌ½Ê†æI6– �`Cµøp‚Q’èu-»ŽD)Oíò㶯ÑMÓ@‚@-¬Ì××öÅëPFžFûc Šü ¥½ � ß—ÿ§ã$tX¬f÷’0 Ý&�–¤ÁIg¶º˜ñSÃrqj#‹8„Ig--[äÀ±÷�·ky�ÔO4Äš9æºó˜+ÌÑyL†FÜùËÚýÅûäËð¤T(ʶ.±!tˆƒL§Õý¿“/§PÂèm”*Jí¡!-L÷³ål¨¹ã9FŠÉ�­£VâÏ$dŠO b'’Íè`rÄ'%¬•¶a[lØÛ5Ôð8^…ˆ]˜ÎWrüEâ]ž:Jàºn«“dàäAqz‡&ƒ�E�}jX ?‚ÐÏP!mVh¨Þâª<}Ê$ºP×#.=ª8ñÝ{— ÆÂܽà'v0ú¢R.÷X¿¹.ßÐXS}pü.8Üfê½òeœ?çM1#h‡660LÖö‡[½§[»Nq{sÉ”Êôãí§5š¸’ZbûÖœ¢OT9ù•õ¼_»%~£fƒ*nsSgo—fäéMºób`+Þöèÿ&‡N1“½Ð²%–ÏݦËUf×Ö5Ôï7]üàŠ4žNè7o¢¥Hu9œ‡çzjj9]‘“–˜¦B˜ÿpÇk÷ñô%ÝéTƒ¸º‚ж!h´0Ý`:Æú_…7`j÷€u_ÝŒí¤2Óâ2£Tcf Hä›Md�™»A‰PM)áÉ*D#¹—tÍz~‹dÀöön?Ê—‘{‚ =Éä�WakÅãJ:Kwv© |.MË—âÙW¨æ'¨^ô¸——–ï)硟,«ù\¨Q‚½o›Wò1{º-=t/Ÿ·;§$‡CŸ’÷jzzú¤y )5ˆ+�BL3öPK¦}-~Æ"3y·z ¯©® ‹Û–_œg3¯ÖP_m:ù;ãJäô¡›7—BÍ/"ÒîŽNveA³�òï×éà@Ñÿ� ý/K¶�Aï°È;C¹�58OMgÍ—UmJ^Ë£vÈjˆÎðlá8²Õíï-[¿:Š+!Ë �ø¥«£—ŸQÓ6&C‡ö�Š𚇅XíÙ䦭&cS½éH†�’œ¡ùˆc~ür;š¸G3ð³þòçÔžÕkL¶¢­iì¯ÐNÌ/öÿTé�įh¤[u­b´ÔCÐ-½Á-:\G€7pó ¹"WD!7ä6‚(påÅ<»ûg—Hwµgä’9s"û¤ÇÈólß}žþEÀ¿U\lØqZ˜‡˜Û°J\Á–]—¸™‡ÙG…—ë…¹T†±·Ð¤ä?^J÷ bÃÃSã“8p8ÈZ®‡ 7ÐÔ¨7rvR-Ý*ÚCrKùpá�…äÓ"ùÕl Ç›:©cf“`T1õy‚ªé@½À3-G2k6¯Y—ðáX+P6•U¯öÈ{Ì#ʼno ¢}-3"âðO¶Xâ`üZ}´jfH¤?Ï> stream H‰TQ»nÃ0 ÜýSt�±Ü‚—´2ô�&íîÈtj –Ùò÷%E7E[§ïHÕvÿ¸wý ê-Œö€3t½kNã%X„ž{Ymoçåÿvh<(®ÓŒÃÞu#“¨wzœæp…Õ.KïÓ;P¯¡Åл3¬ŽÙÇ'‡‹÷ß8 ›!…º†»DmŸÿÒ *êþÈãÕ#äñž-­Ç'ßX �;#˜¼«ÁTeèÚÿo‰Å©³_MHL‘SešÒ‘˜u1„+Áã�àa-5šk´¼­ê³8>üúK;¥Hce¾c·‚ðºË‚ ¶Y£äeJ~,u$S#–h!4Kô2a"X^IýDD•/ AX”‘8^Õ-_{ �¢�ûŒs´½ÃÛÊýè9Iþ’´™¥ endstream endobj 116 0 obj << /Type /Font /Subtype /Type1 /FirstChar 49 /LastChar 56 /Widths [ 423 516 523 558 523 568 491 547 ] /Encoding 117 0 R /BaseFont /FNDNJF+Acta-Bold /FontDescriptor 118 0 R /ToUnicode 120 0 R >> endobj 117 0 obj << /Type /Encoding /Differences [ 49 /one /two /three /four /five /six /seven /eight ] >> endobj 118 0 obj << /Type /FontDescriptor /Ascent 730 /CapHeight 700 /Descent -210 /Flags 6 /FontBBox [ -52 -261 1660 942 ] /FontName /FNDNJF+Acta-Bold /ItalicAngle 0 /StemV 0 /XHeight 500 /CharSet (/space/one/two/three/four/five/six/seven/eight) /FontFile3 119 0 R >> endobj 119 0 obj << /Filter /FlateDecode /Length 980 /Subtype /Type1C >> stream H‰t’mLSgÇïÓrï�NŠôr�Ü’§uÌ S,°‡ã¥”—&§ÈжÀ•®…RÈ`HÀ³ŒÀ4XP£Ø†R”€ƒ­áÃ1ÊD£!&‹¸�.‹ Ûrî|HØÕ/û´œ'9/ÿÿ/'Q !œiÈ0dgîN3:ŽÇ¤Û,¦—E,i� El -"—"˜Æé4DÁ[Á_½¨SS „2òô¶ªz»X^áÐí2FëÞ‰‹�Ó�¨×eˆV›Îd«Ñ·:äôQFAa}•9V—f±è^�×èìæ³½ÎlŠýÏ“BrPj–Ú*CQª–ê£þFŸ k NáPx” íϺ`¢ Á–NêRÂhãKzŒ+NOì8=ÿ3];èkº¦ñ]ìÔÎ'\¸�þ„ö¸{Ç'…Éúq«/¬œîH‹§û«ÅKšrñTmµ6eõÌgãi«µÁX"t†>𽻏8»?99÷@JJîÜ#¬RéZ½0ìTžçOûÜpW‚äeçJÛ‡é±È’O£»+þôÒªS­€¤V?úØQJøX’ø{îÔ,’F8²�ì!�ÚÃ’ù�…"àŸ‚`ãï’ Â$ê“Ä�F߀×éÁnûy—àžÁª3-~š‚/üj0oËÊ»@C‚ Š[—ª!›_Λ%ôeÜÆrk«WnÍÝ~=p‡„ý�ÚÜà‘œ(CEzþ�åÖßn !ûfåÛ†]Z—ë¼[ðT:kÄšF1iU/;…õ±ÊÝ UGýj¸ ;¹>©(”+…Ô%ÿRn Kžli;Œ°\IeåFU±0`�oèWäÈ:Hí[ÙÜ|ÚLmRqÍäÃnmýÌ7“º—�LJ‚¡t¢–ûëäáîÚ«.·¯áJY…Ýz"ãÇ\PBÒïË޹µ_Š œøð—ÀÐ2bT£²ÇýÛhB¾wD*¥`(æ c>Z¤!¶wâÞþ‘ËCš™1CŒ"»yPä>%*1¯ÅTŒ/®L‚ôSM×ÃI™™¼K’ˆ(�èßÈk°¶ó¼‰U¦¾:iÚ¤v¼äÇÍ”R*—Vù™={–äÐÃÌŒ³£ç–Ú2½1JÃ{Œª§Å/=ð«¯C¡å×y‚ opóÓRŸ0S|ÇŒ¹•تâ¬L!ii/ÄB NCÄó}_'�bniyhòæ´°9…¹yÂ…� -·4YàÇ{¾óáEãÃò¡Àr$ûà±ñUy á_ÒX\)âo�ïžðýØØÄøÇ^¬jqJmç ßÉ�2'ëÚ:ý:4„HWùL#Ô¾ endstream endobj 120 0 obj << /Filter /FlateDecode /Length 216 >> stream H‰T�?oà ÅwŠSuÀ$KË‹«HÒVq’ÃÙBŠtƃ¿}€æ�:pâÝã§{‡hÚ¯–lñËNw`°dg·°Fèq´r ÆêðP¹êIyîÖ9àÔÒà ª qŠæx…ÍAÊÏòÄdK#lÎòr��nñþ†R€ê …hŽÊ« AdîÝ<¯a›µ|Œvg¯4²¢¡ÚÉ:–}Hæ¿÷$úáO¾ŸVeïE$ž^‚ÓN¯ zaŽóâ9IÊ` _ã�O#Ó)î Øýj˜ endstream endobj 121 0 obj << /Type /ExtGState /SA false /SM 0.02 /BG2 /Default /UCR2 /Default >> endobj 122 0 obj << /Length 4856 /Filter /FlateDecode >> stream H‰”W[sÚJ~çWèmñ–º"”öëÞr¬–ZGËu¬ëû_ H{û¹kmDϵ2«†‘…ðݱã8²^àÀ„A[ïùnd{íÇ]oÕ»Yô†\Øb±îyŽ%ÿà'ôaRäŒì(ˆe5O�hÏmcß³ª~ûH_yÍ+V4iñO°e²^³¬2³âÿ^sÆ×¼hO<ͳ"KX®å§ŠÁYóý®�…1m~ðèùÆøFcz¼QÐ}«Ô<©³ÌÊ‚m~iÆmÎ Fð+ÛÀ%ðÃ[ǹçE‘­¹2à.H=øÈ«ˆÀiÛŸúðø4¸™¾ïÐgÕFŸËMkûÓ\¡çÙ£BŸÛKl*^^lËæ ¿Ÿt_25å9«�Å—'¾©2=àVÝÍ#oV¬é ÕàãÓmç ÈyÚb«·0·{,Œq3œ2~"UáÉƾí)²Ut1‚kˆ¤Êöäê‹ÀvŸØÞF¤‘í¹®Ð£SD|ÿ$-Åvпo NØÇp­?`h =ù*©»¾Jé«„Œÿ+y²à¡Ê à¦yqS/ˆíQÙÿ:Y^i‰® ¡ÚñÙÖ¨Á­Õ7&ôz³rÖ.Xñ\†M³*ÓàG™Ájæ­Œ{W>Ƹ:!¸‹¬ÒBbBÉ{‚HÞ˜¤Õ îdBÈŠ�–SJƒÖ•ägÏ¥F• ê\KÉEr mª“ƒš"“ƒÂY¡K›¼¶[™‹SÑ1De /Žm¬’T[q£ v ܱò€$T<)wðDp�@KØç, Ÿ‚•g;ñÈWìôã1±ó,ŠíqŸ×Û2ïÔ¯ÈØ£Ò­C|ú&8`�<©Øa¤Á¤Ù4¢ÖÞ)¢øí¸Éµ-ÏIðëd¤ÒÒí^¢µb¸²¥Ãpˆw’qà—žƒg½vÂ6wyñ,ÿVbøE|W•Í^ ËþíÍÓ·;ä3*’²8ðùŒ2Ó€ø¬e0Ú§l8óÀQ½ØMù�çå^yªøØk¤zË ÎŠ$oR²AÊ­[�,jö·� y%.£a4–G€•w\‰òUðyàS!ê¬nj%¢§ÃïO³Lþ‡Pãáj…ÑÏPYÁs˪ÃfL¾~xá¿á…ÿ†gþ‹^‚ªÅöõW3�ܬ¥nNev~árgªËþφ t‹k­'Qóø Ø“›qàÆäÔTËxiù�åÕf¤ ‚"Ì3~»‡†DDZdP±É3±䬨4P”’~߬rØ�"ͺ*w„\ú™ñ„ïV2‰K œÃ'/&7ò](ÉÇcËì±ç«ºÃ•¾çzà&줡ô«åÕµéPÛ[ÓC#�.âÉ“™"ÛÚ"lñɘ}‡<8éöxt’X¾)«¬Þîl­Áw&øjcRye†l*†ü'iuêä�1>ð[QšàÝódv«…%89K;%Ç =¿ÚÕ!¸Ò=¯Û½fçN+ƒ09Â[â ¬BÑCêˆtÿCh–ï Wˆ5ò¥M¿«8b;�£×ÁN%šHn¯»”šÝŽUÙ/®drkÎ$•îã˜Zþì�U¥âØÑYHCEVhi�TM’aœB‘U�4ßi jä¯ñQHAÕ�DÐêv¹´f“e¿(k-äåñ,�"«áHÁ spÑ}¹¯ÊšË…¤ r9ÄH ¼*s=jS²\ «�ÌÒ4“—Î̈f-`Ü#Xé†7ßW2ZÊ™r)×–î« ®û¤Ed Aï+»…S;˜UœÍÎÙª¬X]¶ƒ¤!�ãÂÅ]kší·'¡²,9À]\¿AÓ¢�þKn¥Y¯"äUdùnµp0n7äVHÜšòY.àS7i$ÈöyõËŒC•‹á³wpŠÈ÷FÃÏ£`L´i´çÚã`4RÃax»¬6g܇#Ø�ïŽ%)o<"R~Ð5D¨ê˜êÚˆ„ûœ·²¾†PVpI^ Û¤É0K2õ ¤Ü|æí\$*¢šÿ]Û�v0Œ\ãÆÆ½¹�¦hñÈÌL Bå ZkÔ¹¥) �ÁìÚ±ŒÎ�YöÝå•,—ène«B=Hª€vú«¦‚`H;+ø…û!€”„_F?¥df>)%DhBÔI©UMÐQ=b]öˆ¨¡ÊQ¢N{Šòd­{PMµÇêšTÂó­:�¯Ý5pbõ~„LgJ¢êLm-*4ºo 3J:˵¨€@Ø)éqÛ¶±õã¹F\÷'«îwÓà¢D­öÔࢅZ ±)–;IÅ”Ëc$G§ F=ÂN»‹²jwu�‹:4‘êqÍNȨçe[‰½,áeÿx<Ú[Îòzû³A¦ÛfoÊð-݇ÓÙ·‚<Ú®¸ì{xõÞØ¦HH¸-JH†ä'à9�L@h6¹Öšã6K¶Z€, eTú�:Ž„žìhwû-Píhž‘ �‘0^W„BMy�¡”0Ó@@^©Àê]÷Œ®38A�\Gp±0*û%ƒ4‰G¨y5†`Á5˯�lFeC(¡/!¢bHt3¿ì�èêT‰A"•êaÒ ³ImÁ¡'v RIS˦Ö"TgŸÓ…š†Xu™Z ÝJK*Îê,©Xö?Ï>¦òš¤ˆE—Ý®þM ¹Ä»JéLZ,øQÃ7º“@daýjl¤˜AyFþ§s ê¾®¡û_«e»m#‰îóZÍaμH€ã•BÑŽÎȶ&’�E4 l’=ƒ@Ûü€|�çƒçVU”�lȪ꺻ºî½„ÝAvðƒ×ù¤X²Iúnê0+ž…^’ŒA‹µŸ�¦¨£O\ £ÎÙ+›ŒÝ·úŽC°Áô#ðbâ¨þKú!2êí%qÃè�OMü`4pòáæz}{ónM�Ç‹øØÚb‘Dãþ×ç³úA0ƒ9›výq}ûþîíúÝÃ7&^‚χÉr<âîÅÄKüâøG½~}¿Zßßÿ%»ÂÀ¿£VŽZ¡Z!Ñ÷�H[uõbØ9»˜ËA'5X:o[åš ³dÅã\@ý®»tŒFaP|\Ð}Šöy:�õÕµÈ^+ôö/âgáÈó'w~œýVÕÏj¿©«ãAº=NÖ?ßýö†ª“´=NB‘„ì9È[Ã÷‡?Ëwª•ŠÈ¦ÑÀÆ4YmŸ¤&QÀU+�êk}lÚÏÀ”ýI[{HÕÈãìÀ¼ÉŸò· Hí–~  †¼€\Ñÿš¬§5i!.ñ�!¡ì–ÿƒb�VÛ)•J€pÛO=TGaJµ,š�£&h‘¤ÅÞºv¶äxؤšj«c×)Pƒô¼t†]0Ãí׺0�+“±Ù`£! ¶Pgír¬f��uç3 '%oó„È&þdlž§%e�Ä¥D�ôYÄW�J»®aeè4»V:ªQµÎR:Ô(ÁC�üCi°õïA�¸�úx¥Ú‡ôT_rmµZwu5xw¤+³T¸ 1jÖœby¯be ÙjL©_²˜€;Ð�ðH.yºù„­Ä|õØýà+(­X–Î'iQ•;uº$WÒTì‚Å,Õ7ŽBÌL0Y<Þ�Ÿ>ãËG4PP¥°­Ý1ŸêEk¿Š£€nEÒáeÁò\ÅÜ;¢¶”j!Q«Û�Ó$?Pcø(9pFç:GVM³=I¢K�øß¯˜Ûº*i=}PdBd]©Å'$¦¯Æw¡tÎÔ~èÃÝ÷hCä<€O²œ_„K \Èõ»½Å,1IFqÌ[K�Ó°waœÜàv/N»O[µ©,�Kõs‘ê‘òÆÇ€RÎzÑžD.Y’ah(À<7’;´e–7ƒaev³ÐkìÓ.+Âu1Ÿsݦ…¥¢"~AU.•}Ñ®lræ—üFF]J$”�HõÆVyµ³MKŸ-.k Ú-}@]¬‹4u+�5Ë\éÀ(Gï‚7~VG“9r¼Û—ÒpÅì�BsIií–=RY´„é¦cU3†¡ÐO�â·æ3—~va/ÕKÕh÷¶Þˆ#+jVÜ"bIÌ—ƒ©[ÛtSë¼±ðƒÁ1V‘MKÏå_(–ïŽ&3ÒÚãë¥v�:áá’3 uëꄇ»cÁó‚ЇAÏ”Èy6'1þ€ u„ÜÇÉ¿þÝPå%ç(ºŽL~ˆdÜݬÞ?Ü¥$4ÔQ ”®yîóž‘Q½N“ ½—´NÛªîB æˆò¶$ÐÚb:Ô‹´:0á:í,7Fý¤„¦„,—“=³Ù˜–„·ÄâéC'¯0Ê/1BhCªÿ� «« Ô¥/÷ÒØ£Mí ÅÏ’0œb¹‚Þ+7öˈBȧYºYÓO©UV ÂÆÞr\]Ò§ÜšÜ[µ®Ê’´jUïfØû·Â=�(ŒÆe_®ð‰3à¶ðµ�0—jiyR§ö]`Pjê£×NŒù“Æ¢b¥µº”ãÔc�¢®�«°ÚÝð«ÂÔxD¥ú«jøÚr³£^xîBÅZ�ör5;iÄå™ý„âÿ¾×v�MS¡21¬w‹8z’[£‡/–;ø.Øù”æG3X®¯)Ã+�H¤Ð'L‘‚¨vº±HÄÈÝ«Îã…Ø4Û¯™l†]Þ [Ê »vù.C"•Z¦Ü‹ˆ¤¯e*åºå¦6Ëm‹¹Ù›šJÛ«a£ ñ\ v¶ýÅÅ4š¾7Dº7|uÏ›êŸn@"–€eïbyál~�‚D1 \ã°ªš_5�‰ç¸z†(¬~¯eµ_“\¬ØŒQœ‡nñ¥ã ^s^�M´üO«&¹Èôk²ò‡éÌ —‰È>Á"…!¤ 3¶nz²Ïþ[Õ²¤ïÉšAÈkâœdæ‡Áx]Ö–“ñ¾¹û>^ìÜ÷üQo|WÇ<äöæÝÍêê–öKD‹x¶Œ¿µÂ›o¬�àJcoñ½>Ü\¯±ÊZ¸•»ð˜ÇÇr€á|»ëódÞ‹g·^Ïšd¸Çøœ#аE¤L­;i|X,'ÍÖà¤Ù??i_¦î?…=<Ç‘7ø‚õÃÿ`ËѨ endstream endobj 123 0 obj << /Type /Font /Subtype /Type1 /FirstChar 46 /LastChar 115 /Widths [ 296 0 0 0 0 0 0 0 0 0 0 0 296 0 0 0 0 0 0 722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 574 0 0 0 0 0 0 0 0 0 0 0 0 0 537 0 0 0 574 0 630 0 0 0 0 260 0 574 610 0 0 389 444 ] /Encoding /WinAnsiEncoding /BaseFont /FNDNFM+Avenir-Heavy /FontDescriptor 124 0 R >> endobj 124 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -228 /Flags 32 /FontBBox [ -166 -240 1160 938 ] /FontName /FNDNFM+Avenir-Heavy /ItalicAngle 0 /StemV 120 /XHeight 480 /StemH 120 /CharSet (/space/A/n/a/l/s/period/o/r/g/S/e/colon) /FontFile3 125 0 R >> endobj 125 0 obj << /Filter /FlateDecode /Length 1098 /Subtype /Type1C >> stream H‰lRkLW¾³�Y~lÇt‡¥„Å™‘A—KÒÀ]‹ò…YÜ–×â)Ò¤TQŠJc»--� P­ 5RV”¦X²5)�D@Ó„R M¥&¶ÎÐÛ†^°šx¹É9ßùîw¾{)¤�!Š¢|�{3ŒézC­Xmµ¿œ,šk]ñí’Ž’ÒVµŽÅ��Ц¿â•�yc/À‰-ðÉ‹Ÿ*Ü$§¨–:m5.»µ´Ì)„Þ!¼³'F0XlÅ¢�år8Å*‡�R}Øf¯±ÙÍNÑ.†ÊJáàÞ!¢½–DŸ]/X‚Y°‹¥VRh-‚Ón¶ˆUf{…`+Ò¬Õ6§«F I‚¹Úa#xÂá8Zì°Z¬f»Ut„oêÿ_/dPh Ò¡ ´½�Œ(¥#ÊDY(1Ä$Cr’,Dí¨bê†,Rf”�”MÈY¹�aÞƒpjvË'§µjTt½ü+Ï@ÿÐPÉÕ¢C¥eEÜFÒ!\C l×ó1lüªx^-ÄwÕB4 „�ÍÇ4Ík%ì|³¶Ñã­„»ô&Çv{×ò”˜¢M§j —œÀ)<¨dº]@KMÝ(¹Ô¶¶MûM¶¡Ë Ã/a¿$ÂãVX^Æ©)²rûnUraJ£w±fI<¨@çñr,Ü÷özGn»Ä>Ž©oXyýaƒ¶.ü¹¢5”b %…Ñz‰žl†PlŽOpæär÷Ò”—¯ w~­®ÌäOT©°§¾ƒ#y¶1l1™cƒÆÇ.޹Ɵ¥�Ѳ%[Šb,…ž) ÏOp=4Óݰ ô Y”‡ÜsÔr©òµWUùÀÁØ'ë±|B xn¦ojŒ{õ¾²¤Êb3é’s†fÞåWS<7gt³Ã‡ö½Ï3�p#Q©!»ÿ¢cUH³Aü%Ð쬔-9µlPâiûƒ·,­7Y‡CwaÂ��± ¶ßý¾ûV?ßRF‡•¦`Ÿä7{<\â¥iòǺe˜@žÕH)*6_ÐkþöÀž¸œŒ]±¦{s?y½ <ƒ=]µkMǨiÒÇ´¨×š°šôØU+ùnJ™$RòAÍÎO’$´ÑìÍñ/¼�ÎEårø‰Œ©ž¼õ ÖÆåNÓlæ<¦UÌw›mZÔO¨=ШýÏ2}ž‚ôØç)1ë™]¨ýfG§––F� ¹Æ¨¨Ü©YŽÁÑDÓ{ä�` 7”´@:{iSȇ4ëßûécPr¬oGÇ©“�<ø¨ÎÕן}[ÇîMË-Ï>Â1¡sX­b„†•uTR²Ž ’ú×Qyëï«ÔÂÁo<]¨ôšvÔ’Ô¹_·S_ ðx?¸†ˆ…ÇËò*z®Urq Êì‘ñºº'@ŠhLؽo1`àzÛ•ÁËÇ+º9ÆÕ¾–׎ϸá37­ØúO”[#¾Òmí¿ c $ endstream endobj 126 0 obj << /Type /Font /Subtype /Type1 /FirstChar 49 /LastChar 116 /Widths [ 556 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 593 0 0 0 0 0 0 0 0 0 0 0 0 611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 519 0 482 611 556 0 0 0 240 0 0 240 852 556 594 0 0 352 0 352 ] /Encoding /WinAnsiEncoding /BaseFont /FNDNHL+Avenir-Roman /FontDescriptor 127 0 R >> endobj 127 0 obj << /Type /FontDescriptor /Ascent 756 /CapHeight 708 /Descent -228 /Flags 32 /FontBBox [ -166 -240 1000 928 ] /FontName /FNDNHL+Avenir-Roman /ItalicAngle 0 /StemV 78 /XHeight 468 /StemH 78 /CharSet (/space/E/d/i/t/o/r/a/l/c/m/e/n/one/R/two) /FontFile3 128 0 R >> endobj 128 0 obj << /Filter /FlateDecode /Length 1189 /Subtype /Type1C >> stream H‰T’}LgÇŸëy×¹h�=[•c×s¶E|Á—-Ë\dˆ/¼‰ ¨ Q˜Ô¶JZw­E&ºÍ "³þ¡¨�èxqèÊæþ`3(�›‰ÚjŠ/yÛé³ Nf¦¿Ã’]5Æ™çþzòû}¾Ÿßï �Ò Š¢&¤d-ÉJËœ‘ìwº]Ò¬\O©Í½Ÿªð”2y”;ÆH> _>«xö.›×5ÊÆÁ�ñ߯2Z=ÒPTí¡ÅžÍå’kc‘Oœf�çξ˜ìð¬wŠ+˽>g©WLwÛ=Òf�dó9 ¢˜\R"æFë½b®Óë”üêí‹pÑåm¢äÜèR%§CôI6‡³Ô&‹žb¦Ëíñ•ovŠÉ©¢Íí˜íQëU†wËz¯Ëá²I.§7áµ!¥¤§�¡wZ„ÐÊ@h9�V"´¡ñê�4 mA‡Q?µ†:L=Ô,Ðx4;4wi í ›h9E—¢;êWª)ÓC«Ì�„á¡<Ã"–ä’„Î,†» ÜS¦vø�Ìêj°î¡: Y¦;�J>&#µ,¸ÁÆDÂá‹ÀÄ€~ZˆŒ&ì¼,òÆVáÞÌ•ƒ�§"|äׂä”Mδ 9B2:Ø]ƒ!€AÂÔ™¾cTìxx “~�`ç°:¨?ꇆmÑ"hïWëdˆba‰0�YR½ hêÃáÇ1°˜XŽ�·’Îʉx“ýýn…E[“`Z¨¢V†VŸ…¤ŒîÑwȰs0† m'»ê;ùk?¥š>+Õ-IûœÌ6q{æô®ˆtµ�>!Ô²œ¯¬Æð 7Ø]MUÇ�Å@�&儈�ºÔ·f­çÉ2C©– &UdÌåW¬ûæ·‹—ŽýmÒ_Ùƒ=T‡L+.eºá—üe�)<1ÇO%oó X®\jì:eÊ9ÇØÝŽò<~f&¾¿ÿÛñã§ö Ú__Ù“}A%@kYTúæÎpŠÝˆ‡ª‰RÍvæOåIÜ4hâ‚D|<&ÊáöîVÕfŒŠÏH²Z3n>|xùæààå¤xA§ MÁ¤¨Dµ–ÂDCþ†�½iü{˯öí4)ºffÏí'“ˆ`± ‰í'ˆû3Ô9'�Xièݾû6»ë£_›t¢únŠÊÀ ¬þ"°30÷WŸ+E‰,7§–Æ MMÞ`°©)xBj).–>)¢-CUeT¦ûžÏÁê”Z•2óBv�þ:†Êè7!–;s݈a+ûôçkƒ—Zìf�4`hÔÊçΆî5ff$ˆá¤Æ®»Ab–ºV¹„ï*ŠÏ[ùs ü¦j–Ëo©niŽIfKön(ŒÑý/ €¹S¯Ø×ÚÖ$ ¤C»˜U˜Œ{TÀŠ×PóòWÂ-™î€mb}f0?y¤Žo�òˆ˜‰yJ± ²ñåº_®_ÐTk(«ÜÕéÜœ§íá�C‡«w½ÌÞíÛ÷ìx¥ÿzz@QÀbþPŠ D€É‰d²%ý²Ÿ�Þ�të÷�ºcBU„Ùî—¾òñ)»O_0Á6´ºò†¡¼r ZëXøaðûFæÕi•î ðÈðŸql� endstream endobj 129 0 obj << /Type /Font /Subtype /Type1 /FirstChar 65 /LastChar 116 /Widths [ 556 0 0 0 0 0 0 0 278 0 0 0 778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 500 500 500 333 0 0 278 0 0 278 0 500 500 0 0 333 444 333 ] /Encoding /WinAnsiEncoding /BaseFont /FNDNIC+Helvetica-Condensed-Black /FontDescriptor 130 0 R >> endobj 130 0 obj << /Type /FontDescriptor /Ascent 750 /CapHeight 750 /Descent -189 /Flags 262176 /FontBBox [ -168 -250 1113 1000 ] /FontName /FNDNIC+Helvetica-Condensed-Black /ItalicAngle 0 /StemV 159 /XHeight 560 /StemH 115 /CharSet (/space/A/n/a/l/s/o/f/I/t/e/r/M/d/i/c) /FontFile3 131 0 R >> endobj 131 0 obj << /Filter /FlateDecode /Length 1336 /Subtype /Type1C >> stream H‰tS{LSW¿—Ò{ºMŠöRd-Þ{çªñ^æ#!ÙP4 ˆƒ€Rh…b¥¬­­uƒIÆ£EïQÅ‚È:23Œ‹Î9³EÙþ0lc‹saº¤æ»x0Û)‰þ·Üä»9'çû�ï÷84@Ñ4ýVbJBÊÆõË“�f‡ÑnÊ×G®·ŒÅ6£!r�YŸ¿×h‘¤¥%6P ŸŠãpÝó©çå (Ê[§‚áú¼®pyŸŠ  éö¡õ–—ÕTPh–ä/bÖ®y'Â_WûëÚ˜Ù* ñKžQØæ²Ù�ûlÂÆâ|‹µÄbÕÛ�†(Aˆ7›…t?‚MH7ÚŒVÙ}5�`² zÁnÕŒûôÖ½‚e�°ÙTl±»JŒ‘ä�YˆOôņ«`"¶ýy6“Á¤·šŒ¶¨ÿ§HÑä£RÔ2ŠŠ¢¨u• £6QÔŠJ¥©mÔ<¢%£äT•C�¤ÃéjúŸ€¬€ú€á€ïda²=²3� 3¥ „,¯CLBx­SÕ(°ã�ê…Årà˜Ó˜ü¼zºBŽ ¼æE…~€óêE ûh&åFçuLW8éQH��3tº'¼¨@Ji­×!MÀ*úˆð/ˆ20‡–I¤‚f&ä0Ÿ�¹³K—GÚj˜È™Ty5-¥Ê±ûE£¬ý{¹C:øLÕ±8’ÀÈ@dÍì \‡Íꂚò�ÙZ£ãtÿ¥öÎξ³õ\co»¢ŸVà æHg¥×«�¿§_Å1kÆ!‘XhàAdFêj¯ÜÐöv”˜S�$ÚyÖ¾Áž˜�YÍʯS~¿u¡ëó+œÒH¢©Èô@ ^QìS)|êFˆÚrÇx88> ëx|á�‡9ÀtµxÜ­ûèû†›½Þ{ŠÆžú{}ÅèOˆiyå=ý”¡�†ÞAŽ}ÚÕô¡½�¯wÔì¯s¸ËÔµˆi‡d€ÐZ'd8Uƒ >&Tw±ý�OÔÕ·F¹ËY†¶WæææÔŽõqЀw©‰n"®¬F׊ò:ôÚ…æ·Eg vWÄ)Lƒânäj÷õnÞðŸmB~Rãƒ@Ÿêˆ>Xé•õA&`õEtùÓ�áÁæ=Nî}âB5Ä"ÒaY‡ƒk¢³±N3KõI60nŽ•€óütçcÐ)X^ÉTeËH«Sz�9¯™BJ1?Ð@ôCâýÃP¥´»€’Ƙ–¶£Ü@ÝŽB¡š¯Ù)ߌÑíÙIcÎû UÝq>XB¥1,ÎŒ!6š4cõ ´„«½ ÜM¨,þÀ‰þÀ‘ît`j�N¿i„Y;ÛwMSÏŒ�ˆØo%ênm;çæz<'ö{>PÌèìnĶ?H|/3'7÷ WͰ}÷ÐKïé!§ÈC­Æ!‹!èç`�sp�*épð*’Ä&õ@S÷Å‹MÅ®C{«—i‹·÷Vñ³Rè vv0‚È6³ÝC¯¦ú¦Ðu�ÃÚ¶¶šª6žm†d´Ñ�—êâÉ0ÝHù«Ë'…øTM�—ÁŠg°/&Y—â$Ns�EÝÀ -–-ß�ƒòš‹ÎšyöÇ/Ó'm·MŠæòãe¥š{©‰c'³>¾ìáqƒµ•¿m•^{ü̃7±ì¬n„gÇmMÖÖMßÉ–ó£Õc=§´5;¤L"Â}¢À}i«�£U#»éï«?z�ƒ@TZé®rñŽC½<\%>¿KÞ¨ˆc‰•DÀŽéŠlhc½âî9J©*¦Õÿ 0'��O endstream endobj 1 0 obj << /Type /Page /Parent 68 0 R /Resources 9 0 R /CropBox [ 9 9 603 787.5 ] /Annots [ 2 0 R 157 0 R 202 0 R ] /TrimBox [ 9 9 603 787.5 ] /ArtBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /Rotate 0 /Contents [ 239 0 R 237 0 R 199 0 R 154 0 R 18 0 R 153 0 R 155 0 R 156 0 R 200 0 R 201 0 R 238 0 R ] >> endobj 2 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 521.259 33.415 558.5 42.747 ] /Border [ 0 0 0 ] >> endobj 3 0 obj << /Type /Font /Subtype /Type1 /FirstChar 32 /LastChar 150 /Widths [ 278 0 0 0 0 1000 0 0 333 333 0 0 278 389 278 444 556 556 556 556 556 556 556 556 556 556 278 0 600 0 600 500 0 667 611 667 722 500 500 722 722 278 0 611 500 944 722 832 556 0 611 500 556 0 667 0 0 611 0 0 0 0 0 0 0 500 556 444 556 500 333 556 556 278 0 500 278 833 556 556 556 556 333 443 333 556 500 778 500 500 444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 278 0 0 0 500 ] /Encoding /WinAnsiEncoding /BaseFont /FNDNOP+Syntax-Bold /FontDescriptor 4 0 R >> endobj 4 0 obj << /Type /FontDescriptor /Ascent 750 /CapHeight 692 /Descent -242 /Flags 262176 /FontBBox [ -166 -242 1008 918 ] /FontName /FNDNOP+Syntax-Bold /ItalicAngle 0 /StemV 122 /XHeight 530 /StemH 122 /CharSet (/space/one/two/three/Y/e/s/D/i/c/u/l/a/k/o/f/v/d/n/m/t/r/g/b/N/four/five/six/seven/eight/nine/zero/I/M/comma/A/C/S/B/G/slash/P/p/w/h/R/hyphen/y/parenleft/parenright/x/greater/percent/F/L/E/less/colon/O/z/K/H/question/V/period/quoteright/q/T/endash) /FontFile3 5 0 R >> endobj 5 0 obj << /Filter /FlateDecode /Length 4382 /Subtype /Type1C >> stream H‰dUPSW~/á½DÈË‹šh]ñ_°(U¬�ŠÊ"f# R« †l³ã,k-5‹øC;ÛnU`Õ-j!èt©È®‚ ØZ¬´T°ÛU—©´»LëÄ™óèI‡½O;Óív’wOrßýÎýÎwÏ9—¦BdMÓ|JúºôŒÌE›«ÊܶÊ%ÉÎ’iÚ(êiQ"ÎPiqÖ|·ÿ»… x#àd”†fŽš’Ñôëk�åU.GQ±Û4×Ós +“1a©iM�3ßnÚ\Uá¶—V˜6”írºÊ�.›Û^c2­))1Y%T…Éj¯°»‚‰H‹8¹)²)Š�ʉªŽT³êõê u>Ï‘¯xmï0¤·Jƒúñ8˜Æ!RùÕ0&6 YÎb›Íéïéiö··7gpŸ6önÒØ£¡¡G�’†bc^LŠ5ð½b^�~6û´?Ãó‚—0Fè-3&¶eµ0„ƒ˜õôÄÈGÄ4AEõ³£PÏà|–3¡0ñ-}”r¸”!,ÿ6X˜¡ƒÅ=@rÃêÛ ª�_‹³0E‡±#ý²†P�.Ád( ~fAŠbWCô<`+S˜‡sû�Å:\œ…ô<”T"Êo¡Jø‘E䂌¾ Çä7!W€cÄé1–¬®=:ù VE�t¨c¹ÃMž‰T/}NTË�+àâDásg°ã{;ÃíëÇé6Ð@%häâqx$€9,hEk6ZÐŒæ.´€¬]`³5Z4Å›ÍEÀ æ¶ÃÃmñh6pd‹D/§€“C“8öèD"ƒJ_Aû]3ÄÁ†«ˆ•¾$ôÎkÅ”žªca%D½ sï£!&½ôW)†�ÍÌ•>ÿÛíúϺ^JŒ/̬1r{°#Y5L€yàø±æ.¡àÊ'åwõü(½š‘{yý oë|ñýFß}„bÈõÙqOöZÃõæÜûW¯ê{¯–¤ïônÆhcÚvÜÇðC¾žâLÝ‹ëJ-Û^>Þ¼KŠ–D³W=I¯®¦€›œôI†€)ºƒ°„á‹ûÙâ™A‹Á­± Ÿ m,Ÿz0 `&Kdk­óI"Ã;PhQEDn9!”_¹VsCO^3 „ Yü*r «]¥F_�HÃ9†°æ úqséí‹g;õwz ̳—fÇl?Ú”÷T g6H'ÇAÑ\<>±N¨óVÖíÒ­tc2æƒ<¦CÞXô)ðqÃ(KÞ¼{»ƒìÁ@ø›Áiú¦“µ51b ¶½¿Ó’aËÞ€2/(ÿdüàB{ó=Wï¿ ‰Ö*zäƒ~ä¹ð@ î¹Ç·¢ ±„‰XPÿ¸Y„ÉNàp hø1X…Þ�Ï_l0ðûÇl�žmºÌ¬Ý¤ÎƬֳ7�|Î1®þýôå®.w–5«d»×°£qó¹^r>áù¿m»í2ð§×87e¿ ÃPm~ý9¨†_îNh1ð©ým]ï=ÔAØœ>Tø Ey&ª�’Ò$ièÖtiû½àkl𽧇"¶’!å�q:æÙqÑ:äGÍÑw­¥³ÕH ÷˜¦÷¸k�üÚ%Ð"lÌ»xóF{×-�5¢r¯1Ýnsæè¥:«ÿ¿ÎÀòcÍÁò·3Ͼò q%t !‡ùœå‹‡:v[Ö§—¦ Û½ �t””ÿ³„ ÛNÏ2= KIDÓÀ0 è{ÜEíÆÞQ¦Û²ê�=æã|\€ÜKpäÿ¹ã#âÌ_Kœ•g#¤ûÝ' ã},érkÁ…$O¢a–±R"9"K˜'¤Ó�Îé3w9.4’SX�B¼ü ñ"†“füÒ"¬ ¼Àýl¤0$eA–ån�ÆÒIP?…ÀT²¼“�£ÄÈ uôí«gôRœ#Ô‹/( ¢ÃBºܳOé�ÔœÛa(fv8^ø,9™aÃý¾\†õeišXöÒÏúN’v¶ çÖ©DäÂHK¢j@-„Q–`|¯ìÏ 8}‡�£¦à`t²$MƒjÕ/©¡ßGÔ(ƒ ÇÇDáý©37£\„š$ÿ)´z3ú�“KÕC¼3è>8‚rÁ3ôâÑ_ ,>P&C(s_úmî’‹ý6xð¿d¦Ð›Lÿ­Ú¢1ö@¿µBæ²4ãô‘}'x¶|1ˆþ_0]�-ߨÁzQ7ÎÖ`¸xÀ:`óXz÷Z¨—ë'ûB¨",×/#,¹�ƒå—”¡7[bZ9P÷¾‚AWpî ×Y<ëã9Á¹††ffâYO*ªK[)[W�,Û�S³¿–Ç.òÛFÍÚy¯ˆ"� ·±¤’˜xjNÙÒ'ã”aá;wqËÖ6ýô´üY{U~äî"¾­•©ò)ù#‡“f ¥ åOp$Œùª©ôV/�5Më�G&8¤S”‘R2çIΫÈ�”w‡Åcˆ;ôÒÒð ›9=—ŒŒäÙ‹8éÖPWPž§I–åú#ë·†pîkî}k¼Ùr¯2wôiUF˜ò$ÏÉK9¬¥á¯„…^ÿDGÿ¤–‹öŒûg.75jÜï0Ûµ!;¹™Ú¯Ûù´çÊúã•M×¹;y¾«Sx¹!Ê¥\Œ’7$~PÁ0Áåç§6iË…ÜM¾q³í¼f£„_<{ÚW29ë€7ﭲ⬞¼ßgÕ¡(4ùæ€�7ذŽÂa–²C†3VubçîtÎÉe)Zd­¯�àÙÛ3ýB£‚Õ·ã®Äkô2¿]¾;æ«ç·Î£jgaBé°á8ø42éz´©Ùê³y§2NiŽf\8RÁ±½¯»›Lñçc²xÒ˜zemÝùK¹6DgõSû{¯ž¡a{ýܲïò¬LN)ë 7úíÚâ»2¼¢úúÅò¼XAÎDòtTD ã¬Þ[ÅP†<èî÷D-› ½LaQei9×p:ló¦ÄɉsùDT0´”iÌCQ½º#üñhOmðf�žö[€C"è�翦G ]7 RPxÿþ°9õ‘OD»Çƒ¸�Mx ê"Q32'¶À¤l!J'iëw’hX‡E?´áBˆ‚…0ãndz„˜4!ªÿ0*ØÃ:I}òÄ2_˜q%FYnçÖª Yn–Ç~$ÛÕª‚¡TÕß1ç²®V”rå9{Bø]‰þêD `þ×’\ vvê;‘]È,Yê¢iÚx~çí³-P+*hvN+•™#ûz2X+~X¶æ7‘�ò^ž¸üÿD–]ÑŒCd¢Š}i4Cý0ݶ Ž+Ñé)£QÉù% '˜è¶8'L%!û;È?U>ÈÿñÕ³2OGwí”é.áo›ipŒˆ†}&xÒí*2ý,ó cÕaNO×<¦4ûPDÝqk~Mlc:€ƒ‘à<ýgTø„…ìæÉŸ �h+c×’Xœ«¬úó…ÒîQƒ—ó¸Å˽ƒ#ò²öñæSbˆ?ÄSÊúÙ©K`,öÙ1©ï1H\´6X/«Œ :È¡£:£=ŽêDØÝ¾š_—-JïÞ�›"Â"ÖqsBŸ=í¬~Þ]\¬‹9i©Ô1&'B—9¾d¼Œ;Œ<¿Ë4æ—\å>O×ëÓùL°eRbc“c9o½6pÏÊÄä슔Ëä)DÝoz$W¨\S0/+µ×níkæŒ=�`ÅÃ<ºüµº¢*£¤¬foT�æÚS¦&00°‡D,Ô§‚§ØOÑ“æÍEÉÌ´û²œÊ$'­ŽT;4}º ùìME6Œ`=ùµà¬3#Úƒ”H�+”ôµ{™�ÚD‘kä6]7üÍðˆ7€Â°iÌŽD­V=±`> hþkQu9q*ë¹ ( TsÂi�$]ˆž*°‘‚Ÿ C›ü ÏZì‹ÁåÛ¨/¾J¢�ô9ûÏ�:ùî{f‹7 AåeÀ�”�¿§²d�#S6–^P²¦ˆ¢p‚ø×nígpÈNjžÑB­äŒ°mÀ™JåÛ¥ ޽CÑ$-8ƒ� l׊Ãч‚¯ƒ'LCRQ·ð˜ñÝ$‹»Y„¥)¨nƒíU„ªß¸÷é¶~Ì,Öúêc¸½ÔÑh0i6.x¨È4l[³ ¾7â)뱤=ÙÆ-4N„)Äÿ8ÇÿÇ÷`í‹øˆ÷`øˆíüˆ}™ùH™û^™÷8‹Ï“÷¡“ï‹üÿ‹÷ Œ øÀøL £®Â· endstream endobj 6 0 obj << /Type /Font /Subtype /Type1 /FirstChar 103 /LastChar 109 /Widths [ 545 0 0 0 0 0 869 ] /Encoding /WinAnsiEncoding /BaseFont /FNDOAK+LinotypeSyntaxCom-BoldIt /FontDescriptor 7 0 R >> endobj 7 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent -256 /Flags 32 /FontBBox [ -216 -259 1189 987 ] /FontName /FNDOAK+LinotypeSyntaxCom-BoldIt /ItalicAngle 0 /StemV 0 /CharSet (/m/g) /FontFile3 8 0 R >> endobj 8 0 obj << /Filter /FlateDecode /Length 873 /Subtype /Type1C >> stream H‰tRI�Eµ³ÌôÉaÜ�Ú\�XÄ_@‚b‡ˆc$ „4{°ÇKwu¹»ºz͸—êêêÛã1Ï(“@„„à ..Hpä”äÛ±‘(s@ Ä÷.%Õ÷¾å½¯X8w¦P,ŸzíÒ+ï¾ôÖóo¼]mtj^îl7Þo_¬^áåêÖo4V9O̤G.,¶Ù“çŽVÏ?xô÷Ç‚‡G�¯¾ÊÿËãñzáRá,ïRøæÌéÙƒýîÛÒìþìÂòþúò½ù3¥?®Îèüêú¢¹ü­ôàég×§ïÌ®•F;¥W$ z.¨¨°¡­®eغeÚ¶ýååÍ<í'"�Á08�bâ{I…xÄ%NìDV„…÷�!ê®a!ÙB™&ZaŒ¡fh–&`Ím7Äú½Éú Èc&G,¡«HFY’òM #¹çA$~oïŒä�ÙW³f¤´xÓÑ"‚ ¨ê�ª5Õ*5Ô€M¥©¨-Xà'VíºØ ÛD‘I‡�!ìÚÀîàV�b(лP€ÐЍ…:A2AÔJíÔfNê¥.õb_µT¬˜ª©¡®ub ˜Àé´ÅmRÏÛrÞ>PÇúX?2'Ž`O&ÞMé‹»!ý¼ò=Í'ÃÉpüiÿXè“ÛwÅ¡;°û²ÝG9dJ¿Å”ƒÔ£z´í»A'ÐB¡!BD’$–iL#Æ‘†,Hƒ¤÷øT>ñ?Iý\ºs+¢'•z”GÃÁ!›ìftr*R?õ©ìS7q©ðëÚâÚs%Z:æ@†Ž¬k�š*ÉQåöðPÌzy˜Ë!÷ a„¥”qgYìKㆴBµHi‰º§»P~qy¥„ ÃÔL`©®àªÀƒ’÷X�A—ë¨Çf‚™€™›Äý #L&ÜY^–WÏâ,^-•yûÞÀåš8}»oå&3fDš"¶Ayc>Ÿß™m•pf¤zÒ%0�À�VTÏæWi LÀ��Æ ºáÜêŽ[ûBÞÚ![’<T€­Yk¢¿ÀÓßo.Jk‹â29?-¯ý8½“„PZ¦ å—ÆÁG"–öR‰1׿»Û¡¡‰¦oúXö±gzèÕÅÏ›Sñ_ÜôŸ\ö.þ›{qñË&ïûÓtd=Öcå=¶Ç2qäöq.oܸ±ö§FGô× endstream endobj 9 0 obj << /ProcSet [ /PDF /Text ] /Font << /F3 91 0 R /F5 123 0 R /F6 101 0 R /F10 111 0 R /F11 116 0 R /F12 60 0 R /F13 3 0 R /F14 10 0 R /F15 6 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /GS2 15 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /Properties << /MC1 16 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 10 0 obj << /Type /Font /Subtype /Type1 /FirstChar 1 /LastChar 1 /Widths [ 596 ] /Encoding 11 0 R /BaseFont /FNDNPJ+MyriadPro-Bold /FontDescriptor 12 0 R /ToUnicode 14 0 R >> endobj 11 0 obj << /Type /Encoding /Differences [ 1 /greaterequal ] >> endobj 12 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [ -163 -250 1256 989 ] /FontName /FNDNPJ+MyriadPro-Bold /ItalicAngle 0 /StemV 152 /StemH 112 /CharSet (/greaterequal) /FontFile3 13 0 R >> endobj 13 0 obj << /Filter /FlateDecode /Length 433 /Subtype /Type1C >> stream H‰|�¿KAÅw¼ý½�ÑàZ™ð%˜@Èy^ä@l£ Èq ¶†ÕÏÅsGgÖ …\é…‹„0)ûü�#6ö) )-ä 10“Ì™Ù4!EšÇ÷ó¼7 ²ì> !4ú¬¶P«?ôbŸÆaT§dâ iF&¹'Ç�±åTM«£1»÷kÇ_n‰¯Câûð™\¹mºyñ£Aq˜bŠwvÃæ<ÙÖE��ÏÌL•ŒVs�.ÁT¥Rɵ sYŰ´ÏR¼Å`1Y#t›PÝ•a®Ù„¼‚Å ÓWÆüó<ˆà8ÝÀB6bfv#Hiá­�n1É_¸þŸ)ˆÐ]°œÄ†–Rm2“hR·�|e�ì&)�1+ÿó?–…-Ô²úªµd»Ó•—]¤u¼[èØ²ý³žµ]q¤Î5+Þ:¢ç*P§�0�½ñ2w%¿Å¬ÒìÊO�¹”¡AÙëœ#9!‚‚ü >^–ЧÎ}O\«¢óÚS×Êwx’©�à> stream H‰TP»nÃ0 ÜõSd�e4™ /) xèuÚ]‘hW@M ´<øï+)NŠ<€GîHyêž:rä;{Óc„Á‘eœýÂá‚£#P5XgâÖ4“ “¸_çˆSGƒ‡¦ò#çÈ+ìžÕã¾zùÆÙÑ»³úüJD¿„ðƒR„ Ú,Bž^txÕ‚,º?ò¼„ºôj³öç ²¦¡©T{$ûvS\ó­Y\7ëúxhEÚÝØ¬ÊÇܘ…9…+—ÙÜÞŸ|È^¹Ä¯†h¶ endstream endobj 15 0 obj << /Type /ExtGState /SA true /SM 0.02 /BG2 /Default /UCR2 /Default >> endobj 16 0 obj << /Metadata 17 0 R >> endobj 17 0 obj << /Length 38403 /Subtype /XML /Type /Metadata >> stream 2020-09-01T11:41:50+05:30 Adobe Illustrator 24.1 (Windows) 2020-09-01T11:41:51+05:30 2020-09-01T11:41:51+05:30 196 256 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgBAADEAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9U4q7FWP+YdRksNQjvYo p7h7K1mY2kUzIkolKn+5CsJJF9CiE0pyI/aOEC2Ep0w+9/OrU7S/WzPkXXJmKqWlhiWSJWYAlfUX 4Ph3BIanhUb4aXjULj8+XjnuLWLyhrEt7BDDOLYQvzK3ETyRngEaQLzjMTNwor7e+Ck8SPvPzjks hdvceWNSS3sknluLoxusAW3Sd2IkdFBDC1+E9DzT+bY8KONmWja5NfuqTWv1V3iEyoX5sOgKuOK0 I5DpXARSxnabYGbsVdirsVQa6ny1mTS/qlwPTt0ufrxj/wBFbm7p6Sy13lXhyZafZIOKtS6zpcRK m4V2GxWKsrD5hAxH04aQZAKD+YrOv7qKaVe7BOG/hSUxn8MPCWPiBZ/iOH/lkuP+SX/VTHhKPFDY 8xw/8slx/wAkv+qmPCV8QKieYdPI/eerE38pidvxjDr+ODhKeMIu21CxuTxgnSRwKsisOQH+UvUf TgZAq+KXYq7FXYq7FXYq7FWndERndgqKCWYmgAHUk4qwPzN+ZWieXPMtqNQ1elpqcC2+n6abZ+DX KTUeYXKLIx5LNGoXjx25V64aY8Xckt9+fn5ZvaWt1dzQTw3CSyWnOK5cssRKyUBtvh3TvSuNLfk6 4/OT8tIIZ52toGgtZzbXci281InXkCTW2BZQy0qnL7t8KPgox/mj5LbXJZEW0ksgDYfUFsrprj69 CTI9KW5qDGwAATc9CemNLfkvX86fyze+gs0tYWlnMgBNtMir6PMSc+dspBVk40pWpGK/BMI/zk8i WWn2uoxiK1s9RSWW2lWK5j9VLZWeRuP1YNRVRqVG/auNKJeTIfLX5jeXNfjle2l4iGRopCwZeLJQ kOsixyJTkN3QD33GCk8TKEdHRXRgyMAVYGoIPQg4GTHvMvnJtCv7K0Og6vqiXpC/W9MtluYYSW4/ vyHV0HevGlMVTa8u72MzJZ2y3M0UXqiN5PS5s3LigPFxuU6nFWD+abfzbr1rBBFqR8u3ccqPeWix x3qmGhrFVuCnlsRIOlNu+TAaZzo7vMbL8xoQBy89y3MsZjElh+heEjNZoHu4EdQsYkmCGlH+Gvw1 +GjamHksXXr2ztLeyuPzHuJtR1mKG00snSOMkbSzRBGZSeIcJ6isXYMeVdyi4rXk1qnna2mvW+pf mTNbWvGN7a2GjSysim3EsZabipkJA9Vg1Sfs06gtqI+SJ/xjGtqZZ/zIkngS9+rkpo7CT1EaKYQf uEDH4IpFJAoee/2aYbRw+Sna+bryWW2sk/Mx5rq4bhDIugji73cUQtwaJxXi0oYVpXmFJ2OC/NPD 5faqWOo6/rbrYaP+Y63+rz2j3OnRy6PHDGxCxsGLmNlWhrX4Syh+m2K8uj3HytPqDWzQXkpuGgSI NcE8iZSD6i8qCtKA7iu/ywSDOBJTzIs3Yq7FXYq7FXYqhdQ022v40WbkDGeUbqaFW8aGqn6RhBQR aTXOjalFURAXCnZXXirg+6uQv3N9GSEmk4u5hNt5F/NKK+jun8xiahthMrabYqZIoFIliLpOrBZn Yv8A5H7OPEy4PJT1zyT5/aC6vZvNdxp0VvPPdwz+jZxQ29t8LxxTfvlWRYeFWeQ/EOtBWraiHkhE 0X8ytZ1E3WgecreXSkYF0hs7C5RWSiGL1Fn+Lk0blviVl6fJtRDyVz5F/OZAWXzY05HLhG2n2EVe S8RycPL9k/Fsu+46HZteDyTG/wDKX5nSMVtNaeFJZas/1ay5QxBLgjgGMgkJkkgBDU+FDQ1bHiQM fky630bUZj+8AtkGxLUdz8lQ8fp5fRiZIGLvTO10SxtlIjMoLnlIwlkTk38xCFVr8hkSW4Cl1xbW Vvby3E0kyxQo0kjetOaKoqTQMSdhgSt0W40y+0+31TTpGmtNQhjngncykvE684zSX412etCBiqIu rG0u1AuIw/H7Dbhlr14sKMtab0ONoItLpfLq9be5dPBJAJFA8BTg/wBJY5LiYHEFB9B1BPsTQzV8 Q0VPxlr+GHjY+EsOi6t2WD/ka/8A1Tx40eE0+g6lIjRyJbsjgq6mRyCDsQQY98eJfCU18lQtaW9q 62i2tqY2trQWweOEwkGL06sqj06DiQop2wcTLwvNM4vL1mu80ktx/kswVa/KMJUezVx4iyGMBMo4 44kEcaBI12VFAAA9gMizXYq7FXYq7FXYq7FUNe6jaWSp670aQkRRgEsxAqaAfr6YgIJpgvmjV9et NZh1zy95cTUtRe1ls5ZJbz0SkCVnjQxs6xVkmAXkKkV3NNslwtfiBLrn8xPzWjEyw+ToZp1ef6vH 9bjVZIonhWNzJzKIZVlduBNRw712eFPiDvULnzn+a17Y3lre+SrGWBouP1eW6hmjuUMyxyQsjSBV 5wszjkSu3E48K+IO9KNJ8wedNFuo7m28p6doQMccEmjWt3D6BiZ5XkeO3heJPXWRolqFPL1AB0x4 V4050r8xfzcvLSKebyhb2/rQiVOdwqMrOzcEeJ3V1Kx8S/Kh5bUx4VOQd6MXzv8AmstuxfyzZPP6 8yIiXSqvor6ZhcsWJq/NwRTbhX9oY8KPECceVPOHm69tWm8xaFHpcoagtorhJnp3YMpZD7fEMeFf EDIzr1i9tM9vLE11Ep42s0ghJk41VGLA8Qf5qEfPBTYDbF4/PWpSWmow+YdPh8v84o4dKuI9Rhuv rNzNBI8kaeiEeIxMnFWanLtTEKeTzfzZ+YfnHyzd/U9V1zRLK5e2WaKOWTWJGJe5ZFbjEWqnooQa GvMV2XJFrjv3pQ35webZHkSHzBoq8IPVrJHrooREZia1+yyRyOtKnah+LbAmve1rP5wecNPvbqwt Na0q7msS1vMrjWDN68EbGYScPTi+3BKF4Vr8OwG+KgX3og/nDrI1HUbObX7C2ure6S1tYGXWHjZE mkSV5KIGVv3kUY+PjyVj0wrR816/mj5qlvBI3mLS49LpJdxmJNbadrWEJO/MOpX/AHnlUkrQ1O3Q 4or3qGmfm/5tvL6e3OsaVSG/tdPDqdY4O9wZ/gj6vzb0gAzDgKH2qEke9l3/ACuzyAwl9LWL2Uwo ssoVb9eMLKG9X4wnw8Wr4kdAclYYcM2X6Tqtrq+m2+p6dfXE9ldoJLeb1rheSnoeLsrD6RhoMDKQ Rf77/lpuP+kib/mvGgvGXfvv+Wm4/wCkib/mvGgvGXfvv+Wm4/6SJv8AmvGgvGXfvv8AlpuP+kib /mvGgvGXfvv+Wm4/6SJv+a8aC8Zd++/5abj/AKSJv+a8aC8ZUfVufrno/Wbj0/T509eXryp15VwV uy4jTLr1rRbOZ7wK1rGhkmDryXig5ElaGtKVytyEksrHT9V0601TRrwmwvoUuLZ5Edw0Uqh0YBzH ItQa0b7hkhJrOIKv+Hrz/lsj/wCRLf8AVXDxo8IMU83flfod2Jtf1WOfVJ9OUXkFpapcGQyW61UQ wxXEYeQ8aKrd+lKmo4mQhXVjPlv8qvy88x3w1FtGn0zUoWN1Fbaml3a3f+9EjGb6sbs/uzJupI70 p2xtPCe9mGi/lDomh3FpNpLi0+pQNbQxr67p6TSSTUZZJ35UknkIJ/m9hR4kGF9WQ/4evP8Alsj/ AORLf9VcPGx8IKsHl5Aa3UxmA6IgMS/TRmY/8FTAZJGMBNYoYoYxHCixxr9lEAVRXfYDItiH1WB5 9Nuoo05zPDIsS7A82QqKE0ArWmIQeTBNd8sefb28SXStTl0q1ERR7YW1ncEyFZAJOcktRQuh40p8 PucnxNIx+SR2P5f/AJtwyvLcebp7l3eMn/QLFFEcYfkgT1mQcy6ksBX4cbZcHkmVz5Q/Ml45Ette miJJ9KR7OwkcL9X9Mc6SIrH1v3tQo/lpxx4kcHkhNQ/L38wby+llOv3K2Ukoc2Bt7Ro/REgcwn99 8SleaGvUNvUKBjaRHyXxeQ/zFgsbm3tdelgmmaJobhbHTqpxVRMzrzAkeUqTyPSvTpjaODyWr5H/ ADMKWkba7PFFaXDSNSG1kknhCxCNHkMiEUaOQtXlUPQklVONrweSjL5E/OArD6fm+VHRQJidM01g 53q1PVHHr4435p4PL7Vw8hfmuJGb/FdxxHqekn1HT9uShYwxMp5enVj/AJW1emNrweSjN5P/ADfb T4JrvzQNOeKz46jws7GWP1lVuc6zO8BVdw1OApTG14PJZB5X/MPWDDqGjedjNbR84JXt7XTbiJmE zM4BSbgHVeMe4JFD/McbXg8le08mfnL6d9Dd+Y95EgFjdR2diWjZHb1y0RZV/eoqkVYhSzCnwglt eDyQsvkb8y2mtdOfzlOLkW1w80a2tmskskjShbj4bkMix+ugVB8PwbU7Nrw+SKj8lfnCjzxL5jIh WSCS0nktLKVyi+r60EkfOP4W5RUf1S3wnpXG14PJz/l9+asls8Uvmy5Z2oyyrZWMZEiiMq37uZfh Dxk8K0YNxao6trweSe/4Z86/UeH1xv0h6lfr3o21fS+tet6Xo+rwp6H7nlyr+11xtHBtyT7U/MV2 kc1F+oCJGkb1l5TcUFSwX4lpt1HKvbfAIplMh4rD+b/mmO3065vtb0UpqHMxJE2sRtIHDR2xT1lj WMPcRScml4rxHXvinfzdc/mp53sIYJtQ1nRhHNO1uZ4BrE8PO3LGdEEfJ2bi0ZVhVNm36VV+atYf md5xubuAwa3pLWF7L61n9aOqxXLWvOctRVUKAUtpDEzU2UcgSwwqfioz/mveW+oT30mqaU8iQmRH RNX+sNYy28l1aL6jKqcn+FmWtBuPtUxWj5o7TPzJ813vlKPUpNb0mLUbmWKGBVbUxFG9zvbrKCzv 8fFgWoF7A1xQbvqluk/mx5qhhl/SvmTS5vqoY3jxxayXjM9sPqVIxHFXlMC0w6hagcTsAk35pjcf nFqA8wW6W2q6f+g5YYLh3mk1VbgLIOR41i4sXQMyDhsAeXudkUa6vXdN8w3rJErRG+aRFcLEOMwD Cu4IRaVNKtwA74DFYzJVPNFz52Omj/CttapqQerfpQc4DGEb4R6EyOGL8Pi3oK7HItqO0u71r9G2 n6Vsv9yfox/XvqrJ6Hr8R6npepJz4c68eW9OuKon63P/AMsU33w/9VMVbW8b1Ujkt5IvUJVGcxkE hS1Pgdj0U4qiMVdirsVdirsVQmsM66TetGaOtvKUPgQhpiEF4MvnDVfINwdL1q50u2s6/WFttMXU IppGu2laNUjiiMAZnhdQSxJ4jkamuTawSeVtT/mz5ltFhku9S00rf6fNf2AgbV5QsfDlDNNJxUem vFvVQD1OgAriu/mpXH5lao9xJf217pa6lHCkVvdXQ1aMrb3Ny8aliiyMI2kWAcWKnlyJ4jjiu/mq D82PMt3Nd29hq2mCWOZLW0ecasI5Z7i4CQoaUkBWErzPDiWYENxrRTv5rH/OXV5LmUabqFrc236Q gtITMNThb0bhpU5ktQtwk9NPhTs9eqnFaL0D1/zF/wAHcfrNh/iT67w587v6nx+q8+PLl69Ofvgr dHFtb0W4tbe5j9OeNZErUBhWh8R4H3GRbSEj1qy0rS7Brz6hfX1JIo/q9k880x9aVY+QT1F+FOfJ z2UE4eIsOAI7/DulfyS/8j5/+a8eIrwBSu/Ltp9Um+pofrfpt9X9ae49P1KHhz4vy48utMeIrwBj flOy1c6jeaV5tFp+lQgurOLSpNQMAsyxjBkknP8Ae8xuoPShA64eIrwRZO/ljRXZGeF2aNuUZM0x KsVK1X49jxYj5HBxFPAF3+HdJOxST/kfP/zXjxFHAEPB5N8tW9pFZwWYitIOPo2ySSLGnBgycUDc RxYAig2xsp4Am0Ftb28fpwRrGnXioAFfE++Bklek+Y7a5sI57+W0srpy/K3ju451ChyIz6gCA8kC sRTatN6Vw0iwjP01o3/Lfb/8jU/rjS8QU/8AEXl/0Wm/Sdp6Kcucnrx8RwJDVPKg40NcFLYQV/5k 0tdS0qBJUmjmllaS5jkiMUISB6GU8gRzLUWgO+Gl4gj49e0KReUeo2rrUjks0ZFVNCNm7EUxpbDf 6c0SpH6QtqgVI9aPYePX2xpbDUevaHIiyR6javG4DI6zRkEHcEEHpjS2EXBcQXEQlt5EmiaoWSNg ykqaGhG2xFMCV+KrJ4Y54JIJRyilUo6gkVVhQiooRtiqA/w7pX8kv/I+f/mvDxFhwB3+HdK/kl/5 Hz/8148RXgCg+haaL2KILLwaKRmHrzdVaMD9v/KOPEV4Ar/4d0r+SX/kfP8A8148RXgDv8O6V/JL /wAj5/8AmvHiK8AXfoHTPQ9D039P1fW/vZeXqcOFeXLl9nalaY2nhFUjZlmaF1hdY5SpEbspdQ1N iVBWvyqMDJiHmfRPNl5pk8FvfvDdOtIr6NEuFjoftNaP6aN8qMckCGsiTDLjyV+YFxctMvmJ7OHn IUtotGilCqbhnj/eOikkW5Ee69fi3OG2NeSIj8m+c1sHhfzBM92yAJdHRoAFcCccvTCUIPqxGlft R9aOVDaKPcuk8secJ/Vj/S31SYSyOPR0pJKQyCNYgBInw8WjkO/L7VCTxGG1o9yEfyH55kfS2k8z TUsyp1BU0aOMXfGf1P2d46pSM0qO9NyMCd+5GTeT/N7+tw1yVPUDekp0iMhGLxFeiqxULHIpHIE8 68hxGNoo9zLdC0bzLbWwja7cMZJG9eQJGvpySM0arbIHT92hC78WNKncnASGURJQtvy0sNO1e78w aKLXTfM1+pS91RIJnEiy3C3Fxyga4MdZWX7VKjx2yLawuf8AK78ttTEl1qFgslzfBJLw/W7iMPIo qGZElVaippttllBx+KSyH8nfymglSWLS40kR/VQi7udnHQ09am3bwxoLxyS7XvI3k+xEcGleVP0s FhWPimoPbj0jygdA8soUssUzkcmFa7HuGgkE97Grjy5eafdWF1o35d28F5bxhIH/AE6FZD6BJpxn j5srzOvLqQp3+IEBlfefsTnQvJHlu0uWtn8kjT7K7lnt55l1Z7k+mY2t0lKCQ0WWC6m7grTx4nGg gk97JLf8qfyvgR0j06Pi6PG3K6uHJWRZEbdpSalZ3367/LDQY8UlO4/Kb8spYHhSySHmYizrO7ki HhwQiVpFKUjUcSKY0F45PRvJ+nyWPluysrCWNLK1DwWyvGzsI45GRasJFrsPDIFujyTn09S/3/D/ AMiW/wCquBk709S/3/D/AMiW/wCquKu9PUv9/wAP/Ilv+quKu9PUv9/w/wDIlv8AqriqCtbfVo9d kkvLyO4tpY3NpBHD6RhA9EOC/N+fJqt0FMVTbFXYq7FUp1LVdNlt5rTibxZkaKVIzROLgqQZARTr vxPIeGEBhKYDD9R86/4NsLDTbbSLmTS7azlEH1OCS6jtoLCDkkUszzIeTqoSPl9pvDDwsRktAS/n Pq0c0yf4T1t0hd0MiaaxDemwUutZxyVuVVpud9tsaZcXuVNU/MGXUtJksdW8vaimn6lDNBeo9o6h E/fxyLK8NwTGGEGzhuNHQ8qEkPCjjY35d80jy3eLdaD5a1mPTdSt2eezFrLOga1tlZJmaSaWQzSI iQovqcWpX7VatJ4/czWP8yNYb0+eh30fq3AtwDaElVMiRiZ+MxCx/vC1a1CqSQOmPCjxFO1/M7VZ 5oo30LULYSFwZJrF+KmOBJ6H05pPtepwU/ZLqy1qBV4V41Xy3+Y+s61f30DaJd6bBZCPjLqNs9sL guXqITzkBACD4vf7OPCg5KZda67ZykJNW2lOwEhHEn/JfofYGh9sBDOMwUutNa84yeaptNuvLSwa AoYwa+l9FJzp9kNa8ElUt9IHjgZMixV2KpfqFhZzalpV3LEr3NrNJ9XlPVPUgkV6fMDFUwxV2Kux V2KuxVIfONhpd9Y29vqOnx6jC8rosUsjRqvq200TtVQxPKKR0p4NhAtjKVBJde/MW60IQJ/h68v4 3X7Wnh7kRhXSOjhY+VaSctgfhVvpJixGS0ntvzsv5/QP+CNdiWeRIyZbcr6fNynJxQkKvGrGnQjG k8fuSp/zg8wz6kurw+TtejtbOEwNpksHAzvODL6q0jdqRJblSA27ugNMaTxBHR/nrqLrzbyF5gRS QFDWzcjUNT4QDTdCN+lV7HYUvF7k30X80tS1PWJNNPli9sxEsrte3Qmit2CMgj9OR4ByMgkJ47Ec Tt3w8LE5KCef4rvfrv1X6jHX0/V5fWG/m40p6WHhR4qY3OgWj1a2P1V/BRWP6Y9gP9jTIiTKUAWL eYfy6v8AWruwuW1GeybT2Z4hZXTQK5ZkJMi+i9fhQpsfssw75LiYjHSSSfkxrMlqtpJ5p1gwJGsa uNRcTsQ07M0knoEPy+sAfZGyL1pgtPD7l3/Ko9Ts7cM3mnVFtouUl1LcapKxKCB4j+8MaiMAv6hP iO3ZteD3Jdon5bWWpQ3cOh+cL+7jiVIbm7s9Y9Yif1TK7OyQuvrtQB+X7BAoBja8J8kyt/yY1GGC WL/E2syGWlZX1STmKGI1DLAu5EPH5M3jja8J8nH8mtU9VZB5o1sEQfV+P6Uk4n90YvUKmCnqfFy5 fzAHG14fcnmgeQtT0fkv6SuL4PHHFyv7uS5KiMueagxp8Tep8RrvRfDDxIOO2S2+gWaitz/pTnqJ B+7+iPcf8FU5EyZRgAlOheYvLerS30TaY2mvYyiFvr8MMKykry5QMGdZEHQsD1xZpty8s+Nl/wAk sCu5eWfGy/5JYqviuNAhfnDLaRvSnJGjU0+YxVW/Sul/8tkH/IxP64q79K6X/wAtkH/IxP64q79K 6X/y2Qf8jE/riqIililQSROskbdHUhgabdRiq7FUi85eXbnX9IFhbXs2nyeskv1u1kEUyhK7I5SU CtaGq7iowgokLYS35MXj3kt4/mHVmung+rRy/pBg0SGMRuYuMA4lyqu3YuA1Nhhtjw+5Tf8AJTVS 7Mnm3XoweQCjVGYAOnBqc7d/mK/ZO60ONrw+5f8A8qiuk1azmOu6q1xFAqcv0i49RLdjQSkQBnq0 9TU70FfdtHD7lU/k5cfU7m0TW9SiiuDGy+nqDr6PpxtH+5Ah4ryL8223ejdhja8HuV0/Ki9jt9Og j1rUY49Na2MYS/kQSpaqV9OYLCAyS/7sG1abUx4l4FX/AJVlqf6K/Rv6XueHD0/rv1j/AE3j63q/ 70ehWv7PKnPvy5b48S8D0PItjsVdiqyaGGeF4ZkWWGVSkkbgMrKwoVYHYgjqMVSzTvL+n6I8w0LT bOyt7ji00Fui2qGQVrIRFGQzMCASd9sVRvqal/viH/kc3/VLFXepqX++If8Akc3/AFSxV3qal/vi H/kc3/VLFUPqD+Yjat+j4bNbrknE3Espj48x6lQkYavCvH3pirzTWfJZ1W1a6/Tut2BeOGQwaZd+ iB6ETLxiUq1OfOrD9ogeGW043FTAHvp5rxEjsvzERLyfnKzsY0hSRlYhePPioKU41BClt+2RZ/6V ScRzaJbzaLd+d45jeTPcTKpu5hJasyywXKRSKOT8BGnMmlFrtXFPXekfYuh0u4so7bz9At/LBW5Z QlxEzM5kdafCisYeUrUJPL/KxQfgq3UeneXprvX5pvNtxbWd/Ei8LgXXrGzZ4WUh/wDdDvK1Q0m/ +TQrhRz22QHqX0dk179X8+XlzB9VktLWSV1V41k+Hl6cQUvxT98GVuv2q/EAn5Mp0LyXbazpEobX vM6Rp9YsJob+74yEq00buRwo9fWqrHsF2+HDTEyroHp3ln9PxxOnp2j6WpcWZ5yLccxNJ6nqfAyU 6ceP05CXNthyTv1NS/3xD/yOb/qlgZu9TUv98Q/8jm/6pYq71NS/3xD/AMjm/wCqWKu9TUv98Q/8 jm/6pYq6OO6e6SaZEjEaOgCOXrzKnuqUpwxVE4q7FXYq7FXYq7FXYq7FXYqxTz9fanaQ2LWOtJon 74NPPMkLxSIJI19E+sPhaQvwUqe/c0wgMZSpCWP5s+Vr64W2tb+wkuZGKRQfXFV5Kb1iVkBkU9mS qnscPCgz8lR/zR8tJD6z6jpqw81i9Q38QX1GXmqVpTkV3A8MeFHH5FAS/mP5BjiE082jwoztGDNc wxkupowo6Ke4NfA16b40vF5JtZa1o99brc2VjY3VuxZVmhkSRCUYqwDLGR8LAg++PCjxB3K31y0/ 6tNr96/9UsPCV8UKdxdRtbyrb6XaJOUYRO9GVXp8JZRGtQD2rjwr4oU9NlWDT7WC6020muYokSeV KKrOqgMygxkgE9KnHhXxQiPrlp/1abX71/6pY8JXxQ765af9Wm1+9f8AqljwlfFCIi1uSJBHFYxR xr0RZOIFd+gjwcK+KF3+Ibn/AJZE/wCRp/6p48K+KHf4huf+WRP+Rp/6p48K+KEZpmqNeyTRvEIm iCNs3MEOWH8q/wAmAimcZWj8DJ2KuxV2KuxV2KuxV2KuxV2KuxVj3mm2trme0iuIkmiKSkxyKHWq tEQaGo2OTi1ZXhXmzQdH0K9jtZPM1lp1wsKN6J0CyuT8bGKAgJGoUBnkWP2+0TQ1SiJvp9qQaW2h XUdpYHzXY2s8p+sBV0CCb1i8/wBWtphG9v6UANssY4qfhLGuw3WRvu+1VH+EpI7SW9822s0btHev DJ5YtnEsBla3Ut6ULcTKOKqSeQ22HQKN+77WWadr0OnwWEcXnRIbNbRr4wQaH6KTwAuWuAFT4Sxm QtxG5XYCrYWJHl9qHuvPUek+ZXjvfP8ALcjTH43mh/obi8/HhCUE4WNOTy7h12+Lb4cbXhscmXTf m9+XkKxvLqwSKWFbhZGguAvpyBmjJrHsXEbcR17dSKmwx8Muuvzf/Lu0vJbG41b07yF5I5bc290X VoV5PVRET06Ho3auNhfDKjffnT+XFnbPPLqjEI8sQjW2ueRkhCFlFYwB/erQsQpr1wcQUYynPlbz v5c80rdPolybqO0MYlk4sqn1YxItOQHStGHUEUOEFjKJHNPsKHYq7FUx8vf72Xn/ABjh/wCJS5Cb fi5J5kG12KuxV2KuxV2KuxV2KuxV2KuxVI/MP+9ln/xjm/4lFk4NWXk80/MuLzfb2yalod/dfu5I Vi0+y063v5lekqvMpmIp8Mgr/q8ajkThLXCurGtI1TzvdnUrCTUtWttU9WyrOdDtIHQStJZiZ0We QyRs8Xqs+wCxmnwnjiyIH4Kh+mPzCvtLhmsr/WxpxsbGO0mi0u1mlu3lge4luWPrq6KUjCGkoIdx vXBumguWw/MP6pFYjXNQNoIYHhhi8uWaW8cIMK+isUsi0ZPWU8WSqiN6Dahd1sfgsj0q2856o139 R1q80SFv9LigvdJgVkF9E7rGGLFXaKU85Pi5cvhalcLE0GUW2gTz6e9l5iuYtegljhWaK4tYViaS Mks/p0YUZuLBTXiRscLC+5Oemwwodiq0RRCVpQiiV1CtJQciqklQT1oCxp88VXYq7FXYqmPl7/ey 8/4xw/8AEpchNvxck8yDa7FXYq7FXYq7FXYq7FXYq7FXYqkfmH/eyz/4xzf8SiycGrLyYb550rVt U0aOz0uW5t7iS4j53Fnc/VJI4xXkxcfEy+KruckWqJALz3TtL/MyC+1KW1tNSurOFoJ7JZ9djm9S a2vPUntQf2FeNvSbmNuBrXlTI7thMfwEx0vyx5uiiuba5tNUW5u7a3ju9aj1iMSySW6S24MasJGi 5K/rUqfiI7ruaQZBZoPmH8wfLtov6V8s3M1ld3cZe9udWgu2iF1KsaqhSN3ZEVlJaR6daELQY2VI B6vSdOvpLi2tvrkS2epSwrLcaf6qSvE/FTInJdnCM4HIbdPHC1EIkTRGUwh1MyqHaOo5BWJAYjrQ lThVeSACSaAdTiqlDd2s/wDcTJL8CSfAwb4JK8G2P2WoaHviq0X1kWiUXERadnjhAdau8dearvuV 4moHSmK0rcl5FajkACR3oen6sVcrKyhlIKkVBG4IOKt4qmPl7/ey8/4xw/8AEpchNvxck8yDa7FX Yq7FXYq7FXYq7FXYq7FXYqkfmH/eyz/4xzf8SiycGrLyfMV3F5Vm1Ceym8padd6glys11br5gMcc lxcNNGVjLTejHKZIVLR1LcTTjtXFO/f9iaXMfleLWTbrpGn2Ok3guW1e/TXraRlubi0eK5j4yvyR kecR1FF+IEjccVG9fsS2RfJsI5jyZpUJlkh/RPr68iLMluJYWuvVaQKUjKxqEp+8JLAtSoU79/2I ux1Hyjp91JYHy5Y3E89s31i7stY528cdlFxiS5b1Z1t/iWKNHkYKWbcihqoIPe1qdj5WitrS0n8r 2UrH6vYXcT+ZLeJ1e3RFFvN8W7Ru5LemFbYbUOKgnv8Asa0qbQ4kvI7bydpyQagjRTJHr/qmb1le OOt6GeL988ckYQsrct998VN9/wBijqx8qlWW48l6fL9XtjGip5qjDSWVvGk0RCI/N1aMCRQR0APh ikX3/Yyny3of5XLoOoWGs6fp2g2MlyguLVtbNzHJLCarzb1UKMu3wnffCKYEyvb7kbLo35JTad9X e+gmjuprmWMLcs86lo0e5iAUmRR6UKqysOQFBsaY7Lcllz5X/wCcf5bqfUZms3mkLG5uRe3BVWLx RuzssvGNg9xGCTQgt88aC3Nk2ia9+WOjx3cOl6xp8ELMlzct9cVo6lI4FbnJIy/YSNSFO1Vr9oVO zAiRTG68+eSbQTm416wjNt/fKbmIsp+I8eIapb4D8I3xtHCe5k/lG9s757m6sp47m2eOIJNEwdCV eVWAZajZgQffISbsQZHkW12KuxV2KuxV2KuxVbLLHFE8srBI41LO52AVRUk4qlv+JtI/nm/6Rrj/ AKp4aLHjHe7/ABNpH883/SNcf9U8aK8Y73f4m0j+eb/pGuP+qeNFeMd6X6nqWlXskMiXEsTRB13t LhwQ5U/yr/JhFhjLhPVjj+U/ITzGd7CyaYyCYynR3LGUdJOXGvL364d+5FDvWp5O8gK0zCxtC08j TS8tJlaryceZ+JTTl6ak06kV6479y0O9Ufyt5FdLeN7KzZLQcbVG0dyIl5cqRgr8I5Cu3fHfuWh3 qUXk7yFFLdSJawf6dz+txnTbhopPUKl+URrH8RjUt8O9Md+5aHeqnyv5FN4b42Vob1m9Rrr9Dv6p ehHIvx5V361x37lod62Dyn5Ctyxt7CyhLsruY9HdeTISVY0UVKk7HHfuWh3qc/kv8u52Vp9MsJWR FjRn0VmISNQqKKp9lVAAHYY/BaHerSeV/IsqTRyWVo6XLmW4RtHciSRiGZ3BX4mJUEk+GO/ctDvW R+UPy/jufrUen2KXO/79dGcP8Q4n4gld1NDjv3LQ71sXk38v44JYFsbQwzs7TI+kyuHMrrK/Lkpr V40O/wDKvgMd+5aHeqHyp5DPOtjZn1E9OSujv8SUUcT8O4pGop7Dwx37lod7TeU/ITOXaxsy5YOW OjuSWDFw1ePXkxaviScd+5aHenfl1vL2hwvBbSSiFqcUW1uVAPN5GPxK5JZpSSa4DaYkDqnH+JtI /nm/6Rrj/qngosuMd6MsdQtb6JpLZiyo3BuSOhDUBoVcKejDAkG0Ril2KuxV2KuxVB61GZNGv4xs Xt5VBPuhGKvn/wAw2HkGXUNTa+87anHcafe3BvILe7u2NvPNMkXoIsdm7cIpok9JRWlK7jJW1iJH cyGxm8sx6onlWLzZd3GsoZtJfnd3ckpuHRgecv1b0lmjEbFW2oetcPEjgPknh/KPWOV0y+ZNWQ3U axmmpORGUmSb1Ig1u3Bzw4HsUJFN8Fp4D5IP/lSWrRxItr5n1eGQO7yynUpGaT1Bxb1P3A5MqABG avGg69MbXhPkuuPyRvZrwXI8x6xEVT00ij1SRVUcOJ4H6vzWtAxCsASBttja8J8mU6N5P1TSrP6q tw14vIv6t7dyzy/F1HNoq08B27bYeJicZKO/Qur/AMtv/wAjX/6pY8SPCLv0Lq/8tv8A8jX/AOqW PEvhF36F1f8Alt/+Rr/9UseJfCLv0Lq/8tv/AMjX/wCqWPEvhF36F1f+W3/5Gv8A9UseJfCLv0Lq /wDLb/8AI1/+qWPEvhF36F1f+W3/AORr/wDVLHiXwi79C6v/AC2//I1/+qWPEvhF36F1f+W3/wCR r/8AVLHiXwi79C6v/Lb/API1/wDqljxL4Rd+hdX/AJbf/ka//VLHiXwi79C6v/Lb/wDI1/8Aqljx L4RR2gW09ut7HPxEn1ivwEsKGGPuQv6siTbbCNBNMDJ2KuxV2KuxVDan/wAc27/4wyf8ROKvGvMX m3804/MQttKOumyfUruzcf4fhMcUQYpFMtx6j+pCnqK0bFB6gU1I6Yqio/NvnnTH0+4v5vM+qKEt 5bu0g8twBZVkSGVk/duWhkUSMkvxmjAhRVTyVZLf/nFp9pq7aX/h7XJJGuprG1vBaItpPcQK7FYZ mkHPl6TgBQWqDUYqjX/MrjFHIvlXzE5e3luGjFhRkMUayGJuUij1G5cUUE8mBAOKoGD834rl/wDR PKXmOeEO8TTjTyqh0keM1DOGFDEeQI5LVarvsqi/Kf5m/p7ULXTrryzrmh3VzDJKr6laejByhC+o gk5Fv2/hLItcVZrirsVdirsVdirsVdirsVdirsVdirsVQ1p/f3v/ABmH/JmPFUTirsVdirsVdiqG 1P8A45t3/wAYZP8AiJxV5FqnkfzhL5nF1LH5lnspL59RLReYIDaW4gnnlhhjtJIlLK/CIhKHgGUB /hbFUq0/T/zmgeJo9H1lJoHhFjcXXmK3uIbhYnDD63bypG71HJpAiwsyDieLVJVZu3n38yDqRt4f JEMlqZLmCC4/TVlWWWBCyqEALAlkZWWhK9T0OKppJ5o/MBIruT/BLyGKWFLSKPUrTnMjxO8sh5+m sYikVY6ciW5VGwxVM/KuueYNVF6NZ0CXQZLaVUgSWeK49ZGQNzDQ1QUO1AT861AVToXEBUuJF4hR IW5CgQ1o1fA0O+KrPrtl9We6+sR/VYuZkn5r6aiIkScmrQcCpDeFMVU01XS3RHS8gZJJjbRsJEIa dSQYgQd3HE/D12xVXkuIInijkkRJJ2KQIzAF2ClyqA/aPFGag7AnFXQzwTx+pBIssdWXmjBhyRir Co7qwIPvirop4JWkWKRZGhb05QrAlHoG4tToeLA0Pjiq5HV1DoQysAVYGoIPQg4q3irsVdirsVdi rsVQ1p/f3v8AxmH/ACZjxVE4q7FXYq7FXYqg9akMej38gFSlvKwHyQnFXzprOp/k1Y6zdzXcUL6g 2pzS3kkcGrNxvrJ+czcRdgARm6djxHAjl12yVBgJSPRMobD8o5LP14o7NrW+gvNQH+j6vSSELH9a kCm58FTaletBXlhoI4z3IBLj8lptUup62gurDlcSzenq1A4uRO3BVvKs/qsr0Vemw+ywUUE8Uu5L tO0T8kblNWeyeO3t4zHYzL6OplIp5Ip2MkQe4kYuyCRGLVUcNgK1doKZS7kzMP5JPpr3pW0NlFWC WT6trVVNmLdSjD6zzHACHY9aV3o2NBHFLuVtHg/JzV7vTNAsFtHuollh060aDWI9kma7lX1GulVu MsTNUsdxTwGNBTMjon0f5I+Q4k4RaPZoOQfkrakG5L0+IX/LbrSuHhY+MjL78p/KF9ftf3Ok6e10 /q83VL5AfXLGT4EvFT4jI3bvjwr4zrD8rNBtNO+oNb21zH6ctuZJEuUf0ZpLhzF+4uYVAUXkqKQK 8TQk0GPCvjKDfkz5Ha2+rNo1g0QRYlDDUCVVXMgCMb3kvxOSSpqa748K+MuP5PeSzd3N4dJsjc3Z lNxL/uQq3rq6S/8AH98PJZW6fwGPCvjLNa/KLRtTsvqkcn6OCW7WtvLZG6R4opbl7qdR6lzKriaS Q8xIGFPshceFfG8k01nyBpGtBxqlvb3JkWFJGLaghZbf1PSUlL1dl9Ztv6Cjwr4vkyPS5td02wis re5tWihBCmS3lZviYsf+PgDqeg2HbHhR4qK/S/mT/f8AZ/8ASNL/ANlGPAnxXfpfzJ/v+z/6Rpf+ yjHgXxXfpfzJ/v8As/8ApGl/7KMeBfFd+l/Mn+/7P/pGl/7KMeBfFTPy7cXc8d6920bzfWKFokaN aejHT4WaQ/jkSKbIysJtgZOxV2KuxV2KoXVkV9KvEYVVoJQw9ihxV5XqWqa5HdahBb6z5RtwtyYd NFzqd60nD13QLcIJY6SiOJwVU/bU9gclxFhwBubVtTudWvodP1zymLCCSTgv6Uu5LtIOLiJ5QJAi Pz4chQild+mPEV4Ah1TzDaS3E9nN5Rto53QX2pG+u40ku/XmV4yEl5SSLawr9sqeat1X7LZTwBMp 59didrb9LeWBfTLBdWMMl9fKXtGllEshT1ixBT0ljdfh5c69hjZRwBZ5Q8xWGo+YYtN1LzB5bulk soyLbSNQupLiS+ZjzEbSTFGiCI3wir9CaDqOIp8MdzOdNtPKmqQG40y6S+twQpmtrySZAWRZAOSS MN0dW+RB748RRwBF/wCHdK/kl/5Hz/8ANePEV4A7/DulfyS/8j5/+a8eIrwB3+HdK/kl/wCR8/8A zXjxFeAO/wAO6V/JL/yPn/5rx4ivAHf4d0r+SX/kfP8A8148RXgDv8O6V/JL/wAj5/8AmvHiK8Ad /h3Sv5Jf+R8//NePEV4A7/DulfyS/wDI+f8A5rx4ivAHf4d0r+SX/kfP/wA148RXgDv8O6V/JL/y Pn/5rx4ivAHf4d0r+SX/AJHz/wDNePEV4A7/AA7pX8kv/I+f/mvHiK8AX6VaQWrXsUAIT1waMzOa mGPu5Y4ksgKR+BLsVdirsVdiqG1P/jm3f/GGT/iJxV5hr/5K67qWqPf23mHTbRmklcep5b0y5kAe 4edAZZBzJTmBy7kcj8RJxVE3f5N6jPYPbjWtPWeaH07m5by/pjmaRZHaN5EZOBCRmOPjT9gHqcVd e/lFrV86JPq2l/VIprSY276DYTrK8UR+uSEOB6bXc8jOaFinZviICqje/kzr8urXGo2vmW1tnlNr HHF+hrVlW1tiZHtTxkQmOabi7AU6U3xVHWv5QQ2txFNGdJa4S0aJLz9C6ekkV2s/OKeNUjU/DAfS 486DipoSScVQtt+Wn5l6Poc1poHneC3uy80qAaPaQQOfRhitouEfOOFY/QIZkiNQx+GoGKptqfkf 8wbqS6ltfPk9pJLPbSW9LGB0jht0esRQOgb1ZXDuwpUDgQRSiqHb8v8A8xjfi8H5g3AItuAi+oxe n9bMCRNccBIEK8k5iErxBJpuSSq1Y+UfzgstV0+Wfz1Hq2nfWFk1aGXT7a0kMKBvghMaTij/AAhh 8J2JDAnFUT/g/wDNE2TQn8wSLn4OF0ukWYpxCh6ozMp5UY9qV9t1UOvkr81lguIIvP7QkzerDdtp 1rO5V2ld0McgAQAyRhaOdk248qBVTm8lfm3b3F1d2Pn36y1xeRTrZXFhBHElsHpJCslLgr+6OxVB Vh2qTiqeWmgfmDF5gkvp/NsNzpDuzLo7aZGgRShCos6zCSiseW9T2riqlpvlr8xLbUrae885rfWU TObmybS7eP1VaJUUCSOQMnB1aQEeNDUAYqs0/wAr/mPbmb6353F6Ghnig5aXbRlJJAvozMUcBmho 21ArV3G26qk3lT80GeRh58RVMkTRIukW3wxpy9RDWQ8jJUfFtSmw3xVOtB0XzPY3ssuqeYn1e0dK R20lpb25RzxJb1IQtQCG4gjodySKlVPsVQ1p/f3v/GYf8mY8VROKuxV2KuxV2KobU/8Ajm3f/GGT /iJxV5L56l/Nyw15NP0fzHqLx3Es14J7fQIbm2gs5Gb0rb1wJA80AiI+LiX5rU4qx5vNX5pPc3l4 t15tt+U8oiX/AAxBIiwhXeCJIPXNdwOUtFatFJp8Sqq+sXv5tW88aNrnmm6bi3oPa+XLIIJIljkM r8J1BV/iVY5Buajb7WKqiea/zWg8yTSXE/maXS7Ob6y8Mflyz9K5tY0SRoFkadWQkl1HGrmvWo2V egaT+bNjqpX6n5d1x0Pp+rJ9UQrEZYracLJxlbifSvUencBqVpuqhrH83Ly49aWbyT5jtbSNVZWe wkM7B5ViA9Fa7r8buAxogBFS1AqsuPzgvltXkg8ieZ3mIYwxSWPAELEsvxsryFOXIqKKfiFDQ4qz jRtU/Slgt59UubHlJLH9WvY/RmHoytFyKVb4X4c0Nd1IOKo3FXYq7FXYq7FXYq7FXYq7FXYqhrT+ /vf+Mw/5Mx4qicVdirsVdirsVQ2p/wDHNu/+MMn/ABE4qwb8y9G8y3d/Bd6JpmoahNHbBYpLLVYd MWGVbmNjxEiSHlJGW5tuCi8aVIxVhEPlL80ri707SbvTtfTSYXlB1p/Mdq17D6shX1/UWLmxWLlR QvRgtdjVVrXPJf5mvPqxTS9av4NZsYYbiOPzDaRtHIHt5WSKSSBaKv7yP4oztzptJirV/wCUfzhg W807Tl8wT2b2oVLybzBbNM0kV2JVEblEkikeHkhfpuKjivEqqzeVPzQvoLu5vtP8ww3k7ei8EHma 0VDGKR84wtuFVeM8r8W3qg8diqlb6B+bV/p6adPbeYLa5juGjv8AUTr0UUixSPBdkRcYljkIWYxL IgZRwZKLWgVWal5M/Mhk0m4i0fzI9xDC7SRwearWJ4GmuKvbl2hXmgjiU1Q9+P7IICtQeVvzmjlb 1LXX2gl9WcRjzHAWjlY2kqReq1aRgwzxD4H2f5kqrZfLXn7UdF4QaH5lJu0eSdz5gt7eYXVtNFAi yNdW0crH09Njlil4EfvW6cqqqrXPk780xJHHDYa6LExW5a0g8yW0USPbObZYVBh+CF7f97KoVuRK itVOKqvlzQ/Pml6zeXUej+Y7m8sfQmWO612KVL9onC+jJLJbRRPGsd7IwrKSfSA+HrirMJvNv5yC zjePyHEbqSWUvD+k7YrDFEF9NS1V9R5jzowACbVU4qusfPX5lma8sLvyJLJfWMVq4mhu4ooLozEC doXlHor6fxN6ZmZugJ74q7UPN35wg3SWHkGL4XmS1ml1W1YMsYJjlaMcNpvs8eQK9STirNtGu9Tu 7BZtTsP0bdmSVWtPVSeiJKyxv6iUX95GFen7NaHpiqNxV2KuxVDWn9/e/wDGYf8AJmPFUTirsVdi rsVdiqA1/wD44Opf8ws3/JtsVeN6p5L81Xl1JLb+bprOI3E8sMUekIeEUhQwQk7BxCY92Iq4JG1T k/i0geSZQ6Frv1OOM+YPUuFtp4Jbn9ERUa5cBYpwgWi+iVP7vcMTvhtHCe5K4/LP5gpcek3meKa0 e3dfrR0eJJo7g8ODiIRskiijbc1698Fp4fJNNN0DzDb6rDc3uv8A13T0nuJJbD9Dxxc4pUCwxeqo 5L6LfFyG7dDhtBie5k1NL/5Zf+nZ/wDmjDYY8EnU0v8A5Zf+nZ/+aMbC8Emj+igCTbUA3JNu/wDz RjYXgktik0eaJJYoBJFIoaORYGZWVhUEEJQgjGwvBJfTS/8All/6dn/5oxsLwSdTS/8All/6dn/5 oxsLwSdTS/8All/6dn/5oxsLwSdTS/8All/6dn/5oxsLwSdTS/8All/6dn/5oxsLwSaY6UqlmtuK qKsxt3AAH+wxsLwSWxy6NIzrHArtE3CULAxKtQNxaibGjA0xsLwSX00v/ll/6dn/AOaMbC8EnU0v /ll/6dn/AOaMbC8EnU0v/ll/6dn/AOaMbC8Ek+8o+h9WvfRT00+tfZ4GPf0IuxAyEm6AIG6e5Fm7 FXYq7FXYqg9Zj9TR76OtOdvKtetKoRirwjV7D8gIvNGrW1/qULa+8l2NUVLbVJG5iOQ3QBikZB8D vXh+sYVQEEv/ADjfcw29pbarHJHBcNNBAltrCBZbiSFWYgyLsXWPY7bbDrir1HyN+X3l3S9HS68q SxQabqqx3akQ3BDh0HBuE85ZPhptQe4rirI/8O33/LbF/wAiG/6q4q7/AA7ff8tsX/Ihv+quKu/w 7ff8tsX/ACIb/qrirGNX/JLyzrGpz6nqKpPeXKlZnrdqpDQ/VzSNLpYwfS+GoX8cVY9fflh+VHky ezN28OmvdPEbaVkv3TnBdRGMvILh0TjPNH9sjbr8Kmiq3yd+W35UahqH/Oszo97ocpn5INSQxSSO 9sSGluFDAtZslNx8Pgd1WUeWvyisvLuoXt7p1+/O+VFkinEk6JwJJMZkmZxzJ+L4uwxVkX+Hb7/l ti/5EN/1VxV3+Hb7/lti/wCRDf8AVXFXf4dvv+W2L/kQ3/VXFUs178uLLX7eK31d4LuGCQTQq0Mg 4yAEBwVmG4DHFXn8/wCW/wCUei3lr5W1TUYf0kY0RfrCXSF/WtpYUMkkMsUCu8FvIvboP2itVUbo X5a/l55s0B08u6lINPgkj4zW31+B4pjZwiJ19acfEtsYqVUjxqa4qz+w8o3FjY29lBex+jbRpDHy gavFFCitJRvQYqr/AOHb7/lti/5EN/1VxVF6HZyWgvYpJFlb6wG5KpQbwxdiz/rwKmeKuxV2KuxV 2KobU/8Ajm3f/GGT/iJxV45rDSy6lqSBfzHi9C+lVHsivoP6Uz1MHOoMDm6PDxSNenEDFUie0Qzy 2/rfmu8bPJEwkeiPSOU/ui4+KoTbfuK4pe9aBpf6K0e00/65dX/1dOP1y/k9W6k3rWV6LybenTFC PxV2KuxV2KsQ87akbbVdIUReYAYXM/1jRIBPb0d0til2hWTmqib1OPAkBSw3XFXfl/MiHUtPRPMD JDIrrd+YAxDheVqFtpH+MqfqnrEMK/vAx+1QKsvxV2KuxV2KuxVhvmfTnh8z6bfx3vmLneSxxLba YUk0+L01ePlcxyIyIj/WKsx7op2K4qjfy+skg8vJMl1rNwt2wcL5gLfXY/SRbfiyOqMgb0fUpTdm Ld8VZLirsVQ1p/f3v/GYf8mY8VROKuxV2KuxV2KobU/+Obd/8YZP+InFXi/mPyRbXurajJbflVb6 tJG9w0036cjtpJJrqQq9Y1ZuDSQ8ZwXIIDbUbFXaT+W1l+mtOhuvyvGn2EawW63r680zxIx+tPxi EpLehNXbq3VTQUxV7jirsVdirsVU5Lq2jQPJMiIziJWZgAZGbgEBP7Rf4aeO2KsI896TBq2r6fLF 5afzE1geEt3b6mLJ7N/rNrNxVBLHyk4oJtyv2AtfixVU/LzQP0XfapJ/hX/Dv1gL+/8Ar/176zS6 upPs8m9Onq+r/wA9OP7GKs2d1RS7kKqglmJoAB1JOKqN1qFhab3dzFb/AANJ+9dU+BKB2+IjZeQq e1cVVwQwBBqDuCOlMVdirsVYz5t0r67qmgzfoI6v9VuTJ9a+t/Vls90PqtHUeuNq8aHp74qivJNj 9R8r2Np+i5dF9IOP0ZPc/XZIayMaNcc5ufKvIfGaVp2xVPMVdiqGtP7+9/4zD/kzHiqJxV2KuxV2 KuxVDap/xzbv/jDJ/wAQOKvDdb/LG31DU7y64+UJkur6acGW41GNhBcq6zM6Q3KpJOwK/FtQ1pTa hVAaV+WWqWD2VxDF5LgvbBw9tOupaxOEEbrPEESaY8Qs8akiprU04nqq96XzDoXEctStOVN6Tx0r 9+BW/wDEOgf9XK1/5Hx/81Yqk/maz8geZ7KOy1y4tbu2iZ3SP636VGkheBjWKRDvFM69e9etMVSh /I/5SS33165+qXN0KLHJLdklEVldEFJBUI6ckLVK70NMKpbbflJ+RFtcQ3MNrarNAKRMdSuWoCvH o1wQfh237U8MC2oal+V35TxtBd6Nb6cL63uoroRT6ldxwkxyPJUCKcqjq0rFGMbAVI40wqreX/y+ /LmLTDDrQ057wR/UUkt9RnYfUYJme0Qu0kZEix8Q7KBU1H2dsVRD/ln+S8ksLyrbyrbWjWFpE+oS lIrd4mhdEpNX4kc7sSQdxQ74q5vyx/JFkskMNtx09pXswNRuBwM7c5Ok/wAQZuoaowKn/k+z8meV NCg0XTNUha0gAo0txCXZuIBZuHBeTceTUUVYkncnFU7/AMQ6B/1crX/kfH/zVirv8Q6B/wBXK1/5 Hx/81YqxjzbHpmr6poN1BdaRPHptyZpnu7uVHjWqHlCkDqkjfB0l+Hp74VRXkm40rRfK9jpl1ead b3FuHDw2t9JdQrykZxwmu29dtmr8fToNqYFT3/EOgf8AVytf+R8f/NWKu/xDoH/Vytf+R8f/ADVi rel3VrdPeS20yTxeuB6kbB1qIY9qqSMVR2KuxV2KuxV2KobU/wDjm3f/ABhk/wCInFXk/wCZOlX+ lXyy2l1531ITym7NvokpeESvVY4TJ1ihX0jzXg32gajuqxr9M6fb2aSw/wDKxp7d5ksLqH1wJ7dr NYRGvoxnnG905Rd+LPycilMVTC2mj0me2Fpa/mPdz6pbvI4dUNPjW2aS4L8eM4jtVda/suOhbZVD S6pZ6cxj1d/zBsI3mn0u21CWeiOZ7j04nMziMVHrcoWetADStByKrLqBLOO3trG3/MxVheWqQtJG ixN6n92EV4j6foqIo/hFHHXegVF6e1pqVxDPap+Ylo13c3Xr3icAGBSMmO5ajcVhZmii4/EhDiop sVX+U4bW71NNLmvvP+n3+pwSWpgvpiyQxPHyF83wViYmiGXjQSsRvQtgVmNp+VGn6LpkaHzj5jit LKWCdZZtTCIkVspRYCPTSIQMCOS8d6DfFVlj+TdnYi5nXzp5of60oa4ml1QGoUxnnyEa78IuHLrx JFelFUwP5e6vH5httXi84atHbQuWudOeUSQSRrE6Rji9VVlZ+THiVagqvL4sVVtT8kQ6mYtQtfNG sWiMWltzbXx+rP69z9ZSq0+NKsI1AYfu/gBpiqE1z8tLbU7zT5b7zbrsNzE8Rihhvo4Ip5bdVdSb f0/TLD0S54rXqfkqlx/JcWUHqab5z8wWs6TRXM0s16WikMcnOZp44hbCRpU+FnZq7AmtDVVWvvyY sblWe884eZ3RUhUF9ToqC34HmB6YXkxiVnY/tfFscVVtS/L/AE2DU/rt5541+zee6kvorVtVWKDd 1ZoUiZADAmyhN6A074qibv8ALGO4tzaf4u8yQM8tzcepFqRWX/SGiJUHgaRw+kBGo2Xk3Xliqlaf lJb2t/e3kfmrzHyvxc+rCdQ/dLJdRmL1UURj44VI9IknjxXwxVFeX/y1XRtTh1D/ABP5g1KSHrDq F960Mm0oAkQRoGA9ckDxC+GKsptP7+9/4zD/AJMx4qicVdirsVdirsVQ2p/8c27/AOMMn/ETiryL 8xPJvlQTXc1r5Kg8y29yTf3kias9pI10qSqQIw7M54lQvEfte2FUl0LyXpllqUGpR/lfaadeafG0 llPF5kWVvWS2kliUoSEYmYLCzvWhbl8SrgVLdM8h8bYJqH5Y2d0yQn0zJ5kAekCvHDDIRJKjyFH2 dQiCtOK8RiqfaZoMS3MmqyflrBbapaLZvZk+Y45jI+mpxtArF6KyfV4hyYfEGPKu9VUrsfJt/puv zRadoM/1JIptMnuU1iJLc293M00tzBbTSKfXaIIr8ZfSLt9heJXCqlpHke2WOzmuPystbbUbAwR2 8/8AiUMi8S8rTKizNTjMoPGpJ5daA4FR2nWC296+tad+WSrrVvfStMv+Inh4zCBOM8LT+nFIri4d C0fw1Q9aDCqHsvKCvdWb3v5Y2gktvRihu18xL+5txwT0+BncuYo3cVrRitabjFU/0PyR5c803jt5 18njRorC3EGlodcF7CVnaR51UQSRyRn953qv8vGm4VlMn5U/lDJaX9o1jB9X1OT1r5BeXAMsnP1K lhMGHxitAcVULn8nfyZupEkn0+J2iSSKOt/dABJmdpAAJ6bmVv8AMDFUS35X/lQdNtNM+qxixsI5 4bOEX1xSJLpleYKfWrV2QGvWuKpNJ+Rn5XTWGm2txe3FxLp7kyXsl4hmu4WuGuXt7uiiOSNpXqaI G2HxYqmtt+U35PWwAh0+3CrA9oFN5Oy+hJI8rx8WmI4l5GP+YxVDQ/kt+TEWo3d8LGFpLxPTmja8 mMdGJLkL6vV9uVfDam9VXTfkp+SU397pkD7QihvrqlLaP0ohT1/2U29++K2vvPyf/Ka8ubW9niU6 jaPZuL0XbB5PqPprGJI+fosGji4N+7+yTx4nfFWffpPTf+WuH/kYv9cVWafNDNLePE6yJ6wHJCGH 9zH3GKozFXYq7FX/2Q== Microsoft® Word 2010 Patrick O'Malley application/postscript derived converted from application/vnd.adobe.photoshop to image/tiff saved xmp.iid:f2b6d651-a569-c644-999f-677fe48aff03 2020-08-28T11:39:13+05:30 Adobe Photoshop 21.1 (Windows) / saved xmp.iid:5f1abb4b-622a-e34f-aca2-4c456faaad00 2020-08-28T13:34:20+05:30 Adobe Illustrator 24.1 (Windows) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:20ae9485-0dbf-7b47-bb38-22a3f080099d 2020-08-28T17:53:27+05:30 Adobe Illustrator 24.1 (Windows) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:9d634a46-27f3-9a48-95b0-7d8b12632190 2020-09-01T11:07:32+05:30 Adobe Illustrator 24.1 (Windows) / saved xmp.iid:cb81553f-908e-8340-a03d-893900be8e95 2020-09-01T11:41:51+05:30 Adobe Illustrator 24.1 (Windows) / xmp.iid:9c79c15f-cbc4-fb45-9012-5f245bf2b2e8 xmp.did:9c79c15f-cbc4-fb45-9012-5f245bf2b2e8 xmp.did:f2b6d651-a569-c644-999f-677fe48aff03 xmp.did:cb81553f-908e-8340-a03d-893900be8e95 xmp.iid:cb81553f-908e-8340-a03d-893900be8e95 xmp.did:f2b6d651-a569-c644-999f-677fe48aff03 4 U.S. Web Coated (SWOP) v2 2860 3705 8 8 8 8 5 5 1 4 1 6000000/10000 6000000/10000 2 65535 2860 3705 40.333333 53.623188 Picas 1 False False MyriadPro-Bold Myriad Pro Bold Open Type Version 2.106;PS 2.000;hotconv 1.0.70;makeotf.lib2.5.58329 False MyriadPro-Bold.otf Syntax-Bold Syntax Bold Type 1 001.001 False SXB_.PFB; SXB_.PFM LinotypeSyntaxCom-BoldIt Linotype Syntax Com Bold Italic Open Type Version 2.10 False LinotypeSyntaxCom-BoldIt.ttf Cyan Magenta Yellow Black Default Swatch Group 0 endstream endobj 18 0 obj << /Length 4182 /Filter /FlateDecode >> stream H‰äW[oä¶F_õ+ø²À°hñ.AƒÝñ:Mv�n3ƒE6²†c+ž‘¦Òx/ùõýHJòܼ)Z'­k‹ä¹|çÂs3’…÷ÉÅ73Fn»D ªˆÉ5Ò•I 6Z—,“‹i—“éŒ02›~Ÿdä;0þBpú‘°Œ\“Ÿ~ÆÆ"a¤"É?Aå32K¥5¤\‡Ýuâ%gd•Ì’¿'¯æÉÅã �/rð(�X�„“ù:Éz‰÷øš—þ×ÇdrUÝ>´ŽžÍ�exîAŠÍhn ÛôÓäåê¶i«íÝú,åÒR1i–Ã×öΟ?¾¼¸l.‡U¹ªêª,VÃzÓå¶*GêÛ‡já@3n,›vø\uq[Õ·Ãzñ¹[UЯ«bTÜ _­[<<Ê�þ8Bh«îžžý<ÿ.y=?rq&¨}ÊŰ£|X»zK.®§Œ¼ºœŽÞ|ãCÏ}è2Ë.„@!Œ}”)sj™Å>rp)©•ü˜#žQ$å4l© Æª ¡?ò'Ë,l.÷Ä2�QÍr¢¤¡Rd›‘”1°9£j—#�z¢N¯Í‘øŠÈ÷¿€ÂÊs¶�BQ¦ÕÓ0’0׿Cý[0¸T"Ú9­v,ÓŠŠ±î?S–SÃ�Q ƩВ(Í(ßÍ•gpŽöLíûFP®ìÓ¾A–YÍž…äAç liþ$ Í5•úyœ!P缃¥…ƒÙ�7$Uâ8aG#(“ù³dŠ49¹OXAõAPDNó\ÁYpoøsÅHÈ”‡·—çO__�ê/å8S)B³Ìâ—2øçÞ'°� îÓŒ°“k´n·”�h`hÒc¢Y2V<Ó‹ ™ã¯ ¾c .Gšô˜È R ‚ ¹¤Rè^�8¤25Ò¤ÇD³DzxX QgYF-´ï ò¦1Ü��&=&ò‚Íálåo"\mü?Ä£ù=MzL4Ûë(9¢À‘ Œî&¹ÏšYðÓ kÅÁŸ2IGWÃZà[tõ� –k3Êê—Y`�ßššpù†µ rP.ý"j pFÙa¾€/,²ž9ë…–§“ÿÿÀân¿„pßUޝ.,ö³ŒAò‰`³¡Z¢MiˆVǵG�)”!ûH„¢t1¬ƒ¥Ãb8뙯Å÷KÐ÷úû�¬çË‚°åÿ�-ûqÉ1Á£TjŒ�Úìd¢7%ŒÚ7iÆQ‡{\K�šiC —Ø�Èuî«.*$Êô¸>uþ8½ûöZ�;!Ã(ªä‘Z ’R{ÑèÇ^í¸†ÿGµ˜\‚ZhvÔëSæþajOG—iª­=éåüÀËùsF÷÷×»o¯‰zýÌ|©|J¯<ЫwôÊÿÀÞ?Nïi{¡ÇÈÓzí�^ûœöþþz½½¾[z53þ­“Qž!Ëð 1&Ž;ÕC¬EE¨wÊ3 ô1ïläL¹¯«™ŸûÕÙÎÃL ÀrõŸ¾la…7¯êa\Íza÷»�³\aB“'W?š¢øÏÜ4®^O'Ø'Þ|sür|Í`¹R�c‚ÜCŽ4ÎÈOQ_2޲(oÆìˆµ¨_Lž"‘A>ÌG»@øD{@¤BX"2ƒ]W`¢ÎF´E­bŒŸšø&U ¤BsÊü_É0ó ± ª˜�™¤{ñ=MzL4K^Í“‹+†LæËÄ[Ð~1*³•\ç>P( óõN~LØÙüÿvÉóÜ£ö-™_&îüËSú™¯ `õû"0(Ê4 I£5„ã ¥Re^&?MþáÎ0ÓMº³Ÿçß% ¢1¡1Êü„™'š\V]ùÐudU”÷¤Y÷¡Z¸ºtdáÖMÝmÛb[Õ·^8ENh`ŸÜ¸Ú-«-)ê)›dŽ4õmzR­ sÜ0øIRØm¿„/.Ä\èærá÷�”y¹Âöºã$eÆï+ió�}¨Ð"÷]t�¡ß·L‰�}æÝÈ1Š#W~ ¦DÞø§´<~@�J †VDí‡"PÝ´/:¼VH4U†X#–þu�!Ù=Hso-‹B„˜ ¦£½:0ø9ÂÏö'Dd1�O,)DfÂ~Þ§S2@ļaý�D=3Æö23QË‚ã˜Ñ!ô—p¿ÿí’\{N^Ngç¤iÉôå«o.ÞM¿%UM6E·L\�ù¢ÉÇûsÜ�¥kÉ,H‘EU”ع+n",Œ/¾ÒŽÀõƒ+›õÚ!ÇÖÍÂ!]ºh:Gº­OL²½ÃÞæ³gG;áf'?ßO:çÈ é|S´D¼?ë/Œ†³Â¤¤3{ ¢u·+®mnª’¸O®-+hCŽÇ+`{ÔЭ›û�ì®ë€¦©ÉûIµ$Åf³ªÊâfå¢Nîtn’Ìdì@å¢rÛj[uºr‹4ê‰G%×nQm]Ûµ+ê@¼×VÝ=ù ã/bÂK­4ª!&ÿè6Ö×ô†LCj0É¢¹,T”E?ÖWÍjÕ|L6¨Åê!˜ÚßÉ%!ä][­‹ö3ٴ=Í9©›>P#9³Öøy[mª2¦v+w`gù ?ÖM½Dy÷¶ƒ³ÜâýYd{Ôžõ�û?¸�+¶Ñ9�X}R¾j>ö ü¼Ê9t#‚úÙ6¤wî)=#ƒŠ _élj?¸(β(·MÛ‘ò®¨oÝI$3Z/ö}øg²ztQGŠŽÔÎÁ¸uõ*èÞÀFÐ’ª;í–»ê—$‚ðµúcµZy·Âª޺º«–ŸÉ¶…ßàãíI`ó¡ÙlàÕpå¼>DÆU<ÚãòB±yçÐL"î î¶y@,Ý*ÜÔÃú#&©ùá5ï¶n³�¤nÒ~¾í˜v]|ªÖÕ¯‡ÕÀ¤b± îWÜ­uusÚÛS´7‡–¼›ÎÞX軫n*„(:¶XâÒ‘uTàÝu Â{:üÉžš”a˜Ra TŒÅ\x×G¨¸…]žã�Œã�¢†K?yº?õgýè€ ¨ã šQ°ºLú��è¸'Q!†XF—�Í$ T—�ëÆ ¹+>8ò×+dÀö޼¾"_ õâ<Ö5 Ä»Î}={s ûªZ:ÔÁ�+·E]~&_!ã¿îëT N}Ûf"ö¹cu1ûΊß$98ýñòëÐÑ®à ]­û%›÷%[£vùŠrÛÛ±H%Dl`fçäòú<Gž™}ë`×ÛË·é4fçAH4UÊüVD&˜!Èú_´WËvÛ6Ýç+¸”{DŠßÞéÈŽ«SÛ'‰“vál’–xʇKHññotáïí¼DJv“M6bƒÁÌ�;mß,®V§oüPË@q7‹òúë™ö' 侬~�åе½æ¿gD �î³¼¬-Ê™.M¥“bço KA‹p²´‘”Þxâ¤rìãGU·M´�–Kš…ŠA_)¾eŸá\KÙrùϾ$CJØ|ÙP¥çfMÁ6q£†WÐòçß wGutãn�Ö]N‚•Õ­bFmú¿«ÅçõR¯ÜÏ> gR´hò}©¡Ež¼\B’ü@¢2¼º˜Ú;DýÏíã®o±¿ EâÈ;`áCÝIqÎ zQ4ô lü:«¼�7‡©+eÓågÓœp.©î¡9Aw&ÙÏ4'Èt¹uÒw¤ÓæÄìqO7ɿĶ$:2_ dè CÓ–Äæá¹ó;²Øý¤³×Ñx6yÆpúŒ†"Ä@ܰxô®Àûý0PdIIT²§ð¢'›ëíòÉþèú§Nž:* 1¸{&ïÃù EDSðçŽV×M¢�³"PÓA0·œU>»O˜òp÷+‹�% dyƒt*Ÿ�²ïp÷öuºàLõQ°þ²R†€ýÇa:Â$ñt±��EÿS´ò 8uŠæ©At}|E"ʸ—Œàg?(P¹�|àéoÞÑ:­ûø}˜¨ä!à- œP“àßêŒSÀ“zÈb/K³£´xZ™™Çc~Рw§»dÝ“O§†±-R •Pî{„Àç"©//zX¸;ºN@ãf(Ñèrúdm R–‘ú“òè릅IŠö㦹z”ˆ¿i[�€Î 6�Ø6=ÿ`ؑɯ&Á�4¢™å€1Àc ­œoV_Éàå”+°ûø#4w’ÇŒ�29BS½Ç=Ýt§ÑÒcÑA'Ëb/LƒÿEh³ççš�,�,¿�ÐÁ¹s1ì7ÎE/ª*£}ccö:xUuÕ€v›·2Å‘%¡râù,ÑÌ»nz`I¾«¤¾¹¡G‘¢0‰Ç“8Ó$¦ÝLù²‹‡)›²Vh¤úñª6ÐÂX“-uö±Fò3D]ˆù ž—À¶ïùQgi1ùS/ö'_™æÆðY{*ªhú��¿¶^÷Ç+ï›SÝöäõn¢‚eü9ɨ`0ÿ…ûô~L§µ$za¾f¬ê“5ÚáþKèW�ÐI}[ìÌM¼ˆÇáhcêSõÜÃ0ô`%¬©rQ¡‚¢D„ôm÷T£Ã+óºyVd0�òpj{ å¥ð0º“=yêk3uñø>¶�™Ý.–G·Ò+t¥Óáô½è$2DÂ(°-ÐlÝ+œ§mïäCE%½GËA=ÀÔ[‰s]$Ÿr±E§ªÈéæDæ‘™*ÜAçèÌ׳¹ìróŒsS©~J ¥dÍGIßZª,í3J”í¶ü’2¢ ç�# £ØR n+ËKAR…ðN›×µa%xKCÐ º›áœ�[P ,5�˜;•Ûâ]…Ê<�ŒlúáªÜ«#çNI82T›ôÞuûØXöƒxisÕs5c6ƒ½C�N,/q«ªC<¡ÃhêǺtAË;“Ë©{�b\Þ¬Þ-V"uVñw«Ûw‹«;ælĨTD€G'M¼p\(¨ùºR3ïP‘‚OüKAÀ$L$»½ŸÝö»êÌåÄ3x~gÆhp¾×ý^4Ïf¥EŽì‡ª4sy;¡ÆQØ­¹•úfµïÅAW£q±»z$à˜¼13ð\+¶mƃJj¸à6½ö—=¨ìÍ¡w8±è[HŒL(¶UA\ø'.TåÅÖÐbàoëväÇA¦,¥�²“FµPÿÊÚªœ«é·ªÈá 5ÑgÊ¡>Q*©£� Ùâ©1e–Y—6É‘[5AÈjt0ŽzZ9(ún7Ôßö;{üngtïz­m  ÜUåñ}ðh8èûÑv™Ý¶S|È Ô"Ì(Z¾.ƒ± ÜX ˜Y½e¨ûDÑ¡¿•ˆÊtÈÊAx)NŽ¥f×ëÛõjy­j¶QΰŸˆìÉÖ«S• ù3ðˆÉÆ/ë‹K轤ý™ÜŒ¾2 ¼p²í@7PÏA\Xïg_Ë\¹Œ‡^4ûs¹¸è/ÌŒû¨pz¼Úm°µoÌÒÕ´¥A%Ò�pÓ™«i�t¨�ÉZæ|êã©#�Ž Ó°v?[v].ƒ9#�õfDÀ9t2Ýäü†^†h;4'9Ü8†º -•V¯6ºþ`”ü´ endstream endobj 19 0 obj << /Type /Page /Parent 68 0 R /Resources 25 0 R /CropBox [ 9 9 603 787.5 ] /Annots [ 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 162 0 R 206 0 R ] /TrimBox [ 9 9 603 787.5 ] /ArtBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /Rotate 0 /Contents [ 242 0 R 240 0 R 203 0 R 159 0 R 26 0 R 158 0 R 160 0 R 161 0 R 204 0 R 205 0 R 241 0 R ] >> endobj 20 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/guidelines/CD/lipids) >> /Type /Annot /Subtype /Link /Rect [ 181.679 621.81 294.494 634.474 ] /Border [ 0 0 0 ] >> endobj 21 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/guidelines/CD/lipids) >> /Type /Annot /Subtype /Link /Rect [ 52.5 610.776 147.832 623.44 ] /Border [ 0 0 0 ] >> endobj 22 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/guidelines/CD/lipids) >> /Type /Annot /Subtype /Link /Rect [ 204.156 347.173 294.5 359.838 ] /Border [ 0 0 0 ] >> endobj 23 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/guidelines/CD/lipids) >> /Type /Annot /Subtype /Link /Rect [ 52.5 336.151 162.241 348.815 ] /Border [ 0 0 0 ] >> endobj 24 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 52.5 33.415 89.741 42.747 ] /Border [ 0 0 0 ] >> endobj 25 0 obj << /ProcSet [ /PDF /Text ] /Font << /F3 91 0 R /F5 123 0 R /F6 101 0 R /F7 106 0 R /F10 111 0 R /F11 116 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 26 0 obj << /Length 5110 /Filter /FlateDecode >> stream H‰|WËvÛ8Ýû+¼”çX´H‘zÌαÜéîÉkM÷"™DB"Æ©H©ÕûùÿðÔR‰Ó''Ö½E�xTÕ­ÂÝÛÏñõÎ]½Y_Ýý4½Ž¯×Û«e”]OàþfSø3�§Q’ΓëõþjB�âëg@ëÿœ®¾ŒÚRߌÓÉ|¤·[�·æ¨k훚-ÿʳ3¹ª˜)eÚ³guÁ 0ºUÖ[MÝj;¾ù÷úW˜gGñ,ή×+˜¾ß𦆦IÍG_al^u…©wbª»Öª\w-Îé¾Þˆ½©=ü¶ Ʈ͛½vMG‹e:¿œñ†Î§ÑbäήÕ{Ÿ­l^ Ãí2¢Caxа«�FŸt!ÆÇzWWòǯMZ©zש~f2�7*¢ÚÎËÖ6{Á±€•Îõ~£­ðdO·¥mº]Þ™Ñìë¿Álïœût–F ¾±|RN`ÞÔE—·´2´� —:a›…®s-ÜêJUÝ^ sràÄKXÊ?þér8Ü6yçt è=F5{ógÿ V×Ú¦ªzKkø¾ŸíëèéaM±�ÌâhÊó0º•-ì.÷ÊØ=ÄèXÕª:;ž£ßm•±ýœ�ÅÕÌFݶÚãÿv \yŽ˜}öñ“ÆY´Ä�—Má„ú£@hµëª¶bµÀB�Gª A–fæ� :j†Û®ªï:ðVeêððëèt:E¥VU[ÊB�*Ú5Ç~Ž»ð–»{XÝUæ` 8WØP6Y‚Ö4×}0ü>ªÖ• dßò\`˜áíÓýêñf<ËfQ Kzk'7ð°=iHܽ® å�Í÷\ãÀÞÞöß\飮šZ!Y”òñ2|<ªª£¯�X€-óÎ�í„ u°–Z�q¹.Œ�ìdq3ŽcÜúÿâé×›[yp2m)˜¾È0·¦eÑdî…*Э ³0ó¾±-9ž.gðS˜›àÁš=i-Ó-H2+3ŒF°W:yf;pDø‚k­®wmùcÙ\sa˜B\Vm[!ƒ¨`© CGþaŒGÎö·¥ª'Aú�¿�Òƒ¶èôÉŒ‰„Ø:1lš¶ŒŽÀÍ3ãø GïL¡…²Û nu²\ uQg¡ò¡Ë($Z'Ö ƒzáç-‹ëRRŸ!T·Æ »þñpxÌù‘%K� <6F’mDp]»Î‰*lÉú@ð¥Vá�à©A"�Jƒ‚•,�j>¢þv·jVÂß|úý­u8Øæˆ«gÞԂ≠_»:|*™€cÄ|Tª±š(R�oëy â1Æq|Þý4ç'Ž}‡C€Zœt–D“Y6ÅçîÁ-®sc]^_�žnÖÿ¹Zø7ð†Îf³äâ�ÑãÃÇ÷ï?¬î׿|üð_yµŸšãŒi 0Mf—ýÔ8‚¢»À¦ ÒD%±¼™Œp'ЀÅÜaK2,\›.ÀŠwƃêC¼¯>üÖY�B&e’‘ "r8‘,�F‰2óy-§ñÒ‚n´V›J_äQÍÓù”¹n.†þ�j+iuU Læ‚ìe‰ýg8¤[!'n<Æi4›/“ËØ/Í®¬à?–¤8ág8½Õ/"½ŒûÞ׿Ü:X¼áqxúÿ.õgÁQÃ*f O¶ÂPWa€û=TºŒ¾8��Œ[²¨Š"•vˆ¡ë8 :YÑMüõF1x;Æö‰äW/Çp·K¢d–Q¥ž°Æè(Pf¬™,rÂ9º­áÐÛWÌÊît°¯^ýÐó»Õ»ñC³LâdIQ÷Uê"êz=”A_F;ÌàyYÕ .ÊL/®dáfCXaÂКVCϵ5Û³pUŸ,Æ…�’aÎô·Ã½z†Øúq²…O§KØ&Æ#BA`ž¿ ™Y¿…oÇñuåÇÙ·µÍ<»Ì°­pÜx ‘BL‚ˆˆ8“ÙI M_øF©ûoë�ÿ0öÓÁ,Ìöº€Îß_üÓ j‹©\3¨ÈŠ…u²7äÐöÑå¡¿q�ÜbèÅ �"é“Ó)òW &¾šùá pªÕÂCQ Fë‹„ý>ØáúO}¤T"),ô ûù…¥Át&N¨  vxWn¨þ•&ص*V\Ô–ùb™]Ï »šûf²Tv�E/Á’å{®�I(pŒñ*‚šÎLöÏLüC¤ ƒ 6¦Vã¾Õ�ÃÄí0;ÈÝ¡4ya»ÎâOÐû§2΄ª�L[ûåÅoØöÇÑ,¬& ÿ¿úŽ�ÜBè¾€ÖÉ7�¾Ï‡vÔ}ßþ?é—:¼ÿdÜó°ËŸd<Ù'‹ûÅïý]†>ö·â¿„onMfý¥vÝö%ÇŠä·óÊ=A¦Yiw0±Ó8Ž(5Œ2hˆc×ì%ëVlyg-'ÙÿÉ®–å¶­$º÷Whã U%Òxñ•¬T”�RMœL%Šg£‚"b`„eÏ~–öÆ?<Ýçܾ¸”‹ žÓ÷…ûèîÓ ›w~´m,Œ$þ,å•}ïbq’¢îl‘ÊA:©Pðr؇,Ú®)»þÜ6ÞänÃtM‡¡ùB�ôÝ‚E¶JLpùèÆ9.wC…¤Y'q¦å¢£ïyzcšÛïQß$h;ä½Á-R4ñQD¾a< _¢¸†CÙ½pT$t?â|w¡ Ç’R@^£„ìãý€(œ÷†ä€e´([ºs92qÀ¢Ž ²õÍíæñ:êþÓž ãÒêBãÉd3•Ì[ð-Ñ"›;—•¾#ò¼ùX—ÿ»žÆñZ�§Ë‹t[«PíÊÏîù9íà©­«Së&6«r�þ°�… y;t‡S¸�‹rÑJZ:‰*ËɨÇV–{ %¦hø:oAôzÙM.iœV>÷©‘,Sãºúɨjæ*%÷†Üp„¡…D…»<î²»ª²õþvՒº:VÔ_nŠqýýÐQ™Ï£¥T¡�„+¤z¥™ó6ÉãŸß‰ð’?Í7ÄòJlp/Ï+˜Kvœ÷'ʹDÒ5j.$= å„3J�(¥XÞœÍÒ”Š7×_*ïð4#R³ƒ…&¯/2¹Œd‚C’ÄØ{¢i=`¹,-·¼ñÃêó¡žÆ+Ü ¡èóÂmƒCöÚcš.AÁ ¬rÿƒûîœÃM”Ë«mˆ¤xr¨:_ŽÉO"<ÃÊTCÊ|m j·Ó4*Oeê®â5CM'¹1ÛóÁ�{n‡zg$�ˆ˜ž)]é#’ç°ÄP:Ÿü§Òsñ­A)`¦?7]¾+�—õÂ9J¯4µèÈüCÃÿ¢«ÎõÇRuÏ�",Mb/ùÍaÆGìWpâ¢Ì]®Çêä .ùê#à 4ª+ûÃÖÒåJBlC°-ùÿÏ ¯ÿ;¾@XåZ½W‚p1AyU8“£€Sf†##|!ë»rY–~ØO¬r»+f:Ѐc!Cî¤$Ë ¡ë5š¥ó…ú?r±ËG¾éÀgF¶‡ˆú,½Ý‰MNpð�Nò©¦w°,®&‹õÁ¦¨‡]i´ßî<‘dh|Ac¾Å«%amèÝ1|4êš‹KKG„›ö¹1¢5ÐË^”ú€]Îtí¸:×ÍÕèþ°b”m†Äûs§Ç„/¥e�2€­•·#ZIAÚU¥ŸJv>³¦wx;€åçü²¶Õè—Η£2q„i‰ä(jàldëû°b"Ækr7è»>v‰8ËÉð¼õüÄnŒØ³×òä 5«â¹/Ѐ3ò«Š…&¾� .,ó3½jG8X„AÇt5"MÅû½¬‚PF›{O$~¦-«Éí¸Ìצ|‚äþ¦7AŽÌCÜ•ýP{æN—¤IÓù1|T %JnómUC‹Ñ”‡ƒ³ÌGw’íèƒ[@_›Ö÷²ï¿ùæ}RO5ï�ú ¿žZÁÒ÷ìÊ0¢c3éb®Å�{* ]^áE�ÐÉ/6C“ÛŒ1_ñ•߯9tgÁÒ²ÉXªAp¯ÔÒÐ%ià³zÙ�wDìlëû0êqÃùeºVñuö¨7t*;é"o|f–?åU�ÄT8FÒ“h‚sPDQxG¹BÉjšî׉d£mY䃞:©Þ7ј—ÿ\ÁÅÉ(4‰«]Ä MÔ!—™ÄP ÔŽ š†Ê7U~Œ¦Üú‹ïÂðù¢wùY[¸ÌEäK’199t’JAòu%M¨÷CmÔgõf{óny_=ì_EZÌ.|1›Ê%óT‚Ô¿»Š©Õ¨¥ÖŸÍô^ĤÖ�Ó»Œ©ÆeZÁÔIÍ9µdÙ.?ù ïûqHU×FÞOR\Vÿ-w¿˜é÷–hÅšÒ}Ž/�üálÚæ“¿àc†­Ì- ½yó/¹íÆì_N¾ÏÚPs¨¶Õ¹ízwB)O(ž­ÖÙò‡½È°u$î0œ\qE:>2r+¶È á�Îã ][{ e/(c±Ðð[¦ã7Äþª ñå'»*£� ‚…á–%Rêr‘D s]+yó䙞¶Cò±�È–ÚA'YÈ'?²c)J-KiBº%“!9Uqn ަ_ eH/‹š'€š²xN?m€'qòúƬcâzuâ ½1«*9Ε”hÙ|¸£ñrÍcþ÷€°§ÿ¢ 51¸{žl]s½&ÀË”ÿÔ Ü§¢£¹ÉNÝ$¨à(T3æ:©‹Î çô„z#¢`׬O@ÂéèA¤1×Ð3¶‚äAX òe¦šùRÐRÙŒÆ0ò‰+�\ý\Ô²Y#P™¾�ÞÈ£Üü�‘$ÆM�Üè«cUë›vÃýµŒÒO§[Ÿ, L­ ÈÕ¯G£»«_Ì¢Žh<2×—GF¢kõ½@Ž%Ón'ÓaùyŠƒ-»‡ªteî œ`�F,µfûlä|¨ú»ïœ�«ý�À˜Jf]Cá¸ñSoH]E|È}¯mY6†eS…>¨šžƒƒÁ@•p=]& _†)ë=eÇü#D±z4{¨@Wµâ畨þª‰ceÅ›ÂtÌÃÖ6VUhGxGƒJþÂ0MöüB¿t‰aq1ó:rù½·V>@ú&û¸£�Àý¸~¢Êv¿·¶O¹O�olQ@èé%�ÔF€ÆkE$%t7¶dÙæÔØËácqÑ›)Lænë±”:n}% — …™V»�-VÑÐ>º4hþ$ÕQï[sEÛL/¢3¤Ý*SÁ‰ý;÷T˜ïDn@l€"éö?•`×fÎ"¦'gò�çr°ÛÌELLk·™ÇëR®ÿÐ~òÏø,àQrù±B’Wjú�К ,ŸRäÄUÎú*’ßúJòýüj™‰òÌ–ÉÕÃñÕtÅëÅÕC!ßô·i�4ŠDš~¸}s×ÞK¢$2¼Ç%_Š´1Ó¯^&`åx�å/K%§Qr±ê›M¿º*zù¶¾hDIÊò“ÍõÃ?¯b¹+ŽT�eóY6�⋱“ßî¿ßÜþ†îã2ÙjqÙõ×çœKvŒ’,»ìø÷ýÝ[™÷­öónÎC[bÔ’‡&ÛXfËX{Gœíêã«Ém#A¿ŸµÝGÚy_n0KfÉ"Kd¤éÛH�ÏÝ7r¤Cºò÷D,4Éܱiz[>YÏ’$ZqÞIªŸðöáÕÿð¶Ýï endstream endobj 27 0 obj << /Type /Page /Parent 68 0 R /Resources 29 0 R /CropBox [ 9 9 603 787.5 ] /Annots [ 28 0 R 167 0 R 210 0 R ] /TrimBox [ 9 9 603 787.5 ] /ArtBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /Rotate 0 /Contents [ 245 0 R 243 0 R 207 0 R 164 0 R 30 0 R 163 0 R 165 0 R 166 0 R 208 0 R 209 0 R 244 0 R ] >> endobj 28 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 521.259 33.415 558.5 42.747 ] /Border [ 0 0 0 ] >> endobj 29 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 86 0 R /F3 91 0 R /F5 123 0 R /F6 101 0 R /F10 111 0 R /F11 116 0 R /F12 60 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 30 0 obj << /Length 3546 /Filter /FlateDecode >> stream H‰ÌW[sÛ6žé£~_:kw,šWI܇̤ö¦“ÖéfkMò÷"! 5/*@ÉQßú°¿Àxˆ I”œÔIw21)88—ßwà9^óï~tùÃ­ï¬Ø(ÝØ™z�;�¦NìEŽ?u(-G®ÍbÇõ¼þø ÿ3�uÍüIìëùÁDÌ‚Øä‡¤3'³Î0ÐùÌô’ž­( ­¶¢xªmuÇÃdªç‡Qo�0œèOÆö¡— yL&vÏ‚Ð2ç'ñ�9?ö­ñø^›3È…\ryÅfÎÕ­ã;·W?�<çG¨Úo|}€Îçï0��|‡8£ßa¯ªïˆjú‰%S'-šÑbÄ-{N>ºýgôý|tùÊ`î|9â»ñ)³¦DÍR�û8óbäI›÷ð6OùŸ‡ÑÙ-rìžÏ+a¶ôâ L�_�>œ½{yy]]Ÿ�ƒhvvCX-Þª¥xþ‚Óª(p™¡šT%ƒËŠŠ—7¨D+R®Ä¯ë=ËɆd¸ HŒÔ•²’mS,Þ¯ÞÉÍ~!ìþü×ù�£ÍâEà qáƒëM7œÁÿÀùiä<˦‘É,qý 0b[Á {¼² ÓæûT”`"`ß”àƒ‘° 5öÎ{ñœW’61O}‚ ¾zy%çƒðZ&;épèé|ÜäEõ°M÷?¤…Ê·¸cM6ÖÐà2åŃÞð¸`V®+Ö³±îåÞ�ß§UóÉê\ �¤ hó:Ò¨¥RíÆ œ¢ÂÕr”Þ÷?áÜAÊT¥šVmX@ÓªMÍHµCŒËí–Õ¨ªj+NᘶM[7G<öé�–­v‰¬Ýë’m—�)Ñòß„û›ô°®¬\§OžzöÊÔi 𸆒-°y4ÕB>’Ø-#ã-Bú379ûc×ÒÜÖÒ=À�ö(]iŸß^Ýþ”(\“i;úˆÀ3"É�øÆÀ … -±Rb"—nËû²z͵ ´_ggƒ.¦”ER¦U™æ�î6%–Êýõ¥ø„w ;ü4?ÑfÞB:ázú4éôýãÅè6‘2È#S DŽïD<³^w\ŒzÎ\@Äy·"¡HîO Úƒ çÉó––*UŸæ~·T�?td5ïWŽñ]‰Mo×P˜4ƒºØÚl«0UVåÕª»³±VS?¥­¾)a;àÜ6;]¨QËm-˜2f XÈßá¾'DO¡±U¼ÓÔy\òüƒÕ߈~C W0k£–�j9îsp‹²!…~^\i,<¶ iù2¸:ÕL…î$ ’ÓÈ‚î[#Ð�þ��ÕgÔ•B ¬´0ª[x¶«rGkÚ7”çNyƒÆ¬­e¿æè°àm•Á?ŒM¸çà½-”žÖHytDùÛŽ^fE“^ßß„¤=ü;Hñt tÿÝaœ‘´¹¦° …«Í&ÇpÌìKÊmMQŠ·5,É™µWˆ®`£5ȆúãÇÚ¾NÛQ”ª’ÞõH³ŒöÀr À–R²iÑ ,fìîüs®™Ùpù“gÍËð-«+1� ~B�Ë€E xË>ñâÉÀ}Äìͧ_ÿ&²ÀÅgIå´”d&¥˜w’Áž‹{wáòiEFÆ'Ü|l`™Ë*È.I+†6­õz½ÏmùÕV”îÉìŽÉNW·WM6k´Süˆ)ƒÀ¢Rœã]+>K¸l´¬JÉ*ßËC $ÉCºröÅŠ•˜Åú¬CÜpkÆ{|zŠO„/•pñþÂw§RiŠ*¿¼Q$ýÂ�=9¾ºÌnîÎuxZM»Ý€Mû‹Š.h³)Ø0}ŒÿõÛCà}%Ú® ¼BãP¥·ÖAÓ©:©§xd×|G[yµè™‡¾MèÕ»k9ÝêðÙ°+‚åþWR…Ǧ2­+Ds’ªÈö ÅXiF}s�[Öö©=(IuÅŒþá/äò“x&1ü¦*yÇÞöømº�¡­ Y–÷'!ØÞß@>I‰Õaêo«Úûœl”w�»ê,úôdç{ÞvÌ¢0pÀØõüâOy$0;qã³P>›¸ Ô³Wr :‡�`0ôÝYwÿæ· Èæ5EeYÕꗺǨßH½'/´=£Í`ÁbMã¡<B¬2õkYåyõ€õïÅþ`=$i÷+ 0¶ÁSv:¡¡ŠR5¯ ú½ARó†ÔKF–͵¡ÖóUûg_19ãnêQy­k>TÍáj†É²õiÓKDrvqàèCsuê•ü–K R×çîø­/3ûF” œ¡Så pãó–¢¢cgÁ`ð®däQ)^ïB—j•…ˆ»r%¿lÖU©å*ÏÕí � •ÓçÔщŒn­zMñŠŠÐ)69y ;º)ü.6´R2Þ2CoNstÇM�u¼�kàSÄ@eùòUàøÎ|9O¼V>5ûÜ�%äwŸã6©T*#“ëC±Þ¤­ã×HÍ}ƒÂÛ'+ è£JÜ**© *ǹ*ûH øLQ‰QÙÎâÌÇQä&–œ4½Kpü¾÷Ì>Ú¶aZ-ÔMi³Þ3(¬lQZ«ÞBG¥è"‚>èä8h¯²-EÇo?¶Óx gÁÔ8�F€”VÐmZoAnÕqúˆiJ/SejºC”*;k´ Ðÿ¡6�p(V†ô=4'XK¸xé“_ѪÔÕZcDk… íƒfâbÅ o^«ÃMЪ2cýì÷M‚A¬Þ¥M¹üêå÷?¨ÒSètöFWóöê5�� ­Oyæ&ú¶ÏWýBO¡¼üãÏ8„?ÉÄ¢ÿ±^-½iAøž_Á‘VÁà6Ê”¢’ªR’Þ�m‚‹Á®�#qìHs¾™Ùõ#ôR©§�Yï~;ž�Ç·ž5x:bÇ"xÄò™�nw§…0ª¹û²ÒqëÕå—àÆs=¡¼Ð‡ø¸«q"kÛKV•Ö»s.øG4äR”ÖÇ�¹ß„�~æYu�ÍÎe~½óÙxO('®«êá2)`†0zgæ`%…�HËd‡<%\Ñ7ËÍ(ÐÊ�PîG±Îg5•9ãœ�©h:„‡_™gÞÃZ$¿;^rI¹LJO»°Œ(áš}È«� E¸nTÓ¼®š3‹Þíó6 ¿�_ýO#Ûš°½1ŸtTÒ×QKiHzUoϨ ãžjÕùR¨ïþ\Æ‹,ßK]¯“N>ç , ÑÂX[ì@|JÕ6ÙÔÏ”t�oyÌìrDDê�2K106:,.¢¤ 0ùU§¯aÖK©LãQƒu*sDýÍÛ>}Ùÿ—óè¯gñ¯ºS¨ç#Ù¢CÔ‰§Ÿ j²½¿µ?¾1)GôL”ãu+0´ôeuœˆrÞ ÷„¨¨/$nÂ)&iäâ‡Q Cè݉>�›$$Ó’ñ˜ÏE@a¯KÅ�ãV£ßöáÑ„òC2ïO"OÂ-ÂkÏ]R úöÆ(­ˆcnÀtdóç;ô⼬ڠi¨$‡²–)¯WÇüª¦>"ﶈÀJ©ôÐ(èZ2Ñu½’¥º…pü–2Rs¿0 3'І¹\½1pñö@qtõÕlUXWE§›a@×mšªÜ³àÚÆÌôg½]ÃÍúÛ:Xlxunb½e{féý5¤‰÷«kZ~áóz¹îŠÖû¼ØØžm8½e�äéÊKṈ‘B19Â1(÷Ç\‡E³&ÖDËA[ õÔ}�ÆI–žM^MSÜæIϧÙSÃsðolÎ:dgëã¾#‰iØ*‰Ð OîU ÑBXZSM”(b�xiC”SAnÿièM=O妠yùB–¬žnÞ��GW endstream endobj 31 0 obj << /Type /Page /Parent 68 0 R /Resources 33 0 R /CropBox [ 9 9 603 787.5 ] /Annots [ 32 0 R 172 0 R 214 0 R ] /TrimBox [ 9 9 603 787.5 ] /ArtBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /Rotate 0 /Contents [ 248 0 R 246 0 R 211 0 R 169 0 R 34 0 R 168 0 R 170 0 R 171 0 R 212 0 R 213 0 R 247 0 R ] >> endobj 32 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 52.5 33.415 89.741 42.747 ] /Border [ 0 0 0 ] >> endobj 33 0 obj << /ProcSet [ /PDF /Text ] /Font << /F3 91 0 R /F4 96 0 R /F5 123 0 R /F7 106 0 R /F10 111 0 R /F11 116 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 34 0 obj << /Length 4961 /Filter /FlateDecode >> stream H‰ŒWÛŽÛÈ}÷WÌKM ÑâM³@€¬o¼ oŒµ�}ðä¡E¶F½C‘B“œ±ö’çƒS—®îÖL’�Sìkuõ©ê×ß}JoîÇWßî^½~—ߤ7»Ã«:)oÖð‡¿eÿª4O²¢Ênv§Wkú”Þ<Ú5øïéÕçÅtTýíªØn’r‘f¿x·';ô÷Âõ£iußè»ÛDL»£µ�éhõxºv‹Õg«W·ß}S­Ò$-«úf÷¦u?A«z“¤ «&3ôªë.biõ×^·ÂLÿ/Ý`1œÓO£°á6V«ÑÀ’qÊÝïa"kƇÛUžgÉv¡úV`ÔÔYØ©�a±<™éè¿v¦7�ê„OÖrÎó*LÙÑ~p}E–lл“àV[óH;Z.”Ø÷º×_}«ƒNÒdœ`´>Œ¥­:_á?aÚŸÞìpANc,x¬»o†ÓYYÝ ?šûãªðèØ [E|`•jÒÜÀ/ É«­,ƒ‰ÏÖœ”½Ñ�pÄà‡„ßÁ¾Co¸ m_œUQÀ¾ƒ¨ÚGmi­Dõá›…º¥Ž÷E¿hbùtÂÈsS®’uZoñ&|æà(Ó4©x� Õ~Ä�бÆH.ƒpZ¯ëÓ¶Ú�%'Ë " 9“r“d²ÂrÂqKãÒ·ôö½î øY(;– :Ÿí'‚ƒøùîŒÙb³Å+F^Ì+Gà�‰ s¸Øs×2Þ»ž~™~� u‚¯U™â"FAaCÌáþê~4Ó…´„m?û¯^–åÍWŽƒ3$çÛ §¹W¦'¡ì‚óè!ž£8HÈp· X £Õ½Œÿ¬®“"ܦáƒw¢Ðpp¨4ÙÖEkášÃnòªX—¥Aj˜;©aBbG¨‰màv´$£G1•‡^p«—‹€X´ „φ„‰è,ÚKãQ£lk†G56s§¬XOƒ�T¾{Ù\Ÿ¡ÓŠ’¾„`s�T§£‰Ø~ ;fƒ¿Ï£XLÍÐts‹‘šc¼ë_õdNfïtßÒU&MK% $МI�¾ù8ï'Óȯà ú ­&O“z1]ÎZp-ànññͧj$g0ýÑìÍ4XÚ™þÚû~ãeœô ö؈þ÷,r];BÙEÒé‹0d¡v$>Œá\Øe…P2…¼°Ä¼Rûâ•q«O˜%p­Ø|ÅÂ9©öI,V·�Ï Ü3§ †]·jG%â\GH¡¡#V`_ V'Ýùe˜è¢•¥ü¼�ºä"_ É ~aÙ‘hœÁCà>:6rA°¹ªH™?zË·{€dÕÚ¿4ûŒAŒ¤‡P¨Ý˜ûBˆ˜”¦Ìø(ƒ/.~ž8…ÉDy^�‚Äo•ŠDß*îaVIÚ`È¥?j©ý¤L„¨xÓG»gÜÙ&‹jQ£lô›"æ ‹D,"à_aº~óºÆUÇÄÃM ,y„«,ÁJŠP¦GeOTߣúÞõ—úž(çmÆ´‹hZ~-d›h/Ì耄€Žž³_�y†›çê/²�S �qqªºáª’èå-í y1Œo2~» þ¼øÄžd÷�ØEñL싱È@ìê—ÒŸ8B|#ήA7<9ë`ÿo±*×yÝ̼X1%%Ao2}V „Òv°{Ó².ä¨2ûyØÆòAP�’¯>ÑÝ‘®0áèr_þÓåÞ”)�?Ò½bÆW�ñ‘‹¥Ä¦èÌØðÛꛃJ¸ÍQ0>8MGNDÜÓ–0\vbÞ ¢èáAšyò]›!ò¡ç®×æ—¾µXtOÁ{xnŒ)¶ž–Ü%ÍÄ Yb:Žw·ßÈ'X×l-.-\)·�ßÖÍ�Lf^2ýðÞÚ~‡ªçAsmÔY{x@á€üoþö³]zåœDXµ=àeR²œÔ/4>7ÆÕ`õ%ôN΃Çñö››†½jxt–̵\N"Å0j¯'Ru6œµ5g¼ �X”�HݥèU4ÀÝ #3ÐŬêÈ�ÈdÄû ”kuoÕab8ÎP¼HzÝÀ/¬§™cÉU½¦)ÊšrºŸ„¹�B˺X¦ëÅæ?‡ê†8ä¤A°S›0ƒSÞ ÄŒ4ÇÕ7dðzK,Ô7Dñ¢2‚í�QNöÑâŽÜ�ª#¿¡0QÏ}’G¤ZÔ9í?ð»Ã7”ãw�½=Rk6À‘Á}¿J[ýL7Oq]až¼ ð¶;^¼�òB¬ÚtÞ$Ÿ$dð�ËÔ2ß3Û ßý\?»w`ΚGÁ°žøåX;§3FW³§J€dXfòÖ¬Ã[³~özmõWzí•ÛCÅÂ=ãÒ—¸¼ã„|Ãg�>¶z�?¤õYQÂ;ÁUC„U/|gñº´bàë̘²¨ë!G͔Ԙ*-¢! C�#qX¥IÅ!ÑÜ×µÂöZÐ%•Õmèe‡™^€®—Š>¶º1qMÅõº�>©.Ùˆ‰à#>»ËR \ñ7«qöžMb�A.OÅù�\µ¥‡`HFb’ðg¦¼Ýe#&îT¶î=ê„ÑØËÂb!scEáÅq±x臧^>œæëÓqÔ�| ®±3•­Ò*(”kÂódURmëòf{—"%ÖÞ<Ý@cQMfN{ýGr.C7%3¯÷LçÐ…�µ ¯Ú´¬S^‚\í¥/õ¨”`üt4”oˆ¸’²¸z�¸v”‹BÕ…eÊËRP&|ÇK’’ÞW*lŠŠ ÑTÄý3Õq^UJÖ®^Öƒ2-ç\L1¹!Ò¿ê êõ½öŸ¬ �o>ýP 1ýÑìgc¶`$3òµf4†­8£ÔøLô7™˜»ÉKáîv¾~ï²Íœàåù‹ž«Ó‹5xƒÆ%Ä~aã =¦B+/„Ž=B¶ž®Ê4)~ó’´‘!¿ i€dƒs£° ¦Aÿ£ò–’:ÏrNCÕ’I¾È¶”þ™|«Å·€þj®¸òŸb "àx®3' dN:ã5éQÑý#Ì['¸×Ú÷à×.K,òÖ€$AÕ¾_h=ÎcÍ¿ù®–åÆ�$x×Wè¶tE ÀÇú4+Íx¡±#6dïe.ؤ`ƒMŠ£ýÿðVev5À‘gc"F™Ånô«Y5pž¥ê$�¡ÃI!g,èà2á0»·8ÙµÿþKÏñ+H‹£Å5€µI’,¹ÄS]D+M—-mggHÛíÅ;7f(ÇåÌÎ5n}¹ÖØ=ˆ[—H6àx x­¯ÿ¬¬……õ™5–d0÷N·ó:ºÊJú¤'u ³u*C IˆiP<€¾Ü:u«ðCrvMóÞ Ÿ& éêo#5ÉÛ”B¾B!÷’2ÞŒbIÂ�ÛõÎC>âu³ÎW�ü/ábæçS/ipfôã\=Ë—!˜‰°MB}:Ãz!†Ã~ž$ÇJxÕ­š®ÝÝH1Ú›Á.)®7å|Y@¦Y¢œšéì �\‚† ½†žÞ»M^|8gƒ&‚uæ9ŸÞyí6ƇZThÐ&W/]]9Ö§ÛOËk©[-ŠÙ,[ä9‹E¡]Ìe�ås'áÄ7„åIz=QC7þsgè_’ÑêÖýTb ÑPP~³4]r¥Ï]«w5÷àã—�ÁücÜ |÷ÛAŸ»Þ…³Ìy–¡úË|Ð0OEuAEu§Þ`–¤¹áÝI n#瘚EŸ�HT¼¶‘#›áaÿOùå›ç‰ kÊw@÷Z6§Ø´°RÔvíÖ®�–¦>Ôñ+�Zã�AZ"AE§—‘{ 52[ZÜîãíOÍ„\ôŽBÉ6pMŽØÚžz�V£îu”Qµ, B‹©8Š4*�p(2©ZÛÎP%oÊ(¸Þà°N÷NNK¾ÈT‹K<ËP›È­�Q<¾yZl_d1� ì/r­$j•BÏÐûù‚]”3Ì$æƒôX@UÒLã�P‘( vs±œäÚz,DÃÛ"λ!æE(¬­Iý+ïŒr¡Èë/ ·]¥M,‰ÞѾlËî‡<Übôl‹ lÜòi¡”\y!I�¾MÌ;bNP"Ë–¿w‘„=cÔV:8ÖHþæãw¨`íÜ�#Ñä¾J5˜'‰Ì§§2Q´2ÀH@/oÒlBIuíÔŒ›ší_4 7ãG»±æÝ%‚Iåû‘ô€ô©[Gy!ôoâÇûr†–^Ú:wž…@Úv'†p1dM`K“$|ªï†ÕkÙ£CÑ‹–†áØ8cìL•†*ÍUoX:Ã8“N3÷EÜŸâY¶þF³¸¯•Ä�fεæç^¾¢!N6Œº+q½5£+ü¿æe… ö§®GýKÇê”OÒÄЛ+{oäËdžL�ÌÓÐC)yz9ùøËŽ=I¬ŒùÄkLQyÐ×Ò^\éRžÉÞ�Ä’™î“(†?N S9üvÙŸÒ °¯$&§£ó#¯¬×Z­™ÊI®@Dzß9$ ré™ÊÀ¾09çpèü0âgô‰QaºLÝY, _~˜š�îÈë Yʨe)yƒ‡Âªn3 N닲•fJz/°zïÔClõ�‡aïJ¢¥!ÆÚj¨fq9(‘y"ÏJ;°„DkX& ü@àv@p»™±_Ú8·¦JÿVõŽ¢l+Œ”ÆAHwòY$zs8J©ð4žÄ4F2(¢6äÁa@}áuªÙ°à¿U$üÃPÛŽ[]3¼¸êJX¬Ò�X­sÚøÆæ -–k¦±�~ªó¹5@ú;qíñ0n35ó‰Ò‘Î\_èLõˆ½6~C�9ÊèĵVs:¡1©"^Ê·ÑàoÀa»ÀtoÀ˜â�LsaàhYæ’l½’ç.÷R ŽÆ�€‚’eÚSCˆ~b§‰ãÕ½ŸŠ2I¨½£çý…5sµBS Òäèn$D£\É—fò*P<�ÖßJ ?„åË¥ãr¦;¡æE.N·ë4à‰)°‰In‚‹Äš0ôt@‡^ÒG?Ò}TLR�ps’Ã5Y шÞÈ»5ĉz$—²‰?…ÿغÆåbæP¡� LOîÊ­dÅ÷êÁ^£l™êh¨][ÿ7Xs‰«º¯N{yy5oÆ}ùfÐ}­}ûæ¯Ö;¿ÔªºæË¹6·h¬êÎËš•…(d£vd;2GvðmïF9û?'y‰æMcu‰2zâ>—Þ.؆LEÃF¯“^ ÷ªspNPy°¸,^/[¸ˆÁ?«(@Ôê�êù»…9Œ‹¿É“´(+‡2˸ý,_;øë<¿T$û—Ëy3SÓ�>Þ?ÞÜE;®pfôŸÝYëÉÔ8H\dt£±¤­Síw’ÐÐÿ�ö� ¨=‰®g$J-RÜWø“.¿îoÆ¢Üû=ªs‘Í-ó25Ó©eà�ÕqVmþà*}–ЪàÇq×+϶q1ÆŽQ–ïNÒRÙÈ7|� -E ¼ÛOir-By{µ¾Näßúº½^æ’@òevý´¿º™%ézqýTÉz¿6%Ò­öÙä··÷ݽ±,ÉÃwª¦ŸtOVŽú!]`Aù“K—šÎ“ìbÕÛ;¿º®¼ìÍW­ÔBY~r÷ÃÓïWi*ûÃLÚåE’^Ì�<>üüp÷áÇe¤Ä,òÕârèOï¿Y$ù,Éòürà¯÷å»uüí§‚—¶Ä¬%/MŽ±Ì—©ŽNøµë?®&ZI™~Öõ;δû¾<`.Zn‘g2 ¹ˆ“$’Vsy0ˆf  Ô¾ÕAþYëŸ:sx˔ߖÏÖ³,KVüî¤Ð-||ºúŸbµø® endstream endobj 35 0 obj << /Type /Page /Parent 68 0 R /Resources 37 0 R /CropBox [ 9 9 603 787.5 ] /Annots [ 36 0 R 177 0 R 218 0 R ] /TrimBox [ 9 9 603 787.5 ] /ArtBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /Rotate 0 /Contents [ 251 0 R 249 0 R 215 0 R 174 0 R 38 0 R 173 0 R 175 0 R 176 0 R 216 0 R 217 0 R 250 0 R ] >> endobj 36 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 521.259 33.415 558.5 42.747 ] /Border [ 0 0 0 ] >> endobj 37 0 obj << /ProcSet [ /PDF /Text ] /Font << /F3 91 0 R /F4 96 0 R /F5 123 0 R /F7 106 0 R /F10 111 0 R /F11 116 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 38 0 obj << /Length 4914 /Filter /FlateDecode >> stream H‰tWÉ’¹½÷WôÅlG³Ä"Y\æÖÖ2–c43!1|ùV�$ܵ¨"‡¾û ôÃÎ €­VtDóeb+$ryùæç/ùýÑÝýmw÷æÃú>¿ßî¶Yq?ƒ?ü-ðo�/²ùr=¿ß5w3ÊïŸíJüw¹ûc²Ê¦s˜»�ü~º:SªZä§r0g3\ÅǶ´Z9]…Úv{SŠøþOmKãôÿvÿ€í§y6ÏgÅýîsèlXU‡#Töz«leTØë³>©½©Í ÓµaéaÐaç–ºèÔÝ_ᬷÿ|ÇC›Éû³Œ¼ù°`åÙf»\ß~Ýo#캘¯³åÄÒ�ªÖ¢ /ghÚ²+ÓEÑ“±¬¼ÉÂfºìš)�?�çæÅzËç6º­è<+V+8€‡“ñšêêjÓ›J7F±æ8‚T›Vû%~âž!Ø+Øb8Á¼å| fºèºžVÚ•Öìq*kõá ËÁ‰ØÅ»±ïæg¶‚öÝpŠ'Òç‚ý·«l1©õY×N$~n‚ðF�A&à'~¯¥;0Dÿƒ×Ù×Asºöpü4ž¯�ñ+·°Rk�{Ýêoa¯Ì(^™åxe?³Ä.F°Q׸oüŒFƒ;ô$`¤õddÐÚ ƒñYÄýy#z�Œ˜ÑÞ¯yÑo¸l]d+¾#CðrðŠŒšÎõ5è÷NÛ³÷xQê38X[†�0~èÁ½5�²°a±ZÊ 3tàûàÝqŒlư·Ž}ÕE J‚Æ[7]l 0…ÕDZVVD% ˆÅ$AÞ¤áHãd^Ø¥iÝ:œNôi m_�œ2Vl&; MÆ)­žÓEBˆ‹v/…ïBu•Ï^¾ ªZ5ŒV†üæÃþ*cøT§n<žâŒ°ýÓºj±ûw½:²{΋\÷ö[O;Ø®‘ ²×›KΣó<[-Áfè±xìþ}7•¡OyJóÇägÉbœy8Ë"xj´…�àn³6¼çjµäÓþ˜¸^—æà÷Ê‹ƒÆ´ã �÷V¿âæ#È–àÈ•†§ÕÓøþ~„ò=¡ufû�eJØælŽ�íÆ0B.˜8/g“Íæ6›€ S©”ÑÐEëgQ�,æ_e¨Ã,wuƒnà�JÑ@}‘••qewNS¡¥ü³�esð4 {Æ/ž”èE‚ÝØ÷�¸Ò‘& ­ªâ®Ê%ǹ®4ÞÕ‹b‘¼×Ü,ˆ1ød[²¿AQ}�|} +¯×@Ò¶…Š"¡X¢1Å ðbÿŽ4fc3õ*á#·Z{Å0XÄ`äÛµG¼;ËáEE¡’™�ç�ÚT�IÙò}ä4ô49eŸÛŽ�µÀd %4�"ÇæÂ… óŒ$ý{)ïͱvÇ´Á2e>Bào¶;ë†|ß«ZAm× wÕ"ú(ý-œE]”M|êï*i¹‚1L*)n*iž0-HÜ–ÂÐ"0–86zPSõÿJ¶a%u€–“Õ6LôƒHž6Åãþ3ªÚ7I¸²V'Mʃ5Š[@”¸Ù¢yhUŠøòyE‹<„ É*;_ýY_N—¬aÕY™j³Œ&Á ÐËW`m°´5Ífùvs¿+‘?ž‰´m7L‰P«×ŠÄ7D”Ï]µ²N x‹¯™ˆ‘²³ìûTʸ'e!ù!Ni¼.‘æµ7'#Xæ´>*´‹¶aÌu�¾PAbù¤á€Sf‡Õ,&?Yix¡¤ÖäýNdÓ–õXñÃи¢\ç¦ð¿5ƒ �‰êøL,cYö(-”V0Zçd,LN”{Iž  a#‰´ûú "GÏçt€0&ÑH{ÅRš!üklÁP’–D#g¾SYs§2»ŸÎ1UÎØcÖÔ9.€¬ÿ:B(øž—5_€f{»ݯ&Nñ­(Âf�‘ç~¢óf˜–çù¬à´üe<2‰õË|zÀÇ©€MY«ZMnJ©t2ü»9ž¦Ÿ1~‚ ~÷Õ"|Ó/ÈÎDøXvNõôb¬x?œ®µôÄ|×P âÆ¡D…­ŸÎ�©^1Ï+æxÅPaç›mž*æZ·V|å 1õûyµª¿¾èBCAŒ–§"\,�]öÖ4T‚Yä~†`RžYAeTV%f`ÕEÿ¸;yéår�5F@Š×NktlT®'ŸnŸ>ÎÌDx’©?(#‹|Fy˜ËKD@ -f‚€É;Á‡n¤ÀãÉÜx†>cÊ«BÑ�…r„%VøŠÌÿÜ©»ö|š¦(Q¾¸*++òrá•P tØò[rÙ¾L´¬@î&ÌÅñ™gý(£Ÿ>†N0¤õõ�ðwõ�´7.šVøÅìe�JîQ î!=Dâ~“`ì”H¤N‡Ð ÙÞrpOþœ”!Æô0qØÍî»nwS˜ˆŽ¯ Ù`•[R•c‘îÂðÅC±’б¯-a+%ï�[‡i‚¹ú_@LŠV“yAj†E¢=<† Žô‚ïDòlBez³º³ ë9ˆ»H/l×îkÕ�µòp×UN„¯0{4ìX¤8ë#Ð0è“|á…‚¼Þl‹ûÕ6 ñÞŽ¼`»™ÔÐ'6Z$O7¨B¦…ªçõBÑX®mlz¹äFªÕ�|½]ò)ßZeUHÚbˆñÊ–$±R†‚02+úšWÖ Ö"‰ìËSðñƒ��v¦¡]¥-½f‹Ý# ‘3ù†5,Ž­«…¯k¹ õ-j—´²Éë:ÃÝg¾Àt?è•NŸuCò€h¢àõc:Õ¬cu�󹜗ùÌwž%  ¤F*ˆ·Â¯ò¿�pEágôòƒ‹eß�àË\JJ.¸gR–‚QÄK&e�E>Ü�$¥ŽUÁryÒ±l\@àÇéw51zoiÎã< ªÚþf÷�§‘dµ¦ö%Ts…#2Qé’-ÀšøÀ¶Ý S‚âD ¸Bx2¡yÎ�kƒI‚Ë€Êvg¨%<m»‚ÀMÂZ(0äÔ® CÚã^*E‚Ä€º}.ÝžÊ×Ûj[2“DJÙóBŸŸØ·H1QÐ�‡ÊB�o]³ˆózIÏ0D²ýðŠ—Aï"W¯Ö1ŒdÌâX»~µùtuM×�¯Š‹òàÂpÍ�Ǧ3„±1çî„9íJQ¥ É¿ñÖÜòìH;5·ƒbÔ?Ÿ´`Ã42ÔÀ»æsßX½ð¹d6–î²mûÊöìX w6¥¬P�ÁÅôCOͺ’³%L´˜§N•žÑB¬‡‘Z¥$»È”íöKíÿ*d½/ #ò™è× Ý•¥ªßÓŽmxl¬MŽ¿ç¦¹1ÞZc U‹Úa´¢”pºl’iš,óyõ0 ÁYËËBÅ÷ýðÔ«@ýgáŒP;j 89zQYCx¨>ç“1Ed¹A�‘µ ÇŠ˜d݉òY¡ÜxcÍÄ kwöŠ“œššõ�@bt;‰I‘¼þ©©îo;>@äZs]Uß¿|Lw=Û°Î3Af¿æ½Ϊ3ß9‘O(ÇýÖ¨Øö»3Åѳ{|¤3ŒæÐÝÛ“‘ÇR«$+©¬PiÌs_�3¡¼k˜Ç39�,»„ôä.T2çú ¸r/¶'á#]Î×fâ“#'“òOÛ)Ï©¾ÄˆˆÚ×Ívøþ“•þÑ?†*µ Ú*TÜX�$`þ…ô€×dqRˆ²q@9> {3‹É;ºNUM…áôìª[žW¬à‘‚]DÍ.rýQIùdÎÇ#è®j¸ß1Ê\¿ƒ^¡}@êRõ’,Ð;*èIú�x ÷©¸¤môƒ"­"�øˆé!!úÝU}¤É�«ÖÞÃ\qÉŒ–¹B Œ¾w:jíÜÙ!p]örhѯ©œ,œ�^-ˆä`Ú“pf~—k@+‘“D)˜CÜ+U×]£Hø°×�È” Ó¬"LFEuŽ­k'ó8Q­xFPétT¤Oá›"Þö6£2”3u0Š©Ûtgfµ Õ†èÐΖGÅmOùTwgÓ>æ�_÷ìIá£ëBÓ�O±0`ÀjG½Ë8+—Y¨Üòשÿ5»Ia['ròÙ–®–€jò´QˆÍK’ Ú¶’‚Ÿ<4ç-5^*UÀ¦‰¿ŠóÐÍáÌß„ |÷ï¼WaG3§tk6(j�9»W*ÿ—æãωŠó·È)Ñüz�¼åQNçµ<Š‚©O¤?‰‡`Ô�(œâX”ëb`'Ü/GW“B¹ôÒX zaþy+³Š—®­½H7>›¦·+6Õ®4â ‰™'Ô8iOÊT2%a•„$URW�* ág¯ ëë±æYd¥Æ`GÔéšæ™(2�m}.G�õç+Z�ø ƒO˜Å¯­WÒ$¯@7Ên:¯ˆÞz%¹,ÎPnQë†T¼‚äÖé(-¸ÌÈ Ô[â–ª¡˜£­qu±¶à”‚á"�¦ºk‚ïãŒÚ�À‘?mÿ¶“ÕšFR·â`w5KÕü<°3€¥m :ùá�ýò4ÎúZ¸‘ptBààâ¡À\’€Ã´££ýÎÑ~ tzpƒ@?Ô[ˆP± |VÜ3E£ÎâC]ŸGøÃ@wð3 •ž²Ý—Ë=TªÇ SíZ ÐÑΈ\alÀ~½´üa?€ñ†¦Ög•ƒ …+m0<Œú–xQÿõj#§Îsž¨]Õc{´³›è$4… šÝ`ñ’Heióò5¿ü”6C"õ¾TG Á-Äê±t,×1*tü¢ðS,~| ª³&§¸¢4.AÔ%GJuŽF(\W…&ãö΋[Î}Õ–i3Ò*µåP½´çuÁò¯tÍ�ðßb$[ÅJ¯-‡…çÐwhô�>oiPr$¢ðAðóËÐX%ø Ï<Õ‘=¯ˆ÷á6-æ!HþRDôfá¥XË`h°Ö—+ÍdD¬ˆ{¨€ÏÈwÜË'¡o,~œ7UÛ_dÂ$â5ƒ†ªáDÄÑPæV¸pÏzrd�¿ÚÞ=¤%›Î|Á´R@ìØ´Ä´ü‡4ÂhidËBE • ƒ' zfîå{€> endobj 40 0 obj << /A << /S /URI /URI (http://www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-4648) >> /Type /Annot /Subtype /Link /Rect [ 162.926 119.256 294.494 130.588 ] /Border [ 0 0 0 ] >> endobj 41 0 obj << /A << /S /URI /URI (http://www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-4648) >> /Type /Annot /Subtype /Link /Rect [ 52.5 108.688 236.602 120.02 ] /Border [ 0 0 0 ] >> endobj 42 0 obj << /A << /S /URI /URI (mailto:patrick.omalley@usuhs.edu) >> /Type /Annot /Subtype /Link /Rect [ 266.102 59.983 294.494 71.315 ] /Border [ 0 0 0 ] >> endobj 43 0 obj << /A << /S /URI /URI (mailto:patrick.omalley@usuhs.edu) >> /Type /Annot /Subtype /Link /Rect [ 52.5 49.415 133.821 60.747 ] /Border [ 0 0 0 ] >> endobj 44 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 346.202 700.176 390.307 711.509 ] /Border [ 0 0 0 ] >> endobj 45 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/policy/index.asp) >> /Type /Annot /Subtype /Link /Rect [ 466.759 536.503 558.491 547.168 ] /Border [ 0 0 0 ] >> endobj 46 0 obj << /A << /S /URI /URI (http://www.healthquality.va.gov/policy/index.asp) >> /Type /Annot /Subtype /Link /Rect [ 316.5 526.764 378.969 537.429 ] /Border [ 0 0 0 ] >> endobj 47 0 obj << /A << /S /URI /URI (http://www.ncbi.nlm.nih.gov/books/NBK395866) >> /Type /Annot /Subtype /Link /Rect [ 521.849 322.253 558.483 332.918 ] /Border [ 0 0 0 ] >> endobj 48 0 obj << /A << /S /URI /URI (http://www.ncbi.nlm.nih.gov/books/NBK395866) >> /Type /Annot /Subtype /Link /Rect [ 316.5 312.514 431.869 323.179 ] /Border [ 0 0 0 ] >> endobj 49 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 52.5 33.415 89.741 42.747 ] /Border [ 0 0 0 ] >> endobj 50 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 86 0 R /F3 91 0 R /F5 123 0 R /F6 101 0 R /F7 106 0 R /F10 111 0 R /F11 116 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 51 0 obj << /Length 6019 /Filter /FlateDecode >> stream H‰|WÛnãÈ}÷Wè‘$š¤î�-¯gwâË`¬™Eå¡M¶¤Sl¡IY£|E€ÙN]ºšÔÎl`À:§Ø·ºtUõջ紷©/n–WwÓ^Ú[®/Ò4÷ø#0¿išÅÙhšõ–»‹«E=ëå5Œ­óê"é-süw¼ˆ—Ë/3?'i<͆éÙìèéqqÿéù×§G}u7ä=ç~Úœ6ùóy<™L'8'áÓô^/q’Îg¸å¿¢ß.é<žFúr0¥ñ,Ú;]ëªa:�T+W›�jLÞ—O{`0r�Ã?ít!#Õ~ï¬Ê·—ÿ^¾¿€d>šöà7�L†½å-lÚØËA6›ÄY´S•Ú˜j#¼4{Sr9ˆÓH¿é²Q;6<äZØâómø`ê×¾8Ky꬯ßt¬å_à¦Ð-1šÃ>kë6N«fGVð‚­ò8‹L-ÒÜV¹u…jÇM³mç„¥ñH‚MÕβ·ûC µ,?ŽÁ¾us(Œ.bá×e³µ‡ÍV¸=8�›èRšJ‹À´«˜�)U  {ŠVI<ŽìZ�?7Âë�v&W•ð…-K½ÑßÏY(W[ÚÍI$ª*¾[%lü‹V#l>‚p¹®k›R]D«hººì ƒ9-Dµ°†Èpªjv{ër ³^k×ñ7z»&s•ŠîŒ«›¾°£Ä;,u] g+øbgã SgèHD Õ(Áõa?èº0žÍÀ%¥=j'äþö~°`š+·Ñí8˜‘�yØÖl¶í …­)àùø(lZ7`åªF�§xQu½×`ù²<±dJÁÉhïÌN¹SKaó }Ëìg&)Âbd@«¿vmtUPjH’xâE°4�4TspA[}l‡:ìDÔI`Ù+²ÜG‡ ¦ÊîÖr[Æs9!86˜á8æFà#vŒÿ°cu€õ~!Uæxi­«;kµáV7`ÆB#ÇPŽbÈ �1冭Ñ=£÷Et «VPe�/º£i`:|ɯ 0±Ozȼ¾õ�áÎ%@Xs¤7üª¢0x&óŽ—k\%›ÁÿœH úÄG´)Lîµaª'ØtDƃíg+PŽìzÓ%„B6�òw�›m_h­Öº9 Ã\­&Wæ+(_ª,èÊ0ÊçoÂr«üjÍùÆxQÒi<Äë¦k!t)æv÷b*Ik$ÂD¦ö§Õ¥Lõû½&qJ'¸ßªnîÚ©ó«Éáû„rC[£Xàà>î@Ppé‹ü¸5ùV¨á ҶÝÁâU%c¨q`­Z»7Xé-ÈH7†hZ'dg ¼Èz€–#(ÕCÅ;º€À¬ÃY<ò±BðÅ’í ‡‹À”‹ Áš²NçÛÙ%av0î“`Øò°?B‰‚ód#LÒ¦qÞ3, c0ìlÀ‚v‘˜€8F8HÛÜÎ}Åû$ B|þ¨Ú´#.“h-¤ÇSD+ Cצ]b§^)»3ãx#èºW??8G¡1Ê ñ¤{ÖàEazgÖtO˜aJaô¢}Ê`ÊN°n“Â<¶„›¼qÊM^È,cô Ž2/¬ÁOb,€¨ñ¹ )͵³/úL!‹¼™æÔAŽí‡Ê[ý�Þª%FI`ŒFÐqU(Ïgߦ ÄdXê�·ËžÍWÎ(ÄŽZP£^VÝëlµ¡¤1ƒjÃaƒL~KèÇß‘J³€Ò,�[ûqêÅ:¬-'?ËI7¤©l¥C:�Þ¸„¿@ó˜{ D@ ¥�uŸœuh¾oØcAhÜKÌÒ~‘ÜPKÝo¯6ú7Þ�†yu¡è¹ˆ½ÉäÔ’ñUô!~?Åí€ø}|ÝÒ›øçø1^]þUŸâçXð­ÆòMå/‹”)¶�Ÿ5ö–ô’"~½^+ãýêéIø�®ô·&|~À7©ö¥•$b­~»Ùsn›Ô+5Ztݵ3ÿ�¶Hè*ZÄÿðç'Á3´U[!KýUÕB:ç%.ff¶ÀI»ñ©n4:v<E™à™ IB.$äwcœHÌ;Qè3ƒë‡¯ÝgÛuÕØÊXê¶ñ‰ _°{ðOøö>þßzíIpÃ<ÂÐ\†yŸ¯ñ¹r~‘„uíX�IÃ"}aw%$µB ]E×ñ�ß��ô° øOë^wmÆ’ç|km)ŒBŠÐƒ.:ù2+õÇÉPžº Y™aØ� ß�ð/ʽP¿ÏìLãaGã¯Ò±}Éf 4!¼>ãUô,—†·ªT„»Ú²ä[rJEDÙùÂ8ÉùUÜVíÚÝIÏɤ��$„žáÉ#´[?H9[Kà¸ñ‡' ø '}Ô”³¦X,•vxþ@ž2?s9 Ó6’‰vò‘.ù(l¶Š~Ž?S§˜Þî㥄Ò¥aÏùxxá'ÀX¼N¨µÑÖ"¼ ¥Î�ð�†Œ¾,Ti:Ṻ2`¢ÑpEs—É3 ¦‚øÃ·…HðŒZ#ðÐ`„?Ì ¢§­±]\Ç÷¼×x*ÂL|ã{†që Ï弆„ì¬y®õŽß³e¨PÌÏ®*Ièrò}ur–:i‘P¡¼ �‚°m§.ebî�`®´WwYÚõÅŒ .—ÛÊÂtžM°Ü^-êY/¯aT�WÑ­©óRA»à~º\~�ùC?¿S²¡¢OÇóéÙ2 }M{¯p¤%é“&Њ½}¬…è¯ð�¦¹<>ÂHÕBN[ ¿¼Âw¨>ÖqÊL¼PÃtÐÐÉŸWo^ŒìAÂ9·œ$|Ñ"çb㺕¾¥!Ï 3yqÒÍáÏN>ßÚÛÿkúaOƓ៙ÞÖ°ÑŸÛ>M iOféÙB]ã_³�°ÉIájn½ˆ¼·Q(¨¬ 0Ãï&oÂ4nŸ ~hÞc±ö|<œŸ[û"fNàõ:…^»ˆVf„a€Û2ÃF“ÑñxŒU¾‡n Rl¿²4žMA!X|')Dt„Ñ•�€+“ï¾h4ЀvÎ]-X‘§õ¯þÜt¸¸°ßÕ�‡Ýß²d0šŒf1[øG.šAz§Óï=ä;Ó……×i‡.è�0Φ  ›ý'ïù9nœÄ tïÝå»~û àq—C%An™DïbFÓèé¿Ð�k|¿ü�ójInÜH¢W™ÝÈb…?¨Í@$[ÝS¦¥¶½{‘…n Pnù½ó æsÀÉOUÕ£…ø2QU(Tf½|É�V‹Kûlµ~/x‘3M´V^�n„è͉'°˜±ÿ¥u Õ69jÛ0\&s|ÏÑ='ÝÖ¤�B'@y Êf—[ë¾Î¶—ò¨/jìX-,r!Çý+kå“}V”2ì`ÎʼðBÕ{:¢Ûãs«òí‘Âëiåqü·(R±‹ÍÄüÑ#m =GbhE¬í–ªë#áÂÀ�XÓûÑD; _`ÓAgz¾á¦ÇR$nJ¡¬•-^Ëç�'OGð? #X0IÞ ‘ûü Ò‹Æ)…˜7óa‹Ž§ÝÓ¤»Ð]Óæz„fJ»ž¹‘ ž ûnÜ…Oxx¸´0-á,j±ÄʧlO‚ƒìå­<Ê;‹²òJfBõ)ˆG؆¢ØÈ¸´mëM‘Ù\ç�áëȤ:†G㥘×G� ¥5ûËC±Í÷E]Ö»Wë3Uáº�nµ®ô€}nÛ›¶_{¿/º.t7´Bˆ7Æ75jWkõ³�çø¸± ¨SÚИ¯AhÏÛ|>OϳVÖ¼°åò±˜NÎ¥•=L\ÇuàêºHðÇÃ6ëò™53 šüPã{Ùzjê½ÅTö¡bÛìÕ<†ŠÎTá-öAË5›c™<¸©+íëY®½d’£ÆâÿZ¯>,fŒ=�$®êߨÜÖÅL;=hêéüýr†Qa>ãwœÙNbÏyQÿ�WÙ�“‹ÛûK–|ÙZߌ#…ó}»À*«²]Î,‹Ã‘cñwûÚ–ç[Æž§ºaÍÓ¶¨m2»JÇþiÐ^²�©á3�ûø³ÙígÁÀ{<Ï™õ´¯U}h‹ÖÚDú„$„1»ö-þI=(‹9ÖŒAðLùð#»¡Ÿs¨³YÕZ;}zÊŠFLJP†fq¼øÛ+.€Â*úD27 HŽËFMß¹�q˜€*ÞálIAX°©…¤Ä‚b'ƒàÃ+z37Ñ“HÜ&Ûämnè$‰Ödœ›àÎ9 LW:˜8±ßg w–_¡/ Â'¥.ÇðØCéB¨?S¶Í™^Zû]Çœä(i'fS'yvcÏîU€ÒŒR”¡ÒH’}pþýÝD‡v ù>ÃüáÑïoeâ_ö™øÓ…ø©ˆÊÊ1AøÊ÷ ;1︹OK;˜ÒÖ\}×S¾©r:òE¢GÊ›š”'ÌÌŒóX²Â›Á6v<Œš«M^m‰q'[Ì0(ÉYÕµväM_ÈÀ%ÊÍû{kýÛžp}d]t†P‰òj×=+븵`^2A*° ƒ é]õ{ÃY䆠§”¿-&¼ r"?_LíèpúI}BâÈ…Âe•ãBIð$u‚qê¸nØ(Ýå<æMóŠLréâS€aú¼Ï¶f…µïäɪî²2“qâÏ;‹Î’rÙ‡ÍJù5\o[;ü>¦o6Ï&A´‚–iTÑï©DÃñxQL’¢yÉ‹²Ì(ØÇš†à‡-*š¯›ÌÈrR_˳‹JPkÒýgø*Ê83òµÖt¸.ÀÆðÐGI{Ÿc³‡iËö‡ý¡¤šh_K^ÞÁeÖ”¯b|9€ ÀVÖ•îÀ”¸-yõ{â™ËnèC’þÐŒÍï!ø#ÓÑ•µ)-¬‘¾¿ÿÑâÃñøÉn—\U-#µ'ß~±|?wâx²|§¬¼Ï()�´màη“ë2ûL�ÜŒKþ�g �wÆygœ+ˆeÞ0þh|Ä5ðËr×DV³¾˜e mëU2lãTWpCçùج|ÌPE0~W7›qňT9±ý޾ƒ¢ ‡¦ÞØž‰”R„He04Û$|²QòH‡IÛ5¯;Ù/o1ô NÚâÌZMþµ¢ädÓRàä1ãúdiÌz·°�²>Œ4ŽÐ©†VE°Å*–$'ÕÍ@"L Cy›«4HPhØâß$w¢s!J‹uÓ«-ŠÎ ÒÃêR`Wc‰fãîVü×Ðmæ2!ý^ä�Eçµ)R^ %¬pbYà}:MçóišÎ^ßOMÅÊ÷ãQ¥é†^ÃÐùz5M`ÜË”^©Š¬òï4c¡K;f$: Õ5�Ñ—5Í^J=f“Öë®–BA½*6‹u¡*®6�EU•{UϨ�§�uý¹�Þ]ÿÓK 6áÿ+ˆ“³êãzFßÂg7Ý_ø„Pè†öðþwC¹ yÿÄtqA…Ý@ýü‹–„:Ö£‘™‡Ãhµy5<«rëXʣ묩¨2�õ ~*c„Îi)1æ ’øÀ#åáDäV4»*tÇ¢YHž$HìS~ Â:Õ2·°‡Š¡»ó¥ÅÒsûô’KtMÒ‡M1( Ú¿J@À~K¼ú‰Nâ <¿„q8Õ‘O‚ĉ'É$r%¼ðx_hM%’V'¹~ aâËFp¨’ØÓ«$¶9é •t®T/IΔ*Ï¡›1|±(V?•‹åÓ¶PþéÎù±¼žá¼ÞC;›±6`×›SŒÊTÖ¶ÏÖ7Eb[ôŸÏ6½Ÿa/Ù†0bÙ`‘ÈøD$² Ebª_/´ûëw”ˆ¡7”ˆZŸE1rE$XÓÓšÓS#m‹äß(.‰ “¾o™÷Y«‘ؤ”h=dF²1þ9] e*½V^ä$§¡ò;Ñ&Ãþ�)ëæj�ýzpîù ­¤Ýç¢ÂM9ð1‹K‹®sd¹3oS´2x�Š?—±,Œ Þܧ‹¥5~©›ÏÜÃð³¦>ÆY¨Èò ȶÜ64§ÊÜÓà•<§‹ß9e¬‰cd•¨µ)Ͷ(èVÀñ¤S¡Š ÎþëÕ­êsD§Õ}¦ýÄù–ä \'€êÓKNìwFqH<ÑiµmàJÁy.L§ÎÄ£‚p|ͺN,ñÿðeOÉCFº.cϹ=Vè`‘¹&@ôžcgv¾ömB&*Šœè475EÁõúÔÔ{‹ûƒg»«-�îLF<Ëà¶ØUÅW|ý|¦G‚‡&(·¶ok}ØpÀš“ÐyÙk^V‹—‡¯R]Ê0lN¯ÂpédiÙ¿rTE<J|âžU‘ÿ²];jÃ@ô¾_Á‘Ë;¶Â�­@´ª´°·¢@XÀ(^�öïû<;èfl�íØÏ3ï ™ÉÁ×±íeŸP*Á¬-ôc51*\Íòh?7Ï K #›,úS’!d~«Ëë98ËUlÿµ¹ž¶Çmp'³ØC:„¬P ¸˜¬Õ!kã‰�“…gÿ' "Þré³É=ð"ì/ß]ëë�k;›mµw¸¦çSÉ9‚›é‚8nÇ^êý©¬?[—µ¬�c±éx[%këª#~‘‹ñ˜ñª_‘¼¸•Îù:´nö(KÎ [öË`¸ öç/»Aä°ÇÀgÛo3®Ý %rhºF¸°Ó.ÜD(ozïB£Nb—ŠwD�”„¦Å× 4Ê gâ'ˆ6Ç$Á'í’«‘’F¡eyì XgO ¸Ö¹�±ñA_V•<¤Š0±îšÇì'"{ZúËVi®¾`šZxîq+©6‘3y�í »;;#f±ƒy­·þÇks¨®(—ìù%fŠ*G1ÎyÖ¿¨ß¶vÁÝŸ›\ˆr”Ý‘Þ@ ÿP@—çf»%£ÐtD›Ý/Õ‹£u-´‰´™ÌãóÓ}lO%œ[j¢gÁ#.Ê&?$2×/Áúݼ¡[ì{ÙÖ7PüUé·Îöw[EHYŒŽ™¥L<†(Œb”%Rb;–¼—ö‘,‹¡òOèŽySÈÁ¡<• ZCðI›‚XA¢S�2Œ¤h8nTôŠžQ‰éåIçiouêh!°êëx0µÓàyéìÉÎÁw�%Ž¡éNÊÊŒ–ÁŸV”J¤�µ7ìU;rÕ{^UOý‰ß'Þ€áHohmÀe„ìÄö—shŸñ’†·ËPWz˜u‡þxœÓ�ˆTëîÀõ|:ü3>+ÃG•STÎG…ÏÈ527F ž­÷þ‚×à[¿uO¹û�—XdiK]|êÃP%9W²æg)SVò‹n¦”> endobj 53 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 521.259 33.415 558.5 42.747 ] /Border [ 0 0 0 ] >> endobj 54 0 obj << /ProcSet [ /PDF /Text ] /Font << /F3 91 0 R /F5 123 0 R /F6 101 0 R /F10 111 0 R /F11 116 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 55 0 obj << /Length 5988 /Filter /FlateDecode >> stream H‰tWÝRã:¾ç)¸Û°EIþ‘.¶2�™9 9KA¶ÎΞáB8Ê pì”íÀ0¯q^en/·¥vËaŠ*òuë×êÖן&Ÿnùñ÷æèÃòhò1<æÇËõQzÌà/=ŽÃ >–< D$ÅñrsÄ\?~:Œgññ2ßòåhÄ“àdùS$8dÈ#è¼0†»]èŸ~Î7¹S\ï½Lq^[Ôãpÿ2¨|×Ú{ÃCH„�Ôr¶›©!Ë…©Ã…Í7—¾äéÑF{ˆ)ƒ£«�8•Õ«ƒ*ÒȲ4·Ûy¨  X¨³¹ ØRÑLɬI~¡éJ¾C³�óÙõíd©ØßÀ»MMðcUçÚv€›ìŸ´¦´Ô5¨õ˜ÚÎ}=8cô�VCër¶˜yƒgYz&$ÐsÂãÁ‡7‘äòyé¬,�ÎYŸ–@xoknBÑ_ª×¢r•ÂZO }Þ­-³’¹8÷- •ëUE֬┖Cïe\œD>ån‰¸°ûºß€½‰Á(÷„ˆ÷So˜©’sør?Do9½§dÏ«üÈE“}®ZuïäÚ·@uý�ßèg[e›ƒ{NççŒE©}Ou^_0±OELfñ9<=01áQót‘/Ÿ~¶íî>öd! ¦?Æó�-X6G>Ÿº2„þí}·¾ßïÞ‡õQ¾,H'=?TðêAý…#òª„;׺ƒBO³»·â¹1åäIÿè{f�XA$¢d?|¦|0÷¦­¬Fá;#¤‡à‰·ËñAåì·áDoµks`{�ѡ콻m�ÐDÙ1i¼_}òºÊà-W@÷‚FŠ@ó8óMt´B–F>ò°(ð0™<ØIËblçþŠdúP‡¡¡�ÂeàÍgƒ–Ø’;?%ôEk+òИܪ.õ+™× ߢý$ª8óó©]ËZ«Ö¾)ºâvöB¸´eØ4mó7Hq–ÀçÍ—Ëo'dÚ÷†º¯@]A˜ß¦Yd™kPËù+táAH‚ -{ÅؽSkÝŒ{[,ª]c&Iº¡û¦)Ú�ØVSuÚJ„u:„�V@ˆÖuµA”±S¸)Õ5PðNã¶|º—ŸC<"Ô)šÆ*ô�¢AË®‰¨ÓxÙWVù·Þ�Ÿ…I2í÷Àá‰6–é/ŠˆqxûdƒüÑAuÈbá_dUódJT«¡}–¹Ìsð˜·5¾åÓ|á›®MžWEEæ�opÉçÐ!ídA,DŸVfSg”À4¯›ò �K±ü²*Ǥ2ðó¯Î¯Æ}J *_j¹*?à-ótíó� øóo4ðãʉ€8µÊ¹¯SSt9¢Â¶7ù†N}×o¨|±ó$ 'PÃѼþ,Ìà)šÃ~:‰Æ \j+qYezÚGŸ@h)ó-”0]¿Œ%Y(í³¾ŠeáDïj¤4ŸMýð#N’ŽÔ`ðl´û‰øPöÂI˜âÙ¾0â> ¥­CªEðÒxûÊ7]ªúÙø†¹÷£îµè=Â"éËçbÿìq�{9´ªw߉X² M¤|[¿ FÙÀD, øH­ &ÚŠˆ&Iß®±iªÜ¨¶ïŽ ±)[]6ÀAãUÕÏ@‰‹–’C•»}õ|^ôù½„n¾ÈAž‰l*â8óW„ #)R>xň䀀0èÔþPxsR«�N Í•!xã�_w$ {/ÉÄð�…ËXLKͺS3•ŸæŽZ{ÓésÓþ&Ž�eÌÄA1¯ìQÛz" ›å¨0Û^Þ kÿÙà\-ÄžPœeãÁ ÓÕ-ßB°6Íáî5å¢Xê—1ìO6 UÁj| X‡"ðV¤ ÷67oôÖ»ánË39áå ¼³ {ÿ~Háý*ãäŽ2Á_ì0�4µÞºá}VÈy’ýŸíj[nÛH¢¿’G¹Š¤Ìà&?I²œ˜%•Ål*IùG$l\Xé¬üù‰ýÌíËôø ÒéžÁœ¾�“ºvý×C­UŒsa&hM¹Âxå¼÷ÅQàG礲%t.+Õ…ŸæPTÅ‹‘ý¤Ò•3<‘±ä뇋H©QfŒÛ|äHØY/ˆiI Á²œçÙ±_« ÄeÁDÜb:©áî¿:ô�¥£Ø°˜¥cjÔ¾�jà ¥ÝBO<ÑR ¼8Âp²ƒÃÙë‹Ù±p§�ÚM¦BQ»ÊÎwU±ÁQâ)äš<†O0r#Öý³[ø£(¿ó´&s¹v+Æ�s®MûZ¹Ñðtûü9•ÍUS7yÙ@¸ÇëA“ö’‘F</ͦ A§ÐÔYjäú$(RÓš\ÄÃ\¶öyÅœŒFIä"ÝËÎÐóqX9ÙÉvŸ ls&0æL`Le­) k'Î?­l*?‰§•=Î:†2À•y:)s¥Ç‡yʤbõNÑoo‰¶êÝî2æÛdÜ[z±j Fvo²²ú�[¡d t.ÒHŸ�| Ós|Ùž%ƒ�ÿi¢NSá5ëVRj(�� ÑL„bã ˆvévò`Ì=�1}¡*ûÖ´bäM ™Š¹Ã¶åg8Î¥|ÎI×õ¶læÏ9¤"°ïEf7ÜbŠe9�Ž…¢Ebl._Ž�ô+k+¾Z¥~‰á^B¾•åõê™ÎÎOÀCÚZ¬•Ù,£\}ïÇéU’&s˜Ðn¡çŠh)¹aâ_ÅÑ'žOïö0$�™ôò‹ËoY•ôRàà | ÞI0%�Ê›deºÆ—eàÇ¢pÕðÒë™ ¾c‘yûèV>4ô=>´æTY±PZÛxüï�Ÿh"Ô¼½]Y03€dPÚÿ£¼¡V>Üÿ�¿/~?<%ø)Ê~…Ùƒ6«3í±r}-�5¼¹¿O9Šö£E !뎭©,ï$ÏF‚@AM×áªxˆêO?ör†3 ×-Ã8ôÃ;îŽ-ƒ%ÿ{‚Œ(w›ÒîƒhGïu $‹uN:YäÇžöÓI'óãø22¯“Xùa˜†a¢\SþTÑ&.[žLk¨m+PVš"Zå³ÍÆÔbßVîMYfneéVXÎÆg¹l²ãÀ—·>î�µÐÔ¢íÝ¡5°-¸xу¡’æÄ^ro˜{Å¡±Õ¬S&®TèlH›"‹º ¡=´Jδ�[ÙöE»¨c‘×68òŽ“‚½0Ë2ÇT¤#äD:˜_¦‚Wçâ�(Ì?bñ[ì^dÓÐs¼{Ñ,‚yÓææõÕɇ4ƒîß]5ˆ ÜæN„ý”n‰'³µ6ù®Æò`óšòßí…ô ßûé•úÊŸ‰÷GQÌá¯pÛ¦ %�¸Á8!¡Ãz—»Cæ§ÐëzÒ¥‚‰èõ¢> ÓæPGZ‡pÒgÒ¶×m¿óË“[¹â qq++·BšÐ4SèÀ�ãêkbÉ´u¿9AWoÅ{Æö$™˜zIzš‰Ûc÷^Ô˜¹qœ gx]ÁÄ�¡…÷Ìœ/Î *«ï*ðŽG¾i—ÆtZpìŸá0>ÍH“P÷×­&cÂKÝ”x�tÁ4Ž!®73A¿–Y÷³hŽb?¹•ßš××*«k±×ãk^Ü ºVÞ œñÐ/GËSÈG�žP3ýG±9µsƒY˜úôšÍ!7 Vh.ô‹¢¦òGÛ‡WTû¦¶½žw4nÂc£J+�ã lc`,tÓTðšMóôñMYÌ2(�UÈ,:±hlÊ…Œ°Ùš]ö‚Ó�øÙ•¸3ö Op[°ëÁW�ÞmͶ…¢åá¢A‚â݉ìÄZÑG|Ü›~1eu‰/'–xR+V^òÕ¥Ž,ItÙi/žgÌ=/‰æ?E)=¥!=9ýb¨›GáÅçÿ_gßÍ&c|m}«¬=Pƒü`}4Fàÿ´rÃ|©Kaø¹Ì|Ô {ºÃ[iøA�8ö7Füæ�ÑÖ<0“�æ3µš‡V†šÇnhò�æ¡çÆS‚½½âaû¶ '~à×CñC¶?„­ø!LT¡øñÒ$�_ËÄ4ÆN;Ö>| hå¢NhƒRrõ7»ìp@¡Þ‹ت>Ãüô«s¯ ( ÖYÎoÜYù^à—»¿ßÞÍ?­Åñ©þ䮨f0ò»QJÑB§‘åÈ©æøÑsh¥~�§á>�LŠŒœç¾ÅfsÌmXÉÁƒ™q³7Û]d‡íVŠA=ŸáîmoZhÛò-‡î¿1ƒPWE†9�*Ø÷ à´�à¥VŒ9Ô‰wåûó pn‰4[8 B �_ÅáF.ø—wËU“ù Ib§+.T4™Ê0û9óm—UMÙ§ÚóLàMÛüS‹±^üОí`F{Ù?ƒѤ¼L1G+³ÍæJv¿BÂÉ V ­ãQp³¼Ø`#ÔþB[¢OðÀã¡«q6©Æj\¶ö5Îêó„F5î¢ÛW¹ö¨q)l´ú²F‹‹—4""¾O­€Ï[÷”„�ÅÞ"0*h: zÀâ3|ÀõëÏÆÔ4²ákgüÿ Ø‹uÝZ×óîXÏŸwÌ©“‹ÕÒú©áê3A…ÆE=-¸#öÊ{{È™ E™§â`Dû-K�#d鯂vÅv'KÇz’LP;m†¾—\‡¬ÝšJûD{ܺµ4§UŒì©a õLÌÅü‚’¥ÃV–BÓÞÞ­Ÿõ®xA­Ò]‰‹fyVg%�ÍNœ4BHˆõ (ˆ{»��HyØ�ê¼”oÔoE` êòÆ>×êÜøLk×5fÑz˜&ä&¦åƒµ'Ó�z§Jd>É(­ð[ÏýŠðR†Ë7xR#é—iêEã  δÄtêià&ŽåÙòâ¡°(kÊš©ï¾ŸéúÖ¸íŽÇœZZäÏP´eL#xÝv^¥FûC]™8D³ÉÌ¢Lv„ÔdÇGêñŠ%jã‚R!8F¤)N²Fü;?ÅEѲ{æ…‚)Ÿee¾+¸´ˆ| Õü²îŒÁ¶84TCÎn47ù4]¤éÝ}¶¾ÃØæ… Ñ’õmöôAKÿQ‘úî€ÿó¤¹Ð8ºŠù'‹ƒçÃgŒ"Á�ΙïÚâø3×'ÊâíDt˜#…"™¼4Ø*þh‰œÑxÄDe±ÎAS“H5Uó¢&[UùÀFìy˜X±}¶ìE4Dƒ²ç½KMÛ7mbUÖí®8¢ª¹>åü5Ñ �Ë*?h¼ýdÔ7ÈÎ0‘R³À™ÉH2“¡ KŸOÝþ·VǦ{ýëJ-åÝè:„£àêd9Ø‚@+ve­««¸ºh¡/z,–Æê„B¤±«ÁÞ¤µÈ‡ÏðÔµƒkAjùà߈MýRi¼Ñd¦1îÊþè…îÜ BÏŠ|³`ˆ2sA@lâþ¢02{y»Ül›¤ÒÁÜ"—éØúà&�à :a0!rI¤fòp¸¸LÛxòÜ®}®/l®S)ívPUe�ЛÅN�¶NoÖ·ëtqÃÖæ ì]0£±éêý‘Êgè¸ÉØðq�-qî’ì6N&^r72³å˜É)¯¡4åÇ×}.³¥ë£%|Y\fM¦%ÑÖ8ýÞT(W=Q­:ô´Uw;Gbñ§"‰ºZäãߨ U<ô8š„íš¾¨kžÝØ£’ñM#Õ¹*-ë£üääþ�CøÆŠ’¨Sg'\ü`ÚÀW endstream endobj 56 0 obj << /Type /Page /Parent 68 0 R /Resources 58 0 R /CropBox [ 9 9 603 787.5 ] /Annots [ 57 0 R 192 0 R 230 0 R ] /TrimBox [ 9 9 603 787.5 ] /ArtBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /Rotate 0 /Contents [ 260 0 R 258 0 R 227 0 R 189 0 R 59 0 R 188 0 R 190 0 R 191 0 R 228 0 R 229 0 R 259 0 R ] >> endobj 57 0 obj << /A << /S /URI /URI (http://www.annals.org) >> /Type /Annot /Subtype /Link /Rect [ 52.5 33.415 89.741 42.747 ] /Border [ 0 0 0 ] >> endobj 58 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 86 0 R /F3 91 0 R /F4 96 0 R /F5 123 0 R /F7 106 0 R /F10 111 0 R /QQAPF811d436b 147 0 R >> /ExtGState << /GS1 121 0 R /QQAPGSaa31c724 151 0 R /QQAPGSdea1b4e9 236 0 R >> /ColorSpace << /Cs8 78 0 R >> /XObject << /QQAPIm2e98cb5f 193 0 R /QQAPIm75ba1e00 231 0 R >> >> endobj 59 0 obj << /Length 2378 /Filter /FlateDecode >> stream H‰ÜW[oÛJ~ϯð£»HTÝ/î“c;M³vjÄÞöÜöa*Ol�Ø’1’Ó“ý ì^ÎpHI¹8 l$üÈ™!‡^ôþãÊlë³ËõÙû+àÖ÷géÀ…ßtN4H¼ÀIÂĬgï'u:ÈkXUçå™;XçúÏ÷³_‡““R²lÞ]DqêDÃñ©ÙUŠÑf£d]ËzôîŸëÐX=p¼Ñÿ½8v¢( {ú\#ö aªj "Ç~þ÷Bì÷òéœwEÓHÅP”"oåéÂh½€s×óžãQ0XOáÔoâ$ÕèÝE�%N8œÊ£PÍÁ\9Õ=Q ¹)ò¢”çÄøGYÜWê 7ÄXIõXä²î,x” µ¯ÿÊê¢Ñ&~èdÃŒA:ÞT¥Ùf—ªØl%¡»JlxÏ¥lv²Þf,¦t„ï¦^è´º¦ÊÑvd`ÇX•Õ~3"Ø¿dÆ—ÔÔ•8û'B½+gϯœá•;÷³·“ĉííõ•‰£Õ · òZŠ}³#´Ê YÂ!çÄ@/!m½„Àz‰uÿ%?%n‹þ.õ›ü2&j¹ê ò'—²”ÿij‚ QŠ­D‡"‡^Ây«Ç÷³0%#n+¥ïŒ ÉZz¹¹d«WyÕ4p�}ËÿBKÓÈ�¢ÞEt~Ä^¬Ýx„c™l@rZ}/! u^rtˆ�êÄÞžYAN·êÖò¡ƒázð ¾HÈ>Q2æ 4J½zªy8'HZXŒŽcyºn«s!US•Ó¢­òê´—�Bµ�`%x鸄}EÅ¢õOìüó"mà…øÃË“Ü7#B­¥ˆ[KíjñDä²Àl6@¿"MyÖ)¹q†=Ã:ƒµ{.ü�ix¢±—N|ã¦ÏW²àjNT$á‹gº¡“ oE#”ø]”#âh›­L~'òçJ=}-Ô7]Þ-ê\ 9�(kúA«y&ꆬòµ¡ë®%eæßUÕ�D^äÅîÅ-ËŒU(ÒVµüŸ‰Gzî‹°Ñ´*Åî$GíÒ”_Œyâ\CÊïQPËXÍô¤vâÐj�pmItóz®²ЉØùN>69‰ä¢æUë]u:?~¿šnÐ�”¼bVÀ=ö|F±/ ŠOÝ\�÷ª$¾ Ù;‘%6H„i¦Ë*Ò_‹:¯Êº(‰1~”åIòÚN1ES«†ªéú÷î«J<ó&÷{x£×R•pYù¯I|Ïó=ãÃ7©¾ù1æÂÔ×§²)Ê­Nz¾Ø¥ùŽ�?“ó3?ãŽóÑ­fѼښ×mS!I"Ú4/ʼڗ{Md²¢,ÁÓÌú|M+ÃÈÇŽ3¯�Mú¯�M¿òtxîpR•�*¾�t<ÿt> ='ã¬wpw>‚ƒryÔǼ»ð3l4o É�¬‹­vÂ¥óÑ!º�¥pJr� ³þ”4×a�}]²Lg9gÈ®",»aÙ‹·ðÊžàìgƱÔ3œ™ÓÚ‡6†·ÿTºáÀ„i[’¦+•lú¹fö0Ά܀Í#è¤;ó%2ÎMçiá@¥ó!o'Q8A°`ÎvÂ1 L“aþŠù]w"gÖ1€ª }pWhüˆÔk¾Fɘט|`þœùX~^9”‚Ó&¡WcŒgÉ�sש¶0pôJ¢¸×)'')´¤L\�„¡¤È÷ºD#¶ÏÕÐ�РÄÆÒ„p`Î;qh‚Ð×É!ŠBƒhÅünh�³p–,µí…e3–t‚† û¤Ïq£4©D~†÷jÊ@sÁ0"Ea´ˆùF„7,hsÌ@ "Òü™ä¾ò}ôC‘�¨¢ÁŽ“F¤Œ’�Em2ñ½®xH‡# ÀB��–9 Ê›S»zRMkDØ<ÖÖy�—B›8Dq¬ÎYÐF! z5QCw"jp·üÏÂd´ÿxp® 3,„Кü¡8UõØbS…µq"¶åÑÐÝòh˜ƒHs"œt¬àÈ„™ÍBKµ]ÅÀ1 (í2æ÷ºM†e`ÉÒ6bˆÿ?Jç‚f3 g7\Z7§(,Äž?*þH:BO„œªy¨ÚáÆFµ[u­mZã*ùǾŠZþèãÍ¡(áG™!:Œ݆e¾+õÁ–3‘ÚW[£•p}:ê‚1"LoQÓýñåMw UeJ:2Š¡µÚaÜ�u-ßöO„��e‡öΆî–"ÃÀl@š²¡uikZ·êØè·_t/Ÿ¢•¼y¹÷W Ž�žgçFC¸iÁäî¿:ŽÇzªêŽš�;¾—$½MÃårv;ýô“^üLAœ9^˜e½å|È‚19ÜX·q(1|V¾Ç/‡®²Ð… M³¾2Wï~~©+ô"'‰²ø-]SÔ)¹üú‘Àâ¥ÖLoÂW´Î—³»•VÍsxfwêÿAiwºÉ«CøMµƒWg�ãu&kÊÇL>'ŸOvÅoC¸�ç‡n§™ÞûeL 'ÕÅd' Õÿ<ˆan€yÁ®þíÝÒ°ðI¡?©Ú¾yáAœÒGû8ðq[·–û‰f¦-¹¼&ò¹©™“¥1[:­¦´ð-Sc×�{¦âòK¨T%�¶¢½±¥ÏÌ5Öù‰‹Ö͈~nÄÈwãžy¸ð-óÂ0ê›gu@¯rO°3_é”Âgk.­ÙðåÇ~ßnîpié¡wZR¨¢ÛÆõbÙD4»'ÔHÛÞ°ê ð­�òTn„"Ô+4†c¼hÉå5o›íe)´�ò¥–Ä×ßhã”&Aˆ:#¢ÅrÅôÝô–éy»ýF–eq/ÕŸOSqšiÇÜ.™¾º]^\N>¼©ôBš''„úší4ž,?à€á:)Yj›·�‹“hºÝ3åí·ÅÃCA`u(š¯2–¶JÉV?Š`X8DÍ”noHßU›­TF¿ÁËÝ”i8€w߈ƒ¬ Ìù¨x­¿·«vGI¬ÇVÜ�àNÖM¥£…vñºÙäîÑŸJhÃÍ©‘,]ë ɹü^”­®�ª:?`kJlK5äªØ�k)ö͎Ф*ëÓ^R ‹0!SS¡)ºäFºÖz¦ �Kdk§R[¬Ðž‹ú=>¯’4æÒˆ›ÀEi@Ÿœ†ú_Ê ÆˆrSäE‰y<[ŸýW€m¾Øó endstream endobj 60 0 obj << /Type /Font /Subtype /Type1 /FirstChar 46 /LastChar 117 /Widths [ 272 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 533 575 533 533 533 533 533 533 533 533 533 533 533 533 533 593 533 533 533 533 533 533 533 533 533 533 533 533 590 595 533 533 501 533 532 533 307 533 533 307 533 533 533 533 533 440 533 533 624 ] /Encoding 61 0 R /BaseFont /FNDNKI+Acta-BoldItalic /FontDescriptor 62 0 R /ToUnicode 64 0 R >> endobj 61 0 obj << /Type /Encoding /Differences [ 46 /period 70 /F 84 /T 97 /a /b 101 /e 103 /g 105 /i 108 /l 114 /r 117 /u ] >> endobj 62 0 obj << /Type /FontDescriptor /Ascent 730 /CapHeight 700 /Descent -210 /Flags 70 /FontBBox [ -75 -261 1786 942 ] /FontName /FNDNKI+Acta-BoldItalic /ItalicAngle -15 /StemV 0 /XHeight 510 /CharSet (/space/F/i/g/u/r/e/period/T/a/b/l) /FontFile3 63 0 R >> endobj 63 0 obj << /Filter /FlateDecode /Length 1302 /Subtype /Type1C >> stream H‰|RkPgÝ%ìÖ‚˺(YÌfÁÖ‚€3¾¦‚¨EËCˆäB0X Až’KµˆÄ  ,M 0…Ð5P§[_µê ÕÚÖGýÓ¹«34¡Ó:Ó~¾÷žsî¹ç☳†ãøì¡›Ã|ƒSò’ßÉÎJËKÎ’¦8J,ÇàÜ,gÎkºÇZtÌ‹|õ*„?7{ç”QêŽ9áxh̺ì=9RIFžhaÊ"Ñ2??Ñ®Q¨Tž-JÍÎÅ$Ëóì_bhŒ¸`OÚRQpV–hª=W”“–›–£LK]ú¦´ýᘶ ÂB°uØìlŽÅ`Û°ö™1¶Óá3ðx|Äi‘S9OÌkç=r^él,y¬…>-‹µÐ©åÁb( %ZiS®pyPí'cã„¢ÅXÚŘºêuv8PSñ€0w´ž9'èÞgRžŽ?,?èOèòdÇ2‰¤D!g?|T^>âO¤Jsâ· ´‡èñŸnÝ=µ>põÚëã.]òÑ5>Ò«A„\•î7`•tcˆÎlÍîê1›,Bª¹óc}†�JJJ“$±|}µLý0Ð+3ºÞk¤ž~�Vg–WE¨Õ²9ÐIÖ#j*Õtxv@%q�¼Ô�¿êk$Mð!#Wå'æG3ëÉ À›¼Ù¹+舽xÖ$uw¿Ì¦®­Rgzò­ÕÆ—d¯ûîû‰uàM�=áô´‘¤FÍ=7 ¹bâž:³¢*\í©–S²‘5Ù{Ü=ÂBÞÐÿÃ|ÒÁ|šä[T·¸yVü,äAïwôŽŒ¾'àñŸ¡³¸¨‰-õ!PÚžèèxÎp›i+!Œ[âꢴÍE®HŒf^^˜í²ñ+[C–m%$»™³ômöÓ6BUXTYÊ–×5dùý*+7ï„™q.ð …Ðçá7¢ˆD[Uûå6õáªý©ž+'®ÿSõ3ö¤½ÀÄ03jL% H`ÿì£û»}‘´O€<ëxƒ’=ú‚€ô–‘!+ÃOP�s³fæC"¸ò8'®–F Q Â탺Œú€¸Œ^=ÑĪLD¡<¹0† ÿúY% 6]Ã_Á�°¯Þ*h£¾(IQ¹Åå°@iF®üÀð‹Qºu«.ÃÀer²« SÂ+h¬îêçRxÛ<Àf#7PÖ2h… OáCa+û;yd-ØK4f§M`�À{"7™vžÏe©3e‘rqRœ@r2¿I%¤î®�’í”Æ Ä£R˜ Á°tæ|»cÐ÷s!u§ y×Kê�ÇŽ7h…v)u³î@ c‡™�˜î­j/Él\R¼1$V7ð¥æD{›£ç.üLn¶^8ý…4lINøæŒLÃu!ÿ¨’S˜­àƒC¼Ïƒn’ÞÕ¡° Z çz²ZcwîÞ&Œœ°ÑuãÅiãVþ›Ü°=¹ÊTO;ëË-füìã=ú?è¯/=Þ„Šš•œ›}‰Ó`ZªÙý!çKÕC¡G ¬&(,Ó]¹ÚÉPÃÍõÅ:¦«½£‡¥ê»óš2#·nGÓ· Õd›ýœ_'ŒšXMðo«sž¶î‰“0Ÿã¶ÃM�¢¹{7!"ŒI.Ô÷f¿Î�O]`­›‚º äT4”ò#sûÎ í§]0ŸH¯h”Ÿ{ÝP S4eè"çG !ÉWi¸ÚjˆÖ�(]ó–Í>rÛ,®�þ[€aØ“° endstream endobj 64 0 obj << /Filter /FlateDecode /Length 277 >> stream H‰T‘Mo„ †ïüŠ9nÓjV� ñbÛÄC?R·½»8Z’Šñà¿ïv›`˜y3à oÚ‡V+üÍ.²C£ÒƒÅuÙ¬D¸â¤4¤ Jºãv9÷8‰»}u8·z\@Æß)¹:»Ãé)Íî“;à¯v@«ô§KúñIÝfÌ7Ψ$P×0àÈxóÜ›—~FàA÷wyÙBÎéÑzp5½DÛë AdXƒ(óPÿs¬ŠŠë(¿zËbe’d�5ç"0&òs` Ly` ÄeäÒs¹ò,#7Äe˜ Cx&-ÍrtMgˆ#‰"¥¢"ªˆceÌùx_ofÈÍZò)˜Üð>(�·ÿ1‹ñÏö‹ý0#½ˆ² endstream endobj 66 0 obj << /Nums [ 0 67 0 R ] >> endobj 67 0 obj << /S /D >> endobj 68 0 obj << /Type /Pages /Kids [ 72 0 R 1 0 R 19 0 R 27 0 R 31 0 R 35 0 R 39 0 R 52 0 R 56 0 R ] /Count 9 >> endobj 65 0 obj << /Author () /CreationDate (D:20200903054731Z) /Creator (XPP) /Keywords () /ModDate (D:20211103143227+08'00') /Producer (Íò²Ê°ì¹«´óʦ-PDFÅúÁ¿¼ÓÈëˮӡ 4.7.11 ) /Subject () /Title () /#C1#AC#BD#D3#D3#D2#CF#C2 ({DC26161C-D66E-4738-866F-357E8DD18F6E}) /#D7#F3#CF#C2#CD#BC ({5CE1FF3E-51A1-4FE8-8287-81B4B23687D3}) /#D3#AA#BF#B5#BF#C6#BC#BC ({6BF9BE49-C532-46E2-8E78-F16076AE8B45}) >> endobj 69 0 obj << /Length 3756 /Subtype /XML /Type /Metadata >> stream 2020-09-22T14:01:36+08:00 XPP 2020-09-03T05:47:31Z 2020-09-22T14:01:36+08:00 application/pdf Adobe LiveCycle PDF Generator uuid:975298c9-eda4-2d49-54aa-c5330c13ba3e uuid:9f1bae6d-71e1-4df1-bdae-7350f68faf2c endstream endobj 71 0 obj << /Metadata 69 0 R /OpenAction [ 72 0 R /Fit ] /Outlines 133 0 R /PageLabels 66 0 R /PageMode /UseNone /Pages 68 0 R /Type /Catalog >> endobj 72 0 obj << /Annots [ 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 134 0 R 135 0 R 152 0 R 198 0 R ] /ArtBox [ 9 9 603 787.5 ] /BleedBox [ 9 9 603 787.5 ] /CropBox [ 9 9 603 787.5 ] /MediaBox [ 9 9 603 787.5 ] /Parent 68 0 R /Resources 80 0 R /Rotate 0 /TrimBox [ 9 9 603 787.5 ] /Type /Page /Contents [ 235 0 R 233 0 R 195 0 R 148 0 R 122 0 R 146 0 R 149 0 R 150 0 R 196 0 R 197 0 R 234 0 R ] >> endobj 133 0 obj << /Count 3 /First 140 0 R /Last 141 0 R /Type /Outlines >> endobj 134 0 obj << /AP << /N 136 0 R >> /C [ 1 0 0 ] /CreationDate (D:20200922140029+08'00') /F 4 /M (D:20200922140033+08'00') /NM (aeb10cc5-7b87-4487-b631-3d4237b1ea88) /Name /#23cHp7vcdB7PCuTO4Z_UgjTD /P 72 0 R /Popup 135 0 R /Rect [ 530.021 620.218 567.711 662.18 ] /Subj (þÿ‚ñe‡) /Subtype /Stamp /T (wuyingying) /Type /Annot >> endobj 135 0 obj << /F 28 /Open false /Parent 134 0 R /Rect [ 603 421.108 783 541.108 ] /Subtype /Popup /Type /Annot >> endobj 136 0 obj << /BBox [ 0 0 150 167 ] /Filter [ /FlateDecode ] /FormType 1 /Length 20 /Matrix [ 1 0 0 1 0 0 ] /Name /FRM /Resources << /ProcSet [ /PDF ] /XObject << /F 137 0 R >> >> /Subtype /Form /Type /XObject >> stream H‰*äÒwSpÉç ä0 Ê) endstream endobj 137 0 obj << /BBox [ 0 0 150 167 ] /Filter [ /FlateDecode ] /FormType 1 /Length 38 /Name /FRM /Resources << /ProcSet [ /PDF /ImageC ] /XObject << /Im0 138 0 R >> >> /Subtype /Form /Type /XObject >> stream H‰*ä*BCS443Óɹ\úž¹ .ù\�``¡Ý endstream endobj 138 0 obj << /BitsPerComponent 8 /ColorSpace /DeviceRGB /Filter /DCTDecode /Height 167 /Length 12174 /Name /X /SMask 139 0 R /Subtype /Image /Type /XObject /Width 150 >> stream ÿØÿîAdobed€ÿÛ„    $''''$25552;;;;;;;;;;  ####''',,,ÿÀ§–"ÿÄB   3!1AQa"q�2‘¡±B#$RÁb34r‚ÑC%’Sðáñcs5¢²ƒ&D“TdE£t6ÒUâeò³„ÃÓuãóF'”¤…´•ÄÔäô¥µÅÕåõVfv†–¦¶ÆÖæö7GWgw‡—§·Ç×ç÷;!1AQaq"2�‘¡±B#ÁRÑð3$bár‚’CScs4ñ%¢²ƒ&5ÂÒD“T£dEU6teâò³„ÃÓuãóF”¤…´•ÄÔäô¥µÅÕåõVfv†–¦¶ÆÖæö'7GWgw‡—§·Ç×ç÷ÿÚ ?ÕúÙþ1º¿AúÆîƒÓºs3�±�`ÍŽ.nâY<,ÿüs~»ó³gýµþA.£ÿå³ þ-¿ûobÍúÑþ3~µô¯¬=C§aÛH£÷WXuMqIIN‹ÿƇ×:Øë,ú¶ö±€¹Îuw€Ô’v­®‹õïªuŸªCë8~^Þ•Xµo©¥G´»ü!áe}NúáÖ¾µt_¬mêï­ã š½6G©]û¦?¨?ŵ�^¯ñÕlè,uæ³°í �˜óôÈFRS¹×Φϫ8ýFŒ[Ö¬´¶þ”7›«®lÝPý Ö™#º_Z¾¾õ«�+¢ç}‰Ž»ªW¾úm.o¤àÊœ[è_Ý^ú§õzák~´õê]WÖ ªßVX6‡²Â[ô+j~£…õGëîSú}ö»&þ�c›mu—Ök{ÎÂK@:ÕÙ%=-–×MNºç¶ºØÒç½ä5­RI<�õƒëv6J·'¡Y�Õs˜YéaÓ`µïÍ!•8íi%a}xëÝF¯­=3ê›ßÙ½bºéËfѼ²û_Kö¿‘í\ŸÖ«�kê_»ëÕÜcWMà mY¹–€ncj|µÎÜ}Ï#„”ú\úÓ×zoÕ¾›Õðú[²s3=/_2ÂjßY{¤4nᮡֲªM×8VÆ7{Üãµ­I$ž^7Ѿ¿ÿŒŸ¬Åèí§&ÚÙê=‚ºÛ6}îowÓ`}dÏÅÁÍéÿãEìÀn}f¬Vµ¢_Yk™~¸þ¤Fæò’™ýmÿýC¡åÿ‘ðªê]9µµÏÎcœú›cœZXl®Y¶2ÊiÖÛ71šO¹Ã*‹ÿÅ[nÃ96}jªÌMÛM®lÕºb7�³))Þÿó9ÿ´ßâ’Øýƒ�ÿ0ÿæÿí ½²z?o�éíÿIôâ?´’Jrú×øÃ»¡ýw¯¡g}žž•±¯»!Íy±»«s¹kˆúP>ŠÉ?ã/ëWUë¹}3ê¦'Q¦¢çÐâׇ:¦�ÝçuÕ�ÎRúùþ.>°}dúÅoTéîÆ>ºØ¯s],lnZ8]3êçø±èø½s©ã8u±¸y7c9öî{æÇCl{[£ðIIz¾/Õ/ñ�Š×äu z+fHÆöú~ ÷zµ:cÑ<,n“‘Õº;±Å•ë½-ï6ß““ôÙ’@k«ìmÃô{ò£Ó~»ÿ‹.’ÌÚð0³joRnÌ¡ÛÁßûÙ>™áTQÎÃè™=oü[Yû7 â2èÈ÷;$–5Ïgª/ÓcÙùÃà’–ê_XÕÜ»>´ÞY_Öûã7¥Øqê¤�µíÚfK+aþpò�›þ3~¾tÜ|<ΡÓ0éÇÏøÖó½¤5Ò6äÃÇ+�ÀÁëßã ¯]újì϶¿ZË.Šš[PeàÙGeÛ}JéÎúÓ“›õ{ë€Ìú¹³Œ&¶ÖA}O‡Sé9Ãô-úR’�ïñ�õ;¦õ¬Ÿ¬96ÞÌž�ƒa©•–ŠÝé‡Ú71Ǔخ'þpôoüiÿæÿÚ›ûGÔŸ³Ã·GÚ½^víú:ò»ß®ý#ë·WyÃú½•�ON¿Ñ•MÛA{ž^Ô÷aÃU…õê»Dúå�vOXÇ×"ÜWØj"ÏÒW´úÕpÇ ö¤§c¡ý\ê_Uº&Öo©ô?©u§�Sr¨É-52».s˜i?M jâ¨ôï­�ëgPÇêŸ]r™Ó2:-̳˜Íxm¤¸=þ¦æÞt5·‚ÎÖ¡õRŠú·X¸¿êÆeb®�‹Cëªc‡©@¶C•4ƒ/v«—⯭t玭ÕÎ5�7ý§.ºì¨ê+÷ÚÖ��÷„”èýkêù¿óޝñ…õf¶gôì Žì—ȨXïR·5Í.­ÿᇠ}#«_—{¾´ýVk:‡Öž ÂÞ£Ó�"Šh7}{�gšëÿyMû¨ýjèöâ}@uxVîxmØ™f,vC ^÷î-½ñ£??· + }rÿU޹VN='$ý“u1s½ß¥�¶Õú$”ö?VÿÆ]}EÙý;ë{ñúmÌsqêe,²\çoe€ëhö�AÓþ¯¿êgÕ¬Ì?«Aù¹¿"†d–�Ö¹­nÓ³ÒÓØ¼­çý[ê}*þ‰Eµf=áýNËf-½î¬—4»w/núÙ�•Ó~­õü'úYøï²§Àvס‡SæÝG¬bt «>¶ßckúââ•Òž Ǭ8 ô×ù ×:yù-_ØÝ_ `·ë?ÕLcÔ3zõ^·PªòßJ¦Üß]Æ S‡¹Ð%ÎÑyÞ[úûõ…ì6×gPÊi±ö[´úmü hßéØã3ê×JÆ£êömyNÈÂc0/Ù[K•Kö»Ôl·Á%9_â—§SÕþ¬õΙ�ç2¬·¶—¹�ë –È"~K®oø¿éú®ïªbü�²:ßXÙ¹ž¬î‰ôöÆž ½_Tú‡@ê¸MúžjÁ鱯ꔽÆÇÛ´Ç´ÚÛ\=¾ {¯õÜ/«}2ΫÔŽ¢·5®çKÈhй¾))üØÁÿ›?óWԷ잇ٽIo«·ÆvퟒJ_ó—§ÿÍÏùѶ߱z?hÛ´z›?«º'æ’JhÿŒ,Ëð¾§õ+ñ.~=ìee–TâǶm¬sH#B°>£ýYËÍÅÆë_Xº¡ëy˜ÛÛÓóA¹•Øâ _úkÝ͉ÛÝs¿^pºoRÿÍÂêù?c¶ªÅ×îk6Sœ=ÖÑîj�õÛêBú½õv޹ÑóoÌnEì­Žsë}ncÛc·4ÖÆþçŠJzÿ®¹ÿT¾§7 Ÿ«ØY¿l6]LÛéìÿ�|Îõæ¿Z>µþÖ´SÑñ�ÑpPmø?m6¼8»Ô{+mm'è�Gd_©7£æÙ—™Ôs>Ï™�éÝÓ¨ÞÆý¢á½Í¯kÁs¥Ìh†ëª'×GýpúÁ{zß[è÷a3–Òç¶‹k¬49ÎÆÍÝßâ’›ÿâi§þv½Ð`áÛ¯öêKë×ÖóûVüNƒŒþ‹~6Mõåäâ¿ÒvYk¶‡Yé6²`‚u'•¹þ,¾´u |¯EX= ºí4õ+ƒ«kí6z~³Ü+'Wiä°?Æ?^ë]c2†gá¶ŽŸFEǧå5�kr*qdX縵¦[â’›?T~¼õWáÙõc-ùWeuk½ z•—<»Ökjk€t»Ø}Ú8.Ï'ü^ÑÔ>¬»¤feS“Õžà]Õí¨Yy³xÎy~Œ>— �×_¬ýg>‹:_Õ,JúÏOÌÅu99X¬~G§e›˜æo¥ÛCƒH0|W;õ{£³êÞ=wÙoÖÚ ÚÞ‡l–½Î¬“ŽÐÛ¿™vþ|øIOWõgªtÞ«‘gÔ^§ÓªÈoÕú}!“�c,v1n>öÔö{K¦y*�ø¤ê}c¬ÑÖ2lί}U†e<Úݯ‡4 ´=Â¥Óú†wøÒÍ¿ê×ÖZGN8;*1C™hµ„RXñq³OÒÒ³>¢ýPçª3'ëE—ôœº2hM¢ý´}¥Ít�ÖÜÍÏ÷�oŠJt~¶uÿù�õçôú�_M¯YgNÆw¡E�°]^òÆ›¸3·²Åúïþ0ÛõÇ¥SÓëéÏÅô¯ú†ÏPÖ½‘¶þúè¿ÆçGú¿knëgìêõSK)Áõ+ÙêFïL�çG;ƒÙKü[}jÎÃéøø=všºwF¦‡ N¡xuM¶ÓdìØí„ÁvƒÁ%8ß^zvT¬ÁŪ‡ÝK]{©­¬/tcjý€IÔò·~·ææ;üeôŽŽëì=?*ºFy4ZeÁÂʧk¦5�ª‹Î»ÒºQúÏmù˜õ;#'~ ¶Æ´]È#d‘ºwìÄê]Oßñ�×±¬éýc£ö|2ÇUKÙGéç²Ù³WXᣇ )Óÿ½7 ýX·¨ôZºncm©�ÉÃch¸5î‡4YPk ÷ÕrÝ; ücÑWLÅÆ«¢ætêÙ~Fycl³)ä Üç–Š�%Þé.:¢aÿ�ß®Jñ‹Óú^6UÄ ©®ç¸�©;[i+GëîSþ³ô®�_MhËÏÆµ·u \OÒ?Û¨-cw9�®‘îIImYú«k>§æõ<Ž£•õ‹ÙGRu�k± ¿E-kž÷Lèæ­¬�©=C?êsþ­fõgeßeÂß·Z×X`<<6a=¿yq?ãc7¯õŽ—WC¾¾¢óS«Äp¸ïsý­ŠËµ+o¢u±õ#üY»6ÌCVe9DzŒ{}¶XÖÉl±ÜSÕÍgÿÌ¿ù§ö‘»ìßfûFÍ'÷¶nþ)!Î|ßù‡ÿ:½:¾ÕöO´úpïKw„nÝ4’SÉÿ�Où•»7×Ýÿ8ý*}/ç¶Ä¶8ýЕÉu�ùëÿ3ºíM¿°wWö8ôfvÙéÎÏÒ}Ü­¯¯Ý;¦ÿŒöfõlo¶aÕUfÜ}­~ðjsG¶Èi‚AÕë·×¾‰õ‡êõ¤`߆Ü{Ùcæ1•µŒm�ÚÑ[Ì}?”ô�Kê¿Ô«ØØ7wQÕ3=4ï½áÙMksîséߥ¢ÃÎúÅõ§ªãôñ‘s[ÒòÙêeÔÆTKª÷l÷â7xý#;Öô>µÑÆN¿³/¦PÖÑ~c}+mcšÛ*sKËaÕÌ�x\æ_Jµ�?R~°=�OëUÌ«lÜÚ*}3u£Õn´¿F�Îø¤§¡é6ÿ‹�­}Mé»ïÆÆÝ“^9ûEq2ïQÛIÖÞ%ou?©ŸWzÆOêÆÜ~œÏO‚˱»ZÈ–¼£+„úÇÐnú‘õø®®Ž®Ì‘UÝC kµõØn~ÏT<¶6éä¬tÏñÇÒqº^6&^6uùTÐÊî»Øíö5¡®|ºÙ2Dê’�Ì«¾¯}GÇ·êÏÕòq:¯Sc­À¤ú–‡äX=‰}»Ø=ÌÜap;«çô/ñŽÎ§õæÁVML#%ìk_ñË*öã‚8-át?Pq/úÕõc©eg˜¯ùÏï]I³ê7XëÙÿWèè8õßÓ}ORË1© w¦ñQÛy> �ú¿õ‚ŽªÌ·õ…–õLî¢F'KÉʋۈûwW¸:×0nsIÚ;$§ èÕý_úÑõjï®?_ÁÈ»ãŒì†o®*¿M¾ž6Ñô­çjÝénÿ_[ðiú§Ó÷äãtðrk úõí–—zŽÚN¶ñ+‚å‹î¿GFúÃiê](°ää`ÐM”XlkÚÂê®ØÂC˜£²î>¢t*Ý×2>ºtöÓ‹Òú®9f.FË+‡Öæ0lÔx))óž™õ?«u~½šÎ…Ž,Çé™»�nÆz� þqÀ�W³}zÿÄWÿ¯üŠ¿Õ>µõ©æõzz>Á·ð̷쮿YåÖ�ÓY%Ú´óâ±ÿÆ_×,›‡—õbÚ.~Nnêí`i¬z…Í¥Àþg‚Jy¬<_«â÷ë¯Gg¡Öœ}3’IxÚû_S‡¥auDGÑXT²>¹æu¥—õmÍvUìu¹Îp¨K^âç-ÓéË­ÿ?Uz¶fPê¹uæt+k·oL½Ï±�ÁÏk]车½ ]'Öo©Öj_õHãôWÖòü·Ð9º�'Ó&†û‡‘Ñ%>MõKêçÖŽ§xêßVékìéöµÂÇ>¶í°{›íµÂW¦u^�õÏ®ý@·¦õjÛwY²ö»`u,¶Ø×s Y±õ{©tŸ­Wú­S±GD¹ÀÒ׆²�Ò½‡cç¸éâŠß«_[‡ÔçôcÕ‰êæïPgz×hÍáÛ}M»þˆˆILÿ`u_üm¿æ÷¢?h}‹Ðôw¶7Ï÷müRWÿduÏù¡ûí¿åo³z_mõ,þw÷ýHßóå$”ùïÖüü¾™þ5jÎÁÄwPȦªÍx¬�ÖKš@Úמ…?ã[®äfYÓ¨ú²ûré“f;÷Zͤ¹‚�Â% ë÷OúËÑþµÙõç§c1ظ5WXæË›è¯{^uzÑÿÙ?Uº§XwYÇɱÿXs1Ÿf}¯m,ÜêýM›«éGç”ô™?Xþ¬fôë±-êØXïɡՑþ3*ê˜[:_Ö ²±ºmäZêØïHzVÙa±­!ºr¡ö—zøñÇéšý—>Î~Ã>·<{¾‚­‡õ�üe}vèùtôü«ô¾—��ƒ}ÎëÔØÚºž;ä²·µ®†»Ó1`�UÌßñ¯õ£?þ�{q}šŸCöÖàí¯iaƒê`¤§Ðº%ýQú›“gÕÛõ™ÕÞ^Á�sžjc˜=#wÑåÇ}oú¥Ö:®>¸Ó�”3º�ÃÖéUÒ÷>††¹»‰ïðc–ŽV‡Õ³™õüVgõlÑFaÙêÍ÷»†@#³•~‡þ1?Æ'Ö<§át|l;kšZ ­™²æŽ\SÏ}hú–~­7£ÎM�³«7u¬{=3K‡¥-úF`Ùä½7¦ã`‹Î‡‘Òi˯©õ9ùXØo-®û‹ÃXÚë¨:Ǻ}= /-úÉõ·¬õξÚkK¹Ì"–‘{=I÷>cÓì¶¾µ}`g]úýÓz�Õ·6ú릺=Fº¶›šû]´‹}==Á%5òº?QúÓõ£#©ýb¢ï«xYCsò2XæÓ[˜Æ±¬ßo¢ÙqjØÿY�## t>“Ó:�®Å±”9ÔXÇ»kkïsXçDªo­}~úÕ•wÔ|Ü\oµ´¶Ë)«k6hý#®,à®_¥}XëÝG?'§ã‹rzi.Èa{kvÓ«žÔvIOWoÔæ}Múñõ{¬·eŒ¬†XK™éÆ×†Ä9z'×®x?Uð-¹�£#:³\`ºæ²ÂטݷÜè�x^}ÐrþµýúÉÓ:õøô¿¤dVÛ¬¤¶°Ö—z†Zû �ÇewübýFúÏ×þ³YÔ:V¿ÔÔÀómLÕ¢‡½¥%=·üé³þeÿÎϳ�ÿfûOÙ÷˜ŸÝß·ø$©~Áê¿øÚÿÍÿGü¡ö/GÑÞϧ?G~í¿ŠI)ÖúÛ‘Ò±>®ædu¼we౬õègÒp/`l{™ùÄW;^gÔŸªëžK²†g†ÒÑWºÐÛA²vßð~+Šÿù=Aÿ[¯éô[sª}4þ®Ç8µÞÝß̓‰áuíèX_Y¿Å÷Hè¹YìéöRÊ­qpkœ öí,sÙM% »£ŒQM�G;¬ÑwKÚëò1„ï~4o}_ÌMz}/šÎèyßâ·¯u\~‘‰Ð.®Ü—±öèÑsõÛ�ãù«Ò,ÊÆ£¤^huy¿dÆqum!Ûö0ûH¾–ÕËt:ñþ¼ý[Ìu}:¿«Ù^¯¡UôÖŒÚ+³{KµÜ[¡IO˜Œ›ƒÒ~¶çtþ�P£¯Kem$�ºªÜ~‘'’¹ÖÀp'Q:¯Mú±Ñ±zGøÊÎé]_!½E´boÌÞç6‡‰9ú€èåu?\þ¢ô_¬b:¬œ~’)õUUþ˜<65¯ˆóå%9_UYYÊ£¨}Dpèý !�ê8Wý;¬ikìs`]Íe­úAkýbèã 7«Ý‘ÐzÅx ô¨|îih|þ�üºO+ͺÖ®«õoêßRè•ôÛ�Û}G}®_Y§}m¯p³ôvÏÒ ‡Õß®}W¡uzz�öߞʃÁǶ÷†»{\Íg<$§7®U™G[Σ¨Ú/˯&ÆdZÞ`ypѼŸ%ë}güUôüΡҲ:=ظt<;¨T÷Yºæn¬íoÓüÐîás÷ÿ� g~µ“õSôçw­aòígs±µ”/¬�'®ýHê}+6Ž£›ÕØû>ÐúfÆ6)unôÌ>ݺ8IOkgÔkÔëÂÄ4UõUíÝ—Òåû¬º�¤ý Ãôû-®‘õSê÷BÈv_IÂf-Ïa­Ïiq%¤‡G¹Ç»Bòçu½þ0~¶âÒ_A¦ê�NôÝcØÓSl³wøîá7×o«�Cê—O¯.¯¬y9¶¾ñC¨Þæ9 ±ïÜb÷ŸÍðIOMõÏü]ýWȦî¯ÑŸ“oQu¶n¤“îiiyvë™É³²«F?ÔüϪYÿ[~¬t×tü®�ê}žÛ ÞËkk©c?ºÒëŸX‡Ié¿WYHgY9¸ÌÝe£q¨í ­V}-ÿ‚æÿÆ{¾¯ýwÁfñ�U¶tê¿GMä¾ÐC«cKNàæ””ã¿ë¾ z[s±«¾¿­®1U†m{wDo#ù¸oÐ^«õg¡tÊ:]}W†×ŸÕ0ë~Uòé±ö°Xç8I½Ó \#z–7×Ãÿ7nèÔý^m¿¥ý ßKݲT}.>’ôŒ{ºOèõ`32«.3iÞÐ]é³fèÜc„”øßTÇúÝþ,^Ì:‹+àÜF7¸K=žïV VÏø¹úåõ›¬ýjÇÀêyödc¾»K«sX-cˆú-•Ê}VÈÈê_[:C:�¯ËoÚªf܇FÒá-‡Î‹ÔÆ]]7¥ýWÉ·¦2Œ,Ö¾�¯Çªà×<›]$§ºIpßjÉÿÆ“í~µž¿ìýÞ¶ã¾g�Ó2’Jkgt>¯gøÙÄë,Ä±Ø `ÉØ¡c9ø•’?ÅõýëçV³­ãdÓÓ-u¶Ó‘Y ~æm‡9®äÙë‡^úä~½«ŸW3Mµl5TE{wzfÇ{žÇ~êÙ_ã«ÿ,+ÿ:Ÿý$’ž«¢ýNÀú™‡Ônú¿ë]‘‘Lµ—¸<ÔÛ`µœ—.;7ë·øÔ騶fçtšhǨe�¡à4¿¦ñ*y8ã—Ü»ºƒtVë^C©'kqÓÒð ïÕ/¬ë?Q:¦×[�‹VI®ïlL Z[?=É)�Gú™ÒÆN«ëo]uÌÏÏÝë7ÍeCÑs¨nÖ½–£X�VÆwÕߪ?Z±¨èŒÌ²×}\o£²‹®-šÎ¿¡ì±>¢ýc«3ë•ý Øêþ¯UŠë11ØØïÑ™t¿é¹Ü¹Kæ‹Þ¹ÖºŸÖOÑãõÛÞü#OéI }�;Àú:ZÔ”á`ÿŒŸ¬Yshú·ÔŒÜN©cp²SÛw‘[Ëë¡Úh�ÿ�`ÿž¿³>Ï—ûlý®[3èïú{#ùÍ>ŠËú‡Õþ£ôšNWÖ*^þ£NP»Ö5îØÖ†ýèày «úÑþ6:Mýúþ®dßOQ%ž‹ÝTÚ_ô÷£))ÉwQé=[¨äýJúÓ’Ì.�Ð^úð-aôî{±ÝözÛcݽ®ö0з¾©}{ë=k uþ£”ÜqoI£ÔÆôØàÒEv¿Þ Ìÿ6<˜ôމ×>»uLŸ²]˜àì«ßk…{·8;ˆúO^‡õoêŸXú«õKë;:»kiÉÃy¯Óx|†U~é�ë$§êg×7õ_ªöý`úÅe­§!Ô¾ÆÊÃF2çk/\oøÑè} ý>¿®].÷äYÔòšÂðài-¼{Ày«ÅmÿŠÎ™ƒÕþ¢ßÓú•Büks,ßY$´Rá«H<„±Óñ~¯åÙWÖºÃþ§±Â¾•‰Y/5ÞFéög§.<¤¦ßø´úÛÕ:çIϯ1´´tši¯Ói,ù{§ù±à³~ªu‡õǪaýaúÇ–Ê:ö=âŒLZ±�e~úÉc…„’ëùË…éŸXsºOUÉ£ ^ìlü�®¬5§u;ÜÓ¼8�k׫}`úŸõoêïDÌë� ¸¹øºükÚ縲ÆýCÞæŸ˜IO/þ0:÷ÖN»Öó¾£àcW“Mo®Æ6¦X†1–ŸvøåÞ �wÔO®isºNHNÞÃæ·ÿŧQÍêßã�C¨Zoɺ›M–qí4À^‡Ñ±~¹SÔzŽ~öÛÓžÛ~ÂÀXKFçýƒô²õ,+Ùõˆ½”ŒJFÚý&84;Óvç}ûËœú�oEô/Æ5ŸùÅu­ètWqÂLìú¼ ö?ªtýaÇèí¯ë=¢ìÿQåÏii öýÐ’œ_Ù=KÿïÙgÛ¾Áé}ž=ûçèÇŠK³I%>_Ôü¶aÅ·ÿmì\×^·ÖhúÙÕi£?*ªÙ’ðÖ2çµ­ðt.§®æâtïñÅ‹™�khǪ¶—Ûa†¶h±¢OĨuŸ«¿âó¬õ\®«oÖfVü»®c]Y.ì%%"ÿÝG¨gôo­;&ì�˜Cg­c¬Û,ɘÞLp¶¿ÄÝdýTÍ£&¶]Só^]�iýVºB«Ò*ú�õW¤õšºw^«2ΡŠêÃæ¹Œ´47o‰z½þ%?ñ3—ÿ‡Ÿÿž©IHºïø¯êY�'«ô>¡WJ®àƲªê‹@cáú"Ñ©l­­_P³þ±ô®�‚sXÛz]{.ºÐçz®,©¥ÜÎ¥�Õn»õÿëÖŒ¿«�¥3¨;¬x�åå®eoq!§±zçòÇ7]ǶÜLž—�]µ9ÕØÇ9àµÍ;\½ŠJOõæàñ…õ~¬ ZN#Ž8¹´VßHŸ]Û·†¿G™Oþ2º—I¦¼ß«=µä�EÍͦ–5¢};Œlfî4\ÇÕñ‡�õGì\J²}Æòë �µ¬�oõWoõ;ühõ¬¿X1º>F×x°›çŒu‚'ú©)Çè?ã;¡t l1Ñ\̺(f=÷Ö+cÞæ\v‡jDê»O©_W³zUÕu^¤Þ°ÌÍ�×9Ö†6¹®9ßKró+:WCêÿ^zí{¨™C2rËIhÜÿZ6{¼‰+UŸXzWø¶ýÕ\ªºãz�»!Ö;ù£NŒÓ�¥ê|Sè¯ôî�õŽ�ª˜ø¼ŠÍç" Úèi!çÜO§ �é�nøÊë4uG žšÚ7c×’}LpÿÕÄÖÛ%›µwh½3ëNÿW®è}W"®Ÿ›™nÆãÐé°²’˃š×Ïî•c'ê§Õî¯Ññþ¡3ªwH®ö³i¸Óo~�%>uþ0zÿIêÙõcôŒtóÓ¬¾«PcE§sC\=08Ø~õ…gUúÁ•�`·32ê lÝm�aÃ¥Ä.Ó Їçdu6õ§dôú0ìÛ�ic@º°l—û¼š>õ«Ó0¬§ßS¾­µÝW u7—ÕØ7h±£o³ÚÖ4ëâ’Ÿ?ú£Òó:ÇZfwìۜǸdîs 4IÂÓªßúÓÑ>±}Y£Ë>±Y˜2í4íªû}ºLºl:+Ÿ]?Å—Nú¯ÐlêØù—_c,­�–5¡°óš«âýPúƒoN§&ÿ¬b¼—ÐÛ,§u~Û œÎ;;D”ïýYéØQz®/F̦®±‘Õ/c¨Í¥�#ÍKƒˆÔÎ…üh}r·_õW¬Šó)¹¹4<¶ï"îà,/ñqõ£êßÕ¾µm·ÒÜÀán6=®ÚmsX`Ï+[§ÛÔºÅ#ügtüS‘ÕXN#:m@º·0~ˆ¾~œ†ºRSµëçÿãSö�RïµþÏÝênw«ºyÝô¥%»ûS­ÍoÚ¿`?µ=Sì0ïç?r>’I)©ÖÿÅÿÕ¿¬=AÝO©ÕcòÖ°–Xæ`� T?ñ¤ú—ÿqîÿ·Ÿýë?üfýtë¿Uóð±úE•±—Òç¼>°ù!ÑÝqøî}tÿOGý²Ô”ú'þ4ŸRÿî=ßöóÿ½oý_ú¹Òþ¬â?¤±Ì¦ËÎqyÜC[˼šŽã¹õÓý=öËRÿÇsë§úz?í–¤§Ø©úµÒ¨ë÷}e­�ùúV<¼––€Æý8¬,|ßñ_õG?2üìš-7dØû¬"ç\ò\è¼×ÿÏ®Ÿéèÿ¶Z—þ;Ÿ]?ÓÑÿlµ%>‰ÿ�'Ô¿û�wý¼ÿïWz7ø¼ú³Ð:�}S§Sk2) s­s‡½¥‡Cäååßøî}tÿOGý²Ô¿ñÜúéþž�ûe©)ô¼ïñaõK¨æßÔ2¨µ×dØë­"×\ó¹Ð™@ÿÆ“ê_ýÇ»þÞ÷¯;ÿÇsë§úz?í–¥ÿŽç×OôôÛ-IO¨ôñwõc¡uº§N¦ÖdQ»c�kœ=í,:'-_«]+ ®e}a¡�ÙŒôîyy--öpÞóaxïþ;Ÿ]?ÓÑÿlµ/üw>º§£þÙjJ}ÖÊÛmn©ÿEí-wÀˆ+; }^éŸV°�ÓúSÊa¸‡¸¼îpkN§É¡xßþ;Ÿ]?ÓÑÿlµ/üw>º§£þÙjJ}Ÿ®t>Ÿõ‡§»¦u6¹øïs^CXe†F¡sŸøÒ}Kÿ¸÷ÛÏþõçøî}tÿOGý²Ô¿ñÜúéþž�ûe©)ôOüi>¥ÿÜ{¿íçÿzèúCéÿWpMé�s1Úç<¸¼Ëµ:•ãøî}tÿOGý²Ô¿ñÜúéþž�ûe©)÷t—Š`ÿ�?­×âõlº’ìlfÛ\RÑ9Õký› I)îþ»ý\ú£Öòñ­úÉÕO¶ªÜÚ˜r)£sK¤˜¹¤�|5ÿ0¿Åoÿ> stream H‰ìÔ{LSWð_[,kåQ7 N@˜/Z˜B‡ÊcÄ( ­ ‚í�9Çc„md‚¡“‡"²aœ&2D,cÈ2U6ã–(ÒŽ×`X EPVE¥rwo«ÆþZöÇ–ü>œ“{ν÷|Ϲç\‚@!„B!„B!„B!„B!„B!„B!„B!„B!„B!„B!„Ð?±ò? Ðÿ_»Ýfî>‹�Å/79ÑŒõÚŒ,?‡ š¿÷Óž€u/Þg+bk»øÜÄç/qŒ0#K›Ð¦Kn(smÀÜ#ç—š†µ®söÙß |¹)®�AUûg�D:Hn˜§&=íÉŠñ¾õ÷ì¨*d¼«\3ú,¯w™9YzÝZaºô½Å‹Êš;UA ¬ZZ–Dog³¼˜àé<¾­Û›±+Án(¬Ã"_° Ùã7è�Áé¿S©Ö{2§¬wªÙÎÎt·Uâ�tpuæÛ€¥Qâd*µ£å ਾ°šÙéà¹+R·xQÛ­ÁgÄ‘ç «—G„�aí%"r ½b7¿EA7à�é¥knw_ ±ïUCyYÐd¯ÞÅFçÿJ÷½Z'ËÝå)9ÝW®S©Ž°Øn­f”aqC¯šI‚ºcP}§û¡Ç[ãÊ_ÇÖ¾aLn Žùb{(+W=7X’ccönšVõ/^#܃µðÓ壣à§kékfìÔ_™þüy*÷YßÚ&xíÏÔú|¢s‰6&Ààú½‡3è“ßgeÞ~Ú¥Â�yNåô` (º¨T•ͦ…«Õ_YŽ�²kИï=áM/“䘽>ü©À˜jŸŽáECÅYàOpCu‹ºä�eàÕ6,_§Ù'±Ín¤µ} AQ·lÃøîâ>AÄûÏSmšöé’�ƒ�J¸VØÝ™~“+ê_êDÎÀæºòÝ­´8UÇ�Ÿ7éY×K¥:ÞAn[s!3Jͨ:1_ ס1'^Em»¿u’M©öLØÁ¶‚‡æ•–ÁªûÜ­þ�7x ”šV¥6—?Â=TOS&C¤†Óß«lÕ¦¹÷­"cªNr€s=ì6rß]Í·×'6L5@x™*�3è_^P|A|Wâ\¬ô˜\™j*Uج@áö,•œL•Ño∠W}šOL©„”,SîÌ«¨¿iÛ­ˆ$°åî²Ö¯­G­šR}­EÏqOì±q³ðÌØRò‘ÜÇ_¾òD©S²RÃ:h"Vˈ8Ø5hê­nûÎåDá“ÒÌév–ªM6­¢7퇇™“ß@L¿YÍ©Ã"8D¦*Z8X›fH>ßþnq€ßžšsÊìÙøÒ'5�þ(UIX‡Ž0NަuÏð’fdòÇ;=ô‹_¤wJ!fdiÙ�óôïU“S.>]rÌ€ž|ñ»ÍÛ ™î'`�Ìöû°2W@d}C$˜¥]:—p�år¦.[J§F[(kR|Æa:m÷f¶H!~xV5KéŽ%ÍG¥Ñ¼<Žqç…œoª‘�§¼P!˵äËéœìæ#máƒÆú½à(Ÿ)þ ÌF’¢>¬ò.Uþí·‡Ð¿æ/`MdÉ endstream endobj 140 0 obj << /A 145 0 R /Next 143 0 R /Parent 133 0 R /Title (þÿvî_Uÿ\bS;�\t�N4^ŠcSWettÿ\t) >> endobj 141 0 obj << /A 142 0 R /Parent 133 0 R /Prev 143 0 R /Title (CONCLUSION) >> endobj 142 0 obj << /D [ 39 0 R /XYZ -81 778 1 ] /S /GoTo >> endobj 143 0 obj << /A 144 0 R /Next 141 0 R /Parent 133 0 R /Prev 140 0 R /Title (RECOMMENDATIONS) >> endobj 144 0 obj << /D [ 19 0 R /XYZ -81 692 1 ] /S /GoTo >> endobj 145 0 obj << /D [ 72 0 R /XYZ -81 790 1 ] /S /GoTo >> endobj 146 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 147 0 obj << /Type /Font /Subtype /Type1 /BaseFont /Helvetica /Encoding /WinAnsiEncoding >> endobj 148 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 149 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 150 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 151 0 obj << /Type /ExtGState /SMask /None /ca 1 /CA 1 >> endobj 152 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 153 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 154 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 155 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 156 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 157 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 158 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 159 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 160 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 161 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 162 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 163 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 164 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 165 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 166 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 167 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 168 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 169 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 170 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 171 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 172 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 173 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 174 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 175 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 176 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 177 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 178 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 179 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 180 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 181 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 182 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 183 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 184 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 185 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 186 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 187 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 188 0 obj << /Length 0 /LC /QQAP >> stream endstream endobj 189 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 190 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 191 0 obj << /Length 190 /LC /QQAP >> stream q /QQAPGSaa31c724 gs 1 0 0 1 460 16.5 cm 0 Tr /QQAPF811d436b 11 Tf 0 0 1 rg 100 Tz 0 Ts 0 Tw 0 Tc BT 1 0 0 1 0 0 Tm ( )Tj ET 1 0 0 1 0 0 cm 1 0 0 1 -460 -16.5 cm Q endstream endobj 192 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 193 0 obj << /Length 87916 /Type /XObject /Subtype /Image /Width 1 /Height 1 /ColorSpace /DeviceRGB /BitsPerComponent 8 /Filter /FlateDecode /SMask 194 0 R >> stream xœì}`ÇÖ®,wcÓ;˜!�›^nB )Ûj¶Ü»MïÆ…bB³�mz¯.ê]rï•B ¡Á÷^¥}3»ZiW’¹Ø÷ýïý‡õjvvvfΙoÎ™Š }®Ïõ¹s!ÉC£A ÿÒ º‡„@Ì �Þõ¹>×çú\Ÿë¡ÓÃ/ù�öµ$†¤Æ©KGø“øÇ÷>×çú\Ÿës½uZEWƒ#2œ‰ª±ÞNiG�ViP#Oš‘5š?+»þªÖܯì|\�TµÀGí(bkúè>×çú\Ÿë•ÓwUà]dEY«?k4ZXÀ[ÑÐùã�JEù/{%§7Ï]{8;òP~ä¡¢ð}ùÑGJÖÈÝx$o·¤ä‡;Mj¨W÷¡sŸës}®ÏõÂö.kHàŒá³U†+[‘sןQ}y8ÁŽÏ­Ùôèì9QÊYኙái3#2>‹È˜¹FõUd:-:Ó{[Þª½ùÒ’«-¨¾Ýçú\Ÿës}®ŽŒÏúßjTgî@�GµíY~‹I-Y¼+Ï+¶à«uY­Ìú×¢œ‰!Y‚”¯+G«F*ÀuL°Ò1Tõú|åG« hÑ9‘ro?mïúÿ�Á>×çú\Ÿ{Y�F÷DÁ¹èÌ-HöÅ;[SO-Û_ÂØ5ä·É&ËFû+‡y§rSög ¸ ²Eý=Åönwñ@Ñð ô×çg} Uèo{Ú‡Ï}®Ïõ¹>×KGfø j‚üx«&‘wfñÞRæ¶â©aÙo-Í¢î'ì%è!µgËÜäƒÜ$ƒØÂl!g{¶ ¿—d°Ÿrt`ú¿–d9Eg¯=�û뽺>|îs}®Ïõ¹^:L†Ø ´f€ÓªVDVrcí‘3^[‹¾ˆÌþ×"…c¨j˜¿b »x¨�l€‡h�—x˜¿r¸�tt Ü1X6ʇ;:H4&H ;7BÓÞ_‘37:gÑÎÌ£²Ò¦®¾þç>×çú\Ÿë¥Ã†\s~PÙz@vqÑîRÚÆâ—åL UŽð• ô$ì)î),�¼@üÖ"Á'+ÄÓ—ó>[É™»N8+,åËpÞ¼(1+:ÍwkÚê}YÉ™ß<©ï蛿Ñçú\Ÿës½vÚYèô¹ßÿnÛr², ¡xFxæ› $ãÄC<mýíaóÏwkî>mnÑ@´W÷ásŸës}®ÏõÊépþõ~ýÆceÞñ§>^“;~�r¤wˆGêOÁP_±c¨ìÕi³×¨ü·fïM»zþvó“¤ �w×�vV·á÷�(uh´3ŸûÀ¹Ïõ¹>×çzç°~€¨7+Ú·$•{Æ–íè/ì-èÎàÎ$�4_<5"Ýc“*9ëÚƒËm(«ÑÑDl0±%ˆÒ-D«ñ.ÿ¿³Øçú\Ÿës/¥ÃúœŸ6"»„ç}ãK>^•é (·÷òŽ ”ük±À9Z¾îä©ß+áâÁNTI†:³Bq}+rëaӷן”_yXpéNñw·Ïÿ|ÿÚ�g•Íð©vYbŸës}®Ïõ¹ž; å6t"ÉY—í.šž3~~ÆPÿ4VÊ@oÞhÁ'+”ìõ"yÙ�¬ïÕ��’ü¤9w½ê�êû¨Cù+öæ-ÙS¼pgñâ]%‹v®Ü_q°0>µìÇÛÕ�}èÜçþï;M_ÏÉiL‰)?ý®“¤=ÈáMüêyrŒRa:Æÿy.öê ƒ¿H·1ˆþ9%Hx›ôz÷)ÄÔ-úávø‘"Ú¦üÉ Ó‡ú(ú{H{‰ýŸ,—yDËÏþVߊ"3¶–ðI’}áÆ¦ãyóã³ m[0È[:ÊWöÉeÀFé•û�ÍøÀ_“9}íÑÖÔS¡» i›rgEd¿·X11H0q¾tl dL°Â1P>>T>>HþöŠì™‘9 wæ”_¾Õiœ„˜LB~»+Ú—”2”]±z(?¯ ëNDÈ%gP�WãªË¹±\iLW.r顯�ŶÛ~AGJé“„”˜ò^Éñ#1J¤ÉÖ G0Àg„¹¤ ß7*6Ò/=CŒeøKÜõ¨¹ IÉú.twÑ´ˆœ) 3‡xˆ°ù£$ï-TxoÌøéÏŽV™[äi ÂÍÿ.ì`¡ë–| -¿¹$gBPÚ(oÑHþ /Î@_É /Ñ`OþPoÁ˜ ÅÄùÊiùAñ9Ùg%á³QÃA”%R1<‡[ÿ˯d¡ ÉYFIïsÝ;�™ô5¬�ÿß%áÿÕUW†[›µQ)À„.Zƒ2í©Óc9ŒS×}êÆÇ`Ëc#îåµW0ýebÉèÃ�Óc�]jÈIÕ•�†…ĸr^úíñºÃE.sþµ4c¨o ¯t¨¿tr¨ˆ%Îý®¢�&”ç¿ë‘‚S väÑ¢ó>Xš1)$}¸—tˆ›p�+o�;w°Ÿx˜¯td jl�b\?¨ü`Y¦St~Øþ¢Ë7Ÿuêùn Ø=ÕÈÿRßË«‘#‹ºÆÀ··ôj9ÚNö6'F�þ±„gÝŸñ#£I½ZcŒm¿zÎ+Ó0e˜.é}‘ü’Ûšît]ÂóÞÊ›¡”i™Ò �Û>òoR’´qi{6e¡� ~ v ¥çBJ>Yž96P5ÀK4È“ë*û,Lr$ãÇF|žFE’�Z”�ÿyTÞ”ÐtGÿ´¡¢!î¢á’Ѿ’qAÂ×CEï/SMKŸ¾R>7"m^¤ÊkKÖêý…É—°Åݲa$ÏÏÚËGdNõ`ñª7ôê8b3D±7-Qÿ!zQ20æ_H(þ5(ÑÞ°Ìè+&xDªÝ%×d–É 4΀Q†z–zãþrÒ—»ë67u‹Fh˜7B4Fp¯ý€÷ò­g‘GÊfGL Íæ¡ä)å/z¹ëÀ çÝÊÎ-œs̘²) ²Gû¤r•�öWÍŠÈÜp¬ ?[ð›ëUáû‹�¢³ßZž6r¾t Ÿd ‡h| òÝ%éô茭'‹¯hkÑ­%Ä—jÈÙ#@´žqFL4áû2;C'Üš®}®;§Ó C¬æÿ¾_uBŒŠÆH»}¯'üÂÞѱÎ�#Ø_Sý/–RD£ä õ* oêb4™`ܲF.m‚¿6�FÁm�NRrùáŠ#gg­/|-$}¨»d¤—üõi³#DnTb pM;²=ù´×–â�VçŒ –òôá�õ´Xî�&9s¯Q£[ÄMÔûñÓeMuþk“OÌ�©¢íqqþ¯s&…ĸýòú?ìHUø¶× ¸Gnªü?† ËL_±>F¢Ø‘±Á°Ïñ¹q¿¿´Ÿ×óDCJ4D�va„ºû¯þ‡Ôh´ÐÙä¤\ô:x\†ßÕ辊ûáÖæOƒ¬é};…§Ò¨#O@‚MÿÁ×™×d�ôó– ÷¼»B²#£N­íÙ(úîÏ¥‰…_†¼š1ØW6ÀG6ÂWôÞ¥ÛYî·¶¡«ÂÕjD�è:™µÙBI­Kºqù쩤{`™é>=G‰ÂÜçžãˆE§“vBÕ‡jT;PÁnG;Ù»�ú¤¶©iÑRu‹þþFµÝP]œ@ܸ¬ !ÔLõ�¤ÑA\Où…ÝâÕãP á|0t_ˆ¦˜Â*À—Öî³Ö ¹V�ÞÔ·#��H‹Z›—.‚�n\ÝÐ�÷2ýä hËJ÷;ò¯ /Ì.µö§~/8=�é}H ÕÄŸq<®i�ã�gÅ”¾¹H:*@2È]øZ ø“•‚ä²›m¨œ”Þ–Tä±)÷½ÅYýýYü¡>Ê7ç+]Ö+¹Å¿·Ž|Õ%¯“°5G¢ßYÔ¤ƒ·9:I!/9<ÿç,d¿gÒóÊ9#áÕ�³ö¶ ÅŸªVä꽦ôoîJ¿¼•svÃÉS‘GŠÃ¬ÞŸ®€Ö,ü§Rø�ü5ó×(\}°hõÁ’ÕËV,×°ƒÅ‡ c¹§“².—\~p¯ª³Q­­›z\Ðàu°{Ðè‘„0MkÍhPHyÚ„\¾SŸqñÁ~å›’OG)?X¸z?Hš‹œôù Û_2„íϯ$J¾çÞ¸p£¦²Íˆ~rµé w¯dŽ [jUðµ¦.äÖ“–S?ÿ�yá¶òô�Œ³7о»{åNõ³f(„Ú½î5ˆAêË…½Á#Ü|åú½êè¤Óó6L  ñ öO ;G .?ìhC•�‹·j—ìÉý22ÜüSiz8v“?-¢`ZD JeÓÂK¦‡ÍZ[0{m6}�*`›ji‚|ŸøÌ÷·ªšÑM&Õxm4êÖ•tïdS�hئU¶džú%�{jéÞB�˜‚¹Ñ U3"òM‡‹ÝºË×ÌÈüikr¦…e� ~•732÷óµyÎsüb37-(¼t»¹K;æ¥C;B’{_­È½Ì°<°Œüv¿’“óíÎéȤ ËŸ[z䛥‡Î¬_‹jíöGœ¢ëÞñ…¯T�ò“õ÷TrM Q²7ȸ[߆wh`šó_U-iåWwòO}â̺cç×>·lùêÃg¢Ž–ïà�:ýã=`•thõmmåBp©Ð ´€*ëZþ®n¹÷¬ùî“æ;Oš^:ºû¸ñþ“ÆÇÕ­5MšæNt·UjŽ™®o¥ô}}®;§ÕÇ4úBĶ‚¹û¬�_ðsÄá¢�]ÅŒÍÙ3Ö¤½»XyiŽþ’1�ÒÑ�2ŒF ä�ßüÃÈ_1*@5*P¯€üU£ý¥ƒëØ€´1>Ò×CU“Èß],�ºZî¼^¹hONRöw•í„Z©³`�õ½Þá3Ê#õíHþ··cRÊ—ì-¡}�3#<ë½åY“d8¦�ñW9¦� Hã+�²\€¸Ž”� �({-XñÆÕ»ËT_F¤/ÜžsLq±¦V.øUا�W.}Uë±Mfm¡ÀÙnj¤ä‡»±¼³Á;‹è›r¿Ø�?3*(3"³¿\WðÕº|§u™!Û3ã9¥Vvt"x“aØ'GJ)Y«ð%ëìµ5ÇJg­Ëž*î%qôOû÷bÉvÞ¹Fr�¿þx‰ó–â)KÓ‡øH<•#ü”-•‡íËiAÐô¢C0@Ó¾ðËß ¼ò•Šübó™›ò¿ OŸžþźìÏ¢²go,`mÉ]°3{¿âBE Ä|ÌÚÑ£´®}!buCgzÙOå7¥œ�Tv8/òpþ–¤ò£i?^úëÎã®V�ÁžØ¸UÑSñõ;0µ¹©9õÓÝ­É¥þÛ æm*ûpUþó•ãBT#¼$]ùön‚~l¡[`ëÆ·uåÙºò!¹ þ¡$²u“¡$±uÙ¹ ìYZêç&dÏ–8°øƒ¼ÄcCÓ&-T~ºZéµUu@~¾®Vv½eg ôit—^0 òèY£&)ã⪃%Œ­S# ¦,ʤâ#éï.éÇ–Ú±$¶,±=Käà*i†œrãƒé‡O™\[ÏÞMèÀög †ù+&„¨¦­ÊñÛ’yDvºY£khŒUÖ·1rÕ ¶FÞ…?¢Ožr�+™QðÖÊÜ×¥cƒ¤CU£½…c‚ÒC²Þ\’ýñŠ úzùúCYj5�¸àv;\HNî¯ÅgyñQIgçl*žª š4?ó«0¥ ð×VöÞ?¨l[s¸ä«è’‰óCýå¼äãeŸ¯«¾¹×#Vci.»|sòi¿„b`N¾»,T�ñAÒׂ$£ýA𥝅¤M^”ñiD&ksÚ×I…QaÐ�éÿØàÞÖ~@vqé�³Ì˜S_n(žU8=²µÚ^"Ê�•5}m挨œ¯Öç¹lÈóÞ”½jWÞNNÙ÷7ž‚¶Ÿ‹H4Ëú\÷N ¨™ ¤÷i"ÈÿqÍþ<�myS×ä¾¾ k¤_Æ@O¨ò6,®�+ǜΥÒyT'>•. 2„ðúÏ$•&€Y¦sÍé©T1yTל)°`ò­ýDƒ½%@ýdUf@LVÖ¹íˆIE“ØÓ�«€=a<`º9¬<¿pO!‡·Wæ�VörçØ1R,h©æL!ÕUJeIÌw\8TŒ_�e"™Ó…æ ¾ž•tž9�gÉäÙ0SùJƒ3?^™é“–÷ݽ6ô‘À™<*÷‚9Й÷˜¼]¾ñd[êiϸ¢�VåŽ Læ)æ)êÏLíÇàØ{ÊíØÒ~LîOáoé»+sœ×)·œ,nÔhᎬÌ·¤ØoðÅœó×6rλƔ´"ïí%y.Ëö‰É)¿r[Wò˽š°Ces¢K'ÍWóä�ð’½5_ê¶Nøó£Î|GŽ«ÖlJ.go+ødM΄ùé#C2û»‰û{(ìèœnü@‡a ‡xËÇÉÞ[®dnÊÞ+ýûF=2�£ïþ¨\wü4cKÁû+3'.PŽ’ëíÓ—‡Æ€d‹Lî”6a!h[Ó?]•N�NŸ¿]uH~á~�¦M,£¡¡óÊ9S¹'øé«&ºë�ýÒ ‹w8oÈ~g©Ê14c PÝUvl•¹לÁ£ÐR(.|”¸ÇŒÆï�9ZOŒœù¢„ÿÁh\H.ØOìþÿ^Biæ ä1%ç$ Ë8׌.0§ ¬™¢î’ñÁŸ­V­Ú©ªh b‡A矟/Ÿ$ªÑù3⢫Ëö~¾>ç�ÅÙÃüÒì½ä¶,�•ÓI+ç$ :à(aÅÀgž¶Ìu¬!q‡CqN¥‚`t4€à&גɵfòx‹)mfdæÊ½ÙO[u¶€1>÷´zá š—ªfä°ü|Pb>:ÇàŒžJ;:ÏÎ9ŖƱÔ6ý|s&ǘl^ÊáÞò÷–fønÍ,¾ü°�Ô= +QøLPÓ´ãÝ—ÿøëPÆ‹žs‹95g]¾Ç¶‚5û³*êÛ°¡ðËTlJ>Ñ{Uöø`é› Òg­T.ˆ•T«lôðY²StÚ?¡àÓˆ¼×æg ô�ÛºÊ,Rs'¡]hCçZ¹¤‚öÚŠ ìØ–eùnÎ<ÿÓÃN5BJ£O?z_ÏÿîÁâ§gDf� ‘òöc ìÜ´¶N\xeó�<ŸCüÿúJŒÊÒcLi&׎-´e‹ûÓÒC1ÈK9Ò_ š›¯P°7¥EÌù㩦U£ï“Õð™ŒzÁ5�ÐÏëÑ ##×iùçâ‹¿Ï|k‘jx€ÔÞShÅ›»ð-�¹æZµ^Bq‘¢›B¥%SœORœ€>Ƀ>t…žq„wâ£$4s²˜'´˜Ç7Ãã` gáœd€â†2’ü¯#™HOA!Ø0CØ‚ÉÝ6*ò~ø‹ØÅ�qÄ`¨MC扇XýÕ#9ôR}ùfõ†ãeŒÍ¹o.Võ‘ÓÂ] ôaËy|›y<óys†€BSœI)NRô†oæ’bæ’„R Îf e^’9=É’žD™›L¥ )s¸æ.bÈ5ÏÚU8ØG4eY{Kú…ߟt˜R¡{Q¹ˆ A—9ÿË£¨ãeN_çLZœ6ÈKjÍ�O[À¦�«o�SÍèK†¨ÓsÖ(7ɯSªÐ�×Þ’ÑÁú7àÎHíHî…뻥Öž¼°ò`Ùæ~ý«Ÿ,w¿²iŸô›…ÎÏÝT452ïó¨|ï-Ù;ù§šíQƒ§y´úHñìèìIKÒ{ɬi"[šÄr®H8oZè)À¶²fò±%¯‡¤Ï Wm9œ«ß.I£KŽ®�Vƒ$çüè·³ü½éÃüDë,< l÷µ&Úkè•§5ˆè¸YGÓj+Ïĕѓ+3™ÊHF¿cî"Ò’Ö¨ÄÒ-MÀ;”P«“�šctž-ƒoë*àUë7Éæ­Ï^µ/ÿ^:FˤWËu‡ÏZ?¢Öƒ�&±©iEÉÎ…ì*ûtUîäùƒÝaϤ-Àg@P+µà3MÑ 3-Ép Ó<Ë<¨O2R)ôT TS]Î"HN@–NKg ÆÁ¸f0ÏÒ%ÙÂ%*á0rHÀSË_:e§�n¢×$ŸEd$J¾mǹ ïq5„hãH<$L¼Òµ£ÍÈAÙEÿøâ�WgŽò÷÷ZÐRÌ€]CÁžÍ¥| À6…Âø5sS�¥T•&2§§šÓOšÓ“a-¦ÁGf€k fÑNRæj3Å™gÁ�RæðP®ñ-h©žÂפÍ^¯_m%O�êµÒƒg þëÔ ÉY?í*ù$,k¤ŸØÎMj´ΰMã6 Tï©4®5K0ÌCøÁbq@ŒêÊýæN‚ˆë5zƒj@ÒVµÅ`¼|íϪ‚K–\~ðç³Ö¿A[ÕHÁÅ ¢ +Žœ H,^º§d󱢫wjÛq|>’~É7¡àßk2GúŠ`š�9Ö4¾•lAÓ¦U?¢9©ú1%C=e.Q„ƨ~yÐÒIT•´ÉÔv/¶©‘Dá9ú–¢É‹Óz‹,™°ë‰dubj€ÎötÑ>ÂJ #“jÃE ¹�&s ú¾T·præ’ÓmdŽ…SŠ¥3ÇÂEì‹~lѰ@Õ Us£Ò8åMÚ “}øLBB'>µ�=BÒ²ë vÍŠÈ™´ m[dÏ–š»ÍP©Ècî„ÕÈ}s§“T§“fY" !`£ü¢Ì€{ íP\RQ!áAeÛõtâ`¦4éé<Uû ú{¹ÉÌ™ ÍÖM9Â/íã5¹‹vc#þ$H#«Ï8›¼C ž"ú>J ϿܩŠãm´Ž�R ÝšZšØ‚%°c¦Œ �´Tá³QvéFM§Ö"|µ Ú48koìVë¾û,òXù¼Í¥“¦ñ8xp†­?Zà˜$ðQ 2ñ¦'�ê�Ž( ©.| '›»Ylé,±„VªrÅ› nRí2lxQ»H¨4 •!™ë¬9l0ëe»‚Ä[2ÅýØi#2>\•’˜YKÞd1Ð�õø¬!! ‚à ¡=Å&=Ê ./Ú]úÑÊ ç¶^s´$ @ÄI3—êÜ$k¦È–ÅsðHì›:Ö_ìè+ã+å'å/ †Ó ý”#|Ò‡y¥ò”9óh€^| 4¦°ÆQJ;ÃC[éè`åçáò]¼>£z¯ù ±Ý{ÜøuòYç-å“‚CØReÐÌ�µ5vÎÐÐ./:¸²—bîšÚÏ-Å1HøÅÚô㹿þ'|Ö‰?a)ÉŒ$Å£AçÏè¨mEªš�Ö.TÍç6ýù¤ycÒ¹¹K'Èú{ˆ,ÜfôTh6Ò0– ñÙ…hhir�EÐ�-u ’}%?‘wµ]κ1BmÌw+š"�–}¾¡È18½Ÿ›šD|ƈ„Ì Õ~”Ë:êŸ{ ÑΆ£0zpÖO•.rØN�Ÿ€›f7�½FçX²Rì=¸¯ék³vñϵ¿’ø¬uÝà3‚iÎÚX:�pŒÆ7¡øƒ°‚‘þi°?Ó%•Ê54öU:ñ¨Î"l¸ß‚.±dɬi\¶(WpÈÖ]aï®´eJ˜@vÀ‡-°uçÛzpmÙè°¸²ù¶l‰n–š½+:ïKbË–ÙºKl=ÐWØšÞËvÖ®ƒ‡h¨—dâ‚ô™Q¹+öåV·wÀÐÁ­Q3iŒÏ¸¬3v@<ÀÆÞÉ?ÅÞ”÷æÂÌA>r+Z*PÞ,Aµ�—{W"k7…ƒ›b¸ÆøE’·WH>\*›¹:cÆšœ™á¹Ó"3!EäN Ï�º*÷ãeYï,LsôöÛyÊ-˜RP›,�í”DqNFSÀÀóÏ×ÈwóÊÚô§“�^ã3|€ÞíŠÆõ'Êçn* ì.¶fŠ9(¥h«¶ Ú«æŒu¿ˆú1…¯È>�Ê<�vÅŸI¸÷œ©wÄ6�ˆÒÜ¢$(Øj<ˆ®²ÜzX}äôœÈâ‰AªþbPS !Iæ|ªV¿¥aÚ&ÖZ•‘jÇ� �ÍŒLÛ«úŸÒCžu‚–Æ•ÛUkŽžšµ¾h\¨ H‘%“oNÇ”“ÄE;¬’ᕦ›™#ê–è8aSw^˜PÅC„jP"TÝ€6%¢ÏAG7Rð=>k=Q|¦ÐS©®ÉÖ®ÉC=yï-P.ˆÍòŒïUòê9Søl¸uª'\¾Yy°ô«õÐtkO¥‹Gq9F¥�„ÃIÎ|À_K†Ðš!´w¥k˜¿ld€ÈÑ�;Þ7uœ?¬/w¬7g¼ïu>  ¾üqþœqÉãNNð?9ÞÜ$;¤€�ã}EãüDãýø¯û¦¼î›<Áxrýcøc¸cSƤŒ÷×çåºNH™È�Â}o±øË¥WL涤ü6Ã9ù: !¶˜zÓ†ø¨Â75G/sŽÎ{}A†ƒ‡ÄÂ9ÅŠ1�:�CuZ³•¼”ãüŸ,SÌ[+ Ù•¾öhñÆc¥›N”oJ*ߘ ):éôÆ“g6;~ 486köÉ¿ˆy ìÜeæ@}�“dÆ9λøÌ|ž¥:$>«›/aˆÏ½¨[8>ßyÒ¼)ùÔ¼�ù“¨z@|¶tÆÌgPßO ”+»Zß�mB÷gJ')¿ŠL?ž}Uw´Ÿ”‰¿‰ Mlõª+>(@Z;DDu|‚^w +DõYdú¾´Ëøx„†ÓÚÑù‹¿>Š:qvÎ×Å“¦õ•Ú» As�N¹‡dÏé&ÞÛAÝ(\;í´ t¢¾«èyäF tÿ ú®*W€ÜE6nkW±KhÉ�1G4–´T*( ­¾�+Òf˜vñYˆ9*ô /á”YìuŠ{•m¯¢öl¬3î‰kÞ5èhÈÉôïC˦®ÌéŸx'ѹ¥Ð�Si¨�ëµbB†ñŒ�¼¿Xñïå’/ÂD.«SÜ“=7Ý7\#9ëk!±!ñ<×&òXËe¯ã²6¤²Ö¥º¯å¸GñYkE¬µB÷HŽ{dŠÛZŽÛZ{-¾²ŽB‚ð�{ÉËuu_Ïõ\/ðýZ+‰ÜŸÏ)Ì(»ŒÏ1@tIXa„*DMO$¨ˆêìµÇaGNÏÏ ±óZºÃÞ$ÊWIœ]$n2ÐüÍY!Ü-ºt³R]§F÷nÒhwìiC©Ñn ß‚ OšAÉuçµâ·Ë{ mX°®¡cÉPÕaðíØ¢ÑAªyQ*iñõrò M~/ä�G¡Až6vnœeÅ•¼¹X5ÈKjÅSQ¥ ÖqFÄ:¨¤ÁÉ™°�&°pâ b&û �Â¥ª3·±¹1Ä% ,Á“ WëŸGaHª5‚ëÐÚ„˜„^«ê»vò.ºm)û×BÙ ÏTW�IP2TNÂæ/áÉæZиön‚‰¡â9ëäâÓt£#ãó™ïÆò¾ñJ(ÿwX6€hÇ`Õè@娺‚ÕÔòOlq+ú´Ôë Õ��Fú+†ûɇøÈxÊ<v® [W4™]¹Ö,®¥«ÐœÕu´“[Dõg88gØr(,¾¹óIÐôŒ L£E)~ÿ»©ë•Åg‚¬bž¸°éU‡Nr÷q ЯX›ŠÞ’õQXºI̘|m&Ú×ì,Pž#ü$o-”¸¬•Í�OO.¼uþ�–{µðh¶'­È“6¤\Û‘Š6”Z¡ç3”Àðù}}Z�Gàgò¸yÜï+°{4ü´Ò“Ö—˜ž¶Aªî@ê:‘–.B�'wlèøDÂg�IÄÙªpæ…»ó÷”²&{D ÌÆ›©§ :ìÉ·cIFøÊ§¯”�~ߤ;¿ƒ€Rz›'a#‚lJ==c�âµ@¹ƒ»Ä’!F‡S).ÉæL^?¶È1XÀðô•ǤzDhþ{\»ômN‹9šñmÐÞ²�óG*í\eæ4tAQv>; á˜0€žÀà�ð¿*öÛ¢¼t³îÅñÙ@¯Öh �šJÂ8"¡„åŽíjäxÚ÷¡»ÏL]“>Ê_`ǘÓùfL9evkè:ciŽÄæ."[†p¨·dÊ¡Çù¹ß+õ:?yK8Õð‡É—¢Ž–Äå2¢ÓgG¥}¡ü<\Gr2aži(Éÿ‡I›€Yáò™aŠ©+e-“¼½H<)Du׆%ìÇâ�’½·Té­�žºQÕ¡=¾§‹@º�Ûu�Ôè¦7í¾‹�¸y¨SäÚ ›1ê·dDßêBþ!„írF®éðDtZðÐ7¡ú¡~PDÇÒ/û%œ~gYΰ1Í0ù§¥X@™N\(gl�>Á¶þÐtó1ýG`ì@—–Ÿ»Ïü:ûÍùªÁž W…™v-28Lžƒ»`b�‚­úå~³®iŒ"ë±t⸤¢ìêƒ5ÇOÍÛT4iQæ`_•5�Û�É¥Î;F™wÒœ%‚�…3ÇÖ9ÅbÞ kWA?wá(_ñgk+v¨ª;±ùÏD‰'Ù &ðYçG(yrp’"�8§ÃpðÑò+#ŽŸqÚ˜?eIú /‘5“gÁäS�R­œ¸ÔÙÉÖÀ™›tE W‰…¿?[>Ê_õÉJÙ²�*Pwº°š§!¦ííQ#7ï<‰Nù0Ê!™/ˆaa‘é’Ò¿>ú¸Ù#9¼£ø“ՙޡiýý¶n|KZªµ3ÏÚYH�Ã7s†ó—,èpdp¨·ô­%ìMYÒR¸¿+©ùÀÁZ�ë9íh¯#Ö0´¥SÔÔ�¿A˜&ÒH †¾‚›ºPR#�jˆuÐ<mÐ=Öq3ò  ¹p·c³àòô•’‰Aò2+6†ˆOk�ÓÂy@—°q ò俳$#8.³¡ëŸPÝ{ìÞŸ ëýÑš§mŽ8­Ïªpðä[°RÑu prŽ…3ßÊ…?ÌKúFˆÌ9JZöKe‹n^m|F%aÏ@Ô« éjBºê�ÎZH5Hg5ÒY‰t=ÅéôGà²W‚.¡Á#)¯xÁë IÇeŒ€„·È¨¢Çgp÷¨¦-úxÙìèâ !iýÝ%–tl¶CŠ%�kË�ñ–Ì\.˸X�ZÐ]D˜'C!-(>ó‹~ñßQòáòô!@tã›Á^Àg+wˆ¿øÃ%òe;²[ý(û�ÏÞc€ÙS}“zÊ;¦ð“•¹cƒÓzˆl\ºÐ–;¬¼~n"{7áð ´7«æ¬Ï^¼¸¦C'Šx©‘ÐWc˜LS‰%W�ƸÈpÆØ£i>wõÏ-ɧ<ãJ?\]860c §È†Á·dÈ,é ¦ØšÅ³÷à�’O^¤ø*\±îpae“Ö¨!õ®àý(:Oì„5nm±.t®ƒîâ£ÿ§D°pugR€›fR� ëNžýx™lh³\Eè]Ý =p“ ”gg„·pꪌþÅÖ^ ÐKïŒñÙ¸~¢Ezúêß+OË °uP™X—>œÇhAƒ£·c|ESWH÷ª®´hçéð�dêÕ]¿ ÒÖððZí�Òš_ ªΩº’]ùcú³Ë²'ßñ_âT\<þ)³ñï_0ZWgIªÅKHBªÝˆavˆ¬èŸõŒÂë3(üßÔD)ÿ, ‚_jõg+·K:ÁOâ¼Zré�´WÇg]cL”BbÛÔÈÅE�Ø¢·—¤ö[|¦§Âõz ¾�+w¸¿pÚJy¢à¢vV1™½Çg„8èª6гN_Ût¼Ô+¦øßaùeóWt—dËìYüþnü¡^RÇ�´·—gÌÙ�±lwÎïOÔíD$5‘ çá³É6‹ÐÈ<3ñ5ºü0­üç�'N³·•ü;¬pB¨jdˆj€¯Ôž-¶gËú{(†úJ%o/–Ì[Ÿ¶rO浿Z:„['\4zæàå¤1c =x›bš4Be$f Çü"Öw]±¨õ™PClèDõÔ¢_D(ƒl±%M¤[@A¡qÍ\’­˜œ�î‚ §(Uæ·�:ô¹z•‡�0Á êN?ûl/|oYÎPßtkWN³‡³ƒÌ\°uO¢)óEŒu‚Ÿ+Ô]x|FÌÖûè?o:5M�+RÔ�ÝY[òuMÁÚšÜ¨šœ°š¬¥Õ¡ÕÁ•9aåÕ�¯!ê6Âà•‰êóÒ‘•RÏbÒ=¡„µ…‰`�é…kVì/�– S6Üß]WË1gpíÝ¥“‚%îkwª°^Y5¢¯<Ý&<«kA¶¥ž¡m)~cAú@O©%[љƶ,ÞèÁçaRaéÍv£Lé“Û[ÕUx îrÏýúuòYïíe³¢rÞ]�ÿúÂìqAªñ Ò'.P½³$çóˆïmë�æ^ÔÚfð¾^ÊäwuB«ð<>þ”¶j ½üçÍÉg|âKf­Ï{wEúëóÅ©Æ+^ŸŸþîòÜϳ½cr"æüpûY«Ž££¦…Àu-j?HΑ1#Ãtõ@6{À*‚¼è>ˆ—¡>u"êd§ü‹(Õ¸->›;áøL‚ʱfr†yŠÿ½LåóµôÏZý*½¢—×i³KDà X'Ï=íº­xò"` )-™bØ÷ˆÍ3w�Û"õ•½·ˆ¿roF‚µ�x£¬/P‚ë>|hizð]Uùöæ ¿F‰SVwzcê§M)7¥|ÔÊ™Z+e?)Ù�´ý�öN[|}„/é•(pdñ&ªtdGb‘j/ 1Í8óëÂ]%­Ìî'µqÆŽ€Bçš18–,þOÅÛ $Á[µjíž&p†\M5hýàYëú§çl,›œ*”9ÝÞÇ .„ÖÓ„ÑìpQñ•§�¡Jê#À“Ûc§ïtÅ®jô”¨ïnVî–~³ê@‰ïöüyë3�¾Îù"JN‹N ŒË_±3›_påqÜAï]7Àgä2.eSxEÌ )¹]#—"V°YéBÎÿüp¯äüª…¾ñ9¬-™_DH�6æÐ£süc Vï)8žöÝŸU]ºó°š¨VQ"NÀÖÏñ!0¨KCèFÐ绻챙tí«HÒK*¢t©5�Í+÷›–ìÊž–6:Pnç*†›;ÁÒÐÅ•Œ :Ç�-rôW|¹Z‘(8Ý¢Å6UþÑNg‡J•d�`5âQMûºc%ó6¿"è.´`ŠÐíàœ:*M`Ã’ ó–}¶Z~Hñm³ÁÑoX42®Ú:íOŸ~/¬ÎXT—:­þø”ºÃãŽn<0ªÐá±Mǧ<±ª/+�®Fì4 "ÿñl¼¬Wp�‘V/�õÝà©>„NÃlE�“ß$½·<{¸—Ä–×pQh|3:׊Åâ­úx©ôë£9-¤3j Qè9¯OùӭаÃ%3Ö½ ïϘӱuÊ|KºÀÁC4i¾�¾î{ŒZOjâëÄ÷ÔéAI¬x_k};rùÆSaÞO{„§6ŸÈ�K-<¬8›ÿíÍû•míˆö˜$= RM,Nƒ&Ô~è’¯!Þïð¾-KIÈGLsUc×7×î§f~“È-Þt,oÓ±Â}âsªÒ_~»_תÖB Ó*1¢-ì`bUmÓýÇõüUÿÇ£Ö»Uê'-H=:n؉/l$Ë9gÞ¦½7 Ó†>.’°bxRÝ‚$ ιmÊ{gIú‰µ+ºã�ßN˜L¡2R­Y¢!^ò÷–xnÊüñ^a)e/Òô2;\¨Œ[=�öÛ©A~»_y´|fdþk�bWž9Åg´¿à³­›h¤¯rö¥¼ô:~4'^í PŒ·ød|V·!•מÇÖŠhMÇߨÛ7¬~—}ÃN»ú]vµ»íëön<2ñ‘Èyú3ÒÕA¬ïzÍA ¥ê9ôÃ÷(¶ÿ&Rõ5‚�C˜z¤‹—‰ã”°·äO^�9Ä]lCGÇi*ƒ téá~iÓWÊ’²/·éN§5ƽHh±No»|kþ®‚�Wf�ñ•:°xpB5:ànËðýk�È«´¢J !„Œö²já(„'O'˜T]òÖ¬Fº�5œ~Ða àE¬/Y’n`Z< “k"¤>ß6.OüCé´q©iƒ‡Ú7u� ÖæÑ#0ø�kÏ„OƒhoüY‘yú—#ªb8ç7/[´ Ž[’š{éÂõ¿Ÿ6i÷çTwŸSÓÔSŽE.+øw¡‡‚ÉŠž¿£ðÓ°œ±�J{w±‹kF‡m=œ©ë±dòú{È'©¾X“¹�ÿM>žõŠâ3.ÍX@¬›ç~¾¿â@éÔÈ¢Q2[7x ¾ל!°c‹Ç¦9GÈÏ_{ˆëZY#‚�!Ö@O5¢nj¼ª¬M_T›ôQã�u v­»¬kâÌëÍŸm·ªÛ7¤ñøä'ŠùHÇD£Û:ÌP“0Qý‰†�hä¯ÑÿÔ˜ŠìÅ SC,=“ø€9Q¦˜b”}x<ëFå åÿÏêÎ褗�p>�s Øù|®ñ¤'Ùº FÊgFÈs¾½×¦ã”)ÐÒ?Y"Y³+£›T©‡’«é¾Âã�a†ž&+<±ttF½‰á/èuý#�„½‡�b#F¡K˜q�á¬B ¾Nª_Â~X²ÕÒS‘Å‘,ŽÏwÕœÌù)<é’_|)#:×i}–óútúz…lfؾ|iéM€Òz™ÄÛ¹îŠÕð«=qäÔÍРÓt� å]¼»jñ¼è¸û¥§ÔÚ]BÕnE··²  áú)ŸôO—g†Æ*®ýÕÒ¡ÛüYÓûD½¬ŽÐ*‘ *l^SÎ¹ßæï€‡ ÷“ÃþL¸}Û<Ђ)pð”LMw]/¿ñ°A§ hÈÂk¤ b¢Ù�4ýõ¬$±ADo82©i߀¦D«ºXjM¥~‡eí.»g;<Ù3ùf#ÒqQ·àó¢Û Ô¡�2­¿ïèÆß8Œq<&©ý…¯uj§ik X‡Î:C‚Tg{Æ.CÕ„TÆtpðÚæ°£E_DåŽHG×Ùñ)´$3—æ´${wÑØÅWQÒïnÕêWaw§LâµA�ÎŒÝ+: R “p©›\gNãÚ³„£}e3–‰÷ εðY7x¡&Ïìêz±k¢íP5¹–ÇÀ§ïw5è[#hÝzØ3RƒÈe©Ã2"€ë[FàlHä¢Õí¡¤G?ÜP| ð™˜6²$à‰CÃ×´¨ª¾›¿ïìÜèâ·ª&)^ó“¼³<÷íÅi_®Íwß”¹ö@Î÷pÅAntºŽAüÿ jˆ–Ž´)…3$¯W¬=ZJÛ”ÿÖBåð •­‡dÀÅ­'©L!•Æ·fH†ùfLÉtÛ�), XyFÉ|%A, ðÁñQJÆE߸‚w–fñÑM&‡»ÓP]¸–,á/ñä…i>›•-„؈m(Y˜qÙíBºê¯>Í\ÕÈ�V¿TÝ»†xËÚífu‰f϶Sž&XVíØpxrmò$©ú©¹‚ÔýŠÔß@o¢t i¸�4ÜA1º‹^o¨ æ© ƒúÃ@B5àÔø"t¿Þ…ƒ˜êÏ:½¬gŸ\Ð=e™I:Âðù̯KöÎ Ïí—në*£:‹Ì\àä%KgÞ@¶èõk�äa=¦“è@DËSƒv¶#Žä8oÌšæà.´` °­Ø@Km ðŽãH奿µã:9c[RÕÐù¤^ówr¿ºë~�^«ÕFÔu¿ª {ôWòw=RѨ¥G&©}ÔC>Déïäi+RÛ—f´£=rZÒ6±˜Œ™¡Ÿ_¦×0uþzL#µWƒš “D\úÚE¸Ñ5IxS¡Ñ2ŧ�’ Ï:ääþ´`oÙôÕ™o„¦õ‘;xÊxˆ†x ÇHÞY¦pÚ�š ,úñ!~z‚®Õgˆd˜âÝJ=r& j�åk÷š×*öŒ+zw¹b\ ÂžÉ·@O½„†‹c6÷˜¥KJ•£Ÿä˵ykÖµÁÅ’„<¿bàŒ¼>�8‘[ìº)wò¢¬žRK¦Ÿáž4®K8ÄWòþRå²]9-ˆŸ ‘Öyí×Ô­Hý­§§÷Ö(¼jŽLnÚ?¤6(ÏfuñÔê8JUåY¢EP¡ãíŸì›t7yî‘ÿ_²%�Ò#ål¬ÈßZQ¸¥¢hÛãÂØÇ…q�жã‡Rì£bŒ¶ÁÀõaIÌÃà‡‹EƒÅ ´¿ÑRE‘–´Á´á ×B@1dÿí�J*άº"ëxò¢©�ª>¢ÖÁžaö{‹Ï„’5Âg ”g~ ÞUðéªÌ‘¾*[W)ÕElæ,3s–Z»H³Eÿš¯Ú¦jÖ�xD'‚Ïáê¤Êö¨#_®Ï$sð›C€«ûaï–«pl Ò%Jyúê£NB|à­›÷Ÿ)Š.�œÛ|²hí‘‚ˆCùó"tG¹áûåî³±{òRäÁÜr¿f_6 u‡ 6'•R],½ò°¢¾«SßÝ�è‘Ç�ˆ1¤àÈŽƒ¢ÕoÕøºÝ4‰6R߆TÔ¶ß}Üxíî³ËT\¸v¿ü‡Û…oä]ø-÷F×sÎýšsöWp“ÿÍ%ßÝ9óÓ½ ×üðGÅÕ?ŸÝzTÿwM{m+œ[®&¨åd�4f:Y{Gÿ€$�ºW(L[­$·w[1„–,‘5KÐßS4ÔOÝçøôÐäê£ïמ˜V“òEç« ÙÕ\H•\q¸$†sö ì›ìòŸÚ»B¡WÐMâ³ÁoíÚ½ó¬kåÞœ/ÖeŽ �ös“X‚¦Ù™�¶a¦ÚГ¹ ƇJf…Kö§¯]‹7UÐè¿Cø¨NB»o¸MYñÆ?ÛÊŠf$&µØ;.ÿÕ™ ùpð[Ñ’,™\K¸{Ü*jÞQFÊ·ÔqÁ¯ÂÙnëúßHZÍ+ÑzN¨ ÆýöwSä‘’/£²á¾að°">Û¸‰Fù‹?[-åþn€Ï„¦˜€ÿð'ŒV¤êú³ÒÍU‚¯jŽ¿Þx`HmœUSœYK<µ!†R¿…ÒG©O0«K4¯�³¬�³¨O´ªßi×¼³ó®!�{‡7îÕ¸4z…ÓðêB7Mû!ÏÚC£ª�ªþ°�£uÁ€F(a‘`ñ`€×1Òyþg:>1¶áÈäÚ£ï6ñ¾x*_ðì;!Òù ݬˆ¬Ž*q=f˜±‰Ži‚jtbÀvÞæ–‚7ªÃåÏ3çTŠŸÊ�Ú¸JFø‚–T~,ëZA×é¶ô±C¤½òhÙ�²OÂÒFú‹m ¾ó>S�Å– þéóÞ_ËkÚõ3À¿6xbàåe.|µ¾à­åY¯…dŒ Ê 4Þý£1rŒà~˜~¦Ã£ÛfúIGùˆÇøI_ RLV¾¬œ¼0ÿÝE™_­Ïž¿3ë ¸´²™0iÍD戶½™uÅ‚iËàu€ó¿=¬Ë<}�ôtÄá¢E» ýãrÙ[rhrfGfÏ Ïþ,çŸûqXºc ´¿»ÄŠÉ3góáéuó4‰Ù¼KZ²•sê/ÞÛ R7sÏ´`­‡ž)z|z¥¡†ã3‚áóùßž-;P:+"w´?\)OÕâ3v'Ï–-r ÍY-*¸üĤþŒèâÖ7…Hë_�Ïy–PÏû æÐðÊÛæx«Æ­”úm”æXJûv‹¦m¢â)µ1fõqæõÛÍêãÍâ-ë¬kmjwôkH°¯Ot¨ÛÑ¿z—CÕ[@u;û%¼)±_ãŽ~µ»[pß’ÐPãÛ†�¶µ»õT· R ©)QKà•†;úƒ+¸7I‰vDÒzî´¯Únß°odÑ7jR>¯L[Üu3éªï^ïé%ÃpNí_Ô VdUkôÉò9Ñ…“BTƒ<6ô xæ] Õ•oëÆ œµZ’õ}E;)dœ6HZËd§þÞ]öáêôaþbkVŠ<�Thæ"°bñ†ø ß[¢Xµ/¿ÑC<ÖR$ò/²cμ»<{tpZW¡[Šná.0A,ž-H¡ŽÜvl^h:0ú½!ùÚ-èYü~®üþ®²aA™*ÿ&ó�Í<¬8ߨÖÏ^#£´®<5ýAÛ›�Áò/÷›…¿mh¾ú ùÛ;­qÂoiÑY¬Èp –ôÛÒùt>Å)™BçRæñÌà9w@…æX1¤cüÅNü?¬µRÇh5¤¶êqÏÃg´X€Øä~ÿWàŽ¢©krGøÊ!ß!>kϦÁNL(dD‰¾»ÝØA\i¯·Ýzÿºu}óõôʜ啼Y5ÇŸír¨ßiÙgÞ´�Ú‡BtŒYK,µ!íèH¤ÖÏí”Ú픚x*Jfµñ±-ë·[ªI0¯ÜAT}ã,¶›ƒÀ¿hãÛ©-1VͱVÀü¬M0AX°Æ8™ÃH⬠m×FòükCµÜÄ[6í°©M´«Ù9°áðë�)3*²#AK„ª*Ä*f{Ä0c|ÆÊÔÓë÷k"ŽœšUä¨èÏâÙÀ3­R(ôds6׎Í,rŠ’~s»©CÇ�UMDh2ž�Àûå—¼ÊÞY®â#°q:y…GÛmÝÅÃ}ø3V«EØÎÚt�”<€-ÅÙ9ÑåCÓzI¬YK&vĤ 2gðá9,Ý<5jIãX0ùpÇN‡Jç‚ø-]Å6,þ@oñ¸…Ê©a™!qg®Þï ‹hŒþê?º “yZßUþÃ��ÜÒå;s}bŠ?_“ÿÉÊÂwg�«á§â-è!qpöc‹lÝA3Á³ck B“!èÏÚ»rìÝRÀÕÖ•Ó�)DtÚzˆ@SeÏñ—L\(›½>CtêOâ \&ñ™Ä4 6ý»º¹üdzäŒKKvd|¾F4.XÔ¶Ë|K�]A�ÝP)Ö ž™܇4j#}…“ý¹3—KëU^›ÓíÎ[¾· l~ø�@k¬>X¸ú`Ñ@ {JᇠVîÉ]¹§xqBÞüØ4ŸMRÚZÙ§+¥SgŒòW ô‘Y3¸Vèn0ð�/&=�LH™Ë1cˆ­ØiC¼±Š›5h¾t³%qþàJī䈚„ÆP8à 6I¹W½wœzgiÆp_™5ShFãêγ`ðÞU×qÿ\eÞúzñ¼º“Sª÷ ªÝe]½�ÚoÞààp<¥>Î Ü4 T›@©A©*�R™©*þ¬ÝnÖg”íF ½á[±V�±f�±”ºX xÚcÞcQ @{»Y#ðŒ¡4'XÔl£ÔÅ[Ô�7¯Ž…±Áðq†¤�ùů Ô* í'Z×ïÔ|ì�ÇbïÖÛEˆºíÒA ªß�ψ>Ã_ 1=ûóý¥ûJ§G•Žò‘8°øVNð„> ‹cÎäØ{ _•Ð"¹Öc³àü''‰¤¦ÙÆ9GÛZòÆ¢´^"K&ÇŒ–‚[O|Ç@áaIù-=>£ÐqåNåʃå3"Kƒ•ýÝx6ŒT ÅéŽ5$Ç4=ÿ4RÏàðh FŠ9í¤µ»p �tâÕ¼¨´MG ê» V²“Ì9Ì~V£&ù_•�gnmM>µhwsKî´ˆÌ-Íx-(s„OÚ`O`˜‹ú¹UŸoÅâ€B@õK¥2Lð§sÍi\+@©–4@\sìÔ?:œžjIÚ°ön'ƒ9³×Is¯<í@ ¥ƒ¤Ü#¤Ôc³ªîWwe^¸Ë9µxGŽÛ×™Ÿ,—þòY»‰¬ÁGç¡'³@Õô„¹Ë ¸Ô×… üí™Ü!~2 ÿ¿»DùÉJÕô°´ÏÃÒ?_ƒ„§Ï„”ñJŸ÷„à»ÊªiaÙÿ^™õÁRÅ[ %ƒ%£ýă|øýÜyVpY„çrB{| ƒG™�bI—š9‹,]A«Ç‘0NtéY«vq«¾]zå°:"BtxaÒŒ&áú–’É Ó¸Ã³q|N�gì2ùÈ‚Á·að‡y‰?^¢Ú–ñóƒ6|V¶>XÙ©ñῊšÎŒòëqɧ—ì)£o.þ4"oÊÒÌ1ÁÊÁ>2{6ÐÉ%Vt±%]€�µj�Ï䦥”¹pÐ=%øÚsµíñѵ[`{º§LœÏuZ/øî~‹Ÿ ú¡áÕßa©­jF²Ïÿ¶%©hÉÞb—Y3"r§,J-ò _…µ«žñ眧F øŒÍ~ÇZFKt�Y�[WYwÅ`oÙ0_É(ñXÙXÝIX�úó°ž? `â­ Ѩ ÉÈÅp_  +xÈØbТY³’ÌÉØŽÄh¡%iKÏ9îÉï"¦Ìá[°Äý½¥Ž~ü9áâ-Çs7êÖ·ö¾ºü“œAÿ;öXOëàNÂ…æ«àÄWte z4Äg¸Ÿƒ�â“%’�‡³Z|t¼sC×êÁZJ]ÓñàÜ“’˜™WËÉ�š÷ŒlÞ3°v5›µÄPê);ÍáüºX³êx @uq–õ±õqT@uqÔší°s£Àr,µ)† =Aà߮ǙÁyÔ(¶ëi¨KC`§ÔÅ¥À‰|±T�ØU‚~~�°:�Z‰ˆ¿®'T “`^·Ó¦n§mÞaµ)Óï)W#U?ÃÉ„¦†Âÿ[Ž*/¶óÆQåyßø¢w–ä ÷SZ1Ôy|há2x–nÂ!Òw‚9Q‡²Òn`&mg�’ Ðà‡�—ï-šžëè/w` -q ZOîâÉ!ÖZáïO5„$]ZR|Õ?±èÝeYC½Å¶nBôHP|ƒ_9ñôäÌ1¼Âã`(¹ @GAˆ(¢ÇØ9Á#ª�±lIu¼·@ÆÜ�žvá>¡ï‡:�¶E«íD ¿¿¿-åÔ’}eŒ-…Ÿ®Ê˜²P5&H9Ø[Ò�ͳa¥Z�èÃÎB3'¡ö¬mÝÑTÚìѯ µ-�«=ž¦G ;bOK0GVN|[Þ@wî”P®ëúÔM(G -,C~ti`ÁþöWÓ^ѹûóÝ·eÏS½³H5>H9ÈClÇX²ÐýRô¼9.Ü„�†ÜÐÄXyšÑ„TºÈ‚!²b ­Y|€Ÿ¦:ù±#bM÷ÿ›&6ß–Í…äʵcléršÜÊ…-Ð:;ag Š1B “K™wÜœŽâ³³˜ê̳fòGûKß^(anÊÜ.8]Ý¢qÖ÷ĽZN£¿â3Zåÿ|Úq´ü³ucƒ”öl‰9<ÏQ‹Ïp?7À�™+¥'Ò.µ"„%:û©iG:ž5ß,¬(Ü\-qkIù°i喝]¶ÛÔl¥¶Aج2†Zoј`ݘh[·Ó®n'¡kL쯳ÛiÛ¸(Û¶­ ýZ@˜êݶ€°1¾¦6€wX7$ZÖÇÃÞŒšx¨x×$@@nŽ¥´ (Ý„þ¬�5«Mˆ|§C]x ¼ #ñÔí²­Ýe[µ» lÌñÅ©&ÑÒ.ûºÝö�®Oú¸2mYçÍB¸øÑ4>ÿ§A2>×´!Û¹å¬-ùo,Ìà!ÆŽ¹‹„J“ýÓ’­Ú�Bx”ðØ”NíÌl]j"Y¼‡3çÂÿ¸ì÷–gŒô–öcÀ#˜QÍ– ­'É[‹¤þ›ÄÏÚõ}&ØzÃÒ³1ùo-Iê#±a‹,X|`Ûj{�isß‚.„ÝÎ4Ø)�ÝãW>ñªïvFC‚«;‚�Q‚è�ŠÂÐ!%ƒY¼IÂ9Q™Ç²i×™V0±…±7·ì“�[y Ä=¦hêêÌ)K2Æ„**ú±Å@÷°°L;aF;Ž�M�A Ú6!™ø¸>�©ôb”p܆ªßÚ…gO¾ðÝ…œÐXA=‚�f…m"?4ø‰oWþ¬ÚÎ;ë·½pVTÆ;Ë2KFx‰ú1!²Ù°DfX™Ð%X+€b²? [ ñY‹ØÚDš¡ËCt|éž/zeð¨L`bÀ…ÿ–ó¤NRx"¤3€³0"´ø,…—Nbt÷ždxÄð\¾9]cAKà!é'you¶ë–Lnîe|g$D?ëñ•r„^gb›�àÕóê�ÊÕ‡J§G{YÚSªŸiI€¶lѨ՗a²¬ópã_!¼±CÁ¹ùaÝù³Âu•fݱ÷šö�¬O´oN´¬ÛjÞgÕ¼ƒZ“`QóÈûîÀ(ª®ïd7›B‡@DAì>>"ÍHÊÖ4Ò¡IO¡#EHGz‡d{ßlzotEÁ‚4EA „�¶ÙMo;ß½wfvg“¨àûþó~¬Çav2{§Ü{÷ÜsÏù�d{ÞÁ†]ƒšw3ì¡ßç¦ßëfØëÖ„Ä@î·ÙvFë÷ŽÖís«?àÖ°Ÿø“»g„î«áº]ƒôáõ ´ºDk õÈìÜ Ày;²‡5;ÁVŸìÒ¸{HãÞ�{F€ß6Q®JnØ?ØÑ?»ìuÓÝx`tÓ!÷¦ÃãZŽ¿Ñ,þ¤5eËÏXw›¥ýè_N׌¦ŒæñW*ëϺž/NTÌÙ˜;na– €DŽÜÊ2YY³„ É žä�àÔ´â»:Œ`6£zU™@¾‡õÖŽÒÂ&ˆÊ=6h^Y¨ì/³5±á±Å¶<é� ÕäåÊè=YÍæØj}u­X¢°ln\Ñ;«rÁ´×ÕWâ tàI oWäÄ�[g®Ä‘'[ÓbËõÚââȃç;p%p©B:À±…6©ƒùHq•ÐYJgŽdt°äÓ5¹»”—qÒšCPýŸùñÑ–ãgÂÊf¯Í}}¡r,@汓¿Ô–ͧ³EHÛOCÆR(HgšÔ?”q[ŒD,ª0¼%H`Šsâ„]tŽƒ#u` ûKÜ#”Ó£d;ÒŠZMølÑ»]p4iÛžZî¿³àƒ¨ìqóµÃ‚”NÌTGNƒ-€tUм/´â(`è9‚ÀôžB d^?¹ רQ¾3”’•\î·âOæ1è¶ùÙ@ĈØP€øœñi9ÀÑMLfè›Yž"Êê y™b®xt¨òجùñ9?ýÑÚ…Qý‹‡Ï¤Í�ò�ØoæÂÕŸï.ú0&d¨Æž‡ð¼g„ÏtŽ2#Ed̉ќ¿^Ef¤ND Í¹«ñaÍ%Ym^t�ÌC|Ró~·æd'}Ã�HÓ串¹6�4UÝ�—ª¼þôøÔ§üYÕBÏ'bï* 牘óTÌvÀ×§ð+8Ⱦ>–p*%¼ÇÄqv•˜])d=>éýäÈTÝ�Ñú¯œa´8PËéõñàZÈX½Ãªy§µ>Á¾.eHõÞñO�O~œúɱ×1ó‰\ˆ‰./Q%ö�"áá·ñŒÛ*!ümµ”÷DæóD\›·º¶"¹ñ—2¬§Óbýõßê½×,ñùç{†ØÃ@³rŸ§q“–Œ´@òé¬4gŽxü\qœò×’Ín×ýøGÝõ?õ·6Ýy¬ÿí±þîcÃï�wÁN•áÖ£¦›�š®Þ×]¾Ûxö·ŽÀÚ·—*G„)�xÜÞËä±÷• Q~´ZµGqÁ”Ñ̈ð¹R×¹Oy~ÑŠÞþ¨yª1‘Z0u¦rUŒQŽ�6Ï1aÊ1貚¶½eTðÛÑÐ.ªWÁœ}¤v@ý†­‘ŠÏH¼¤thb•� W͈ÍI’Û�™['@ÂÆ6LQüsÔ¾Ζ¢É«‹Æ…©FË�}E¶>4ržÉ�gÄàvfȱæ`YEc‰$˜žÛžW ?ä¶Fg®Ì™«€Î„þB(>bÒ-Pîâ¯8W9,PþÒ|՛˳X›3¥%WÚ©!êL–<^imsÏù¹ˆäÒ¢s_ŠÌ¬uòQ8pÄvl!Á/4ç$˜>Ð8¸ºN¤Ã† fŸm[¡Qƒ1Å 'oO#³ n|òÁÁ t< —øY”Ì"ðŸN¼7tEp„%FŒjBdŠºp$�¶DçÌIµò„ƒ Í[ä�î¢~y‘vflV²ôÛŠ…ãEÄgËRªþ 7û̵Éÿ]•;,Deg‰Ï6\¡K€bÜü,îzí�ªŽnS0ëÎЕîéϹ5E›¤^�Ç^7ìVçØ’lÛœ]š¡¥7‰Ñ°ÛYwø¥ÇGÞ¯IŸ×úý ýÏê¦k†™úY`Ût#Óp#K#ˆ‰þF¶þfú+�ì¦ÙÍà´ë™�72¯f¾Ww}³¯N4]`xs¢CsÝ�7‘§Gt´°©Iüèà›Õê öï’›LÕ_U鯃Ëåà—hÂ˼ž�ïžy‹ÿªùFnËÍlÃ­ÜÆßJ ÷Ï7?ø¾£þî¿a¡ý+õÙã-U ˜-ú§GË÷–ÍX“å&wðSÐàTZ‚ºêq Úq•.lÙkaêw#„ŸF‰¹›”¡;ó¦/Ý[°â@áê¥@¢–.ßS´bÅ¢”ây;²yë5ŸÄh'.PŒ ×8û«"Ùx¼…@Õqô˜�¥L?s°š|$ Y¬ºIRüÓþ×óR*¸[ ælÈûdmþŒ˜¼�ÖäÀœ${FLîŒþ·f™k–ékò¦ÆæÕñÝå“>‡y7Ê$Úº.!ÍC„bg¤>r·pՔ،¯´?t’Mì<6`ûÕì*ôØRøöŠœQ¡êA�JG_©�7ßž'·šu&@h†k€PIf…\ÄàŠ 5ÞGêì/u� R€j$¾4Ö¯ µ¶1Áš—BÒ_ S»GhÆE¦O\œñîÊœ©±…Þ[N/Þ]~þúcs“E�šõé˜sáúªÅE§¿¼(s`PºKB÷àÃÄgȤÖ@�Gwž@éM…pMéüÞȪ`²±xˆM&+A&O)Ý؉�8G` ÚÏ"ð·ÈšàYé2ãøÌ4á3RÑYiÈJ/³‚ê4\† à†çœ¤3…ö<á° ù{K2Åå<®ï¡úÚ½XŸ~ìæ¥mÈô®½0/±è�åÙCå¶<J›"Ä3AÃds•enÉÔuB&¼D³ÛØ…µ?®¹p´13Ò�ú~Ë7C²cS¢�!h³@‰¥5~e[·Û¥áðتÔ•™+±†o°î*¬§ë6`Ýz€íp¿ß1`=M¤ȃzx&Ü6Â3�èHWÖ~»6=°éøËÍÉZâMq }œM#\=´jM°«Ýë^ÉŸÓ|i?Öù Öý멇¿5â%ÐÕÑtëÉýçòžA�X fl%Ó¾XBòÿŸ1J_Æ';é§oG¦”O‰Î$µç4~>4ɲS­ Ç—Ò–­qò–�˜«®xe¡æÍeyÿY]096wJlîTW8-&JlþäØâÿ¬È}wiÖë 3F…¦ÍpòKgp•4”„ÏCdÃâ;ùˆÆ†+=cåç¯Uwš’N¢�'õM¯ÝË;GXxõ�öò^õwñ’od—vоùRøõvÁ…í‚ó@¾BÁ÷û•m³@ȯç¶òÏn8yzõኹÛ3fÇj^_¤¬pô�ÉhÞ¢Bšw1ƒ¥pðQŽŠPM�M?ZíÏFD€_¥7&KÏ…Ä~¼©`ÂBõðP¥³/Tƒi,`Š‘ˆÌ^´e¶,è¿áä#G€,&u��¾)Ÿ´XñÞrå䕚QšO¢ÕŸÄ¨gÆ(gÆ(€ÌŠ‘á2;ZñY”ÂcµÒ3Jå£ò\«fmÌðÛ––X´dOÅÚ“Á›Sžc|ÆÍŒw«Û·¥Vð¶ç½±,}h°Òž#µõÁÅzO4�aK‘"*�¾.0�Ï`� ³R‘aY´}KAc“ƶ�×ì âVkƒ¼p'–q|Fþ6*öâš9¡u3�¬µ8¹² B…^…ðàu%pËÂí?ÐíþŠ-€Cƒ·ÌŠ©°bÊ ‹ŽÔçél/|†�¼íI 3}Ö«¿¾öاÿ¢á³¥ÅË„ÏD/3ta ü²¹_MX¨uõ3xk8& 1ù0�#[24PõÞ²ì_µã¥IFa¢ÀNLçé©Ä:µ¿îðDCŠk[£#Ñΰh³´¦;]Ê€†ƒ£«ù3eEa5ß#4î@KŸGLQªðk¢]ºýD»¨éø†=CôI¶†�6HàNS<½õ+džýcyØ£ÓXw�ŸxQ&Nóœ·Ñ÷~pû®±§OŸ3OcŸ·ºŒT 7Ù�Ð.¨‚ƒÚË� §ÞCùµmyRko>ë'&épá@Ê`Iì9b€i¤ƒqõO9*Tå‚9J� —S€¿ðS8ú*íxrBG%•gè¼fOþ2ļ¡þ½ªÍìJIî=ä‹èDê_ºC\ÚŒX+°Ó†QÄØGÈãíF¬i6bz#ö¤“”ÞñZ›0vh�Ìž+d0…40yœ`@¯ÀUG†”ŸÆª4ß@ÿp'•,Yv!,¾`J”öåEšÁÁrg?™ Â…•7ßšW-­>;›7“O‡æ ËJW_ù° µ{¨fÒç¹o/Ϙ¼:ýÓµÌÍY~[µ;µ1ûóã§i¿þœyþvñ¥û§~zxþZÕ··ž~ÿký÷¿Ö]ºýô›OÎ]­*ÿáQÞÅ?4gUŸ¹#/»¦,ûY[q¥øü}k7Á;JÔ1i_$á<»¤øÚ¢½§§¬Îxi¾ÚÙ` ߆…L¸lP0‰îu‚ÆÛp¥¶,‘#OæÈA¦{耡€A10.Fæà/�Æ?¡“�ĨA®œiÇÙr„6)\¤c©­Ørèµ8'•õm>tQ†à/µò”[±ät ôzµfÃ$6L±-ø9Ol=7Ð%|$h™@BX{P¨“òá�û;ù�y�ÔŽÚ!t¨£±•V^`V^i¸âÇ„ylY '¦dü‚ ¯õ銒k$Wù ÷é�ψ�ë‘θåX¹÷†¼—ç§»(lØø¢ƒ€Æš†À�£¨ž¼\“¬¸ÜN)Ï\fO;Vu©®ì‹Z±‡þÐøö=.�Ûl Ûi- ö­)¿¨;øR�xÖ}í ¬æ;¨¸b=fÛʳmMÚ$‰Z „Žîê«O³W5Ÿ|W·XCŠP×›vÒÐUϦ%™¡Kq5ó�"Ò�B·7‹ü?½­ÿò•Rüœ-÷*üù®aì‹Ïd©¸óÆá9Ö¶Ò7g¹úI!Í wrÖEÒHk�xErm¡cªÄ�‹w(2œÂžeï+´óÚr¤6l�­°f‹áròàÅñœ=Ê',ÎÞ®Õ™C»©–uª£vÕñ›TL¶°þÞ¸ÑôÈ&@¢‚»Q@fS{ôôôØ÷0™O t68M†Ëdt¦”î!vòÕŒ‹PÌZ-8{ÇЊ›°4­ë ë—“5&\ã ¤ã9`š�+²çÈÝ‚åE©Ä¿QøÐÌeaƶÎ?N×çÇ4?nÜ?ʰ˱õ+}²}}¢C}Ò`’µÂ™²Vaµ?¢»nä>ã³¼s´ i1ü~¶6{%Â硟㭛â Û³>ÁZ·Ë®fï]ÚÔê‚-Xg8ßh9©4½róüoÓ ,TСÀvïë={ñ‰ÏÈy£uÃñŠÙ›Š&Df @j¡9 Ÿ¢"0ä$†`ÖzbÁ#Úhl�%£C28µFÞÖÞørä�dxÑp±É ¥2 –¿µ\»ò@Q›…ú×/>÷ûúùÞç͘Ïéç0Ããy×½¿ÈŸ°0Ã5@eÏÓX{àJ>˜Ü‰l¹‹ŸrÂ|)3æäµÈ$-ºº89ÿ³µ9o.Hê'µçòé<0Р�O0¹ÃcŽÜ�%È•õ—�QL\’>%6Óg[æÂxõAå© Wÿ¬Ôué;î$³ûý�˜õŠ&ÑËg†r‚Ñ\Õäwp‰’‹¿.ùªxjLþèyéN¾º×I8\²Ћz$Ê�Øš!>ÚAªñ Ôo,Q|­�•5-:Q6å£xÀŒi¸ÄfO�É™•7#:FtÞô輩«sÿ»2û½eY¨G…H‡…«�|•¶<͹�ÃfÃÈ ç_ȪoÏ;±øCdî¡JÐÒÞ^’ýÁÊÜ©Q¹3¢ò?ŠÎ…O�ÉFë 9p5!6oFl’,põ©QÚék²§Çæ¿»LûÚ"íØHíà`µ£œ�AFp!¤?{ñm˜r'žþ'1ª=òÓ$>ÿ[�éÿú‡ÒîMø Æ7¿Ô¬ÜW6=* …`t¦±%Vžà�Fƒœ6÷`™çZUþ�ÛÍ­‘ŠÏ-M7rôyËÓ&ö�h€îÁöµIκ£u'Þ¯°lÀj¿E¶ßncOÏÿŸ‘ÖßÓX{E[¯]Ð|üÍÆ½ƒRlõñÖD¨xíé.‡º£cŸ =Z¾;‰u0#f‰Ï&Ó9Lÿõkì=öõƒBÏ]Q‰ÏWÿ¨Ys¤bÆÚ8˜úÈèL"U½9V9Ç’:°˜¢Q#(Z÷‰Ĥ)CL®ø„Uî{‹P*Cù‡QéÉšËít¡¼5 ø¡Ü°Ñ³þj$¤¾å°†¿�Çs~ôÙQôÖ²‚AZ[ŽÒ¨”�Ø*c ž|€�lÒ| w͉J »ðGÏÂx-kcîÛ‚Uƒ&°æ·áHhPñ–@°ñ–8p$ÃÔ/‡(Þ]¨ütµÊo[úÚc¥¹ßW=™LÓ«êz?ˆ±Ïƒÿæ{ß¿¯‘hŒ O5waä§ã ßX–S©r 9|L8t*è\µK6ÄGóöü¬�V¨YëdKwçl8^º%íÌ6þ×Ûßl}³Ctn‡àÌvþ©­©§¶œ¬Ø|âôæg¾8yvóɳOœY{¤bõ¾’Å ¹�[4Þë•ï,¸‡*œ} –ÄŽ«€98~ \å‹“g¶¦žÝÎ?÷¥ðü¸Êp6NúÍVÁÙÍ'ÎÆ=²=óÓ(ÅÄJ KƒæjË– 44¡³¤Ù¨°Œ™1êýʳm¦zá>æ&o�ψ)ïâ v•~¸2Ì€ìÙB8ë™#§�ix�¾“¯ô•93Vößí©ÍLý©§¹ö;�>3\â?-Ýu)®ºÝƒZ�¿TsìíÇ ÿªŠ$Ìp.¨Á峞þ»í?X$ÌaQí•Õç7ª›Olüʵ!‰¡G܈ƒ^»Û¹úè„ÇŠ`ìn ÖÝj• �°Ðn�ÿ,uKâ 9<õ†âgA¥¬­þ‹•uúÇ?Vì/™“ë¢rò‘Ó¨øÌ$î‘"-Àƒà€†|¨�“•iˆô•‚kmЦ�E½Óðø"æÚKŒ'v —}«–Ÿ¿×fš¡÷nOýásŸ§7b–?°c¦Ö™‘r N,{÷síÈ`¥-GçÂst9 ìò<³6GÊ8Ñi�ðHyK|†_:êkÎÔ)xÍiï7|I·×Müµš´UÚ…ßÇÚÇzZ(yþ>S/†ãk;Öp½¦l‡AâÝ|à%ý.g]"]‡ÓqÄÙèí÷ z|ô�{꥘îJehú¡Ew1õ¥ç½ŸÞ¿íÇ]ùŸAe¥—ÿ›~®k鉟÷ÞVújd†k ÆŽ#±ö䣬[‰æ- ”¶.íbæÕŽ™k5ï-Ë¿ {H€Æ‰%s`Ki�â’Ïð‚ž .>*gžŒkï.KŸ½V¹|wnŵjZ‘$BxÈÈØë¦Éƒ¶&Ú’~«»>›{š´SÛºúÅ_ª£•M�É¡vô‘¢iƒ˜puÀæ¹VxE‹Ïßni%’6MÆZÊmö~}FŠ�ÿbDZpùwï5²×"CýåŽlįå‘jÅfœg¨Pʥтh71‡K§Äd�‹P9CGnÄg�4+  ²ù~2· íì¨tyÉ•ó½¿hcŸG'€Œ† ýsv”½¶P3$@×›¼D@y¦yHlY"†wê ?ñ; ¤‘Û”�F‹Œfd]FÝý†3)-jn«ðÝÑ×[øïÕˆ=e­ë¾[Ž'ÚŒÆnª>ñL½¶¿¾OémÝži(ˆ2f4ïsÓ§8è’h!^Ã�àdØ3¢:õãÅqXW% l4u‘ÞíØHy/!½{«åÍüížåKöÚÂ,nþã©�Ø1í×Áñyo/Ï¢†4ƒÔ(0ÜŒLØ:`èŸ5 ­"A^XB"€šƒ ÑL4>ã„?¬“pK î²6l‰‹¿âÕù2Þzéí’;„2˜�Y>9¡)þSÕö2“Pk‰h-�êÚ×-Ÿµ©x,èÝ~Rºgš[‚Ïhž|;¦È�+ÀߤúÓogñëK•ch†*}”¶l©õœ4«Ïøt¦”á!pdK\ýU£‚eï®ÌâmÑîO¿PÝ -ÌÝÈC;”§2öŠú Lö)j­õû‰ò1*ÀsØŒ³wì.ÿ *Û-Lãè+…î'$¡±¥ö\Ù° Õ{‹D‡³~hF ‘=”,à–hÿw-×txêÌó··å¾¾0s°ŸÊŽ-§{J°ñÀøD{éÈ0ÅÔâ¬ï«Û)ÏAÖ�‰tÊHy.âÙ,^¹.w¢ðs+Lb;ØO†ðYŠ%ÓhœTGÙ¨� �hmÉå?͹Œ_¸¥¶È#ø·ºl㉊Ù‹ÆÍS„ÌH�. p ý§àI†ùK?\*ßr¬´ÅÄ·cn^ ­´wUßh<�ØžÜ ólPûVe.ª;·k¸‰u5b=]æFLU½Ÿÿæ©ýëin¹žÞ˜1¯éÄšö Õ'Ûé­qòOCœmS¢KËžÑubNí% ôy†Œ’}ñÙ¢XÓz&¡œnyð/:Æó7·¿Âçú6,>­Œ÷eî„%šAÐx]żøxÁHÂ~ªt¶ŒÁUÚråv\¹WæÈ#™m ” (-ö>2pÜž##2 sFyº­pçX�gÍ380:ã­…ÒˆmŠº>û>__xæ×i�U–ø ½nÞkˆ=tjÆÚ‚ÑJ'_1.óñ!>{¦Ú1… ¾�ßÕO´ÿæè¹'†…ˆËý€š!Gžºpñ 莹 W2*\õþÊt¿mÚ‹¶˜mŒ=”;ï¥æZ@_ïÛ¦þ½÷QZƒYèÝ LƒÀ¥šo+Þ†2;$¾F¬P2HÈ�OŸ£¸^ÝnÖ0)‹ ÷ºê7ò$ ?ËJ®ÌÝQðæÒü!�Z;®Šæ…ì™^":Gêä«®˜³FúSeŠ÷é1�'F‹Âú6q²£›‡5xÝ|÷Ð?®è½å™Ã”¶,™µ—ÄŠ%øLç¦9ñø/‡ç°×f~WG¡Ã}Á>¤¥ 3¿Mb‚t÷I3ÎŒ4&\íìÉÕaû (ÐmrT°jÚ2ىܟ(MÚ4ìÁzZÚýÐüÍ¡–â55…k*Oïnp뮇V2u�©B-†øç¸y̲uô`�õµç¼¦ÃoèwÔ%1’|nгiIréÚ?¶F2·å÷ÓÐí3kïý`æs ‰E×êW0Ëï½Äç{bâ2„Î70ëÓÎ-ÇOylÊ;_�7 ¬/Ð|<ùÖÞrº·Ü�#p扜}®¾š!�™Ãƒ²FgŒ Ñš)% Q� RŒ Tºú+}• .äá§y«­f!'4&Œ§¶cŠG*>\"[¿/�ÂAÜR¿i’p]ô/]Œ¦Ì½z¸é9-P2\yµ¿|ZtŽ{¨ÌÑ =`<â†tÏ4›9�ÈÎÑG>Ð_æ qðØùlØBk¨c àÈņ³'?ùÈpÕ{Ë•AÛ4go³Rm¸iü%ãÃÓ}×i6š²¿¨øŒïRF;Ðã~þ½nÅ�òi±£ÂÕ@Ë¢ã´*p¶{¨a@ÝÆnMÖ…_Û)±½f¨ìik®¼Qÿsvý÷Òž?Oc€rKÐÔÿuS5ݵÿææ)Íîtbú?jK¶„ŸŽ×§¸Bãs"NžomH°�é ¼òD�éCÊsOï¡á¹ð¹—ê`ÄŒ7Cpú»ÌsV†™x§LÝ€Õ�wõ¬fÄfŽ—C+¥·ªˆ0Þ9�Á–8p5.Ù(¿“ゎMýçsí?×L[®ýdeæ§Q™Ť Ã߀| ¶Qª�—˧,Õ¼<_3<>M›æ¥´ò�Yá6[¶Ì™+ N“Mÿ®7Ï’øÙÑ�=®ÕÿQ¥¿ó°ñ—?ëoüYýOÝõûº÷ënÞ¯Û÷ëoÜor“”_îÕÿr¯îÎݯ~¯l|¢ë0tB÷`³`HäœÓ7'M^™5*DfÏиR+6¸CÅÆðÒ¡³–ZlØR:Ì·’Fc§Y³E�½ÌÏ“>–Å0 ¬! JÚ  Éó5Û³»¨$_´�ùíšà]þÌ•Ÿï+›•*{ŒE¡` y®äúËÜ#2 ;ÈM2)Kyx¼Ól¹[€a’ñ‘Ï�Jíù»„‡mŸqÔ=©Õ×·Yü5T[v¶¿<ÃÔ¸Pù0[ÙýúØ#§g¬)sXžù qJ[Ž`È\Ákó…{³n´Á_õJTŽ·Ä~o¸oO‚,xÉwŸb‹â2§¯ÖŽŽÐ8ùÊ`\c¥�±Œæi奿¾@{0Ï€jõq2¸yà!»ÅúNZk̽ê–,zÞÇë²ÇGf¸ø(í™@]‡“>€Ï¶<ÁÐ É{‹•ëW´Ô/*<[ükîòÚÓ7|UòŸU¹Ã‚•Ðë’)�¬ Ð+Õ†'t ”�›ŸÁ\§¾_%Ì+)&5¢q'´f€qzÐuYFO[ºm˜Žàó]ã³mM�Ø0¸»ë~Zõ� VÜ||’a÷C¢�åLADд†dFýÞAÕGßh¾°²|È}®KÜU¯#Ï&ÔFß«7[ôÞ>úÌóT˜Ñ„Ðd™@\�GVÊP•W‚«=ÐÑ‚#uð‘�QO_¡Ïü´k0bz 3 ø;ÜÏ t7p¤Ùˆ¾bðxS7ÝP8}mÁ´µeS¡AY¤„�XRÖÀ<×3Ö•L‹ÉŸ•óQlî§ks=7åÅåÆÌ••þø-Øõ�(“ÏvbI‚ ÿm“f¹ú)©5O†3UšéÑðXlÂç.�@2GÌ`§9ù¤Ž I›#ß.>‡',0W`oü¤âóßcl?ùK°ÆzÿÌt)üZ0áÚÃeû*¦Ä–Ž U9ú æ Ÿlþ@ÿ´7IDçjZ,#©y´»úÕèÔEnÁëÍ üZ“ïí[‹”ƒdŽÐÙOZy‡üù^p½ÕÕ_>ažèKÅ÷5ÈÒ…[¥þ¢ä~ÅDÙ�<îî7b>_(ÞZ¡ãÀ•Û2å4oØtil¾½�xx°dú Õáì«mÔ—óâ~Ì£+ÎŒt4ãbP\ÞÛ83Ú7h"º‡À:ÿ‹\ƒägmÍÐw�@A"t¨¨Ð˜¨Í-вy�šÙEÒ¥©ÒNìôàÒŽ<ßža ¥RßCR£jLåaÎúzᬖCcš’� 6†x2±l¢uC²ÍÓ=+�¿�ýzëºï§»Ò2ã5RËì@4 íä½=›À»êÄ�S—îG=ïÝoŸ»š0*>ã••,ùš³¥tÂÂL×¹ÐÓæð…ʳ„Á•ºúË&ÎW®:tŽJûL5S¿v£Ú[pfþ�õÜ-9ï-SöMuà¤YÃìT©V‘Gââ/·@ÃÚ¤¼[ÓAl |.þþþšcç¼¾€œZãQ†ëQaé0YR.Z·pRÂ(BdSÒŒS��P¿©}maú»KUÇ(ƒw¤ïH+{ÔhžSÃ�熞�ÇÊ>[_0n~¶‹�ʆ-�ÎÌ^iˆÆAB¦Ð"é} ¿7 ­òѹ ðrl½O ’¾½XºMy§k7½V#19꥓÷¿è¿@mÊ,Ì¢“õw&~¡ßàlü¹çY�Rö~Tñˆ`…OHT+Š¥Cþ@�{ pÉÁïùÅ÷ÒÏÜ-øîÏSWŸœ¿þôë5ßÜ|zñ—šo €�'@¾�R¾‚?}}óé…Õg®=.ûéQþ¥G™_?Pœ½ŸZþ`Å¡oßY$"uñÛsRɬ…�sÉÎ[è»Ï'Ÿ:X|_P~Wsþ÷¼o”þXyêZÕÙ›O.üRý5,¿š¸Ê/ÄÀ-¸âðך3WŸ”]©ÊûîQú…?%÷vÈž¼Bá¡tñ“ÛrtO $ebCÒ~‰{¨lf´<ã›?;L òâ}úi:¨‡ê:±Ñ)ÞÖ¬IK4 ƒCÎ&¤�¡ÏAüT\á�ù[˳Vï/G̺©.RZwO{[Ýöª_ÚýØþèrëÃo[+¿k©¼ÔòðR{å�­�~ÒöèûÖGß·TÂmÛ£Ëí/wTþÔñøçÎg‘Ê+�àä—»@É¿—wÝÉ輸뱀UwpRcÊ ¨<ÇÓp|Æ!Z—H¯Ýå\¹ïuìÌÚîë’¦_òÛ;ÛyïÛ®‡—;+m‡Å^ArHGÕ•öª+P~î+í�‰ãí•?µ>ü|ÅjoaúûX·�Aæ°q³ÝË.÷?ÃgÓûîAž6›��ž½¡t\d@N¶×ŸA•]zDˆâÃ¥š…¿£d=ÞH¯U*†X΃8(OýWôöÕð@‰#—Oc¢lqL>ƒ#rTNX¤™»]«ë&çžègàW¢¢ków�þ`uþèðŒA²>"gDÂEp¢rKp„ —óœ}�æ&vâŠúˆ)^]¤}o™ÊgKV²øŒ¡ƒxo`øéž>êPÅŒ5ùî ò}Ôt¨Û§B^#/jÞXÒÊ�ƒ Ì“…œ·½ÅN<ɸyêOV‰%EW‰Õ“Þª¹fÈ—ô¬˜LéIT|î Ñ*9Ÿ‰j7v2óëÐøÒ·–å RØrEˆ=’ŒÐ‡Ù?Cýe¯„I?X$þ,ZðeæÂ]EŸï.]±§|Õ� +‚mÙêeÑûK£” Yðµbå¾òe{J}•–�ã»5Ûs}æŒÕši«³&DÊF‡ÊøAB?kïcV^' ËÇÈœoã�fÏ䉯̾–:e¹tÎZ%okvp|þ‚¯ —ì+^¾¿tåÁ2p9$ðê«)Û{K—î)]�RžPà³%û³µé¯N#R:* f·åÊl¸«Ï4Jw•ê+H6'VzöVž+ó¹¡íÿ‹Oïvc$ðè'_œ(cnÊ|%R>vy™•>±‚ë/öɰ@ù+3¿Òü„2S˜l¹¦æÖ…5WÕ]/løúxcEB}éÕEkkJ×Õ–®­)\S_¼¾®h’�µÅ¨ò´h}MÑú:´_Wô·ÛÂuµ±µ9«žf-ýSòXÆ«;1¹ùà«Í{G4¥8éltdZm$G¢7í´6$ØÖ%©=øzUêÔ‡BÏUh­vamÎҺ¨š¢O‹7ׂR¸¹®hsMñƧämXÊÆ^R î§pc]ñæš²uçwÝ;ƒuÖÁ¹FΕ�}^fê¡ÿ¢ÆÈþLvä»U�kŸš±¶Ô}~–£¯œÎFq‚°²„Žþø0é¬Êâu(? •O�Š:”AÄHàó‘ÌývT¼¾(}x¨Úž+A“k�5˜êrÄ9ßZ’{¤¢ï;d)-]„&?iIÞàÀt{žLÃ!™˜´2%D‚*ÕéÒ]B¯?ž’ny�Q@ˆ’^ mXB'?ùŽèåyï.ÍÞž}îÊœÅlK~|øù¾òÉQ##rÓµÀjÎ oD¦JæŸÂÙéš�š6úÒ¡—Ø–+6Ö¬özý…Íy+Ú”Ü&éL½xº^<­I<µY4µY0µE0­Y0£Y8­Y8ƒpš^4M/œªOÅOkMÕ‹àW ”ÓHM1'7óÿÓxâÍÆÔ7�mJÚ–âÒ˜`ÀœÌøÜ´Ã¦ lãèmÉÎú$'ýîÁ†ƒ£š¿Ò|ìÍþš“ESÅÓ "ü*àÆf K˜¯Û[D”(ÓšD3š¤³õꀧ¹k W´X{Ì™‚QPÙòý;í3á!‰¤ ²~¸Sô“)Q…n™¾28 †T�0×É`ñkáBÞ:ÕµJ¬_³\ùì£ë#Jk/:ÏÜZ>aI®«¿’Á’àË p?è\ÓVi÷gBå“ZD]¶ùh…׿ hvðW¡¹*?.$³’ôìDê¨4‚ÁiNª5O=+7Ã>óW\tÜꎪ?ˆNØïָ߽þ€{ý!pžß¼—øUã¾1ºîàdÝ�‘:ð«½Ãt»êSœ`nÙ=Bæä¶AdîÞi…’zÓuñ0i‹!Ѧœ™ì¨ßåÚ¸gXã¾áºƒ#Á%ˆëÂK¸iÝëÖŠ_qÿ3È�Q†£õ‡Æé޾¡“zÕd,m¿™M0¦Rûû_ibÏ^_FâU)VÊÒïî.N)š¼*´{HC‡+ÏölÑ?ÉÛ DÁ›%O;°N“Šhìgœ0a�M žè;7ž(Ÿ½©x\„f ¿ÆŽ mƒpíÆ‹ïä«¢ü4Z©¹p¿Ãt[(ù×ÇÍë�œþ$6,ò™·Å3}3;™Y Ú ¥pš•Ç[fÝCnõ™ õPÄÂ$ƒÐQJ;SjÏ‘�Öþg‰*|›ì âŽJûNñYß„So|ž=x®NÆY"é �Ïr+o%4Ò9Iñ¨4€Ro˜NZ¬â­“\}ÐÖEÞ½Ùý¦×¾åš/ùþ)k F“îm® ö_h˽ѹO¼QÙ²æHù§krdži\`f1!Acó¡ˆqNoÄõ & "Ák�Û‘ˆœÚdØ)Ž\Dí#¶÷ÚñÀð'fp”t¦/Áˆ/KJ°°ÓðÔ�䵈d¸�çæR2¸°ÈÿŒ{ÁÜ^<1ñ$qð“QÅÞGaÇ•ƒÉ MÃi”53�L¶‹ó ØOH\,¨þ`‰2fo6žËØÜh_°�Å©?@çÒoÌO9û_ Ÿ+ ¿A 3é08'_ùËó$Þ±ü+�Ú;ÍmŽÒë{Z[®iôYþ¸~ê“þ^tÉu»v9’š’ôI.É.)ºC›ª•Ü/óâ¯õK÷—O�ÊqQ¹ %®FA:ÁÈmÎ-…²™üm&n0È"Dð×)�ÍDJò’™Ða ¦eÞ@/259â °f#!Óƒ;D™S„dfDÀ1åO³oP¡R<%½#ÉëÂ†Ñ©àÆœ8’Ñ!é­Tï5çµ4¹ñ=?Æý_þX4r@njî• øÓo/˦!°ý[yâ-_`Ã�‰3&.”ølH«lÅ:)�‹lcF¬«±îÂ�&5§ ºº6$Ù#o Ú?H”¦ZK<­%ŽÖÇhÚi vZПô‰4]"¨Ç†x:�†D¹“Þ¶ì´Te€Ã PÀŸšÐA\D£(oœÈwж��< ¯3aÙ7$2zÓpÑ%>£ÐuI6M»ìu»ŽNª”ê®å¼ÖÔ—LA×£PK@žf-–"*÷ßš3i‘‚�Ïb:$ ’ÏX¥Ü#?gÊßúÏú3:óâ�GË÷—L‰Ís�ÈpàÈÞÄ�”føøk^�Pýón=ÖeÂg#î†}wÉî²£‹F…§ƒAœÁ–âlÒÐÂÌD)Næ¤Ñ¼À”(Æ^|/$þ%º<¤û@œ!V±…Y¤#d^Qi7k òüÛ“¶ÉyÓb ÆD¨]ü¥6\Ô™‘g‰W¦¬dn&¨žIm¼„,ÁÈPÕDZyù- )®iØê+”d¤p–�a<'ߪy�¸Ÿ*´ìw˜E% |ο|oþ®’Vf»©�9T|š2ºRØbÿYz%½EùaO⎈æ´ÚÞdfm _–åµH “ò…ã)±€àÙ­½Ìµ@\Δpž/7� 8>#ý´g®Ä-D=+&]Uq»�œ‚ö™o¼Ÿ^øŒÿÛÚƒ%ŠÎñ¶•O\”�7xbkŽQg‹ó¹Äu®ü�%’q2ƒE<¬I‹îÆÚª«Ëv4)>3~YÿÕÎа@AÈ~·H³%‚-\ÔkAy]õQ‰H@â¯HO&-qV$>v hʈ#~Ž—`¾Vœ5i¡ë‘ƒ4(Ü�€ŠÝa£ßi tïºD«t9üŠÏ,ÐxÒ˜èØ¼ß­V0çaI ÖU†;³–lê×ÿŸ©ã ÒŸ«›±­ÇKX²^™¯�`Å&r¦TÓL·ÕÌ(•úô/mf¶#µµ÷ tRË~}kÁî¢÷£ó†«¹J€Ï(;Iƒ#tP½±@±MÞÐMèŸ8F]ZUveÙþSÓÖ��̨vöƒ|DøDÛ™³)¹‚©.Wìà§²çÉàdÜ`fš-GBà3¥ÉöNƒcŽÏ@ÍæŠ\xòI‘JvôÉûèyûõõªðø‚ÿFº…©œ|Ádòº#ã™ ÆË”wÛ#öLÑ _ɸÈôÏÖȯ>jï0’ƒ¤Õ¸6ãn.]Æþ]ˆM‘éN¼�Þ†h³ÆÜgeÑÉo`°] L(z{YöÐ@˜òÛx›òš²šÈ`Ÿm‹Ì’ù­‰%|@$l&D¥›ÈšÎ÷2‰€ð]$O«/�kõˆíPlÎæ@¤‹…|¶äˆ .¤D"5ëäh²a‚v"uÓxĦW\yÜñbã3ñ¡ØÌP&÷îÍÇÊçl,7O�78¦` ©²ãh†j'/Uî8^ØnêòøÜ…5Þ«.ÝÞ$û´ñÐKº]ÎúDܶ #½Ýþr‹ˆ@õ0W ­7V ¨4&ÅdþjmvÒ 75C�z5qž€c2þ'ÜÜŒÏ8Èï?¡ëÉ‹!Žg¨ÆÃ%Hû–½Cžy¯*k5¦¿†õ´öY“#”¬ÿI[3’VÊ;Umk•ÎZ“56\�2¥Šðž ùs|¤îáésÖªÏ^«ê2#‰ÅT±>ÃrAµ¦å^ J(xkyö�¹WAó€Ù£hL€¥Â!Aš–©6Ì£Ì=a³ú(ïۨç<·”¼³*{ü¢L÷ˆ¬Qá™ÈÕY5*L1*Læ"ö³Fj†+Í•:ñ Õ1 ñXЋm<Óp-ËšFþÀ€ô·©B6 êÐ|!óì� …ï­,¢´‡^Á|B „ìÁhîà…£�9O4Ìp÷ß�É1W:i‘:p›\ˆ»'ø«è6bm�X]SçO ?ÿ^{î꣢oïæœ¿“uþvÆÙ›¹ßÜ.þáÞ™�¯Þo¬ÒPºÉÄa{1Ò*bzÙT¤îÕ"(؃�æ  ’egXÛ '.ÊpõUÚ³ÍøLÂ&‘Úæùòk3ñdb|­–`8ô&ù )£ž»ÚšpC¦%3M+iÇI qkOÂb5"'ÈÆMg¨?+Íê:©�3X¢~²ñ‘™ìuš_µ™YÉšz?”. ÞÆïOPZ«µ…îa*g?Ìé͇ v=Eto…7}x�vÆJ¥0÷2•—Õ\†±£ãÉõºòízéLýáq�_¹ê“ìt‰6(Úšö·[ ÷Úêâíõ;íôq ÷‡�„®tdÍ õaÀ-Q”g$¤AÄÏÄ@±/Çg ÂÃêiIP�9…Ö÷L[˜|6�Ñ”äмhݱ·Ÿh"±'ç0c‹I;³˜'ÿ»ŠÂWøHm´ÞKwê—ï)��í¢rä¡ä¨ýEæo�Ì`­Wß~ÜJà›æä½aÁÔz�gW‚¨‚»=Âb­ë\%Š|¶a ì¹¢á!ê«TG3.¶S¼¨Áÿ†¶ž¬ŠËÉҳ˔ù~™å±>}V¬öÓí'ÑšObT3£å3£¥³c¥³c¯PO_¡ù(V;1’ÿr„|è\¹=OŒòÂu"ŸQg‡¡d<Á°�ô÷?Wn>šækMv2ëGÿ­…o-ͬ´ã ¡¿7Åž"Ü·ò#¡$PH-Gøì-�<Ϭ´á¾io/Q|)þ®Õ¬N˜�´§´ÝÎFC˃'õ?ÿZYþýïŠò‡³¯¤¨üRúýFþÅu'/¬I=¿êØ™ÕÇN¯=^±áPÁ.qiÆ©ŸïT𻥠°}5dËáÐr Õû0†éÚ°MÇ‹goο ËÅWiÇ¢\ BÜò !â³Üš%þ›s/aã�2B`j3Âm†kÒ/}¤Ap<Ń7n¯ãÆd¢4U�ÍþUF¸Sænsæn:Z´&X¬qs7iNA©Àñ@9•6kêÚ(i»_Tp¦hS°eA­_ŸD(ŸS0:L&§hqY=tè\'r UÎŒ–•|ÿGU#D…áÌH-÷/7žŠoU2›�¿Ýv¹êSœðµ¶¿ßê“í‰vM‰¶†�u‰Ö¸%^]€n{3DSl ÒNBøiÄÑÍê±)D%Þl¯À=:ôD8¾¤Иn›`gH²×%;4¤8âkÏrçpm1Ù©i÷€Æ¯†4£M¢]Œ=:ƒõ´XÎÌ(ŠÓ¿«,óŠÄçüoïG¦”¸2Ç-HéÀ%𴘿5@>a‘6p[F}Y=F Dè�ϨlÐ#*±�GK<6ç�[�î ‚ Caü�@¨ƒ¯Ø-Dõéjeþ7¿w˜ð•ÛÖÑýÛŸO.Ý|Xöý½Üo~Ë8{[{êNzůšŠÛšS@njNÝP�ºª>u#½âwyɯ{4—¤h?Z*x=B6Ô†Òİ‚™ML.yB:›ïä+‘þñjeúÙ[œ1,>í÷‹ÂI‹ †*í¹�бñ‰¬O8>{¦z&îùCD9—‚„ÓV(åw[IºÒaÂKcgWwcSÛožV|wKZôþôK[„_¯rÿù Ä Ÿ�eÌ­¥Ÿm(œ¹.wöúΖ¼ /ó'Ä‹/œ¾ñT‡ÔénjBÜ^Ús/,î£\ã:ÒŸ5M±‡‹>ZŸ?&2ÛÉGiËì…σ6ƒ+%|6|žIp/ ä«pðUÙû¨Àom¹"ODçðiÌãÖ(fq}Cýœãà@ ¤3e 6˜L©í}4ö<•ƒ�,"v“Åú)ðDÞ„ày½}áÉð>¹bPe¶�Ň^7¤×%®„|¶åЇ*ÞZª]¾›ÈkÙkˆ{Ñ>&‹¾‹2%Ý[¶§ôè‚Q¡j{ŽˆÎ“A²^[&ß‘Çw�Pz¬“_úµ–$®¡è‡Ÿ÷Ð�?Ôœ·´QæÝ�úaýÑ·êM¬?øjýÁWêŒÿ©;0®nß躽#ëv‚¾I =\%¤>qöº�Žº8 MU›ãI¸øSuCø¥‡‘^M1†Xvš¼!‘Q›ìP›âZ·{„n÷ÝÞñuû_­;ÜÕËÿ,ÇÃG;ôjÝቺÔÿÔ‰gY—ã¡qä€;:è­stŽÈÑOê®™«¼t«†:÷ÄHƒm™;µ“²ßA‘v2�5Ì©�aGrnºB1>Téì#·áàûjo8Wöj¤†·I}µ²©Ãêz°èÝ9žë _Y�7(@a &þ¸Q”ˆéF U¸/4™<‘0Íy \8ü±Áü™Qòüžv¯Ò¤@÷ÆÉnd±y¤ë>}µòhÖåÍ©å+ö•†'•r¶–|º¾äƒèÒ7WL\’7qqΟg°"{öÚ¬à¸Ì­ü’«õ–œNPlì{Ðhñg#‚÷ë÷jV(š›7j^¦OƒƒÐ˜ú �@7´ã‰�ü$ƒæJ‡ËF†Ê‘ùèÄ=T�rvÃ}ä­¦"$0Wìà'°åœ¤³N LÆñ™HRIc©µ W:Äf¢c4ž”9& Ø� » ®ZhË&�-p-Ò#ºI‡HGJ} ®�Èf|¸G6§JâûXâólâûXê÷XP­­ÒD>Í�ª*ÛYõ­¤»æ Õ1MÍLªÚ¿GhН—k7b;ø§¹;+&.Ê说g!|f h!Êߪøï Íît…�¨ÆzÝAp†{Ðûýú“�Z9Ë-M @íÏO…[èâ+·@ËY¯º_×mÂgÒ4bVÿ,¦ï½tFŒà Â�+Û±€š·"µƒüÓ\‘5\"$æÚ”œ|#æ*Þ_ªù|WŽAúíZlåî¼™kóÇFd;ûÊ!Çš'Å9Á3•æ×ÞЇóØ3h0àˆØüq!|�é…_›;ÍÏmi}²Ôcqî 0ú­ª)óôµ/�•,M)ñÙ^ñѺò·W¾¼(`Ýè)_&F¨Á}ΊUÏKÌVž½£ïÁ„¨/ÚH^)Ýëºè¹+,Û_:9¦`d¨ÖÞG‰r¦âÞã6^|g.h ð¥É›‹å“—«§¯Nÿ8ZûILÆ?Ê,°]­þ$Z3#F3#6cj”fê*å;ŸËÇ.P –ð1Øi(M˜Ä åw€ñž@ÁVðS½$x/R4e™|ú å'Qê™1'-.Åd€?‚WIš£‚ÎIÇ/ýqTúŒÕš�¢3ÞY$›8_>*®í2¸rki ÷‚Žyö\€ñéQJ~É­.3<™šé‹ø1iV8ÙαôoBâ‹ßZ–34P£þ‘ß ZÛq$@i™¸H´=³¡ËÒeËdç0vw·êŒú‡XýM¬ú2Vy{P�ýY‚Ý/ú;¹WˆÝ/ÀîçbwӱߤØ�ÝÁ‡‰:RZq+Da:®N²­I´Áñ¹i»usœMK¢Us"4#7ÆY5î@m£Ûa�ëÆÐ1üi§Uãv«æ8šÉ¸A(Ï„þl£KrÁÒgc—·c·øØu)vS…ÝÍí¾“…ý–ûLrHö{öG‰ñ~…ñÑùž'?uÖþ†µéeŸÑÜï-ñùùœ óàokÆ�ÇOÏÞT‚BÌvLðà*Ð^>‰ÕÊNýÞEþŽÄv ý£ÜîÙ•}á·È”²ÿ®Ì„Þï~R�–ŸÁ“¹*&,Ö„ìÐê»,sÏõ~ž~׿p€ê!Uxx­šN,b{æ–d ÔÚâøŒ¬Ðp²æ-ÀSŽÓ̉I–ÞjE‹ƒïê>ß]0#:×=,Ë‘'‡hždÎqœÿŒPsÖÞ2+)ŒƒóC´#Gèè#*ðˆ\BDëXV„Å7ópC:r€ŸT°’Ë�¶?=?¥tΦüw–iÇF*GI†ø †ùK܃Ó_™—>%*Ëo«öXö%ÐAº¨´¥TŸê~Tk³þ .”sî:d�\]0,8ÝŽ'£¡œ@½´&3Í-H2!‚¿ôèwIé7åÜ8Yp+­è¶ ø6¿øï¶@ÄÅ¿ŠŠn‰Šo¥ßL-¾u¼ðæáÜëÉÚÜøŠW¨†ˆ¡‰ 4!‚ì]lí!°ãÊ]5£ƒ%‘)割K‡²®§ÜäÝß”Â/¹™Zz+µô6U~É/Ââ›ââ⢛¢b° ¿´ äΉ¼›GònïÎþmÑ�‹çKF„ª|d�âƒÄgètÄ“� “}¶V‘{é‘€l¼/ >[7>7vbqiå¼m…g¹ÈŸ ÖY0kž+{wizÌÁ2ê ‹e[G%ABÑD׊¤IóßJ֭Ǻk±Î»ØmÑ㣓[ Ñ'ÙÕÅ¡�ÀD¨!”®N²ôÞÖPØ«ÛiUgÝ�h­K†‹Œ@Ç¿jH¤×'ÒêhõñÖM‰Ö-ñÖ†í«5rÿÀÍÎuIöõ»G6(¸Xó·X÷#x=�Èu¹éŸn¸—´�Ô|­ˆÔ®‹Ð-»/eò¹«ŒDyPY¿Ub�œš±¦`LxºOnƒó±tˆEÒ±áR�5ŠÓ7|¶´�ài^t!o¨‹Ç³¿Š/ygi&¤.ô‘X{óa臧Ж'ªzg™zÍáò6ªVCmOÖk02ßÞD]­ìœŸXôÞ²ì!AZ0g'ðÙú*;2ÅCýÔo-PÎÝ û¥f‹M®ðLJóS ¦¬Îv Ñ‚¾Lë‹Ï^©ÐÙêäVÞ Ô^ÐôôgG0õƒøœökMI½Á^`M_L®<ŸzÔe?¯Ú[à³³äý˜¼q Ô#Ãexiƒýä#çjÆG¨¦¬ÎànÉÜ¥ºX×a2tP0º·¦n®#Éy2ëbpBÑ[Ës‡iì¸2èà GÉT;Žx Ÿdl°`v´ôn;äƒí ”þQºŒÐxÒMáùlG&ý�üKS£³_ Ó PÃäÈœeí&2žhx dò éw÷@'òq÷-/ª�¼Ÿ.KëV»‘8”ЀaʯÏŠ‘¾)A¡�S7tÓ™'ù¸p©×Zñ÷÷Z¨øln£/Ò‡tY!FvðBÔ÷l>~ èã"3ÐÛãã97¡« ®D ’N]©Ý—Aò²Rúf¯…/³?Ì3nñ& PNwãAÖºFñÇõ_kØe_ŸL�i@|N´ªI¢ýYOº[$ÒSõ»lëRìê“íuÉŽ�)N:¾íØø•#ŒL²Ó'2šmšhMf�œáÊ Àç§ÉCÿ86«ã·˜M­Ã÷˜ºï³¿LÌ¢CS:¹xú¿�Ϧ‚`¼Þ­êåûʦÆŽ Õ8òdtŸ™B€ÏÎ~ÒWçK8kDdþÖ¿Ägˆb›:±xáÎÖ’×g"ïwPõ'éLTû>Šá!òWie_kÇL­~ñ™(’²JFÝÇŒ$E[Æ…ßçnÏ{ãó¬ÁAj4YCÙÆ½¥ o‰ [2:P9}™bãè¹�GvËOß N,ø`Eöˆ`5Œle‰¬)¾aˆzÖ!–Qd߀Nb8§àŠxâ1!BïXñ­Z¬“Z!}­0” 6kÓ�ƒŸ_¹¯ß’vÊ?®pêúüWªF„*\|$Îé?ùèÅû«óDÉøÖÐCjј…¥ÛRi6�“�ݺ K–s¡Ž”ÉO8@�M¥qá@iË V¼µP²M¡#xòŸ]Œ½]Œz›ŽŸþ46÷å­«ŸŒŒˆ¬ÑÖq¤Ð h�’¹NZiÀºI/MËrÍÄÙý`Ùð@×-.¹ÎÞ ˜)5@”‰­ذd.þŠ ó%Üui dVS‹†ÿ‚}ÈVB&€>sß°öÈ™�Öæ¹ÏKGþ´|+–ŸÑ¬Y13:]}þQ«…b`‰ÓæXªçØŠw�¾é'i­:¦üÞ?¤.ÁÎ�l‹;l�nÖ®­u‰t¼Iu»ÔïÖ°ßM`TÓ>·¦½nÍûÜZö»éö¸éöŽh>8²á«AuñÎMÉvDÁ¡‹§øN'XƒBšv¬MýäÏ¢¬³ ¨ý(7h?vÓgò�;l½º†%^=_“3¡}Š×+øæ·)Eÿ�ÊΡ;Ô!Ù [‰øËÞX Ù$¬í4'§£T¸E¥™îœùX×µþpÙ¬u…ã#3a^l0@Ðóذ¤>R·Ù¬XMæÅÊüäí[ŽM½ð¬� —®ÕÐÆ‚SÜ-ß àk<`�)f°$®>ÒñárïXyáÅ?pP€Ï{ÕßúÇÝ>kh ‚Àso�Éí¶U¯t϶0B†¥XÍ>i&�¤á³È#Vöóc*>÷3^öZŠ2öz*cO·>nÆö§_ŠH)ûtSÙÄŹÃB MÕ�+à«¿(ë¿Ë5s¿H—”Ü0‰àzKè¢ükF1øZë`–ÎÙ˜;.2kÌ>€†˜u]`Çä”͈Ö$IÏ7›óÊ=»à�ÑhzHH&ÜŽÅ,š¹¡pì¼ _µ= /!ÃKÔõAþ’7?WE&dâëÜÆÓšCoMâiõ;4à«®v(ý’ïö≋sBºrŽÏÖ`Pf+]To.’Fî�4q|6)ÏØóv–ÿ>dEáÕÓnÞ¨Y¾§|Jlž[¸ÆÁGL3á³§Ô† ½hÆÏ“{ƨ*®7vPðÙTïàLÁìgÙâSÞžÚÛue;𤳇Æ7íqmL²«ÝA„âz/2[ë’lt)_¹Öt¯>úNUê'�Þ�„>•b?¸T'ñ­û>‘ùW‹9�O|T{â½æc¯4í¢OqÔ'0 q4ÜwÇgC¢�!e@í¡wï«WbµW°ž¶€—¿ [>Ù“¨ølF„ç«4‚yƒŸ})4¡ð­å¬ä +àÆ†Îuƒäï-”¬NÑà,¤Úc¾Ó?T|àÊuË!$pvô‘Óàê$ÄgPû¾r÷p™ÇÕùÛz¤¹õô÷š(ÅS1Û¢-ñk]¾]µzoá§krÇDÈ�|%àÈR�ûŸH‡Ì•¿µXö¥ê‰�ˆ×3ta[RO{m)™´0c Ðí9k•¯á˜çñ Kòè³Zy@‡:K€{>Иbð8î!’YQ²K÷;;Mï¢8›ß³Ñ dO1}!ú‹®KÍ»:?¹ôÓõE¯.Ê€™GüÕö\ÅŽ`\„jÊJmØŽ¬³×Ÿ´“*4å½ôVÙñÿaZ«Ê–5G+>^“3&Bë•2ÐøÝ8"gùð`ù‡KE⢟[-½§žaÛ·�ÂÕuD,žùEé˜È '�&|ä…žêÄ‘Ž VN^�±…¾ƒx#¦åß¿ÜþŸÑÚÌÔ³ãd™ç¦Âñ r�Á@ØŸå¶å� Í—Ê6Í53˜Ó‹ˆÏf/#œéüo SÊÞ_�;< Ì-ðÙŽ)qñ•Lœ'ó]§¼ñ˜Â·ƒQ‘Ƭ�沟e õ÷®†ÚŸ´õ9Ë©´[—äØ�HoL µ ˆ&=œi†xû¦¤M»GŽMªNûø¡b~uYró�,¸ùÿØûîð¨Š6Þdw³©j t ØEEQQ)I¶¥÷z€š¢©ôR6Û{zB:M° 6)RÓ³5=Ùsgæìž=» ~âýë>ÜóŒ¸-sæÌ¼ó{˼E÷Öqëº_Ô_ì¸ZÔP“úH¹´U0O}t𿀇.Ý¥c§Cû .‡£øj[†[Û±W¥!}׋±þö~3ÛzâÙ$I)ÄLXí@2Å>9>¤ŠG‘¤óOl+›¶L ÀŠÎBøÌ0áóÈ ñ›1¼Tþ)F¸Ù˜—#ˆø¾{°ô›ë;O¼wbTh¾#[DaçÁŠ“Þ0° ¨ºÏÇJ}?•ÝhÁm&ýfD&#™…,�nÍ“ð{y,«èÛÈ”Ê×W•Œ˜&¦úˆ™Á4 žK€pÜ"Ñœ$ù�¢+x˜*X”‡mý�žùhcÕ³‹TÃD46Šncf[ò)©Ï'{ ÷þ¸�Tl+·ärLZåœÄò‰‘ùs€¢áä+$š£š±Rº*µèn!Z:H8>Ÿÿ­aõ!Xš||¤ÊfÞFµ`|E׉Íóˆ�ÏY#¬ùánÏ“RÁ)Ifõ—¿šVì)›µ®È3Bâì/0y¡ã©äXü±Á¢7W)—]ë1Ñ�•2aÅäÉ$`Kì¦ùßdÀ6ì/þpC1`n~Bš9ü“Â�:ù*=ÂUﮕf_ ŸŸ¾Ëh™:#:¯É*¼‘rö†™õG=Dñ83D£‚¥¯.Dm‘5tBSщO“µµl˜õ�`']XÓ¯�§Ò[åþºÌi-õ»èmÈÅyÄá<ìµ)NÚŒašý“š³fÝ´wküëyÏû;à¡$ÖÛ�×=oûÔà«þ[Õ'>m‘ø¶Y¿wTGŠSûN�ÏêTjËn·–ÃÏ6 æ.fbýz2U£ì‘lgÓ¢E’qzð'~bóìé>ÒÁjËÞŸ<#(0eÞ`À,î4¶À×ËѹGKÕ™tzÍÕ¬ú­Q/B·OyaÞú‚ç–”º+`>^€Ï ³(><:Kä$yy¹$z«\‹™mƒFòÃ�†iõèÖ �^Àü™÷ôŸfžôù¼â¹¥%ÐÊÊBÉͼàÉ �ÅwN]&d&½r¿e˜„HòÇ]]üÁÓsÖ×LŠT ñÅ�oÙx2<¿†¢¡~Ü}§º8ÛjF丼Ž:úÃÔm‘3G<.Düîj)·úš9o¹ÍŠ’…àd¨’ÿg!Û>TÂf�èlð¶Šéqec#a­@:‡çÈá»Éž�Qy%©Ê¿7‹ÐdZ@KFx„WþÝíØ]µo¯)®te ¡}Æ;ÏŽ] ò� Ï^ÅÿîzkÉ¿ñIšåAú‘A¸öû›‘;‹^‹SŽŠ’;H •Œ%�Évæ81ùcC…o®K¾®ïˆ�>ŸÍë:@#±i=hÝcwÈf­Í÷ˆP:£º&|fŠ�}åž…%ÈK¾þìž›7ÖS}™X[{?–Ì;‹2#¸‹|ùö,<`ŸGó¸0EcB¥3–‹ÖfàyY-ôjBšÇ¡’uëHRñÀýûtêdÚkÔy³ÕÇ«w¹Â€>vÝ‘BiÛf§K¦ëR�ÛR]ÛMläκ[¸¤ûN%¬<'zˆ"­¦ÞðұЉ¢ë×b-?Þ¯ØÖ*bè?£ßí®Kq0¤P4;í iè±ۥùÐ8µèƒæ³i˜QCæ3ÛZ-µ&S8cÄ¿´Hañé ‰tË~E²þhÍÇëó'E ]üøT¼*Ìv.£2¥.¾ÂÉ!Ùâo;êQˆ��õ�híè=f* ~ö·¿¼Tæ*q…¡ýx^,*-"Ÿ'ý2»º�¨ ez"òj“§ÊæSËÃXàWþºh÷©™ñ%žÐ`"b!L 1ŸëÀ»ú‰=Âeolj?Ë<¡7Wî3b_ÿú`従³+=Ãån¾óy(Ì�ª¾Š\ý$B²ënbËnL Ï!s m‚â§èíÂ� ”¼µR¹éX’Ƀσ,„nKøØ0ìæ£ö‡jærâ¹åÃBÄŽ,XhƉ-*{y™"t{ᥛÚR•[ðÛh[xf¤òŸÂRNN_…lì0ן�ýR²8|×Ý_8}qÖ_K5ÉþÿÔp×n@G .xo�O�U¹*Ø SþC/žd”¢QüW£ŽWÿÞ£'X|¿mWäÙyÜíúÌ·+ýþ¾ï&éËKUÃå`E`Òi.t:‚îî² ‘% ’”ÿh°ò®Ç0ãÜ4ÿo_0A³Ñ ïÿ,ëÌüMUÏ,V¡Ì�æðXŸ<¡ K<.Lñnœd—ø\‡uÕ¶ÿ|6šà´k»Õzz—NÊÒ{A³o„z]“joH¶M :�®OvÔ¤¸LhÎyç–*k>�õµ‡Ø–¾IäbBÖ£î½}¦±`¥.{†áÀXMª³>…ªÙ�NS©Ú½ÎšCžZÁœæSÉX¿ÚHô5È^üGp6Úî_Œ ×V ÿÄÔF†|0ù__k^¹¯vnRáĘq…áãidö>°ÒpÿÜçƒ�ÌŠ=2ufØa̗¸49P-“ö¬ß_œ¸·`M†bY²8ò ~Ð'yœ$î‚5ÜÙËó^Y,œ%u DEè¼rìæBã7?ù˜ù{kĹÅßw[²•ÚLFŒq>[``Ô͇úÏs¾òù¢ö¥•ÅÃEŽœ<˜–&pÐ7?Ѥ©÷Ù©Ÿö˜¼(;ÿÇâÝuo®-&‚%HzÈ7&¦fòK"ys)ï~vùïÞdÓ–©Æ„IÚÓ|Å–È�!ð”¾[à»QüÈ@J½H>°¼$?�šmà§`NŠÎÝŒro|Ѹ(ùÐ1�‘çÌÂgYR0;^º�[×nr‡D'ÞuôÁaœ­µS—äı¾{˜_VïšŸå —ˆŸ‹à–]íüæÏ¶+·Ô¿ÝÕþùP³Þp«Ápûµ[úÛ�†[õ†ë÷µ¿ÝÓþt¯ãÌ�ö˜´’Ë%ãÂä.¾J*SŽH`ÂL¡>†4;ü)»ÈøŒê_ÀJv¬«˜¥„Îl >C×D6ÀgÙÜx™¤æ«ì³ü9AÌdz#“¹>ü°ävõ§ZJ׸s:ö�×g¸¶¦;´¤Úk‘Ù¹%ÕN�AÕî¤wîm8üòaöà flC%³û1«w¦öb]�šêR´¢ùíGŸÑ¤Ñ¤ÑÚRh-;(êTGmÚÃþIzîû-uŸ[‰=hËk¬˜ŽeÉxkqGÁÌxMïÿKEÍ,uÁ“‚¯oGgœ~'¾eÞ@‰nLùuaŽ �8±rGñFfO‰â½ºB:}¹è�5Ê÷ ¤¿—Tøn‚jæZéqâW– §.L‰âOç�ÎÄsaå9°ùo.�-¢1…v r©ðhX2>R>/QRõÝmB³6Ï1Ö4ØZ‘¥¨ýi鮪wÖ•��V¸úñ¡rA@ äºúËF‹¦¯T.N)jé1§ÐGøœ[ô]Xjõ«q0rÊŽOYŒò�À¼:⩱JÿÏTZ¤$®ýhCñë¢C%@š¥H`*i¶à¹Eùó“äÅßÝî �Éd:€š,œÖŠ,¬¾ãlêÀ¶¯eo«œ¶ªtx€ÈÍWäÀä;2ù#B$¯¯”l_¹Cøô°˜ïØÒÞÿ鱓ó>­™d$!ÍWT )ÌÏ¥±dÐÉ�-ê/x~ÆÒ¯òÐmEKÒOÄí­Z³¯ûOmíþðËÕ{kWØVÈÚ$[¸IõÊþøp™[€Ì�#ƒÑ|Ф™…}rQÑÙ¹C|3'†kon/àÓüð­…ËÒ«Ví­Yk‚V½æPÕÚCUñ YªÐÖÄ£OÀ¨âöV/˨ŒØQÌÚ,ý0Iüú2ÙÄpðr Çg&ÔÓaêÚñ ±Åa[ 5=V¼�DDO×e†Uø¢eF“ùÞºÊq0´†\‘ñÙ�#ŸÚ®ºxÏ"AYᳩÏ�Ï6{ ënzøMžZÓ™ùjçî‘úTÇÖZs2 ?Ñ&Ûµ¤Û5¦RÛw¹höŒkÎñîÿ!ëkEæ‹~ë­O,è@I¨^:Ýå<­2ÈpüEí®ášt'uªCëNª&ÅQ›<´}ÿ³zî|í¹}fùùñÙ ¥­ï…É� aþ‰iž¬ bE`•YúsPÊÙ×W•�’9²aòO"óJíÏwh^YŽ~|·ñP_þˆ ÙØˆ‚±!ò±Qc#òQ=8ÙÈp‰{°HË.ðHKàÆÉsð>ML�ªcˆüÓ ¤êæ/š¼HÁùTyå¯6k¶" Ÿ¶Ì1nÓ;ð·Õw~‘U뷵셥ªá¡ :*STx [Bõ¸úŠ'Fˆ>Š—ŠNÝÂÕ4|! }Xj^�)«^�eÞ™Ò¬1xŽáè0ñôUÊ-yßt"Pu¹~ÑÎÒ9«S"en�v.•%pbó=‚¥³V«âTh,6:óŠ˜ tü$¿"Aª™ŒøéjÕ…ÛÑ©•o'VNˆ‚©KhLž³¿Ø•ß!X°±`Ÿâ€¸r«^aöÈ݆c§ßßP9a±ÊÕ_@e£êósÜü”vóòì¼Ä%�#$Ë÷LlþË+K€B1+±böºŠw×Uþ�¶±æ�„Ê™k«Þ^[5}UÉ KTãB#CD°˜GO™D¡´ñ½À¤ñ‡I\9Ü‘ÁðPÓ–¿²ܱræºÊwÖWÍÞX9{cùì�e¦¶þÄìõ•¨�˜½¡lö†òÙëªf%V¿WúZ\ÙóKUãÂE#ƒ¥®~2¦”ÎQÒ¼Å&|†'¹¼‘Áâ7V•$ì¯í$'Ö¶’þž®ËôĈ4­Ö\¼›V13áСó? Ÿi áP_ÉäE^Iòoi-é_,m%TüO|ƬÄè^¬õÚúT�˜Ó~øÙöô!ÚdZ ñÓ£í¦Tûæ]tÝžám™o?,Þ„nb}ÝV=[D£Ñ.øÆú=× ´EQú¬7ô{GkS�P)Š.™Öž1LwàùV>³ë'fÔö›—lôY›Q[=–Õ#[Ô{+ë®þoðÙЃí|ÍÜvzêÒâa�'V…aqc@"´:ü³¸tX®¬º.udŠ�ÙR'¶Ä‰#uâˆÙbT�&‹6•„óæÂlù(¬Ãž#²C�öÞ| yHœºD²Eõ@M R°e�¶2'™•á¿%«ûméžÚwã &EÉ]ý$T¶Èˆj^94@]ш`Ùk+áŸKïé±n‚ãaX½Û|¬zþ§ÅS–åxËäQ¡³‡ÈRŒ BüÎZ±àL¬×gÄZ:±mÇ*B¶W¾´,L„܉•ÐÒÁW0Ô_8%JàµQYó YÙOpw «ÉŸÇŠ#£¿Dó°µwãQq?uI!à‰àvT.¤G _]‘¿(¹¸QO&Y Âãs ˜Ñ�7êã×ÂÌHÑJg_…-‚¥ÁÀ².È£û@³›œÎl4ÏÅW8$P<"D:: p^¹umÖÇ´p¹ç⢱…ÁʲaÁRÀ»9“ç¹)Æ%Gò�ùó)ÞbÊB¾ýÇ\GŽÌ‘%v ��ŽˆRyD*ÆšûD•aa®$˜)Jî3/Y¾ Ï÷ /ðQŽ Q ໜýÄ4ò5Zž—Ù7ø0cŒŸ`l„dN|ñnÙ](u‰õ¶³š­§ä2‰xf­SXq12ùÄk0ó†šñÃAÜþÌó—>·HÅ\/}¨%Ÿ Ø0Ñ7fMà 3oe’E²«ëÖéæÊõjÞúýžÚtgM2tQÖ'SôÐEÙ®9�Ú¶Ï¥uŸg½€iø­ëÓ›!Ùh ‡ÖøluÎ×ßÞ}-_[©Íš®ßç¡MqÔí´ïH…Úwo>øÒ#qv»3Ì~cÖú¬ œÛÀÖ�< Ë(¬ÙJãø×«…�Û éû$ë̼Ïj§,Êâ/td¢ZE¦ÒÕDƒM�iïu ڙ轶€OgK(ÐŒ³ƒ=‚7"�L·€k·€GåÈQFå\–òF‡K^[‘¿4µ¤} €™±ÂdÒk”9³ó‹Ü³Ì­Õ¯®(¢� CåùÇá Q€tü"ÕœxIVñ$«~è¼ñ°kýÑ“ï¯/œ£pñ‡•P…¨)˜ŠDÃüÒU?7u#¥ `ïÉ‹·Vìªzoý‰É‹ÃÂ`%Yü’7>\øÆ*åŠ]eÚ¬·ßH:‡²Ñ¬ŸaP|¶0&¸º=FìHá;O½²¢pD0`|êÂlW_ÁÈ é”EE>› ¾¾ÚÐ;ŸÍT¾:ûãíå{+f®/ «ˆ))²±#+ÓÂ<º7׉Á¥3ré(¢થ,ìÿÎ/ °02À©Å޾RG?9�zÀµ½ò&X¼ÜÎKn·/¿"±ó’Ú³d°À®¯ˆÎá:ú œüx·@­Â‚+àæoÊe ¾rãH]YrG†È@Z rP ¾Ö›öâ›ÂggÁ„ñ‡ñJé©;ÝÄüXvÌS‰Ï¦ÿñ0Ï=¢º ?.É"Š»Ä]P¦G ØH¦Å*£·µ÷“DæÁNĈ¾mðÙhCÑÄ/úÛ5?JÕÅÑêœ74Gµd8¶¥Âb¯”.C½Ó^›JkÛ=T�õâmE,ÖqÏdÖ0ÛI¬¸¬D“Eé~ƒöJžº0@süeÝžúºn¥=•í{F>:>óaÙ§˜æwÌØE’p¬yŠ¥g|¶ŒÉøl=(¢«ÿ¤®¡žÀb]¿§^wôä{›*` P6ŸÆÌA¡ÍˆÎ¨›±¦È#Èœ|' Ýðœyž‘Es’ �}Ov‘˜‚e~ Nÿ¶8£òÍÄRx¬€ª±{Aá™ÆF9‹æ:.üá”± …‹¢íi�'ÿq�Kñɤs É®>L‘Í5WW‡a>¦rWÈJŸ—Þ²p#À&À¿|{fŽ=;Çž•Maqa–~†ð}Xþ€çÀàRX9èsHuðCo±ƒ·4CB…Õñ•fÙyçdIF¤"�÷IQ¢ùñ’3W5=Ösÿ4ã3Ž€`Z»°-™•Þ›‹žY¬ Fþ´f|fæÑÙ"�`éqù�œD‘DQãñøLÚ¿èk[AàF¬O×úõa­œ¥Éœ¦Ù?¬9á9Å^»�b؉ËÏöíôæŒ�rÞÖ|·3jI`@ê‰ Š6ºeÔèi«?“¡–{i�=§ÍpoO¥kAÿ©4í.7õÁ MRvÃ×Ù¸Y›°kXá3fõȤ§¶Ú¿F2Û7â¡Àýä±Y†ö 3IY~»¿j_Õ;ëJÇG+]ýD„©¹®\.^�fÚre¢`Šì¼ràÑ�éȵ7×!BŠ-®(AUÚ„Ï0Vš 1Ð[àäÇ-~?!?§âzi,�Ãgòx‰çFÆÕŽm9µœ­/,- uòWõÙŽ-µƒuá@Μ´Höþºü4É·æÒi&Ø„õR/ü•^3#¾Ð#\êäk˜ ’úÀÓL÷ ÙKK¥¡[$(%¾0Dñ†vÝÑÓÞ_TM[¢¡pr›;„Í⋱ÖAÝÏͤƒBlI$lÍ—ÉËa½‡LkåŽaÙžê9ëJÇ€q¢ !T ôúŠFEL_­Z³+ß@¤ã°š6Sf¤£ªo#Sk€r1â³È~!Ì&-D™£ #4DWô‰¹2Ô¿üzÈdS9v^Ù¸k"t¸ ٜ͑> XŽÐ\CÓ;¿ýÞa,nLÃk xãe^ópxÇÃ9ñú°&�ÇiÌ‹‹Ê¦àßæ�ûRa–BXuÝêw¼!ÁâiK%þ›¤¿>èë5Ï&!ûXMùÓtáÄd•[Í=�V}¼±hB´Âlyüx-.…Åê‰g˜tVœâXéU<’ˆdTÅ;²ÁgÌ CmÞZ6· ÃÝÍÍuÉâyº#SÔ»‡´dÐ ÃÆNºvÅ÷QÔÉŽm§Üç-„ÙG�:£Ñl&Áž­„C¶3@ÿ�n¬ùzCå§ZÑûº ®úTºa·[SšK˾1ºœ×ëó—õ×_� ÷H’/YZ"³ #ùI>&±#Äù¾î¾ž.ÑÖ¼ã?Ò�rÈÓìê’ݨ~k¸ÊÙWFñB%NB±ÄÞ똄ß,X•ÌTFÙ\EnÃLÐ(Œ,¸I!öŠ) …ÈD� ·tŸ6•�C[)üBÎüq‹„%ÉK¾¯ï1�Å2;¤W„u€lÒÁþP\ý㊽µ³V«&E«\ýd0ÑK¤2 K@燇Œ•m‘ÿpÛЇY¦ÇçœòŸCÓO¾º2t¸œî'³÷âÓ|xtˆ99tVÞÈ`é›qʤ}e:sì ®ht1iÕÏKvW¿ûiÕäØ÷` nó†r`~?�0髊6çÿðwwî™lÁh &�éÜBÖ4NxŸ»Ý†­9P9'±`l„, «´{ •L[&ß*»«%J’¶òÆ‚cjÞiß/*`nŠ@‰£¯r[˜6沃y­¹Ô ¬‡ë%¤2¥ÈVÌû·ÿÂz4xrìÏÜZ3u‰Ê¦ ’Ù3DHÌË¢±r�áŠw×(÷I¿é$ÕŒèGÁ}Í,]ôUprÕŒ„Ò ‹óÝDÎ,¾£ß-Há–ÿæ*eøÉ…ê.R¢ ã@fð™øþ n]ß�Åï/}/)\”ÂÕWT{{d½$x&VÈüDtånWyÆÌ7�©0Ôý[2k›+žYT4ÄO�ëPÁ2¨)À,©B;x\ȃ>b»˜:õ‰ÐVÂj8° #Cl�ŽíØÈmƒen “ñyÁ*3›>\� �xíægS¼rPãR¢š�0•+4}˜J@z™ïåƒÌÈ͵óÎE”)¦à5mpá¡'‰å^|Üýfd¸ä­UâÄÝ„~1`�<­øŒ4Á3¿Ô¯ÜWûNB�g¤Ü” Í\–9ÿü¬>$ç¯iúŒIh$i}$ ´úÈjóÚÈ (ÊO¯¥æËÞ{ûÇ·§¹è“Qm<“óNª.™jHsm>ôÒ_‚hLsŌϠ#ɦF¢o+ÑÚØ�5~ß\µY“·°óÀsíÃõi.{]Õ»Gê�<ÓÈ÷º]‘‚uÝÇú:Hˆ$<5?‰í.µh¾„Ä…Ø�Õ;š;îýÔY­¿KkÂgÌ2[ƒÌÓ¿Y,3>ëz±4^�ïÖÒ©Ë Üƒäl ЂípAs`‰ñKí½¥öLÅGBa`cÂÒ„�^ò(Œ< fS€ºº@D÷‘Ñ¡W­j¦¸W•^pÙ„ÏHrÝóÙ¾ÿ&áßZRXÇ <Ë<ýVç²&ß3AùåÅU³Ë€ð 4/XžÃžë³áyd¨ø…%Òà­ª‹4õZ&Óôà-íÆO2kç}râÙ˜ü!~2SfÏ””Ê�Ãâ½g¤ò£…¢î·bæé†Žý�:¿Ì=¸­ì�µEã#åCCUN¾b±{¨x|”hÖZyÈŠ—´“+q“WÝ|ˆ`kå°¢Óê´õaIŠßKRŽ‹T9³eT)²¯æ¸æ>#X°AZýS“>›Ç fé׿ÕëWÌßX:!JåÂæSÙTÇ$�º0‡º ‰¬`¡sÁÞtdŠé€C1þueX& rgH©�%¶ŸŸC÷á;xC·j(Qã–L¦©ì žÉÕÒÈœcï͇¹ R K‚d]ž#‡ÎÈrš‹×Áỡʚn‡ ŲøÐÍ΢qrØ\ܬïÂÄïÁ?%�‰‹#¥³ãÅ»ù'-�ðQƲOÛ…ÓŒwøêÆâ]u3‹G‡Š�ˆà,¤ÁbÐÒ©‹Åœõ¼?Éù„m§là‡ƒà³é%ñ-èÏð ¹æËNáG�&u¤¹µÃÊÚ¦T¢¨Ê¶ƒ>Õ¹ùЋ·ÅK0í¯XŸÁìEîn ú™±¡¿ë¸Óz~O›Ü¿#{FÇžñ�»GjÒ‡µí«ç¾Ú,Xð°üL}%Õ'‚!ˆ-ný„–ýHg’Ä…À¹Óßo¹Zg¸z¢óÎE¬¯Ý‚ù6{ò?-è딲ª›K§DˇIÁê€-FCt��XRªo¾+ß‘)(OöýQ âëèl]ìÆõ“Cw;¦ÈÑWì ¥²yxºN >Cÿ:À|÷ñKKùK¶K4}Ö¶Sòk2>[X$®K`¿ÝÕm9~’½µzÚŠÒá�:S€<øxŠ9W?þ¤E’÷•ŸgÖtô£ìÛft6šdoݺ£µïm811JéÊ‘QäÈ¥0r¨,®‹/oB´Òkƒò«ŸôšÑ•`¸øqùϦώUn+}#¾tBlÑð© ›ëÂÎvŒ�”ÌX­òýTvPy¡Á€u“¢oÈb‰í[!+Ùr3Úõc•ÎMR��Êwká#†Ì‘‘ëâ—31:oÞyþ7w{É\Þü fFºú`õ�Š9‰HF �RP)  92 æÀ*Ø^@Ô”€íéÄâ!ЍÍúoP��9b'¹›çÈÌue ¼@ÏÈ2f²d"|FñM8>£‚S¦È)@åÄ–8s$¨Ø«ÀÅ/ÏÍ/wˆ/hyÐm•5ÜKÕŠEŸ8ùñýrèœl3›�¤‘­ƒ(ÞíŇ“ãÃsöxFË?\'W]1ç}úÿø /œˆQÕŒ+!ɵ¯¯)"D•FMiÏñà,÷ É+KE‘[xHY…%w†ÙP/!Ùl`â÷HźëëRÚÅ ‡žkO¦O¦™RÕ%Ûé`¡@]šsËÁçÿÇ`ꟈüŸ¶ 6IxÃG÷yÖy»ùBf“2Z�3 rÝ;¶ã�§úÀ-wF“2änM f¸«ŸûÍàlµoÈ38›‡�2F÷AÙ^}½õ’¤õ|fËÖ|ëï" òIë¿@´ùá~»«ß€‚ã&D!�Oeå1 ?Ôîà«pñ•�ô—{KÇFˆÆF‰=£¥°Eáµ;¡oê„(Å„¹g¨xl¸dL”jd¨Ü=Pî¨pàðaaeo‹·•=,š#"~{µhGvUiŠÁg‹4hž„®íFìXá…Ø]uo'”Œ‹Êwõ•‚-OgÀšàï\:‡?èU7|µ_£àh�½¬Û5R—â ƒyê̵“©º §æÏÞã…b�ßÕœI¦BóÆD =úZþùð«ƒ%Ë5‚íÙÓ5Ç_j:þrsÎŒf)çAaœú2ë¼ Á¹�¨wD²™šŸdà€­l;øÿú{a¦æŸž;ª­ý¢­z[ë*äÒK`¾4¬ŽÿýjÁð9µqÕ¾Ú9IÅPÊòƒÁwN~"»yYTŸ qó‡5�_�Ê�³4gîêÜò>J|”$ü(QòQ¢ôãé¼xÉüxá¼xÞ¼DþÇIÂwÖˆ¦¯’L]š?:ü-ŸÎγ·8éñ€¢êä'.}/A",¿l²£,£³EPeÆ«˜|×þ„EÒŸ.×÷áG –ÆÏCk.þ›VñÖš’±ár'ŽŒÊ΋GEi0X÷é‹KóC>—µt‘Üò 5c+èç‡?›¿Ì=‘\1ï“’×V&%óŒ,*$ð5-VùABaØ–‚-G*¿ú¹^ÝmªÖÔGŽÆ"-¡…+‘ì` IûK?L*òŒÈwËP¼¸t&ß9³~/IÁ¯ý£‡˜*bÏ e•^ ‚ìE€cº°¥”…ȃ‚‘kÏÌr Cƒy¨lZ÷Íe¼9 ò9‰Ê¹I°Në¿oó’&ÊæÄKÞ\)zn±`\¸xX�äøŠã§É&|fæ8ûe{„ðƇñ^Z"zs•äÝDù{ ²×ÌE÷EMÛ:¹PìGxeØùGñ…s×¼»FpcjŒpJŒbX�‰)¡2PÍÁ…è^ È€è>@ü“NY¬ðÞ$þõo]?Aî¶›ä©Ãg‚B´=0êsÍ”XÅ�`˜7€(‹žÃàYÙì5Ò½²óÖøLÚ T‚ÏÄÞ%‰¤ùïӫെ¶å¾¡Þ?Z�î¨NµÇkmãþštÇæý“ä,ÄnBÄL97LÝ�TP4ª>hÓènìùûL󹽚ÊD�2@/œ«åÎTóç4I™�Šãž9ÐSÿ3pSâ;˾3ohKw$ø±B!Ó…D{°þÖî¿Ï6�JQ—­lU-j­Ûilú3¶#åÞ¼�-�aD÷O¸` »‚sEeÔÎH(õˆT9ù¢ü“fÓÙbêÂç@¾G´púŠìÓ×».ÿ©¹r«í§ÛêŸnk¾­ûéNûÏ·Û¾ÕþË-ݯw´¿ÜjûõoõåÛmßÝ4|{;VyfLî„(æA׆iõ©@fó—Œ�V|œ$>yùvo?iM ÓŽõBD€ÛTÕ=Ø.É™À�'^_]<&Ré ¦C¯¿<;o!…#¥ûІ _X¦Ü¢:uù~/féÌÌh!HŠ+.Gì(}Eјp�Í·‡VY>�¢íæÑ9â‘aò×Vä¯ÝWÑaŽ;#‰Ï–—¸|{§¹ç¨êÛ廫8[«ßY[üêò¢I‘Šñ‹ ÁØÆ-RL[¡z}…lÞ†‚À-ùë×(ÎÞü«ÙTæÏ”)›l×"¨Æ›æÕF=$+ýýí”·�ˆkã¿ÛzÈS�á¬N%jmCZ›FoÝ7¶éøìž °Þf“ý™x +#`ÖÛÙÕr§å÷“-rÚNoo.]ÛR´¢QÛT÷ lƒæb&öðÖÛOñŒ–$† Ü<:Sß6øL–¡Á;hBéºt¿•6ÖmÓE蜶âeÚË(C9Gš-»zìšXÏšÕçà[ûHÑå ´S¯®-R�ðYDõ‘P¼E€òÝrž�á.Ý[®!%Ÿì#5S5j£és<ɤ¶+¿ÐìµV85Jóâù7�g•%t MŽÍgn–ýz»�ð&qšAð™Ð@ÿuWî®ØsâƒOË'Å(†ŠXÐ :wùH¨L©«¿h|”øýuëUé{¬’Àçv ËàÕ†l¯x!6d  0ñ)—ýDN� �0éì„‚4Ù….‚Il�Ì»�È­íÁÎüÚø%÷ÌêýµìÏŠæn(y-®`ê² ãMY$viþ‹Ë ÞN,›÷iYÈŽ²„}'öJÏÕ]þûnswgŒï·]!˃Îÿ¬ïIØ[97©tl¸¦»÷Ѽù^g6Ôú?H’KÏÞ$á³il`Ešt}›³�ŒT9%¦hˆ¿ÂÉG l|ríÙ¹~"÷`ÙÔXÕú¬‹s‘Öó‹Ùðú­æ"­7z0¯M’i1‚�|˜Oý™%4–Ø5P29šç»‘߈’Óê͵_‰†÷ÖI* ÛEU—¹8l'Ê^ :IVýõB´xtˆ”ÎÌ£0sí9€ïäØys�táÂz„H^_]¸–¨:mËïM=m!T\üãáÚÕï$–zF¨9I¢Ã\ ƒçâ/.[�(=óãß½HC=˜·©¿Ç܆d°}ßßÕÿàbkÝ6µÔ§åàdÝn·ötºn;LËo€•íÛÓiêô¡ºc/=R-Ã:fdEÿïëéêÔ·ªÝh¹y±ùjuóeE÷yÏå4|'Ö]«ê~x ë|€õ¶Á#ø`XµJ6.Lúa¢\têF÷cÈÜÌRLÓŠÛLZ:°Ú+w’ùµq»‹#w–/X_ôáº3×”¿Wöêê’éñ%3×}´¹Äo{Ù’½Õ›sÏ-ú¡ôÜõ«·š[4�]=}ýýdÒ0�°¼ï¯·Åí®~7äR§˜Ä†ê% {‹‡pdÃe­S^xØmfq„l�d$Ã:(#�˜­rñ“PÐ/ž)°øŽ¾âQá²7ãäÇ*®w›á¿5œ)òøµ ßQøæ ÅØ0™+‡OÅ�Z, Ìè,ñ°åôe¢-™'t˜)Ñt?Ùùp@·—é7K¾?н®ª1ïMÊg¢ÅÃB�ú#B±„Ð;zq‡ú '„ ?HÈÏ«ù �}#Ó¿…RŸ¾ _h0ùÕþ\¶»â­5ÅJ'_©F’B|fÂ$íCÄ“#•>ëÄ@‚²q¯2w4ð#üc#éÛ�øL,A/¦¿Ûpæ@‹"È�ý’vÏ0m²ƒa'U³fæ@뺦¹h÷{>â3±[uX¿Î’éœx\¿ìëÄútXwÖñk¿‹u>Äzš cs¿3vš­¦e·¹‘DæÆæQͧ´0Ý’°6É~~=´ÍËðŸ1Úˆâ.ßUùΚÒ1¡*g¶ºÄ0ev^bGhdž‰?LU]ºeÉõ�YÖfp|6sm0ÂŽ~¬µ»Öˆ)Îß]”Z4{�ôù%ù#ÄÐ[�­€!-x`2ƒTƒ‘!ª7VæÇnW˜ŽwI‡»Vdú4â³��ÝͯõßZ3뢨(Äg¡=KˆgFza‰2j‡)u AŒ–žþŸ1+|&Q¥ã‘¡ ÷Á-•ŸëDóZNÖìÖœFÓ¦SÛ¶CtÛNŠ.ÝYŸæ¢>0ù~ÞÂŽ+ÙX_´r˜=emäS›ñ��ä‹´ÏÃg# oLõC´ïÕbÍ¿7}Ëm+]«—x·dM×d¿Ü–õr£`Á�ÒuXÓ%äólÒû13ZÆbµ1ͻ̟m·�ù °¯¿ýõ«wÖWxF+œý ‰ðY@ãˆÝü„ÓbDœB ±ü3>“?臸Ô÷Ùñ“ó7UNY\„*ŒYËÅÝ_�ý„ã"¥ï'¨øµH÷$‡4F+&Ô�j¥/ù>2­zf|Ÿ¨¢¡AV. _Y?ÍOì(.ù`}Ñ'G«t}D¹kÉ !IÕ¥{‹3jf&–x„IœØH‡&!rÞ่^]" Û,j ÇÛP œ‰O¬WÝ4½¸úß‹$Ìn¤ôÉe¤Ì*¾µD|Ьëû"ç´÷uÏÇ*ÝCd¾2{o8`wx�ä•%Ò°-²{z³‡ªY…3šÎ@ˆÚQ3}EÅØ ‰++—sY@ÿF´_‹‡~.yÔ‰ã3ÁŸä²l8«¥ßÜX²«zF\±G˜Ê‰#F¾|0WÝGèÂæMX$Y¸Qòã-u¯ù`ÔhµW§.#ž¯Ýª—U]Jž]–QÎø´`V|áÔ¥…£BΞíòQˆ ÐÑri°"¹lBTÁܤ‚œâKÖ©·Œûú.8Ÿ-�ØÇ*½?-šˆ Å;ÀHdß³g �Y¢±!²7âTŸdŸé ƒ+©“�Ó7Øt’ÚŸáç½XWcÓÙƒ…ᚬ×Úö�jÙåÜšBÑ!€Ò]tÍNº&}˜.ëÅâ ìvò^ë6-Ù‡Hª»‘¼Õ‰7f!j2 læñY$]cr éxÐñ{YcívuQtkîlݱ ǧ¶x^{|V½lQÇåX_›éä‘$ZO�q@#j·Í¯Œ7J¿úmqzå[ñeQr'ŽÏ`ç9p€”%zy¹dñ—2�Ñ\¿³þŸ5+0šA鬛SûÞºr¶ægÁgƒïâ'™-[�$¯ý¹¥Û8Øø-"´ißâ–�o~{˜p¤jþÕÏÅ RÒ9ª7—îç,Ì£x é¾²¡²WV)ý6K¾ºÚhʘA‚h‚5‚®øUWƒ“k^‹+"¢³a*6„ÏbðÔtT¨hæJQÒž"öX|6�Û,ü¶F±m0‚ ½#- �Ïàî¯=Š?„k7JWŽÈ‘¥°‡>¹N~y£Ãd3VÉãwê-Ñë¦NÀŒu¢ì‘~[˧.ÓÅwbgQ˜™([‘è³£ƒ³âDkÒU:ò‘ó?>ìcfÀôl`V¹e—ÃR«_YY€*AçÚûdA?¦´!�Âg—+™Ÿˆî묪€‘6Ä ä gü¾üÜïÛó¾ŽJ«üpCÁ[« Ƈ Ýý„NL±#Keï%†±Þ0? jg~¢‘‘ª—ãJ‚¶(» =ëŒ$ç«[˜ÿ{Ê.8Ÿ·›z7®ùpCÑ„E ·1•‘gÂgo8‡ÎL±gˆä�5Š#å¿uY¡ú{£íB™>€–¬÷¡…ÌûÛ{nÖ5¯Õ ?֞ܶg¨:ÃA—b¯Ù SôÃZ®)T˜7cÏè¶Ü·ï©VöߪÆz‘U¹‡ìýdÞƒ–ÝEì,b˜…Ôg#yóqßæ.¬WÝ}÷ûGgµ”%èLuæë�ǧ´Û¶o\ë±·šê¯a]õœMéAL·!Ïf=ƒá³5MZãs7,°þuXò X`=Tâì 8)òŒbäÑ}#Õn9^ÝaÎ`iEÖÖøl4#~:·¯ú�¤ Ï%JÝ ñ™ê�çÀä ”?·Xæ»Iúãß]½˜õÜ EÚ·8L=Òa;óêv”¿¶ºÐ#\æ¤t`Š`ø9L\É£³%®þ’ñ‘²Ö«¶dV@AUˆ4*3Û†Ì4á׬/ë`0{ zgysQÎxrFë&ž³Z°WtÆüDä�?ŠQÚB´yþ­©ˆØf2à•_ŒL«š¾ºlL˜Ò•-¦1dv ×90Ï3Rþ^¼lŸô\×`øÜÚ�mɪX¸¹dJ¬jH €ÆÚëq€Ï†·cÂD$ˆÒùu�döI–X70«F,EpšùeÕÔîÁ"N�•k¿æµœtx¨äŕʰm ¢8/A̓ƒ3fÙÎ]ýØÕ…Å»ÏÌý¤â¹¥ò1¡bwX·—ê# ,ѼÅT6–£T0¨S"%®“gHÏw²šµîh!Û'×þß¿úÁnúá/u >•xFÉ]ü…”Zù¼¹PÃeŠ&†ÊÞO�^¬ï¶¥Šÿ�3äOüI¸Å'¾¿ë¸ßt>³MÞ‘ûzÛþ1º}.”‹C“n×’ ð™¢ÛIÓïvm98¶1ëݪeÝ׋°þ‡˜º1Ê6±Â¶ ,±ç-ŽFftØo€öä»ç›Ïl(KhT†4óæ´}ÞpÐS¿w”~ïè¶CÏ6‰˜ŸØ†éÿ„0Ž™{&ßΖ²™›ÿ‰ÚЗ¸Ká�ôÝV¥¬@±ÂgT} –Ÿ©œµVÎ=ñS—9GРøLî?®øöZlFåŒÄ �pJ‰ ñ™¤S–À=XþÒRYÔ²‡&QŠPCˆµ3¿B¯áy½ã�øqiFÍûIE“b¤CÂ%Œ*CˆêÍ )ó³é~‚áâ–ås>UüpCc.4l‚Jó„™FØÚŽmÎ<9ï³x(¦s„Hr@eS g‘Ð3\<7^¨ª»:€8Idj-9o­Ñ˜ÄÎmI–r¬|ðÛ­½›³k½7—>·H92PæÂ–P¼%ö>"‡ë$˜¼F W\¸eŠ_&ã3ø[”=òÃ�%¸ȨL1ŠáÑ|Ä®¾Ðÿü£õriÝÕ. ç%Ñ¿¼,“Œµ°O`¼Cõ”eC‚Ä4vž½/JôÁ8q„€¥ÎŒSnË=ßecÜxüÇÌKÖ¤ëßÊ=ÇÜ~ê¥U…£Â`2“4 6Ó½EŽ !Å+‹Â8îêÏê›7q‘rN‚ri²äFS—)·f†˜_=�ø ¶ç©+—îª�™X2&BæÙ÷ 2Ûyç Ê�-}>J±`ƒô«ºn˲‘œŸŸ-ú°e `•ؾ—*?Ó˼uǧjv�Ц:éS[vÚµ¦Átš�ö† uº›þЄ¦¬Yw¤‹ê¿:Œi®bý­&¯9““ï€}d;*2“ ‰HðŸ>ÌØM}ZÀ/ºnŸm:{´±8Q+óÕñfµe¿Ðzd¼îÀHÝžaú=#5‡¦4ó>¾S°k¼Ù„É1›0ÉZiÃ6³EÔcÀÙÒƒßÅ·?ͬõÚ\>9Z„IÀIñ>y.¾‚ñ1s“Uïö`ƒtnۯфÏ`æ•~‘ZùêªRèPÍ ÃAè ãFCòßZ©HHWYöŒ-ƒ>ÂÏšÏ_½¿îàI¯M/--$pôÍ¥ú `jS*i±k o|´ðýDešy,[æÇÔ1±z Ã;�펞zý‰ Q W”öÖÛ”÷ *P÷&DÉ®—ž¹r�\R|Ћtî€O lüñ\Û+ò2uæ¼üÒ�èŒòw 'F(†øC‰Ñ~¡€Ê9ø †…^\VöeÑï÷¤º¦W°¬ÕMüAÀÑJÇE:ûÉ) ©½�6Ž þpñÔ¥%ÌOTgðjæ¦|ò˼N€FoÕwn8zæý5¢U®"* ùá!{‘hLÏ.V27(OÝìÁ� 3Ãçãö¼i½þzdH:zzî'Õ“c”CB$4܈ͷóÊÚ“`L®“_ÞP?ÞäÅŠ·ãT[•ßýÑiñ*·¢ÜA%é§é‚t%®¹š\ûZ\ñ(XñÌB甸†æ•;<@ñâbk£àÏ6â|| œ ŽÏƒ"3ñÎ<Ñÿú±µúGYkY\oŽöÐäö}£ÔÉNÚ�NêÇ– ‡ÆT;Mª½>Õ¡-͵íÀ„–ìwïå² zcê_±¾˜æ¡ô[-4þ’$“…eüCsʬnè¼×ók¸Ôñ“¬©v{cÑòy –÷�áÈ Æ«÷�lÝ;T¿g¨aïýÁ M9ïÜ/XÝ{»V0’Ë�bFÒ DáÇÍ„Õx­lF´‹kÖÍI*™]àÊÐ}ø8>ÓY€�æMŽ-d|¢úé–Î,‘Ú³qàÈÀ/õ}(�É—ÃÓa¶FçÁlKy.~R §¿¿VµWpºË¢Ym{3³"ðü·Z»¿È®ößrbúò2ÏP•‹¯ìGhGÅý©¼óœüÅ#CE/®�„o•]{Ôßk5Ä >ÿt£1áPí»+ÆEBá¦UD‡ƒ€Dil�ý¦,R°?Uüñ ½ïÉÅ+ã 0È{ʶUÀ4jû°/xµ>_–½´L5:Faسðä?à‘ar¶·âòã÷VŒ8›#†{SÔ¯Úröê‰á*·z}]8gVΘÁôEÑ_–Üm5±HÌÂÅžìiqR‚„ôWsâá³ï&ULŒPõQ!8g;ú œX|�°ÂéËT‹¶©þxÔcãg2ø<=£yøþÚ£ÕêÞYWå)‡Éa`A« Š'rf >;ù‰ÜC¤¢T3ãKB¶*~êè·Då[ÈÖ‚Ï$®ð”]Fä[µƒwÎûóêçcUÃB`zܤ Eh&h¸Ã¯ÄH#·Éš{‰ó—�Ïf�Äzy,6yƒö`Ú›ç·Åêófµí™Ð¾{TûN·Öm´†»Æ ;mª½.Å^›LÓ¤:«wy¨LU{§‘P_òIÛ%A_ýe¬§ëoCÒl'´÷÷š=îPÃÌÞwð«nÈÝÐ.Äï®f¬éwÝÕ²úÓûŠ›ea­¼µÙÓõÇž××¹gDמ!štõn×Ö]ÃÕ‡žiË{ÿ�jy÷õrÒØkûüÖøl;/ÿˆÏ6àà¤'ª_²»îíøÒ1áJ–ˆÎÀ3Ìà R$Sc”Á_äãÕ!ÚT¬pÙÜ/´ka6¼…›Ë¦Ä ”ÂÐ$˜aŒ‡¤S ` ’”ŠêŸzl,Ÿ†Û‡|‰÷+Ï…§”Í\S4>¢ÐÍ_AcŠ¡¹Ì” ‰gÂI1ò÷ã…y'~´¨Ï�ÁgÐçW?ÞY¹¯r& ÇCåH`ZET¸{u½°¼(ðs;ó_vð ð;(]›~CXGÍ’6$ÐNýt+foÙ¬MeãÂ%C%T°�|P½rÜBd“c^‹²Ë~%ŸàÌyþfìîSï®),qbr©¾"*GL÷ÉÀ›#ù(1?]ðM—yæÍúë“>®iV!;øñï•ûjg%TLŠÌwcÃb»ì<'otˆô™¨|ƦÒ=¢3V…&­6ªíĘñFR|÷glzå[kËÆ ³ *#×�Í|€³ Sàæ+�?eYÑŒµ…¡_–ñ*~Õ™2"’M\�!²§ïêCÎQÛ ÞŽ/ƒéÄý„tÌÖŽ2Uæ=ב#ªš±R¶á@éÿ<'_V84¿ƒÏ8½ö\m¿¥éTšV`ȞѾw|_úðÞT'C:¥%Õ®i»]k²]GMŸLmOsêØ=¼}ÿ$ÍáWZŽÏi°ó×—¯7\>Þ³k½‚uÞÆzÁcľ&¬¿º|Àio ñîº3‹Ö_ìý³R÷=·©z{CñÚ&yd³À§9÷]MöšÃÏxö¸·¥º¶¦8iÓAsÓíñèÈšÚÄ}ÿoe\÷•X¯y;ÛZ¯ÍfÎ6 i08&¡+aÜ5ânêÕWCRª¡'C°ÌÇçyöL>�Íó—¼±Bµ"­´Ã”À³™c«;‘ðù�ú�‡*?ÚX -ŸP+‡É7ì™#oH èù{½øòõfÛ´Ï„‘U SœúeÙîï%N^¤(§sd–%Þ��h ¾«¿À׬5ª•»JÚ­óáÛ².øÈ(Âå—ØŒŠ7×ÀsFG˜–\ ñÙ â3<M�+Y‘q¢ƒ˜Ï'¸¬gý±È<ÀÄA2]õ#ï»z¶=¯Î{sÑ´åÃame…�»�A{¦ÅÂì|?Þé구«dÁcf_M©}3®`t°À9PD÷;ùІ†HÇŨÞX)�þRùíµ¢êŠÅ®ôdOk: „¤:õÓÒýµo¯«ðŒÈ uõ»°ù#‚EÏ/V¼ŸP³³ðÚ#ƒ%�œÍî1шÀƒˆN\ŠN¯|}u±G˜rˆŸÜha,¾[42¤`Tˆ|B¤ü•e…ó6Ǧ~}Ë€fÏ<#$K AÆÁïö”\`¥~½×ýq¼hÊbå°P��rkûðñì¯` 8²£C•ï®Q��¢óñAð™ äU&ÈÒú±>CÇÍS-uÛuŠà®¬7ÛÓÇu§1¤Ñu©”¶hˆnOµÓí°Óm§´'ÓôinÚôáÚ]£õû'è�LmË~£Y0¿^v¯põ½òÏïפÕu¨ùBvÛ¥¼Öï¹móÚ.pÏ{prßýªäG'¶4—¯Ó,ÕHýô¼¹¹3 ™Ó´'¶í÷hÝ=L³wxã'}:½s]»ÛI½k¨nï8í±éóÜ-IÄî�ÅzZñPò¾ÈxÊf+�Ít™‘p-!„4üÜ-UtŽñEå´å…î�2G†˜Î�ÀªpðL‡?>BüÞå.ñ²)A׃á³™Ú±Ÿn¶%¨ü`Cù¸¨|? [ƒøìÀâ¾¶TµU ¤S«d›–AÃw¸»ö‡{ k|6—M]R0"Dîè+¦°…v¨˜ŠÑ:±Å£ƒ%/Lj|7‰OýÒØcÎq÷ÌÏÊÿ:<¹üÕUù£a¸‡À%Äyé½¹Ðy#T2kma2þÔÿIžü'|¶üˆ„${±.²º?¢“ËßM(®€<މW6€AºˆÁ g®–­ÛS¢é%ÜÕˆ3dØ €Â4þ™à”º7Ö� •‘�Œ�MZš?}U¡ÿE‡ç;mÎ|Ÿ¢Í[ ¯¿ó]ìÞš™ ¥“¢U£B壂¤¢/ÅÊ� µ½¸ô›;(\Èh0�ÅgóTìÕí(y}MñÄEE#ƒóGøŠFI<ÂT“"¯,UdÛRüù‘Ú+·HÞ&íŒ8زE󭟶Ë«{¯ÅrÁNtòRa….^¡ ü‹sE@Oy?A®:ýGײïÙ€4¶HFl£9zÕêk5­5[2NgÖŒÎý5iCu©ôŽtªn§½f»�!Ù®3Å®}‡½zµ-ÙY“æ¦ß5L¿g˜vŸ‡öÈduæË­Ù3[¸´ò´ ¼š ëyó… ›„^¨ùÀ&ðná}Ü’ónÛñê£/©NjÛëѶk˜f�›n¯kK½%ÝA�AÓìvhÝå¬Þå®90E{ì�fIðƒº ¬å fTC‡ë¨ƒ�3†ÙPó€ýokAÁ àÿúŒXƒÎ¸áX͇›NLZ ¤SÕKˆgh¤²x.�âI‘B¯$…òìí̲ÿÿ Ÿ�&|¾ôgsÂÁÚ÷’ðÔ+|輫`�ü„c#ijWK·fŸ²6>“¬öFS”ô…ëÍ뎞b|^ùê²ü±!2g1‚sl ÆË–¹ûË_ˆ)˜/Ü/;­ï7§h°¡…áþ*Éyu°RÌå°`TS¥½…qˆÞ\á„ñÜÄ|Ažqè?ìàÇ ó`dæz‘qï—ïkJØS½`ý‰c >Ø5>›QÇÚòO–SÐ[c/�Nu×*Zj¿TË‚9oOÖd¸#�šfEŸl§ùÒN»ÓN›JÕ¦9µ¥Ð[vRÕɺ 'uš«n—{ûÞ‘†}º=cu{=û=Ûyjöyªx¶í‡MÚÁqšžê}š½#5{†ëö¸ëv»hÒ4i4M*ô^hw9¶ìrkÚ7J›õZw^½r©æÛLL3ðjHfA•Œ‡ÙüHVF�ÁàØú¯-Ó&ÿ—[­+÷VÎJ,õŒ’© |yA �É…Ï/³×‹¿¿a0{)Û2[|6ËÏßüÖ�pèÔìÄbÏ(•3 +He\ýE“£EÞ몳·»­Ê§šžÔh4%¸x£eÃÑ*ß/k_‹;1è˾"KhËäÁЇöÌ<‹ï ›¡x7N—^tOÓGøÔ‰©Öà7·õoάñÚ\:%F5$Pbª)ò\G&ßÕW¸Ò‚õªª+M=6sý¤D:迃üÐ2><ÉÒõû†ÏUm­yuiÉØ`¹GHeäA­a¡€Æ’•Á#DüÊ yØVå�fÓS‰2»“ÜoÔPœ_¶¯Ž¹¥ü½Ä‚¹Ê>^W¾½$~oÙñ‚KQ4èãøã>)¼q‹ÞÈ-þî³ãg¥Ö°?+do) ÞQº4£tŸô»«÷º�Ö;€@±ÿ…ÏF4»ÍÇò¿I)öû¼(h‹réîò¢ó'nhj·d'¶€±¥?+C§¿~ / ÿ-Þ–ïÆÜOeçA:7ã3¢œdc©ÞO�|÷{sÿÍ–‘ô‚`$|¶82ÙþØüO?<¼ëUën~Õ|*¹Eê¯Ï›£;üœz÷Èö½nÚTÇV€Ÿéö°’, ‡F¼iR)ºTª.…¦K¦ëR\ éC @ôÍpmMuÖ¥AÍU›æ¢ËpÖd80צ9jÓèØÕ;©Ú�õvØ èÌp1¤¹ê3F´¯É�þPès·t½þÏJ¬¯ÙT Ëš’lùa¡ikê&s& ­š­8Ÿù%:¥üµÕE£Â¤ŽT@–â9°�ú#xm•ɳšh©¾µ½ìô�ÙùßfðÏîÌ©:¨8Sþݵ?i»Q*“fYrò�6ãø|¯ASrê§Ãʯ¶sk¾ÈªÝ+ýºà̵Ë×›j{ñŒ£fojÒ–±rÓ4}eÙd|xú°º Ãæ.9âÊ3;ÅSjO–uK¼o&|”ÄО˜ÃÃg�n[­‚ƒW#VæºMÍj3"¥9¹UF6Àqa÷`÷¶v•:‰¤�zÈZVwû9Qœ´”~eÖ £,ëu…æ¼ñðµáËÖw•Ñ<0Åу§'غŠí]ÈÎm†¨&«®>4XÏnÊò`Pëøå`¢øuYËHÚ^,·÷œ”Ûfxvó¾)µ}¥v®ÑìÙ©äTôkìE’†~èà«|'§ì¹ð˜n— Þ<|Rqõ^ÙÉON^záNå�GLi¥ÍôH&4âÕ,Î:<)¯¼]üä�û·JÈÒÝ¢Ú uÿ÷5Œñÿ½GOŸü¯Ý{z­¸òöòɸŒÛ˜LÃULA{¡Š5èBñðÁLI¼rƒaÞì:Å®kdXü®1¨ZV.QVnì|ÅŸ¢ìDð44®öA²µ{¯•qmß ¢ki� †kx�õ¿ oõñÿ);#Uöâ�½ª›Yʼn Ò_•Fµ¾Ù¬xék÷Õº;‹Œl¥çÖ¸”ž[ãÁl²$¼d–uÉ,ÛR`ò,[²Û?ùžHö”.�i÷`¦í}@486s«’9V÷fXߟc[LfhÔ-YÔèáÒæ¥¿~X,ùÇ�us*Îm"{–Vòv(ðf3yŠ.g~m‚kÅ:dÂê¹’�¥y?„f´ê•PßKbïktSÚz¨j÷P¾Ù_Ý-"1kÛùr]�׆ų ]+!‚Ì临|øsó^IµE²šä°šŽZË�mVÓCZ¿‡âƒ!éÞãO^}ÄŸG¿ˆ]½W¾"iû ùkºF¬ùhhF“@Um™œÙ‘�®ÑÖÝÉ4³:~ªwû%´"½$çr ÝUÏ™ íœAâÙ“bötŸ•ß6(½qw…½K9ÉË…€¿öLŸ^ê¯GȈ7X^h��Fuÿé�¢�Ñ4(?!ìTj´óœ/Üz¼2eÇÀY�Çgÿyï�RÛSp¶£ÝOí{qoYË> ]ƨ¶Ÿ,Ò­\2‹Ïæ±ñØäÙà'žúytð•“�—™×»Î°îúk2ë5¾;·ŠÔ1·x²ÍÔO±5=µ}å-ýV»�•�¸Í肎åòáJ«A%ðÂbótM„]W"}ùþÑìÛùsŠÒ•È�K¢>+Yþné’¦% ^+]Pûч’yöÅ lïϳ)šg]<ϦdžmÉëbÐã©Ö¥³Á¨É€Fñ\›»óìïÌu¸7¿Öƒ…u‹ç×+]ôz)8óo‹¸.÷»‘Qr@I¶Ô¨¸ONB©|Æ5q^÷A�Ùjf˜f�{IÏ£y$œµ‰çï<¹î‡qÙï L¬Û]^S¤¬éš`Õ9ÎÆU^«GBóþ Ó¦Æm¤gOh4¼¤U}c|Î?pøÜ14»Y`¢“—ÌNïä)iê¯ø"8)dùÚGªz­C/}lj[3b gåt Ï|pJc2£Œ(Ì‚³ÄÊYA p8Kêt7¨h;BÑ{zÒ©k\ǃkz Ÿ5øLþ/)g�)·©ë>’VßKæ@¦ü±øìÆ~ñ”7í�Ôi”J±îp™ñYWòp®Ã£yޏ!‡.p,ß[T¯xiã{‘-‹–½óà·�î¬l[÷ã5Y÷K©¡�)´«Å+Ë4¦º�·ãŽ"¢|,TúÌÈj3:ó�> Žèæ“ýЃvò”7ð‘üg°ÒgJb!û�@÷�Œ×âuÿ ðYdMâÕ+6v ËnJ‘Ö=¶®—ôÝ>ŠBåªÂ³tÊ‹JÊr¶›]è=uÝ£2[õKjÐ3ÁÑ[nK>’N=éÚ;Ël\äö"y]_E³Þ²v#=g&m9U\Îp‰ªŠ?sÃÈÆµ¢'?¯Êï2qíÛý’ê{+�<¤tÏ.òÍÑMæävšÜ5ZÝöÉÊJ–½]ÙêÁŠ7ï¯hV¼ô�‹?\ØøáÒÆÅËÞ(^þƃȦ¥Ëß,‰|çÁ/¯jw/öûëbÏ«ê!·6.,;³–y|ø¯Ñ”WðÎÁ,ã%ŒK[Ù_—wýžð¼£62ÌùûLdÊÞS“?™Ð²¿²N…�§ÌÊUjå]Û;®®W\óU§±™c—eÜ/×…a è(C<¤Öá3ù>xôÆðgŸkûH=¶°ßÌ ÷ñ)?„g¶šñ^ߌ&þÉu|”5Ýɼ[—([—h›nQìà†„=r.ÎÆ=ÚÉ'®I ¼ýH¥¼ðb ÿKÃ0úM˵úà›ÐWFø}9!­Ðð¤a^Q|Nþ�©õÓk·•,8KÈœ:çXvf”‚à3©iñ Ð¶nJ'ïÄ7üT÷U|7Lá9V=l~Î,ñ–_RvÇåìUåïOÙ|(­ðHzᑌ-G3¶Ë,Ô;ü™ñ‚WÖá•ì‚£päÝÂãé[N¤ãZp,}Ó\S6QåHÈÛ·vÇÉ÷+H«¯|È<¹¬¹¼éÁŽ•·²ÆÝJxKÚã®Ôçf\·Ñ?ÞŒét'îû¢¸o‹¢¿¾ýõ±¯Å|{#®ËM±ûߊ^wÒG¯ŸùìXY NÎ¥*C;:y­4iã�øÌí²Ü½ ë÷'o<˜¶ùpFÁ‘¬ÂcY…ÇáØ„Kc]ú–£p™…ÔU'¿úw�eÏ,@6�§œHÚtT½áPLÆÎEÊÂáóÓ\Çœ“ß’\¿»¸¦Hlã¡°"§ÅÅÖt_ÕÈ/îÃa©^“Ró÷\*çSá “i|¦ãÛNܹ¾#Ù9-©¶·´–W<™¹1\>3v#Ý̇ú†Ïä�ǃ—~¾îí!kê÷Tœ­ÝÉbpR[º‘sEí\ã�Üc^ó‰mî/ýb˜ºçäԌ헟ð Ò°=êñQÍ46š°#—ƒ–æ¶ËjJNPXw‹"øL¶×Û»)ø$¼? ¥ûĤۼµ�4˜‡OžÝ¾ÿ´è‘¦¤ÂÀ¶–YÎ >Ñ�M¢î•1—ï=Ûsúnæ¶³‘ª! 3ÎÊè>9³Shê—£²ÞœÞ¢wZ£iõ=“D [±=ú˜�³s�©ñÓ¯6ÎñÜy÷,J“cí=ãê÷�þg°ê‡‘Qóä…{ΗÜ-#Û(=Ñ­Î?®åUvÜ'Qcm°ß>´F[£yÅЙa¶Þa¹L¶EÚ¸‹­»ÆÛ;‹íœ£¬\ÐâIO�ýÐCVû¢B:KDÒzÝ¥-úÈ?¬út¸üÛÐ÷I)s2-Z;tɺ e냗oŽÜ02r#ܨe›á‚#7‚›�XþâWÂ(Ö�ŒÌ^žOŽ\Ž07#ŠÈõCå ^”=|Y^ÐâìUY^.% EP’•ÅLÙUæ�½e§²Köˆïn^v5gú¥Œñ—ÒÂ/§�¹”v!5ìbFÄ¥5SolZr¯¤ìôæÆ¦ôSq— Ξ�wèæ´ø‚�óÒûÍͼ(oØ’üa‹ó‚–æ±±o ^ʺÈÍAË7­Ø´"?hE^Ðr¤“M3Éu½õ}U­ú&;�M,8|C7Å‹ÈS³P¹Íg憶ÁÙ�üœº+lȧdý1kQ¼½9ª²UoEû‘©='%æl;÷”N©5`DŒ.|Öó#Û6Ó Žœ¿¦Ýè¬7z';Ÿ]Ø1^—x+`£«ì?õ'CRG,Ê}Âk½”Ÿ¼x7!ïð’„­³Ä›—$ìþ-í€bé´mçóö]ÝtøÆæ£76¹‘·ÿJæÎ‹Òü¿fž§Ø±jSÐâµ½geùN΀Ú KýfTR›!ªÖýÉñ1�”õý”µ,»C踯C×Âu$ŽüÙ!ìÅ]6ß}–ùuX:\‡°Ìák:„dw‹Ó¿Ï莟²¿›Ý5"Ñ{¢"dEŽ¢àÌ©;ÏJØé[ìftÅd¤òkÌ“‹Ì£ß™’SLéiæñ9æé%²]Rå]r† ¦¼’�W|ý“àÆ|ùö>Ó»�Uþ86¥cxöW!Ù_�^ûÕèìoBÖt³öë°Ü!ˆ}]‡1ùÆä’†gwƒ„¥“¤†fwds]íüŽ!9íH^Ïf_Ïošÿåèu_g|þ30­i`j}Ÿ'ï”ZäC€£ó*;—(‘ØÉGñF/åç#Ô½¦§î9[ª_˜FJUÇ£õålŒ†ø|ðüýÐåy߆e´è�Ô »ºI@âÇC“ÎÍ(*ã-òÕ0E5«6t™¼þ½~I¼ev.±¶¢8›n1V.1Ö.q6nâšžÒz~ò}T_�PLIÎØv‘w†¸†‡Ï‚ñnB?$L'W¯NÙ8{ÍÇÃÓú©ìEñè2X¹E×èƒzÛ"@Ý~dú ñvvd»RGÎÙ/ž{ÎÏ”í°t£×Ì<·I뼦äûÏÚØoÁæ!K6_¶aø²ü!Kò,\ç?k�×´5]Çgv ÏèšÕndöÇÃ3Á“ß�Ö¼Wb“^ê†=dõ{(jyKÜÅvR7©µHÆ®±�­Ñ%ÚÖ�¬äªÑ¢±¨à¬œe<ˆ&´Ú‰âÜ¢šøÉ›ö�¾Ó'±Íðœv#²:†çþôó�)¹~³óû,Ü4`iá�È-#" à‚à–oye2»™8’ñ­A‘ÛàF,ß:jÅÖ±¿nŸ½}eÚ¡u»~¯`ôÖüUÃç{ 3fYƧƒ¤Mz$4ðQ×ñTÚ‘Í7bk¸’mè¶cÚíÐÙå`Vh’îñvâšdýo}_EÃÊ7üѨ“›&7íźÀÄf� /ášöb]o­k(o(…k¨dŸ$˜Ø2 áÍ@5À¤U_uë²6C¥_ŽTv U»F$˜Ÿ³0iÚ®Ë/?¼|¿‚voŸjôü�5dBþÕbæÐåG9ûnFf ^¾É{Rz×q©�B“Ú�Hh3XÙz@›}›õJo˜Ñ4 £Y@zS¸ÀTâØÜ!‘4Á-¨ H„k�Ú, ¹Y5óN³Ü¬—޽Gà‰MßðW5ð•ÖíN6²°÷�Û¸ËmÉÉP«m»ýjç]Ó]Ù GòCÒE)qYžèö­2ºâ3Ü™cÖìþu�—¯û!<£U¿”Æ=ÕïõOî–(Î?Å®wÓ—â¿ó<¹"÷ÛqÙïöK©+’�Ûœcmº¬"°¢XGYÿÄV}T_ŽN˜‘š·ÿ*oïPÝw/nÃ``œ�ÏZ#RÉίž'ÞHÏã«×]EvÞp�¡üÙÚMZÇSEÎô•,Î?CWrc:(帬½Ã—ü8>³ÍÈÔ§þwPÚÇÃ3>™ùUHÆ7a©ÂR¿ Ik72í“ ”«Þ% YÑ´—²q€ª¡¿²^Em_™“—ØÁ3¾¦Gœ½{œ­+™wj­¸ˆ­á�¦S£Ë*;×kçhkºß©”|Xw‡Q‘ƒ•»’“ÊÉ„·8t+�xGOy]ŸÄ=RÞHiÞ;éÝ~ê©? JþldÚ—!Yíµ&.óUrÈoÎ×£³¾ Ëù:$ó(�P¯´NéÝ&¯ë9{]Äê‚‚Ã×+ô#u¯Üø3цýWEáÊ/‚³ZöI­ç¥BÏ‘ôÝ\ÙJHºâÖâ´�Y²M»€K\ÓUì(’9¸ËÝ•ŽžÔɽ¤Ž Ù^ñÄyJœ<¥µ=¤/xuô’‘}¤ŽÞ’Úžñu<ãêx�@½•Ž> äꥬã.'ÎCQÇ[öºŸøqÓÕ[ýRZNÿxXê—#Õ߇)»†ÇwŸ$8;!xaê˜È숕¹pcW¬± yðluà¥×xe·qÉß�Iÿ|TöÇA9ïÎ:0ûÉøÊëx+œ<=É•:6wlÖuYCšk{Èk{(�<è¯r'Oyõòˆéäãèƒ`ÙÀ%ž’šîdËP[² °»Ö£Fçh›nq¶±öî1õ|ßé›Ú94}üÊE�� 5¼eÿ3…ÏZþ|¹¨büʵ]Ʀ¿7$ýÍéVúOR\}ÄÎU&kØ h²'Ÿþ¼b}ûðì¦=µE2Û®±vÝâœ<âí]WÕí©lÜSñþ ¤NcÓÎÏÜrºø1c¸ÍoðÐ$>ëR©¥ÔÏÈd6f‚~ç%»óF ëâÁcëzªÞí•à<&9gÏuvå ~ÝpÉSf¾´Àgúº6#“›õU½î§jÐ]ÕÐ/±q€ºI Š¸^Ä4OÊhLê[MO‰½Gœ�Gœ�(\ÝÆ-ÖÚ5ÆÚ  Äpv^‰¦aí‹n¦�k¬U—8;w•¸4°ÚUf%’²§Ï�zéçB+7™µ²�`ï¡vðH¨å©¨ç-kè#}½§ Éh£ â�ëË›©#T§§ºeßô–�I¨TÍz'4ë+s€üí�òOF¦wŸ9æ—üSןTÖèWJži˜åÌŒè�=¦¯ûldNóAkêx%ØÑNK¡)D“šéÊ:²W¤ÄÆ™œòië‡ g‹~œ‹ˆ­shA±¨º¸âž]ç"~¡«+ú�râБdWÇhº)­E ÖîJö'1âb£“£ƒYÓ-¶¶G\}/ÅkžŠ†ÞŠf=•­z+Þë§øïå'Ôm‡%|”øÕˆÄ/‡«¾&ûr˜äË y»áòφÈ?¤úh€úý~ª– N~Š×zÈëøÊ�¼`k¤ö"‰­«Ø–¤*ÞMÕ=7lbâÙìÄ’‡¤ ‹É˜�«’8ÙKÓšîÎZ­üâ]79æjVidû \mºÅÚ‰¤VÝÄ5º°}‘ØVD”`頻Û3ô¾Ó¨” 9îhwä6øÊÆŸXfŒÏ<ÿt´¶è 3=*×u|ÚÇALvþ9muÆÞ'ú5ÝÚ¯u¹;Ï\œÛ.$½q`‚£/Y{bëWÓS\×OÞÌ_õéðT× i¡Ë³N^¨[gJ#憫‡ÏG/? [‘ß)<½EŸD²ó†›ØŠw»Jl݉ý ¯Òûç„S|¦ï’Yy÷ÊÆ¯ÚÐeüÚ÷&6ì.­í&©å&«)R8ˆŽRG‰, W¼ƒÙ;×N¤°qUÚ�"£L­Ü¢ˆcOÐÃ2è1�˜�ú/ZUÃ=ÊFDHµm×èÚžd¹¥½K¼ÙŠTu+20¨�d¢ýÎÎ~<%ÎEfå"cÏa×t‰wt·‘€Û8xÖAˆÍ«æ@Æ|Á|H¡ÔóÇ‹¯åÿZ ¬gëa™?ŽM››÷T?/ñ•i™«vðüýŸÍó˜ž×fx&:׵ܥvôÔ0- ³Çy“?%ì=>ÃÙ�­ñô,Ëú]qȰ¤÷ýèÅ�AªÁcI ȼ¢†ë\%Ü®;Ô¿µs 8¼ƒ«ÄÁEŠÚ^ÛCVËSR×3xÛÐOÕ¨grã€ÔƸö }Ø7�”�ü”¯ûÊáxËêz‰k{ŠÑ“Eû²!è*µ"SyãÙ‘Õ¨n«àh^l´zˆ©áÆ:¢×ôØÙãÕÉ)qmû%¦�LвÑ9ë®qdäß™nD¶€C»®ÙMV¯{ðªCpB¿iê£Wž–ëqÏ`Ö(Ãèï @’ÃçÇf‰lCÏYèb3&«×ŒÔów Ö’�½€4Œ$g_Ï™Y§¼Þ7Ñ‘ psÖÀOöîД/‚“|'¥Í“^/ÕÑî¥ÅÕà>[2&ðYc�Nòa˱[AËÖwKoÚ M˜à'ÝÓƒlLí¡¨ç£üx ¢×$ÙÕíÎ4pÜ»t?ô—ß�[ +V ìW³›Ô¶›Ìº›ÌÎEJÌ"€TD‡­É§F ž2J�iU§UÚÆõ\få,ãfÍYá-×h;ï8{QÜó’5ê.o j hà+©ã+sì.·óÛú¨¬ÐßÑ®%dË×E>é‘�¼„ÕØ’1j k¦_Iæ%³v‰!§Ì�3ÚÐy”¢ßè.U˜™½ýè� ]Öð†¿^!a³#•µýDÈò|—I¹mG¦7 TÔöVع“åÃhV.«Èô{-˜H¸ïõÚïÔÝtE«¢«Lë‡öF) qÇNÖ8'áa¾vÚݲ²!9Q¶œ‰±°êo…««ÄZ$³q—ÚzH<dØAÍ:•£‡ÜÁ]ìàë Šwp—8xJkz’q]R1X*Kö†¢öÈ�Z%Š“”°±[­:K´é!l6†8·]o‚þ$Ñ™˜Ï/;I†¸xþDvci�.`qñöîR–WGöT½Ý/åÛ�Ô>Så;NßÖ— ' _R4†hl€Ï:rK·ú‘çì±t½û”µ=¦æ¬Ê<òÔ€Ó²ûä3Ìbù�)é Kz½¯ºŽŸªž·¼i úý�I_�R˜“®Þ|òa%o%¾ãŸõÇ<€&ŸÅg†I)<Óoá†ÏG¥7P¡¼´Ûz@án2{EC¿„/†ÊFÎO(ÑèöÖc_G^ Ž\ Š\ß>,À^Û3ÞÞElÛ•Ô(Z©Þ ­c”h¿èik�̶+œ„8–‡XÑ> Hlç!sð$M£AOuÓÀ„÷$µ¤úb¨ô›`E»ÁŠwûH›õ’×ï.uôRÔôV“ª]ÄZl§ßnˆ•'ßÉ7ZêÂs®Õd2ÿŽ4�èèe‹ÄÖαNÞ èà4è™ÐzxúcÓ§Än~T©g¾q¥D£íN—3òuF.ÍuC?wˆšÝò%ÙÁ3ÑÝv9�Ý�…_ÝŒŽú Ÿ2OPhÇEGt9Ô}Ñ+ôÖ¶]ó‰Óî‡æÇÇgBqÑýw[ÓA?rìxŒ•sênäƒqä&ÞN$µ# �w26Gäø!k²™*™¬¥Í‹‹n GÛkÐõ´] mÎ:A»úÄéMÉ‹ç×%^§OíÖV®ìX¥Hnã&ƒ�¨éoïç(Š{ÍO òÿÁ@e—°”ÓÕûΗqãŒá ,æ¹øLy-õ¨�ð°qßÙ Qæç�Z”yþžn1²îSþü£¤rjÔ�©¥ %Mú$´˜öùPµçÄô±¿äî:{ÿ‰öÐt�…àá37³Âx„Ü0Õz.MÎ{JÝÛsvþÇAi{*kº“ùiŠl9â¡jä¯ú:H2'nín [£Åçô-',Îû|TÆJ'oÙ²ÃY«m­uc]7…MWáɺ¡ ÃÉ49ën [–lÛ±_XìEbOI-²'IÓ^©­ú&8PõCxª(�»Q41µmPÒ†§”ÞiTr¿é1™ûÿxÈThÁY7’ÁÝòVïrðËO‘Ъèî•3sÄ…SóÙÉ k7=>;x&4 Løn”T–»ÿ©ÖNi£>‹3võ�·®íȬÆþ >Jw˜¼XjÓ)w­!Šb7)•éf,SZgEª*†<ÝÁSé䩨ë£lÐ]ñF€â;ª«?Jí–æ?%e¯k7ºZòŒ]ÞÂ0×J˜yñù}çdþ‘ÕfÔš7{§¼î§¬ï#¯é!µ‘o¨'È‚-GiÈ6 ѺYR´ª=ìøj­›`€fˆFŠÚ^Ë JV·T¶‘ú}DÆ€ùéÛŽÞ¨ÐYzîÿW‘@óZ89#¾‚I+8ñËzÿ™ùß…¯{y{`R³> ¯û«v—×÷–;yªÈ· 2Ë‚LcpôŽ#à|pÏ>$×8±SØYÕú^ eŒcC#ƒQìw;$ΉÎpðdŸSç­$ó=´Ó*$µ¼ØIì�6yq޾qdBÍ‹z&ÞØé"¬óÖÝxI´ÏIz”Zÿì” žv† ûœ�¼Afb�Ø}â‰ó’V+ËNl uÝ¥u=¤u}%õü¤÷V7í›Ü¢—ªõÀ¤�&|3:Õy\Ê€ù9Q9Gn>Ö�¡~ЀG2Ìà³á�î%Ýâ;¥еûÄÙ{ï=ÕÒrÝ:qmÅ8x¡xZü–~óó\~ÎtŸí75kâovÿ^Â;BN¿!¶¢õO4†> Á™áAô÷ŸNømCçŸ×±“7äv°§Î:|v%…Þ¬·ú§1ò¼=d{�gº Ã=ª`–+ úÎÉý"$»i º¶�ÒÞCjã!±ö ßyíÜVÃ:A,)¥bò¥Ooç)®‰Bô•Öç§jèŸøF`R‹Þê÷úª?¬êœÐ%\í;)yè¼ÌÅ »wÿþðofjãî•1ò¼£!+ò}§¯í4ní‡[õV¥ëú’¹FµÜåŽ"…ƒý©´)­Ýå䃲ˆ~@—ÒÍ6¬½þpTG÷Ñœ~v·IÐ!rô@ •A9ýU-z%~4$¹SX’Ϥ¤Q˲·œ¸[Ϋªúªþ Rhƒ./Ùg„dß™[‹äÁËòºÏ\×yüÚö!Ùm‚3>–öVe‹>‰Í{'¡uhç*›s�‰ZWµ·ç:s�èïNÕJÏ ¤ß`3�¶]íÜ¥6L´è£zk ¢õ0õÇÁéíBrÚ‡®ûnl¾ËøuÝ'g ›—úKò¶‹ô`È+:C>l®€�žr©Ñn:±uß±s׊´ë\¸ï�m­ØsævdÚ¡ñQÛG/Y?aùºìm€äÜ¡KÚˆŒ‡Q “¥1Bp�æx©«÷Â~ÙðÝØ¼de·Ì†l«HGœ$¶. [ª}“ºŒQ:·R¿£1[·K™•I»†-ZßiLúû“÷N©ç—TËKáäMÆ:j{Jj“ ŸÖ@ãX×SZ×KRׇ¬Cy= ¡iŸäVýÓÞ’ñqPΣs¾ MwŸæ?9iðLõ|Éæ5»Î_.ªxÂŽ¢<Ó-¥at n�ìG•ÌŽÌ•lbó¿ÍþtxÚû’Z&4ñS6î‘РGB]_µ“—Šå,µð–R[Ï2=Óøw:©žŸxqŽÒ9E-oe-oy¨ÚWÖ¨§²Y€ªy ò��©�Hë’â;--h^JTÚŽó·ËËôµ‚©3ªT¯ˆèGµvŠ~0*zÊl?yë×´}£6�X²®×¬ ßIIÔÎá ?…) Uþªìb¹þ©kçUçÑêŸB»„*�Ç*ÜÆ«|¦$Îθp݈¥ëÃÙ´@±;cû¥³·Êi´{T¿~ 7ïNã³mŠŠÙ]†x¬—CRT‰g®§žŽËÜŸ¹åÌõûì.ÕŸïÄ[?¨_D¨O™Û‘Ó'¯_’ß>dLš¼5™Z¬íø×t•ÖõQ¾5(Íígåõ¼y*¬¡¹~ï©ríþ™qäv�HûdˆêÝ ïLnÙKÙ2Pöf€´U  îÍ^Š–½T­z+Þí-;PònéGƒUŸ'–Ü9"ÝsjvàÌìá sþeÝÊäÝGn^)fèPÆ3Ø0äxºsUn–’ÝûgÆo±$7`f–Ûø´Ç$}3:ñóá V¾×OþVoÙ›}d-{ËZÊÙEXÔIuNò¯½J¡a8ݲ29çZ!³â7Å­û+>¬l;DùÍHu—qè&[–¯‘å;s³Œî�©Ûò…û¾Ìh êÈ«$ZU0‚®'ݨT¡¸Œ¹^üìÜͧÇ.–ì>qkÇÉÛÛNÜ‚ÛzüÖ¶ã–럺²îÎŽcwv¿½ëÄ�='ïî?Stø\Ññ ÷.Þzrç!£¥jŠ@(*÷Ì`Λ†Û$–×™â°?�¿róø…›7”Ñý…*_*-úúU%>#Ь­Ç,Èû|ÔšÆþjO=>[“YXdÕêûƒ“g¦>äQoZoï•<ÙsìBrþ¾’¼�%é}f&{MTw•u£ì*ÿ1TþCˆìûPE§Påw¡ �BÕ?†&v OôŸ8U=xNâø_2W¦lK+<¾÷ô­Ëw˲˜LƒßSàÊäz ÜÚvJ+˜WŠÓ¶ŸZžºãç_3G,J4'Áo’T4.Þm¬¬k˜¤K¨ô§8y—ÑÔ)á~‚ ‘ÿ{¯]FK»„hÝO<‡Ì¹†Ë¼'$ôœ¬ê?+94rͳ›#•?Óm2¦ƒuþt¹êÖ6ƒ1~âWGS�ÉØ8{í'AÙýìɆuä›»£E|MwÙë~ŠO‡'�[½ù —B-ƒfÇj4TT0×J™Ów4û/—œºŸ{ðVö¾ëi;.%n=—¸õ|òöK)»¯gì¿•¬¤àä×Ë/Ücî–15Z Ð—߬0FJ~üÔ£4j„öˆaî?c®=dÎÜzzðÒƒ�¿ßÛrâNá©{…'ïœ,.8ù`Ë Î•À�ü÷ºÈÑ–“÷·�¬ÑÜi]!®'�ñ{»~pìZÙå̽gdwâr�í«dx8d4YãUg]×LѦÿø'öáÅœ~ÏÁä¢ïàéQºúL_㬋�Ѻ*@=$„¿Ð0¡ÕáÐ北*ƒ0Øáµ’gÌ<ÉzÏIYïL­×]Á.•¢ø,±q•:zÈ›ú+:ŒNþ%û¸Ÿyv�nVÉmÓm¼á6ïnþ‘ÚÄhøi54›†¢K£1ò¥ÑM³©4ÜJ´Lc"=ÿ“®ÌÐ:†¯S¢ JTYƒêúMà_,ºš¥o„Ü�¾¾5#‹üEb’ÅjK�÷«¶4>ë Z#tÚÊÀ=ó†A ý¿4>3†µI­Ÿo”2“Vçu‹È|»_J_9»ó†v²=ðÙÉ“ŒÖ~¢JÛ}£L�¾ú2üña–+µŽÑp¯a°�ãæjþÿUDa¢CÊ"1õ ‰ôŠú×]Í9jÇ7øºîÃÇg®bCô+B¦ê"¯©4'®XÜßâ ÊA�ÓüÛ—¨ŸfðÙtI2Ü:Ó· /}Óª~jø©Ò¥D³€Î×…­Èÿ!<ã­~ÉÜäºPˆà³—ìí^².¡ÒÝžTèàŒ«·úüòÓkœSmV˜Ábœhý[ &üuEc„(†ÈÍG!C-ðÿ/vUþÌéW¯s^¶9;ÈéÚH¡Õ¯oÿv1ÑDh®Âšä ÷çœA«5®�Zǯ¹Õ®¢f‚Õµ>'d=Êh4z? ÷“ Ñ&Ñìy©á¥JÃ%M÷™Ë·ýä�a‹ó¿ MoÞKÍNÞÐã³­›Œúý~Rßñ² ÷ugo$ÔÝàeI—žtŠÕiDû‡™ÂÐYCÝéC0l:¼(„É1‘HóUà_âL·V5F¹å¨ ÀÒñëús"ø_ƒ*«{Äý¯z|%uôwÊ WzÍËÖQ³mÞD øÅlh7ŒØçËV�a¬º¤q”8cû…‹6}œÖ$@åàAv$àìgå"±s“Öó•Ëì=Ú“LYµ†n1ÍZÃGÄЈÎã dà r¹�9ßF½vV»p«L¯)¼5þ‰Ã÷&@i“o™öi.Sæòk¶bþéºÿ?!ú¡FA…2_wxý?ËõO]Í+Ú”â_¦‚>'\SE,ôo¾Š¼TJÐæô™Ó‚×ãJf–¸ÐmRî‡CÒêùÊì<%ä1;¹Næà)oÜKõu°$&sW9·}Ÿ. sý⪤·ƒÏ/Î4™*ó:5¸šHRõʨN0Øb9¢·D3aÕ¦Îã×¾= ©Nw¹­‡¸†K¬5Ù�J|vt—4í“ðc˜$Þ¸o&¯æ‰´i¬1.³—©sÿjÑ6¾çó¥—m‘©JÌž‰§/S&€GP¨ÜUÿ„¡¾áÐÆ ¥|~zx•É ^‘ *fíöÓƒæ¯i’Ù8Páà#³ÅY¹³g4t�³)êuW½?$ÉVr©îØE‡-fñ¹Ê¿�5ÄÝà†%xj2.3ãâ4w5[hÍ•76ÌæGS¹fÍše˖͘1cÊ”ÉsæÌ‰ŠŠ:yò$瓾…'x>wîÜ)S¦Ìž={õêÕëׯ¯¬¬ä‡‰»M›6ýöÛoð6}úô æã•}ûöéè5W:šȯ¡öŒuøJ‹¶b›`Émýýb4^^ý†ï˜„/£ÈùÐ¥(W­¢Ëÿâ)2Ì-EØ2†gíé3g-96¥‡ÜÞSjåWƒ=…¬ìöT6ô•¶™6fÕ¦§ Ç÷t8`"§¦ó,¨å¦ñÖÀ«AzÍã³îÑ ¨¹ÊÂ|ñ÷Í:ãÏ}Ø›7oNƒƒGøûû >]ZZÂ÷öìY…X?nܸ¾}ûÂÛàÁƒ¦M›ºÿ>Á7C¼=uêÔ‘#G>,,, }íÚµçtbÌÖ£Œ¿¨®^1­ Þ%ý­R•nÿJ½¿DX¦PíåëE{ð£÷àg¥f®dƒç䬆¤×÷UÕt—[uÛŠÈ©"6n2‘¸e€ò«aÊUY'ŸV3v=�ãê³î®ê‰d¡ Ò¥ÝÌ 4n0V8ðkꆗ<³‘þ"¯ n¨¬]»vذannnß}÷]—.]€À‰Dðâ¥K—&Nœèçç÷Ã?|ÿý÷^^^cÆŒ)..DŽò_0XsM&ÕdhOŸ>�2eЇ‡GûöíÛ¶m ìíß¿ÿ‰'�$%%á9ÀùÓO?ýâ‹/ÜÝÝýõW:¸Ápûöí …béÒ¥3gΜ1cÆâÅ‹÷ïßo.1ÏÅ™çD¡ ü›Óá ŠqiÇbcI}ÁúcÕ-øl‘ZÌãs…†9}óɘ•¹ß‡§¿Ù'¹ŽðYBŽÀvŽ%G»ºK�<$ïô–»†*wþþ¨ü¥ð™1ÏŽÌ¡¨¹pL%x^5ÞVc¦u›kŒóxèÐ!/˜óÿûß6mÚ8;;GDD”——óßzøðá¸qã@°àðÖ¡C‡ž={ò�—ûäÉðç]»v­[·.;;;'''??ï ¢~x1—rs¨û"Êù“Èf®†˜¼¼UE’�{®–Þ,b‘¿E¸n+£1æÏ»Ïܵ<÷Û°Œæ½“kyÉì]Éȳ9ÌNb+×ñ‘¶ ô —^¸Ç­ÔñÜhÍ÷:«Ædsí¨Šg.dãô˜ ¿ Äæ¿e nUäzÅŠÞÞÞíÚµkݺ5à×ËË+++KðÊÎ�;ûöíÛ±cÇÿüç?|ðÀ|ذaeeeŒzrmRiæònNL”q«Ï¿ÜÌUÆ|)›TKµJÙdì±È?!||f´SGè(cÃäí½8li^ûÑéM=¤Ö.ñ5ºÆ°g¬ÇÛyÄ×ï™ðÑ`Uß©ÊûÏ(>kŒðù…c9«nìUüiì¿ê��=·zÆL+6 †UÜãzóæÍ#Füøã�²bÜ»wïÛ·oóýWVV.Z´ÈÝÝýÓO?}ï½÷>ùäµZ]uªLµÉ<š”*ÔRW­OªŽ½Š$ ²c2Ì* H§ S&1Žñ%o‹ü)Ñ¢²i|NÜx|À¼v#ÓõL¨Éâ³U·8öUÓKòz`r›!ŠÉ«rkWvWŸ�ÿ'~sxúôéV?~¬›T&l/ôÄ’ú,--ÅÁ ­ÉØùÉÀõÙ³g>¼wï^qq1n***L&ÕôñýÐd#œG�={öLuNNN@@À·ß~ ò àýé§ŸæÏŸ/ðÊ•+C† ¡~Þÿý¯¾úÊßßÿâÅ‹‚èLbÿžÓÿW3Å"üUà³ ¼‚ò‘Ù¢¢"\ŸÊhØSÉkoãJÆŸ­]c}ÄM{©¿¥LÜ|Z;yCS=þLñðèÑ£»víÚ²eËæÍ›qݽ{7ý Moÿþý‰döìÙãÆ�3fÌÔ©SuÓƒšÚÑáÇe2Ùœ9s"""àsÊ”)¿ýöÛ±cÇxb Pô!š!âEÓ§O =z4"]°`Aff&™¥Æ{˲ø‘.ÙãÇ�;vì„ /^œ››K']@exèêê büŸÿü§]»v~~~H€À $%%yyyÁÏÛo¿o�:u‚Œc?qâÄž={ º­[·"¨‚òpüZRR%ìÛ·oûöí;vìØ»wïéÓ§Ÿ ÎçÎ�Û¹sgaa!DÈ(  .°Ëa ^DjQ|çÏŸ‡­™7o^xx8ô6’”Bddä¶mÛèP IQW‘$†‡·¹HMM…†¡^D7jÔ(ÜLœ81&&æàÁƒPó_çÿùûï¿£Ê ƒP Ê Š¢¿â!H¥Rä™BIýòË/‡âY‹Xä>>k>Ï•ºOZ÷ÁÐôz¾r;·xk7vå`×;÷¸ºÝe­úªDã“^|XÁa³`¶Þóø3þªU«f̘�¶`Ds(¡¢í‹’ýû÷÷õõ‰DÎÎδ=zmh `Ô7nœ;w.Þ8p`÷îÝÝÝÝ»víêââŸÁÁÁcÆÇ `&àeÒ¤IÆëÙ³§§§'"êÒ¥ ®ÄÇǧoß¾|ݺuÆX `\HÚ5`jÀ€H€;+¸Çäñøñãx8 @þî»ïèàn {Ä¡…††~ÿý÷`Îo¾ùæG}%lÚ´‰ŸÈÝ»w£££gΜ A..\lÿ§Þþøãü +ƒŸ&OžŒ_SRRÌ¥ŸÊÕ«W—-[ãB„Ùâf•pQCÈË’%K†½!�P;z�;wþñÇ¡@d¼W¯^°wׯ_¯BiÏ~a•——Na…Ñ­€iYÓHqussƒžñ¬á­[·Ì:ºE°ÝH2ˆúµ ¿È ëúõë¡+<¤u GFP¼½½Õý™Ž€E,ò2bŸÁŠ'­ÚÐu|Þ[}ÕäX+vÛgà3(´½G|ýîñUNMz@·}6‰ÏºêlÜÛ¥×ÄÄDÐ]tÛ»uë†&†ëš5kÀ¾Ð´ñì¤}ûöü1$ ì³Ï>Ccìׯš*ˆ4ZèZ0ˆ ŸmÚ´¡ŸÒ@JѲ€5b [+äÀ�hìðƒÆˆ×AP¬€µ"®Ï?ÿü믿F8hžÙÙÙÈoõ÷ïß���¢"å äå›o¾éСÃW_}…kÇŽ�Zhï/^ÓC\ÈÔ{gg”J¥@Q ÁÐ^ë­·ÀŸ‘’>}úp œĘ̈#"† pX´¸¸8.¨+W®Àx!ƒ@3`nV®\)ÈÿÏÜàža› g”ŽZ­|ñ}"³m˜!Ä„„}ùòË/¡4hŒêÖ7È8ì¬Ò�;wž_ÍŒ{sBo0C‡EY£V@½_²‚èÚ¶m‹è Iü Å"åÐ0i\^¸‚9�¡[˜{Ô7è¬ÔÈàæ†Ö%*RëÖ­8 e âýÜŒXÄ"¥h¸ÿø¬yTÉŒý%¿Søº½kyk�µ²"Û"IÜã[õU~9\¾(qÿö0;¶ëñ™Ñúš‡v„Ö„¶ð+hÀ14ð1€3€i�cÍ›7oܸq³fÍÀ'Ñ AÑŽMøÇ[Ô'ü4iÒ¤U«Vh¶^ô^#t\%77Ð�×ÑHѨÑÞqÔ€²“Ñ‘ž÷Y p ÃåË—�ó‚ÎûíÛ·Á»€áH¡°Œ@¾ýö[„ö-+Lð1"@4|ï»ï¾‹‡À .dN¤È>p†g„³bÅ }¡éø$zÈ>ð‘Âr¡»†Éy@°@o€ä7¬@¥°Güø"4�m0yتøG´ùv˜º›oP×W¬P„lâE¨ªCAÙ`V t‘^�y è.§á-[¶üüóÏ(n‹ ½ud1â æ……+þDÊ�º&YÁ¢E‹`}à‰¤¿wïÞ¨„(ô•Ô…Z‡çÈ*Ò믿ިQ£-Z ;0/’ ‹Xä¯�þá:éåLØŠ¼oÂÖ6ë•TËK©=ÖÊY |®ë£h(v#ßxøN9ÃbþæFFøÌÝÐûÂÂB4sà`ªiÓ¦ÀU44v4|0œœœºædæ“O>>7hР^½zð‰†ƒæ‰¦Š6…>xff&@)++ - �¸Ÿo¼ñˆ487®Ë¥àœ––ôFKDG3G,h›€Y±X‰{ Z=ÒöÎ;ï µ¢ÉËår†ò:ð´… ‚jÃ)‡z€à0 6 EÂ�MüŠäoÑØ‘´}à €—Uæ®EEE#FŒøá‡ øG2ûñãÇùÚÃõèÑ£0 t5 ýœ2<|nSó‡N›6M_ô†`*8E:aé�0(áìÙ³|ÿ.\€Â)mÄQ�DA ã°zõjô ÀBQ|€kؤ„z¡:àP5J�EhØ�¼yyy´°�S¤57èÔ ë„Ha©Aòñ'"¥&µYF^Œ)ôùóç¡"¼Ní8ê5‘x™�2e ºoàÒÐлeË–uëÖ­ÃJýúõ‡V­Æe‹üI1€dC|¾ÿøœÿu(ð9ÅÑSNð¹[œµ«´¦‡¢¾Gü'ƒdý¦(o>bÏÔÒã³É>&Ã’"p9("Z( p° Ú°aC%+Ô'm|LͤaÆh\xÞL®¨¨à|¢!£‘àøŒ��ÏÇŽãG�+˜3Ú;:¶”þg�  Ô£G�@´€Qh¤H H>zôhF7‚õôéÓ¨¨(X@�Èpƒq¡ŸÆÖìܹliz™_{í54và3@ ),((Ì€å©CÚZ³à‚ß ðЄ”½aA�N¤á—_~á{פ ›ˆáà¶@_ô<šzúôiØDè‘"P# ÁÏ/0ðŽŒ =mÚ´A¼Ðð†i£Þp…ÂQ4ÐÕÁ •ûdðœÚhôqóæÍÈ;j"3‡z‘Í���Çs_pV ‹†”ÃðøL-?§jµ¥ƒ ™aÄq¥^Ñk€G8\.ÐíB8ŸX©]»6ªÍ‹äÂ"ù«Ä`æ†ÖÜ}\9zyn‡Ð5Í{§êñÙMê ’6ë•øÍå"Ùæ§ìÌ:�Fˆíú¡húЈ�‰Ñ ÀhÅ@* È�»»ûÉ“'9p¦ž C@`8`>Ñä�=Æpòž€£ÅÑÑœýýý>|Èðšü‘#GÐ姃*h§”‡£mS;À5^‡DMYx#p›Ÿ‘õë×�5  Ësvçëë Xàš¹VÉMRRrE.`eÐêèþƒ¶ R”˜;w.2 ä¨ÓÓÓ¹ è86° ÈŸé �1ºqãÆÐ¡CAqßc7Ó§Og ‘™a»³fÍBfaª ¤ j„ÝágáÉ“'ÿ¾}ûÒÏš ëðA/°/‰‰‰~`UáhÉ¥¿ªªh؉ÀõÔ©S°€w:†rGM@Ri¤ of”6sæLpc 42‹ 2|èÐ!¾Æ`D@¹i�Zp˜rèôàS†|ƒõ�b7nìääT«V-ôÝÐAxn.,b‘¿Jxÿ Ç(*�ÏO>šÃñg+·8[—ØÚÝUoõOvUºZAŸ�†44úàMOH^¡¡�£ KÁîÐô(äò½áºlÙ2ô¦Ñ<³Ÿ IàÀŸ‰DŸÀ«-ZОõüùózà ÈDF{§Ÿq®Ë5sÆÐˆÍGt�>�½h¶œOÚÙzÖÎàÏê½{÷ò›¹F'7oÞD¼@À2Z:ȸ%€ŽÍòc¿xñ",X"��ŽäÀ.àuAÇëÖ­ÀvÐT:è z VÉqlzÅ[àÏ€ Åg€›œñJ\\\ÿþý‘XºÈ„ s˜óóóÁH‘A .RŽÐ@¶¹¡iÆ¢a¡`_ à3ôŒ¼¨T*~I™®�†|üø1R ºN ñBÏ`°H¿¼8ÿHáÒ¥Kg̘�>‚ är9 ˆ¯�={ö 4èõ¥n { GÂsAÑŒüþûï0܈HŽþ<#/°Šô[Ä"­èñYcŸï•1!¿¬ýfLvóÞÉNž 7±µ(¾¦—¼AOÕ‡ƒ“§§=¥_i³à³ntÃÔçx4½qãÆ�bÖ€¥hïè–._¾\ÃúVqq1`�r4+ø"�)q+G8ÏOŸ>¥c­tB K$mÛ¶�{rr2€pA?8âÚ¯_?q¢BŸ€ÇRº#ìÀrm„mõêÕ @ŒmX¬EGG ƒp7xò {„´¡C‹£Ó¹ù>SSSÈ€$Q#X$Ø[Ξ=ÛÍÍñ"m¸âžrT¾öîܹ#Àgú}�¯gx‘A„£†tÞ¾}›Ÿ*„3~üxt:`_P^7D aP—tÙÄõÌ™34mÈ,âEA'$$<§*á-ì&h0²�¤«xP —/_¨‚{ñ�?þ€i»zõ* GÔ=ð„•6gúG�] A¼ô&--�ë‹Ñ/HLÕY°ˆEþjn𶤂 ÿ5ÿ»ˆµ-ú&Öò’ڊĶnñNâ–}“¾�º<õH™.ΙàÏŒ[£&B3-J£ OgíòRFÞÚ¾}{¯^½€Éhæ@:øÜ¹sŒ!XiØí†¨O:ì j„?ù$ ö B E‹C÷è±eËc Â=:t(ÂA€`Ú7`;‡äGŽ Ebk vˆPÏõ»FÑÀó>}úŸ›5kpFÔé°YX.šHú%šС[Á�a©;ý´J—r[�‘¢¢"Ÿi‡¨ÎOáéÓ§�§§'8*è.¬$@Yã¡»†Ä£¼ XÊ'‘qJ5 £7€nš6dñþøã�°‚0MÕEý¯HùÏ?ÿLg°¼Ë ÏW—ÉãÄÐ{”>ÌЩBE𢖑‘a2zè‹Á3�±C3è²Y–¨XäŸ=.2h‚¬�*˜ ¿mè<~í[ƒÕuzHìD2{‘¼žŸêƒÁ Ý#ÔÎ=6ÜsCÉü?´-l˜ Êt|íMM�ŽìÓNº|ÆégAþ'~c\µjÂËBkB˜h‰“?Ž�——€ECC_µ>+€h´Yôˆ‘©Tš’’‚ ú ²&œN3C3�O0=>yæäîÝ»tpƒNëp¾èj�n8bþüùx8,תU 8Ó°aC4à.]º¦ €V lðR‘N:øŒ>/ðúõëˆɦì ëÑ£PÔ–9½§±ƒRp©¿¿?7Œ 4°lÙ2j¹� jeÄb1cø±S*ˆÐ�H¤–N�D|†¢ü™RPjbZyyùÊ•+��P/�Ø›HÚÙA´FÍÉÉ ª‹¦ªÉ„ê`ø �R ¼i;��®z.DS©¨¨€Ñôòò‚ +¬*�š"@]2 nø¥k‹´!ÁHµ¶(MÁ—î^¥RÑ‘jäž¡jèJ`,b‘¿_tC<&­£¼dUà/I{{ÌÞôqPêë½”u¼e¼åïLý)4!sÛù2øj!ÚpÚ´idlÀà™tòå~`w'NÀ½—£3(à ð‚^§I¾DÙ&á¸qãho”ëÞŽ;”¿6hÐS·n]5`”!¢]]]Ñ„éê?  âý„€ÂRÐÍ+ ཈ÏéÇ2´z ›�Z�ú×€Ygggä(‡D"×ô.×ÀŠ[·nQ{D§d€<£Îœ9#Èò¾}ûK ¹¡€”––"@ä…¢%䆲srr† …ÐÙÎÀ+臟á§_©TÂ6Á 4nÜ̹N�:¸l»(ëÆ»Àvh¡Ñµ„x½!XÞ]¼xq5j¤†|!5j‚…e¤c(è�¯.þÕ$gæ«Ò¹.è!ÙÐl l:?³ÜF-<<y¡ <éÔwþje"""‹k àØH$Â�îFGG ´GoÐ1b¡ü™¥óŸ�=:lØ0¤�®’F€ðW®\¼Noð ”C7Ðã ÓÒè’gXh‰n3"‰à�î^½áá£K2~üx“Ó…‘¶………ƒFÚí7¡Sí1ç¼™Tµñs†?§æê¢|xÉ’%æ¨8Ýs±ÓI#P- ¶È?.ã|ªKñ9½ð÷¡Ë Û‡e·è›øºŸâ�¾ÊΣÕ+Ó>¡Óžuà®#͆ø¬Æ€äœ;wŽ›µ‹ÆBÇW¹Î/ßóÉ“'ѺÁý€Tt$BÇøž!tS©& ]u4FþÔ/ÜlÙ²=} ]çÒ¤I“°°°M›6íÚµk?+`âæ+¸9pàžàþĉH6È-�”î\Ä}<¢ø,ØãŽŸe†�œæííM‡d‘k:N°ÍZyy9µG€#:tÄãÆ´¹`oß¾ÞKÆ©}¡#9Ƹªa—lƒˆÒ‘0^ º*ÅÅÅ Õžžž êÐ*]Mg6 pO£;À…>Ó�ªˆtÆ;vì�‡Ò>Œ+tEo8ÁŸÇŽí¼|ù24&H›‰ŠÈ‹W¥R¡V ¡[h t—n"(ws-Ð?Œí:�Òs|˜îm(DÃöb¸=·QR¸BQëÖ­³ ³Eþ/Dcrþ3ýø¼aÿµË6šùV_uó^ªO‡©¦$¿ñ¬œL{®äÀYÇ¿«Âgú@¡PvèÐ�2@·äMÐRbcc�<Ðl/|FEE 'õ©V«é€ Ý>éVü×®]  ´G{sÆÕxÅ„ñæÒÜ÷z�n®Ã"äÈ‘#A‘°fÍšá ¼¥d’¼�<Ã?µ Ã)ô3œ†'ð+{D§óN›ýû÷¿ÿ>?= ûáŒN ¦ŸA5:ãæJé3f L ]·ŒR�–Ñ�(‰LNæ[À¢¢"„@?ŸÁØ�ÕœºŒ—á˜Ñ}q|ƒÏåË—Ó¹.P é\¿~½I8…\½zõÎ�;�?(Ÿ»Ù³g4‰œÒ]¶�ñÑ£GÓsÄŒS…Ðè’yê'�mÈŸôn‹ücÂ[Ÿ"ø@Hônç©»£—oèžþßAIïJþ~Lò<Ù¦‡ìÑWZ_ˆn’>]ÝRLÜÜÜ€QÀ0ŸS§NûÇ£H )ç9}ú´ñÒ<>;í¤3Ä*++ ø »€öN7Y¢ûøñr0Ƽ5X .M—¡¡÷M¡÷Ü™S| Jo`’üüüè—)ä@ð1Þ3&&)(QÚ†ýöÛo‚€rOž<ÙÕÕ•~—„gplŽÝ Ø/Ã"'89PCw8A2>úè#PtoX´.]ºÌ˜1Cp`?R@ŒEª¨Þpo ©ºPÄ&"÷&…z@8K—.…Á¥sÅ!°ÑÜ®à…œ9stY˜5kÖêÕ«ÑOA%œª@WÁÓŘÐFjjªqNé�ƒé¾XÈ,ŸºW‘x‹Xä/�¢…øÌ>¹\±j“ûøì/ƒÓÛ�Lë>5éÈÕ‡å:@æÞÌÿàšÈöíÛ)“ù€À˜Œ€t1ºá´P°DÀ8|‚%‚Åñ¿÷qWÁh!úòèÑ 6„Ç]rà3¼�îÒ].\ÈEÇ¿‚Yº###¥RéÆ�ÑCç>½QÁD> „¤ƒ±àºü¹"ü›mÛ¶q•5ÀUgggîË ‡l< sZà& È@kóaàŽm §t£¶~ýúQŽ-,Y]væÎ�Û£GàrݰaÃF�ÑO{x–8|øp˜B~bY())?~ oüeDÏ©Š<›þ ¥A 0¦ˆ8‰úÀïËЄ?eÊø„ùC§ uiÁ‚P8?::Yý(–žAÅþñÇ&S»Œ@(+à<Ó™�åXÄ"ÿŒ˜\šÂáóå{ši1›ý¦ç?&Ë9"y¾zç#í†z63?� Tß@u@NèÎ�tVXvv¶Abt ¨fŽ$1†Ï5kÖ0F€€+`–ŽÆé2:€ß½\ÐAà$Ý(è$ØÕSÃŽU¢³?qâı¬LŸ>ì+77—OÉΟ?˜EŒ´Ë�tø�—械°صkWº]5ãïïèÐ!�QàÛ#ä‚ΦàGʰÀ%—ËÁ±)»£jlˆd,+V¬ cŸéÒEhàÓ½{w:)¢ªê¡ÑÌŸ?OkŸ‘Y„Éÿ^FÍ+úAô@“qãÆM�:~`æ®_¿ÎÏé¾}û233Õjubb"о  €îÞÏ@H||<ôF?kÒa0dAª®^½ bïëë ]Ñí‘Íyóæq_(¨·õë×C±t<¨ ϨZÆ39éÉÎùå—(:O0 È"ù§E;6¡»ç�VT²[Œ.–o°`£ïôuCf¸BɳFÃø4‚FˆÏh‰t[ Ô|ºñ]ò&`2/^×ç¤ßAØÐj¸3›´ñ°÷h¤C‡¥»ÌÑu.æ|‚%N˜0ý\º(†~,ì€~?~üœùîÝ»¸Ÿ6mÚàÁƒHÏž=AËCCC/^Ì%’Ÿ€ €·Ø™~òoDÔh΀ˆ'N9Áu»uëF—9S£€¤"̧OŸòSÈmåGÏòv_‚^h<؉æôêÕËx­Ÿ@¢££¡"è�®+§LÑn>z �Œù3½‡e¤+ï dºŸÝŒjA ‘—+W®Àp _Ðô<„)ªóç´0,�ŠŠ†OeeÉ’% …�©i~~>ºK€\ÄS£ “Éè!ƒ¨H ˆÅÕÕù‚é¡›\�HŸ;wŽ?Qe�èPÊx�šo}MA6¹x‘)z òHßèg�B,b‘H ¹3£ÿÈGgÅ‘ItªÜCãVï¹9:k7w¬Gf4!â3W¥ÁBÑÕ¡ûðƒUr{Å3†ƒ èWlÑ<Á»té"Ø�óL}©àm>Smù�+==°R„ØßyçÚLJ¥�öïߨ‚æ‰&ŒÆN�g}â¦Ýr‘Ò�7z´# ÈôÑ¡`,‚÷CNàt¥ý" œA¼ðÀ�{si¾ÑÁ¤~�¤Aƒ¡..°;¤]€¶¬ ‘1ãMGX£[IÓ}é k"P» ›ÜŸ°G“'O¦%‘M#ª7ä ‰ü–Q øÓ•??¿Q£FBiÚ¸ vïÞó½Á3ôö mlI5ì8 ݉®¡ÓiùÒÙ�t¢5ºôÈ 9ŠO°[á@EtkÔ::Ä_òÏ÷|ëÖ-º²Ñ ¢û�T¡g‹X䯗*ñ™a—¨ì8ze‘j×BåÎË÷I›zŽaQ™Ö¤n—••-\¸„ ÈÛDëÛ»w¯qK�O°SüJ'Xüýýá“1Ü•š9s&~E˜èòÃ?x¯ÉÓR¨€ª�ÔÑý‘è¦@u�%:�� .üDyÎgÏžå^ç'P‰¨©1£»÷]¬¡s$ °tiD!˜fLCÎÉÉiÈ �.è0ÆLôúnôX7˜:æÃâŒ@RSS‘ØðL$†.E™4i’ØMâ$wݱcÇØ±c‘0äƒÞPˆH*þ¤§Òé✇àå¶¿æ޳€Å~ðàAAŒôP­V‡„„€äÓUBttFú9XF;‚B·âäÉ“üb¢7k×®EŒˆ–FÅ'øìË%yD8ðƒj€|!Xn�œ-ò&UògTå+·J’×Ü~ì�rÞkfçñÆ¢õcٚ˗/Ÿ/ôLOôÑúÓ4ºÑݹsç¢�Àl¹'NäφâÚ õIËþ¯à“›jk²†ÝäsÁ‚ôþ�@<4IÀ ’d†€‰ñw7.¤„è�<@Bãd!üI×k ÙÙÙt"5hòK—.¤ Aýúë¯+dØK5#.†ÝޤHK™9ùóÏ?߸qÃxç=�äççÃ*AóP2ˆwÁÕA‰‡¯X�ž0bUFÖ�GäëkVÀ3ñ'=º„:Ù³g�`?†Ý\.** �ôÓ¥ôS§NåŽÄ5.¬ÒÒRäèJK ѵc…ž‰H¡+ä ËÍB䇃Àccc‘f°à<ªúçÎ�3¶¶öc�\.Ÿ0a<Ã',/¸ôáǦʂÒù?#|ÖþQ©a—=Û{äìãJíȆáÆølê/–p¢±LŸ>àœÉÍÍ5n&¸¢ ¢àEKGãB?—Î}ÐÛ_¦>Ç�Ÿ`Ýüã­­‰{‚†Ÿ™™9eÊ”‘#G¢1¢�£c좠@ˆŽŽ¦­˜ÿ"cØ<5ì—D„ƒ!;xד4m '=ïûÑ£G‰a‘`;€]\“ç¹zõªL&y€ #‘‘‘üjÎ¥¤¤,_¾|Ú´iH<üÓIË|š ¥B¡ Gx'Ožl¼˜E�5“Ï�`à¨Ë–-CÙí‘MäzƒA�aŒfÏž½qãFþ~ü´áÝ„„Øh’�\ð�¿Óñc‡ѳ@NiI!"hH‹"ƒJ¡.Ô(¨Å¤¡ÁõÚµkÉÉÉK–,AŒ(T§ß~ûM°Ñ7w½sç�´ý ƒ(VXÁøLJ¶ˆEþ1ÀP�Ñsí0󤬢Ò`ª´ðƒE*úQýÚ—ââbp6`Ñ¥K—À¥ÑÇçggxõ¿¤¤>A·®_¿~ˆºô@Њ5ìxõ Ac7æ`Í$ ä?Az8€þ/ -Q,l�9Â?¼Ï¸I$róæÍJ¥mƈ¸�‡‘ßs¬œg¹6^�Üݺu é¿À ^á“[Î'Ô �> stream xœí[Ûbë8Ìÿÿt÷¾�%fÙŽ£yj ‚¹ØIN»ûzmlllll|"~Þp5—�fü ¸šÏF'ÆtwÀO‚‘îÎ÷10ÓÝù>;Þ'ÃIwÇû ìt��꣱Ã}4v¼ÏÆ”îÎûIÃÜÆ�Âåþ ý0àxw¾ŽC�Sº;ßÇŽ÷Ùò½šÞF^¼WóÚh�ïÕ´6šðèN÷�°ß«9m´Áz|¯æ´Æ?:ÑAe�Úã�ÏÅâtë#ˆþ·†¡W¥ûhM �‹<÷¼ÆxÁÑ ®¸mšˆwhk1΀M¯!_t¶¤\ÔЉ>Þee#È?ýßûàÙ´h]C#Yו-�Ú^æ'±}6#7)¢­¤«ºFпIþ¿ôÖ…ÏæçTt¡—sQVÃá/AÃæðlRpNEšI×d5Œ0g&g³ŠS2šÐ͹&«>!—/w6­8#£Ý”k²êœ!;šÅÒÊ£�rIU}‚3¤bÇB³XZy´S.iò;ù;ß@ÏZÐtSYTÅ�…nÑ´²8{Ÿ@G©ù�ª0|¶gžV'¯SèhE·S¶&ƒ{ä»z›D•9ª°¥œ/û¡vVø]ù–|\šÁ½ò=•K°OãR±qeçæ-ûÜ|KÿAä:ÑçÆ{·Ç¾Ëd*¼i>ÆûuùÂ}§ßl.:ÞÎQÁ绞ˋÏ÷2>ÒDÎ~|ƒ|ObÐÂû<¾i*§Ç+ä{úí¦ÔÎFŽËÍãM#Ç'®µ¯OñLÿåb/¸2$”F†d#òS\ NfÔ¥M).¤í‹‘ Cög&Ôå,©mäÝ# ÓAE�`¬^â­ÊK;Rڨؗ6Ê_‰Š ‚�v‰¶´XšÜ°±E„(˜k¥ýyÚÒZir;ÀÆ&št`®äikK¥Ñýh0 UjŸg¥÷çYk+µÙ à®kÕA«�íS1»¿ÀZ\©_g[³ Z lŸjÉýÒâFu|?ìeí2X-þ «�Û_ -.TÇ/€½¬_GâëU<,Ã@<³:ßÕ›»H xª®ÈVJF]òaq~?ìU$ƒ<{]™Õ¬—Ng—´Â^EèçÙíÊt¨4‘f§ à–JÙ¼J^@§Ã”áTmËNBÊ'ö*r}?ÍvSއjþ²ä4$\`¯â¶/ ÙnÊñPÍÝø(7?Ï@‡¹ŠÜ½€fœ¬¶m8”c‹›JƒZ`Ë%W/`¹4ßZº¤Þ¾¦ØzÉÍý,Ùx[ò-±;¡© ßäÙ>:ѬŠ÷£ó%·~v¾5rµ¦«Ÿ_ýì :a¾DvDKŠÜ M-¨h^À… äÿ¥¨JD—ýÂ#‰"È7ú[Q•�5�[ÔÁ$G9}°�(mŒKbh�Å »>¤Í’)¯¢ÓAEŠ&j){Õ‡ •ç¥Jd:q�ØX!½êCŠKŠóZ%*�¸Fl,pÁ^µ!E%Çùz%¨{/Ì3‰¼jCŽKŠóZ!„Ø=ã…i&¡WmÈqIQ^+dçÛÈ%Cy±ñÚ¨HÒü„�ß�¯[#ÖÅÊ*ÊÐÓâMçkYÈœæWä‹d¾Æi×(J“`zÂ*׊?Kì�*äÂË„¦…ù#Û¡¬*ð"Ï ùp·G�al——åû3À�ÔiUš}¦'_â:O¹9ß1Ý=¾áWÎðœD'[só¥ùµY¸kŠ÷NùæVúÑp°™Š÷œ|ñƳã­åË�KÏWŠýùZçä|qõ†ùÊŸ…ñ¨Yöc&+òU8e .SêRP»_{²^šÇä+PÊ¡œ¯wŒë‡èÚ“5ÓYÿ%c»gš b}�’— še¤¿�[ó¸q®¹„�×,¹=‰nLÖbÎÈ»³â¿Ð�­åÁ=™úÑÚn+÷ô¦êxp `¦3mRÛ]åþ‹ÆH� 7f:“&¥ÝTíh 3rázD'ά²[ŠýEK’± —# :ræ…ñb¯ð¤š!ÆÙj\„4Æ‚,Vé%žä£ãpª!Ë#aI%ôOô¼tœ§¦E%ÕoŒ—¬T Ö.Ã9zÎSh.‘|®öo€ã£êðŽöžØf>;ßgcçûlì|Ÿ��ï³±ã}4öãûlì|Ÿ��ï³±ó}6.É÷}Ûaó¾Íºq]¼ïùZ…�Üäñý™~ÞhÁùúïÈ;ßn\�ïüî¼]†Ëžßãú“6nñüž³÷+q‡xwÀë ä{ì1OøƒìG6/I9êzþ½¾=ÿW9vÙgÜY‡ëï‡ÞßÂ4âÇjŒÒ±Û†%O˜Ì÷ØešÚÌ øvõû³�‰óÿV0ʦÃßògQ=^Ç·¹�x¯M?�|~¦ZŽD'ãÜg Pigcy#ù ~we=¿V[�N´2žð °>›ß_½¦Çqþ³qüÑ™`´E´½ƒB‰×~5ýLT¢?-¸ÓÌä]Ú>�¯ùç—/xeæoJÓ›õ<ÏOäá·èXû¿à·g8_2^çû�Q±ò}/¹³£ûÐŽ}E¾ ½òm·+þSê}•vÞNmæt¼Ç›ê‘€ùÂO»)Ä!‘ß’3Ð:äͶÈzÌ� ±¤?D¼èíÙý7 ||�ç×òÝî±7Í´}¹TçSßíá+×öy´—ÅâÿÖN.^æít> ßánw_ù¶�£�H•×ðÊÎç‹Bû¾xé»}pÓHj6}œmŒ°YóŽ£pßÇZ¿ Þ8ßøUà´ýu—¸Ì·Œ8‘ÎÃfïvð*g背pÌWC®¡F¼îbÅk&çñ6î3ÞïÍ„c¿ú/¬;ÄXn_œ(xt†)ÃÀ¯ˆ÷o™Îe2^ë‹­[ Þ7ßšœÆiC¯·Ón£}úTx3ìW†£nÁŽd6Ú1ßÙОï >¾æ 1ÅÑQcÌX4Œ·ž_—> stream q endstream endobj 196 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 197 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 198 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 199 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 200 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 201 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 202 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 203 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 204 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 205 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 206 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 207 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 208 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 209 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 210 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 211 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 212 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 213 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 214 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 215 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 216 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 217 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 218 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 219 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 220 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 221 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 222 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 223 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 224 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 225 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 226 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 227 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 228 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 229 0 obj << /Length 89 /LC /QQAP >> stream q /QQAPGSaa31c724 gs q 1 0 0 1 98 16.5 cm 54 0 0 22.6125 0 0 cm /QQAPIm2e98cb5f Do Q Q endstream endobj 230 0 obj << /Type /Annot /Subtype /Link /Rect [ 0 0 1 1 ] /Border [ 0 0 0 ] /A << /Type /Action /S /URI /URI ( ) >> >> endobj 231 0 obj << /Length 1928 /Type /XObject /Subtype /Image /Width 584 /Height 216 /ColorSpace /DeviceRGB /BitsPerComponent 8 /Filter /FlateDecode /SMask 232 0 R >> stream xœíÕ±�\ÉFQCù(™ŒD¦ÂQ ÊAÖ"±€\Y#p{—Ãîi²ºî«ªsPÖ @ƒó¾ÿ¾½ð]ù篼ú€«È“¤k ”'I×(O’®0Pž$]` A×–xõgr„úlÀ¥Õ}‚®-ñêÏäõÙ€R½¿‘tm‰W&G¨ï ”êý�¤kK¼ú3ÙJ}?àŠê]ޤkK¼ú3ÙG}<à¢êiŽôÒ–ýç—/Ÿy;®üêÏdõå€ëª×9Rž3]Óµ9ê³—Vt¤ü-ðU5ÛWÐ5];¡kó¯¬%\îpº¦kº|Ù%mÿ÷uM×¶éÚÛïûõ½Ÿªf;Öÿ»63myetmû®}¨¾°€z¦Ã¼wmZÝòÊèš®ªg:Ìm×&Ô-¯Œ®éðõ@{Ù·u{QàòÊèš®·êuŽw§k¯¨[^]Ó5à«zš/ñµ\wÒ6°nye¤M×€wõ._å“]U·<1º¦kÀ—}£ööd×~¾nybtíÌ®½IܨçøZ·�ú|Ú~¸nyb¤M×àpõ_öc�Ëû¢kº'«‡8ÃÏwí©ºå}‘¶c»ö&m¯žà$HÒϤí3uËã¢kºǪ'8ÉØ®=¬[];¹koÒÆÙêýMòŠ®Ý©[iÓ58V½¿I¾ÐÀ´}û�çeÑ5]ƒcÕû›dlÅî¿<+ùËc¤kõ]�R½¿ItMÚtQïo]Óµí»V߸Šz‹“Ììš´éÚdõ�k©9‰®IÛ®]«O\N=ÊItM×tQ�r]“¶-»V߸¢z—“èš®�ÓµïýQïr]Ó5]ƒCÔ»œDפM×àõ4gÐ5]Ó58J½Î˜®éš®Á~ê�–tMÚt¶To4£kº¦k°«z¦]Ó5]ƒ½Õc�MפM×`{õ^§Ò5]Ó58A=ÙyDMÚtQ¯v]Ó5]ƒsÔÃ�AÔtm§®Áᮣ�íº&m‹víMÚà×v]Ó5]ƒm<HµÖ™DM×ÖíÚ»Éw®ìá:’‘N¦kÒ¶z×ÞÍ? pAw¦1•]Óµ=ºðNÔtM×€�èš®é°QÓ5]v¢k¢¦kÀNtM×t؉¨éš®;Ñ5QÓ5`'º¦kºìDÔDM×€�èš®é°QÓ5]v¢k¢¦kÀNtM×t8SÞˆ_Þ&]øž¼˽+/—®]\}Kàê!ò„¼\§EM×`EõyB/]»¾ú¢@¯^!OÈã¥k×W_èÕ+ä y¼tíúꋽz…> stream xœí]y¸,EuŸ·øË€�èC¥% . £(%±A\ÀQ‚"ˆ4 (bpDå¡$¶ÈâH\¾ bƒ(ú�z5Š ‹�á3nÈD‘ ŒŠðx˜Èc}ËíLíUÝUuzfºßÌåžß?Ó]}êÔ©®ßÔÞ§�@ �@ �@ �@ �@ �@ �@ �@ �@ !°r—]öÚëïö?ð°ÃŽ=þí«WŸ~ƹç}æ’K.»*½þúÿùíï¹';dÚ"‚ùÌ�K¦m!bAàZ€G6§m!b!àX€GÙ›§m!b!`›û}Ú".x4LÛBÄBÀAPÃvÚ´-D,,»àѯ§m!bAà,¨BÚ{Ú"žñèÓ¶± Ðx´öQÓ¶±ðN¨Bzå´-DÌ.Ô<õ_oxô•)š‰˜mlu‘ºþÀ£·™ž�nDiyšq:×Ku»Ÿ¥ãÅWq [ã^/®Ã¦ÉpÜÃ�•ׇCÛqS4Ô…1ÌûbS"1BqPÃÂbàTLl¾¸]0¿£bIJ®ËN”×[þàѵU¤X1úݾG EMOÆPӘᘆ�£˜ÙÚõDmR‰A•Ö\xÜ£'Ö±[–ýDÝ}àѦ�'N°r0Ë<´VÉÒ1TÓŠlÒÿ~�‰»ö†`~GÆÉÙ�«'­tOÚôty÷÷�²÷M˜\˜2�š}Ç«­SjÑ1[¨Kß½B†Ÿð({NÕ™Agnô±:�ˆŽô‰�(­âÔëžtŒ0ç[õñˆ?}¤‚hj}Ñ6]5ñ¨ñqWi?pé?x;ÜKû†økäƒ�6ÙJø¶Çl&Ä€‰>è甆„ä2)?±¯ò2›\«q�·¢ÍHÕ÷=Cùºx´w1£C<ø�×oD<ÀŒñõä»À‹¼kêk#qÙ2·CPJïCr9Bü¾ª“šjq®ÏžÉû®{S³væ!‡XòÛB6þÖQ|²ðEOwGüR.Ò_É'o€ÞãA•çb4ðw9F«Æ*5×x�@$5Æîz¤ÜÓ›,­™âQãæñë/?f;ö`Õ꛳ó�Ѷ{0—ë”�VÞ ¼Æ/UŸ‹‘�P+:ãDe�‘¸Mémè’.>zfÚ Ä£f`Ñ;‹<Ú]³|ãÕoæ»öuèe‡ëœ­Û ù\ÿT=»àÑý[WŸ�Q0ÿU†ª„ Fæß-K:PÝý>}¢Ú5òÝGs¨¡Wlßf‘Gr±uSz‚X¨ÝãcbVúM®Xרñ ùl_€GÙÑ5dcLð*s5:�܉ÛÈ‘Øi1“<:•’躓Ïï·=QãÈ9"íQ$ÇòáÒß<ºº†lŒ€…Ã#‡þ™äÑ“ççôÎ'ð›¥ûñ£ÈŸa�déÞ®¦ >ðhÓìZ7ÌWéÙzTœõ™ � ¼˜I5ŽÄÕÎ*Ô$g[£¬ø“…ÈÇOx”�RG>JC{•Ád*Ÿõ©‡GQiäÔ\%ŸÇÎ' Eó˜*�8¶<ò*Ë âŸVØdµ½jí í¥ò‹²Fmq€çÃ: P¯2tí²·€î¥­…GIFHÓ1åNbjÈCˆPàQ+?mÏwä'4⪾ú}Þyjˆ�CmÒß¶IÞ§†a'B…Rö3ç×zæw#¯=ñ²�kXAf}ØæD9#ŸÒa«?Š >I78$9¨.³Í3Uˆ xÔd•ZÙêv¬ïóŠXáª_fßÉîYDÃû0`ö9%û çºqrKj!Z»$TÇØ;j³qÔ`-Ma2¬t�[¬—äà?F ¹RŽM-gBº5`‘Jóˆ¯OŒ®vè·õ‰Oµ‹j[Ô û×,+eÕŽë=Ç�•Ù ŽòK+ß^H�&F§�¸£Ú€”†‡ã~‚Â굘^›<’5žµB¢µh΢aµ”3ôÒ–`´WhõñÜKí ¬ÿT¿ÅþZ´Ï÷_½ÂKv å¡‰šõÜœ T²È¸”rTØïLѧ�#ŒN/#¦„ïvcObÕê2$4Ø\#¢pµlOZ!7¤T²Ç|¯ ÷ ?OýŒík�Û Ëþû¸ŠU¹6^q7À€‹òJ­ø) åÒ‰²=—û,¹BpJƒCW,Û㢦”YÓ1»U+p|›¡Dˆ:rÔë[âX!i”VÒÏ^rÛü·_L.V�iq=ó’¼øç]Åz‹’ùÀ€û ýO”LxŠÒlò¨›`áÆ—àBÔ‘#xç~T^´ˆÛ�J*žæ{ïÊV~Yu«uÎr}�zD�£J˜ÍgþÙ:)Q3£>+ɘ>ãU?�$=UØBÔ‘#†)Јû,¾õø-†×[¼õ7fi=¸�)ì9’æÓJÊч’¸¶ \_ù$¬Ã‡éñhPQóGí|¤–˜��aBÔ‘£’ÙŠ…he4j4nb×ÒþË^wƒQ\o7e¯sìÝêK“ÓlZ~ô<Î$dAÿæåûÎèÕÒÅ#f•¾™±Í‰$›6!êÈ�Ø%Т6ôÓnÁÈDˆVH£Æû…Ò{»ô» —ꃘŸ6íæó)¢f-w†¶×¾4ê|@Ã- ?ªåQ©ýÙí>Š4-®#¦¿1E$aÛfCyEôeÚf5“†h"ÂÇÚ‡åÂST鬿ˆÞž÷UEcgþé¾¢ý¦’Kü² t7Yœ‘ìýN Éò’ËÄa¤Æ3ä:bú7rH6HÑ<�Ôž%íKH£«.Í�Êd¿<ôýDóßÙ—íúY1 u{Ëïð½¡õ;HÁc · ùï×Džfˆ©�FŽ„@Qâ!G¢8Ió»L,u™\¸¡ÍeS4v~ŒmÅÞÛÚÓÈàm‹~«[¶´ûL)z T0XÌPx»Š““› d£‚m•!¥OB—zà1m‹z�Ø…/w¦Õb¹FMNcDbî ÑiTÇY…�ûCÜG¿Î^vxoþo„x�r=²ÌÛ“Ê €w€›¨æ$÷–Ó»cnƒN`‹�RKB¦)äÝIè��HyÑÇT8|°Å6Q±¶´ÊÁy¤zB¶¾•œ„JƒZiähF¸7Ûb7Ú¤t¨)íÆ™€è:Ÿ+Ág@ 쉼¹�RKBrI÷2:®ÇÍý0dÐ5…t&�ša;̆Ašð]Lj/•µ�ÞÊﵪ‡F�Æöâš¿b_MèyPéÞ  ï ¿ÁcŽwzaˆ?ÍÂin)5%$—13˘¥Ñsðù#=”†Äú¾ZqѤݧ£4pÛsIª?°ÚÚ4ÕE#�¯œŸ&{ÄŸv q�ßá+ÜÖ,ýw&N—L©)!¹ŒEùt¬�)šÚ¶¬@Ò;�GbI²KôÓ$Ž)JÑÊÉ8æ "Y¾Š«Û:]„Þü±—mKh#êÀXƇöwm|¼Åð¸™8í6¥¦„äRíÑMóÛ%Å­ô‘ÜŸÓœ8Ð�HçKÍÁd/íÆmáT[‰R(1žºæž´QE}4NÕó¸ít­<Â*¢áß �àÐý]Ncœ{S8nvÆ,�vÉ.¶ÖÙλðH©-!½f+YÒ#IjÜÊoµŒ‘ŸXÑÈA£õY}4L4.œCçÔpo¢�XéQ„«t1$‡×Këö³Í¿ýU@éÎç>wƒ¶W;gÛù8ͳ,Z#øNTÈ-R¥40äwU%ÅíVCMO×!2½¾Ù1Ë"9zE¦¶+Ñül+ä²ýOg´öšÏ�…š&öpØòz ÞüÎŽˆe1Ú§" æ) Å­Þÿ‘3Ó½–š ÌÕ-¬è›:9¨¬oÛ¸ÍÁË#³\£*ÝÍÿž·/ë\/ÝçSw‰Ñz˯ÍiÜ*­3¦@G”^;i^Sªf0J«Æò’µ„*@;&"µM—½×²wÚÐÉA;Ä>7·J4Ø×·B•ÛEL¼Ræ69ˆ�ª÷>ûöáý:öʹ`+âÎÂXü< Æí>ßÀ#“�þ+J‚õFëmò*,ЂRêR‘¨“ÚY¶AÇô…7 r4;±wT®‰šððHíèÿí¹ºúÚlsþº‹æ»Ñöüw²Å¿6{ P¸Ù‡ *_E±µÍšO|b2+‰�سŽr¤…ôiH˜G�¤¦Õ[ï6!OÒ†‡.ëGâ‘¶‡V~µYÛ ísÄ+$_Ûß5¾I$ý0öç\°°¡è{Éo€8X�&ž&>Á�•D8N$½ø˜5AA²§Ä@ÊŠUXm­èÓÚy$ÇŠ¤5“I½šæ"[GðéŸ`µ>šá-iÓôDR„í¨ˆsïc,‘ž DÊ^9iN™Yá8‘´âããè¼\3&MÇðßž²T¤[¹¥â´�`ˆ€‹G‰xq¬(徑Ú&µ vzÇ�Œ­³›ø`Þ¶’kà¥e»@'ûa‰tgíÄk"¬$Âq"iÅÇO�ɉ‰á$»OjWlÙBgAû†8x”ˆäã|HéS+FÅ'¤ùÁ½pEû toµä^Ü�bâòb”¥·q&?U’•D8N$­øú4À¬†£¾*´T¦"÷mzÚRgAû†Øy”‹"X…8Ù2Pú[öÈâ‚Í„}rúÍ@¬�+Dûó“ŸrËJ"'’*>ÞwÕë˜0•FcÙD<È×4°mÑ>‚!*yúÀä‘Z‰ô`Ùñ®ej;ç›@l_ýP¸<ÖªqÛ¼cÛ<ÞYˆù)­àÔmVá8‘dññö´g’,ùÈ>7- g"?ìbwvmµæwç!O6lØ P }Eô-!¸j@O­/߈Š!¼VËÒ…¾‘þ¤òôx¢„ζÝTÜr‰˜Uˆ™À}øý2¨ïkßd­aéï¼ñÞ^B=òïùRA̸O­ˆ{h¥õë6ö*�õ8CÕ“cD-`Ýjé,ÿR p‹;ˆ ØÕ«àUBìÝ@JÓ>!1ÞFÊì&QË@.Ø(3õðC�å–ÿ¿]\O~õ`GÒ¼-î {ç—Qù6�é\âY@JÙËêÈ-¢6\™e¿—•ä‚­Ônéí=•šTp�Ò]Õ¬‰ 6ŽÕ:={…û“r*Ý~nåÔ"èPòcÕçQ'šÝ-bA.ØŽ)§òUN«…ÈK�”²gWŸSD­øæ¿ˆ«-îñ—í=[úô(¬ø³C�:¸ZùeõùDÔ‹W‹#  ¶ÒmÍ' ¾+VÞ$µÚ§1Û¸Ò_¶ó»–Uäru+�ÖÐÈvâ2b�rÁVâ8>�_YÜ+�hŒÍ®®#ˆÍƒ÷…ûêòªÞkUp�x¼ rx´G7b¶¹`»}„�ÂQ8¡x íâÆ5‘Œý€Â}ÿ(Ê®¶(ø�üxíç@R_¬>wˆÍÀÛ·#u ÞhÑðañ0€ƒªÏb3a[ÀÛ¥#iÛÊ2°—ý³­ñŸÖ†˜e@.ØöƒUè(N4þPË\ÚœB?´ç‘i�£s‹‹�k¨�—XÀ«–ÿÌÙ!½o}?À£w×céÝê–8™ÕíœõHéÔá‘:x2äcŸ³Gí8dÏ1éº�ÛÏ$}𤮻C§¼„]dAàÉܹۋE@þ ç<6®ªÉ’~áD2� ö—ìå‘ÁÇ#êty�vãnÚwò(aBqÍA_î9¹àÑw}Ê&AbœÁGþýÊgzX<ç‘ÀÏ#Ý庇G„!=áýºÕµÇj qæö¸OSÎ'Õ÷òÈþ`¡áM4çòƒ]ûöµ­‰´u® [¹�v–Zl?n×Ã#RµhÏÜeA¥1=Ø:·©Ý÷›�G¤ƒÈ'�ˆ˜Mµ� Ëuz‘ìú†’ݼƔ†….yûƒ‡/gšÓÀÆMVö(|¡>Cæ´²þ#UvÍÌvœº¿]#êT_ÇÅ#rxŒ¥ŸÃ°Îê›!�,_ép Sn备Ö$ñ#ŸG/få-âæ9�²ê3¤£º4Câ¤�*Žvñ| /�È I¡äâQä<•DC`)ì¾ã|&’rjŠYØZõÑò5ÙCÛ‰èÀ˜;–úTMR\¼L#RJ}¹¼ë¨4¼<"Jd�áâQ¯Ìq]�BuDM²ŽìHÊmãY@îÒG>�gg—ˆËåw<:³NCz²cAþ¤¨:ò�õd{?�ÈcÑ;wðÈÕ`š°M^ñ$  Á}]kBŒ_ <Ú3;X\¾jÖö¨Ó�®ìHÐ4eñˆÃùçàQh©iŠ°ÑØÅ@QÊny“æe1ð¨q¥t ðe€FÖ^Je�¥Úbå èÙGý �hƒÄZ6�âR'�YËÚAšrS›³ˆi%ëãQsØ%äçÜÛ@k"ïª×�ïŬ˜ã/?qub Ñwƒktð¨ÄÉ‹™6“¥†vY396›äã‘D凮M Ð�\Gr 0:az¬à:œ}W'äQK”¶›G% /³5«^©±fÄRX\> stream q endstream endobj 234 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 235 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 236 0 obj << /Type /ExtGState /SMask /None /ca 0.13 /CA 0.13 >> endobj 237 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 238 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 239 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 240 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 241 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 242 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 243 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 244 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 245 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 246 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 247 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 248 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 249 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 250 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 251 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 252 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 253 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 254 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 255 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 256 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 257 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj 258 0 obj << /Length 2 /LC /QQAP >> stream q endstream endobj 259 0 obj << /Length 2 /LC /QQAP >> stream Q endstream endobj 260 0 obj << /Length 107 /LC /QQAP >> stream q /QQAPGSdea1b4e9 gs q 0.766 0.6427 -0.6427 0.766 187 204.5 cm 432 0 0 144 0 0 cm /QQAPIm75ba1e00 Do Q Q endstream endobj xref 0 261 0000000000 65535 f 0000054274 00000 n 0000054621 00000 n 0000054772 00000 n 0000055321 00000 n 0000055808 00000 n 0000060280 00000 n 0000060480 00000 n 0000060703 00000 n 0000061665 00000 n 0000062065 00000 n 0000062247 00000 n 0000062318 00000 n 0000062551 00000 n 0000063074 00000 n 0000063363 00000 n 0000063449 00000 n 0000063488 00000 n 0000101975 00000 n 0000106231 00000 n 0000106609 00000 n 0000106795 00000 n 0000106978 00000 n 0000107163 00000 n 0000107347 00000 n 0000107497 00000 n 0000107822 00000 n 0000113006 00000 n 0000113356 00000 n 0000113508 00000 n 0000113844 00000 n 0000117464 00000 n 0000117814 00000 n 0000117964 00000 n 0000118288 00000 n 0000123323 00000 n 0000123673 00000 n 0000123825 00000 n 0000124149 00000 n 0000129137 00000 n 0000129551 00000 n 0000129766 00000 n 0000129977 00000 n 0000130142 00000 n 0000130304 00000 n 0000130460 00000 n 0000130643 00000 n 0000130824 00000 n 0000131002 00000 n 0000131178 00000 n 0000131328 00000 n 0000131664 00000 n 0000137757 00000 n 0000138107 00000 n 0000138259 00000 n 0000138572 00000 n 0000144634 00000 n 0000144984 00000 n 0000145134 00000 n 0000145456 00000 n 0000147908 00000 n 0000148381 00000 n 0000148510 00000 n 0000148773 00000 n 0000150166 00000 n 0000150701 00000 n 0000150516 00000 n 0000150557 00000 n 0000150585 00000 n 0000151097 00000 n 0000000015 00000 n 0000154936 00000 n 0000155088 00000 n 0000000607 00000 n 0000000761 00000 n 0000000917 00000 n 0000001103 00000 n 0000001259 00000 n 0000001409 00000 n 0000001479 00000 n 0000002406 00000 n 0000002788 00000 n 0000003284 00000 n 0000003508 00000 n 0000003830 00000 n 0000006751 00000 n 0000007144 00000 n 0000007739 00000 n 0000008011 00000 n 0000008401 00000 n 0000011706 00000 n 0000012078 00000 n 0000012862 00000 n 0000013426 00000 n 0000014045 00000 n 0000019446 00000 n 0000019819 00000 n 0000020316 00000 n 0000020509 00000 n 0000020813 00000 n 0000023272 00000 n 0000023651 00000 n 0000024694 00000 n 0000025077 00000 n 0000025536 00000 n 0000029708 00000 n 0000030089 00000 n 0000030743 00000 n 0000031073 00000 n 0000031483 00000 n 0000037406 00000 n 0000037786 00000 n 0000038253 00000 n 0000038452 00000 n 0000038748 00000 n 0000041163 00000 n 0000041553 00000 n 0000041764 00000 n 0000041871 00000 n 0000042140 00000 n 0000043211 00000 n 0000043501 00000 n 0000043589 00000 n 0000048520 00000 n 0000048859 00000 n 0000049139 00000 n 0000050329 00000 n 0000050670 00000 n 0000050949 00000 n 0000052230 00000 n 0000052551 00000 n 0000052846 00000 n 0000000037 00000 n 0000155483 00000 n 0000155560 00000 n 0000155893 00000 n 0000156013 00000 n 0000156270 00000 n 0000156531 00000 n 0000168900 00000 n 0000170315 00000 n 0000170420 00000 n 0000170504 00000 n 0000170565 00000 n 0000170668 00000 n 0000170729 00000 n 0000170790 00000 n 0000170851 00000 n 0000170950 00000 n 0000171013 00000 n 0000171076 00000 n 0000171329 00000 n 0000171394 00000 n 0000171544 00000 n 0000171605 00000 n 0000171668 00000 n 0000171731 00000 n 0000171984 00000 n 0000172134 00000 n 0000172195 00000 n 0000172258 00000 n 0000172321 00000 n 0000172574 00000 n 0000172724 00000 n 0000172785 00000 n 0000172848 00000 n 0000172911 00000 n 0000173164 00000 n 0000173314 00000 n 0000173375 00000 n 0000173438 00000 n 0000173501 00000 n 0000173754 00000 n 0000173904 00000 n 0000173965 00000 n 0000174028 00000 n 0000174091 00000 n 0000174344 00000 n 0000174494 00000 n 0000174555 00000 n 0000174618 00000 n 0000174681 00000 n 0000174934 00000 n 0000175084 00000 n 0000175145 00000 n 0000175208 00000 n 0000175271 00000 n 0000175524 00000 n 0000175674 00000 n 0000175735 00000 n 0000175798 00000 n 0000175861 00000 n 0000176114 00000 n 0000176264 00000 n 0000264364 00000 n 0000267627 00000 n 0000267690 00000 n 0000267753 00000 n 0000267904 00000 n 0000268054 00000 n 0000268117 00000 n 0000268180 00000 n 0000268331 00000 n 0000268481 00000 n 0000268544 00000 n 0000268607 00000 n 0000268758 00000 n 0000268908 00000 n 0000268971 00000 n 0000269034 00000 n 0000269185 00000 n 0000269335 00000 n 0000269398 00000 n 0000269461 00000 n 0000269612 00000 n 0000269762 00000 n 0000269825 00000 n 0000269888 00000 n 0000270039 00000 n 0000270189 00000 n 0000270252 00000 n 0000270315 00000 n 0000270466 00000 n 0000270616 00000 n 0000270679 00000 n 0000270742 00000 n 0000270893 00000 n 0000271043 00000 n 0000271106 00000 n 0000271169 00000 n 0000271320 00000 n 0000271470 00000 n 0000273585 00000 n 0000281399 00000 n 0000281462 00000 n 0000281525 00000 n 0000281695 00000 n 0000281766 00000 n 0000281829 00000 n 0000281892 00000 n 0000282062 00000 n 0000282125 00000 n 0000282188 00000 n 0000282358 00000 n 0000282421 00000 n 0000282484 00000 n 0000282654 00000 n 0000282717 00000 n 0000282780 00000 n 0000282950 00000 n 0000283013 00000 n 0000283076 00000 n 0000283246 00000 n 0000283309 00000 n 0000283372 00000 n 0000283542 00000 n 0000283605 00000 n 0000283668 00000 n 0000283838 00000 n 0000283901 00000 n 0000283964 00000 n trailer << /Size 261 /Root 71 0 R /Info 65 0 R /ID [ <9BD7400C2845EE47D207F0397D588EAB> ] >> startxref 284134 %%EOF 1 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj19 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj27 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj31 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj35 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj39 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj52 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj56 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj65 0 obj<>endobj69 0 obj<>stream application/pdf 2020-09-03T05:47:31Z XPP 2023-03-16T09:58:51+08:00 2023-03-16T09:58:51+08:00 Ã�ò²Ê°ì¹«´óʦ-PDFÅúÃ�¿¼ÓÈëˮӡ 4.7.11 uuid:18205d1b-5a4b-41de-b7a9-d39b8ada92ad uuid:2692af6c-8dca-4aad-9ded-10ebe87c197f endstreamendobj72 0 obj<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 603 787.5]/Type/Page>>endobj261 0 obj<>stream BT /CS0 cs 1 scn /GS0 gs /T1_0 1 Tf 8 0 0 8 53.5 713.7472 Tm [(Current)-568(Author)-568(Addresses:)]TJ 0 0 0 1 k /T1_1 1 Tf 8.5 0 0 8.5 166.5594 713.7472 Tm [(Drs.)-535(O\220Malley,)-535(Ritter,)-535(and)-535(Neu-)]TJ -13.301 -1.235 Td [(bauer:)-397(Department)-397(of)-397(Medicine,)-397(Uniformed)-397(Services)-397(Univer-)]TJ 0 -1.235 TD [(sity,)-325(4301)-325(Jones)-325(Bridge)-325(Road,)-325(Bethesda,)-325(MD)-325(20814.)]TJ T* [(Dr.)-399(Arnold:)-399(Department)-399(of)-399(Family)-399(Medicine,)-399(Uniformed)-399(Ser-)]TJ T* [(vices)-478(University)-478(of)-478(the)-478(Health)-478(Sciences,)-478(4301)-478(Jones)-478(Bridge)]TJ T* [(Road,)-325(Bethesda,)-325(MD)-325(20814.)]TJ T* [(Dr.)-708(Kelley:)-708(VA)-708(Pharmacy)-708(Bene\223ts)-708(Management)-708(Services,)]TJ T* [(22948)-325(North)-325(79th)-325(Place,)-325(Scottsdale,)-325(AZ)-325(85255.)]TJ T* [(Drs.)-617(Spacek)-617(and)-617(Downs:)-617(Department)-617(of)-617(Medicine,)-617(South)]TJ T* [(Texas)-401(Veterans)-401(Health)-401(Care)-401(System,)-401(Medicine)-401(Service,)-401(7400)]TJ T* [(Merton)-325(Minter)-325(Boulevard,)-325(San)-325(Antonio,)-325(TX)-325(78229.)]TJ T* [(Dr.)-314(Buelt:)-314(Medicine)-314(Service,)-314(Bay)-314(Pines)-314(VA)-314(Healthcare)-314(System,)]TJ T* [(10000)-325(Bay)-325(Pines)-325(Boulevard,)-325(Bay)-325(Pines,)-325(FL)-325(33744.)]TJ T* [(Dr.)-405(Natarajan:)-405(VA)-405(New)-405(York)-405(Harbor)-405(Healthcare)-405(System,)-405(423)]TJ T* [(East)-325(23rd)-325(Street,)-325(Room)-325(15160-N,)-325(New)-325(York,)-325(NY)-325(10010.)]TJ T* [(Dr.)-325(Donahue:)-325(108)-325(South)-325(Bend)-325(Drive,)-325(Durham,)-325(NC)-325(27713.)]TJ T* [(Dr.)-356(Vagichev)-356(and)-356(Ms.)-356(Thomas:)-356(Walter)-356(Reed)-356(National)-356(Military)]TJ T* [(Medical)-721(Center,)-721(8901)-721(Wisconsin)-721(Avenue,)-721(Bethesda,)-721(MD)]TJ T* (20814.)Tj T* [(Dr.)-472(Ballard-Hernandez:)-472(21121)-472(Amberwick)-472(Lane,)-472(Huntington)]TJ T* [(Beach,)-325(CA)-325(92646.)]TJ T* [(Ms.)-325(Logan:)-325(3775)-325(Lincoln)-325(Road,)-325(Cincinnati,)-325(OH)-325(45247.)]TJ /CS0 cs 1 scn /T1_0 1 Tf 8 0 0 8 53.5 471.7472 Tm [(Author)-310(Contributions:)]TJ 0 0 0 1 k /T1_1 1 Tf 8.5 0 0 8.5 141.3469 471.7472 Tm [(Conception)-292(and)-292(design:)-292(P.G.)-292(O\220Malley,)]TJ -10.335 -1.235 Td [(L.)-462(Spacek,)-462(S.)-462(Natarajan,)-462(J.)-462(Ballard-Hernandez,)-462(J.)-462(Ritter,)-462(B.E.)]TJ T* (Neubauer.)Tj T* [(Analysis)-469(and)-469(interpretation)-469(of)-469(the)-469(data:)-469(P.G.)-469(O\220Malley,)-469(M.J.)]TJ T* [(Arnold,)-730(C.)-730(Kelley,)-730(L.)-730(Spacek,)-730(A.)-730(Buelt,)-730(S.)-730(Natarajan,)-730(E.)]TJ T* [(Vagichev,)-262(J.)-262(Ballard-Hernandez,)-262(A.)-262(Logan,)-262(L.)-262(Thomas,)-262(J.)-262(Ritter,)]TJ T* [(B.E.)-325(Neubauer,)-325(J.R.)-325(Downs.)]TJ T* [(Drafting)-279(of)-279(the)-279(article:)-279(P.G.)-279(O\220Malley,)-279(M.J.)-279(Arnold,)-279(C.)-279(Kelley,)-279(L.)]TJ T* [(Spacek,)-343(A.)-343(Buelt,)-343(S.)-343(Natarajan,)-343(M.P.)-343(Donahue,)-343(E.)-343(Vagichev,)-343(J.)]TJ 31.059 38.353 Td [(Ballard-Hernandez,)-413(A.)-413(Logan,)-413(L.)-413(Thomas,)-413(J.)-413(Ritter,)-413(B.E.)-413(Neu-)]TJ T* [(bauer,)-325(J.R.)-325(Downs.)]TJ T* [(Critical)-852(revision)-852(for)-852(important)-852(intellectual)-852(content:)-852(P.G.)]TJ T* [(O\220Malley,)-319(C.)-319(Kelley,)-319(L.)-319(Spacek,)-319(S.)-319(Natarajan,)-319(M.P.)-319(Donahue,)-319(J.)]TJ T* [(Ballard-Hernandez,)-413(A.)-413(Logan,)-413(L.)-413(Thomas,)-413(J.)-413(Ritter,)-413(B.E.)-413(Neu-)]TJ T* [(bauer,)-325(J.R.)-325(Downs.)]TJ T* [(Final)-453(approval)-453(of)-453(the)-453(article:)-453(P.G.)-453(O\220Malley,)-453(M.J.)-453(Arnold,)-453(C.)]TJ T* [(Kelley,)-499(L.)-499(Spacek,)-499(A.)-499(Buelt,)-499(S.)-499(Natarajan,)-499(M.P.)-499(Donahue,)-499(E.)]TJ T* [(Vagichev,)-262(J.)-262(Ballard-Hernandez,)-262(A.)-262(Logan,)-262(L.)-262(Thomas,)-262(J.)-262(Ritter,)]TJ T* [(B.E.)-325(Neubauer,)-325(J.R.)-325(Downs.)]TJ T* [(Provision)-325(of)-325(study)-325(materials)-325(or)-325(patients:)-325(P.G.)-325(O\220Malley.)]TJ T* [(Statistical)-325(expertise:)-325(P.G.)-325(O\220Malley.)]TJ T* [(Administrative,)-458(technical,)-457(or)-457(logistic)-457(support:)-457(P.G.)-457(O\220Malley,)]TJ T* [(B.E.)-325(Neubauer.)]TJ T* [(Collection)-356(and)-356(assembly)-356(of)-356(data:)-356(P.G.)-356(O\220Malley,)-356(M.J.)-356(Arnold,)]TJ T* [(S.)-325(Natarajan,)-325(J.)-325(Ballard-Hernandez,)-325(B.E.)-325(Neubauer.)]TJ /CS0 cs 1 scn /T1_2 1 Tf 11.5 0 0 11.5 317.5 520.2472 Tm (A)Tj 8.5 0 0 8.5 326.2177 520.2472 Tm (PPENDIX)Tj 0.0001 Tc 11.5 0 0 11.5 369.1499 520.2472 Tm [(:)-254(VA/D)]TJ 0 Tc 8.5 0 0 8.5 408.7897 520.2472 Tm (O)Tj 0.0001 Tc 11.5 0 0 11.5 415.7596 520.2472 Tm [(D)-254(EBPWG)-254(M)]TJ 0 Tc 8.5 0 0 8.5 490.2434 520.2472 Tm (EMBERS)Tj 0 0 0 1 k /T1_1 1 Tf 9.5 0 0 9.5 335.5 507.7472 Tm [(John)-693(R.)-693(Downs,)-693(MD)-693(\()]TJ /T1_3 1 Tf [(VA)-693(Co-Chair)]TJ /T1_1 1 Tf [(\);)-693(Patrick)-693(G.)]TJ -1.895 -1.263 Td [(O\220Malley,)-428(MD,)-428(MPH)-428(\()]TJ /T1_3 1 Tf [(DoD)-428(Co-Chair)]TJ /T1_1 1 Tf [(\);)-428(Brian)-428(Neubauer,)]TJ -0 -1.263 Td [(MD,)-271(MPHE)-271(\()]TJ /T1_3 1 Tf [(DoD)-271(Co-Chair)]TJ /T1_1 1 Tf [(\);)-271(Michael)-271(Arnold,)-271(MD;)-271(Lance)]TJ 0 -1.263 TD [(Spacek,)-895(MD;)-895(Mark)-895(Donahue,)-895(MD;)-895(Cathy)-895(Kelley,)]TJ T* [(PharmD;)-331(Sundar)-331(Natarajan,)-331(MD,)-331(MPH;)-331(Elena)-331(Vagichev,)]TJ T* [(PharmD;)-722(Amanda)-722(Logan,)-722(MPS,)-722(RDN,)-722(LD;)-722(Jennifer)]TJ T* [(Ballard-Hernandez,)-689(DNP,)-689(FNP-BC;)-689(Joan)-689(Ritter,)-689(MD,)]TJ T* [(FACP;)-278(Lauren)-278(Thomas,)-278(MS,)-278(RDN,)-278(LD;)-278(Nikki)-278(Smith,)-278(DNP,)]TJ T* [(FNP-BC;)-255(M.)-255(Eric)-255(Rodgers,)-255(PhD,)-255(FNP;)-255(James)-255(L.)-255(Sall,)-255(PhD,)]TJ T* [(FNP;)-577(James)-577(Reston,)-577(PhD;)-577(ECRI)-577(Institute;)-577(The)-577(Lewin)]TJ T* [(Group;)-325(and)-325(Sigma)-325(Health)-325(Consulting.)]TJ /T1_4 1 Tf 7 0 0 7 53.5 35.7471 Tm (Annals.org)Tj /CS0 cs 1 scn /T1_5 1 Tf 42.787 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 1 rg /GS1 gs /T1_6 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj262 0 obj<>endobj263 0 obj<>stream BT 0 0 0 1 k /GS0 gs /T1_0 1 Tf -0.0195 Tc 8 0 0 8 53.5 714.2472 Tm (16.)Tj /T1_1 1 Tf 1.731 0 Td [(Graversen)-370(P,)-370(Abildstr\370m)-370(SZ,)-370(Jespersen)-370(L,)-370(et)-370(al.)]TJ /T1_0 1 Tf 21.723 0 Td (Cardiovascular)Tj -23.454 -1.209 Td [(risk)-342(prediction:)-342(can)-342(systematic)-342(coronary)-342(risk)-342(evaluation)-342(\(SCORE\))-342(be)]TJ 0 -1.209 TD [(improved)-355(by)-355(adding)-355(simple)-355(risk)-355(markers?)-355(Results)-355(from)-355(the)-355(Copen-)]TJ T* [(hagen)-247(City)-247(Heart)-247(Study.)-247(Eur)-247(J)-247(Prev)-247(Cardiol.)-247(2016;23:1546-56.)-247([PMID:)]TJ T* [(26976846])-299(doi:10.1177/2047487316638201)]TJ T* (17.)Tj /T1_1 1 Tf 1.636 0 Td [(Yeboah)-274(J,)-274(Young)-274(R,)-274(McClelland)-274(RL,)-274(et)-274(al.)]TJ /T1_0 1 Tf 18.345 0 Td [(Utility)-274(of)-274(nontraditional)]TJ -19.981 -1.209 Td [(risk)-502(markers)-502(in)-502(atherosclerotic)-502(cardiovascular)-502(disease)-502(risk)-502(assess-)]TJ T* [(ment.)-369(J)-369(Am)-369(Coll)-369(Cardiol.)-369(2016;67:139-147.)-369([PMID:)-369(26791059])-369(doi:)]TJ T* (10.1016/j.jacc.2015.10.058)Tj T* (18.)Tj /T1_1 1 Tf 1.658 0 Td [(Kim)-297(KP,)-297(Einstein)-297(AJ,)-297(Berrington)-297(de)-297(Gonza)377(\264)-146(lez)-297(A.)]TJ /T1_0 1 Tf 21.408 0 Td [(Coronary)-297(artery)]TJ -23.066 -1.209 Td [(calci\223cation)-495(screening:)-495(estimated)-495(radiation)-495(dose)-495(and)-495(cancer)-495(risk.)]TJ 0 -1.207 TD [(Arch)-688(Intern)-688(Med.)-688(2009;169:1188-94.)-688([PMID:)-688(19597067])-688(doi:10)]TJ T* (.1001/archinternmed.2009.162)Tj T* (19.)Tj /T1_1 1 Tf 1.714 0 Td [(Yebyo)-353(HG,)-353(Aschmann)-353(HE,)-353(Kaufmann)-353(M,)-353(et)-353(al.)]TJ /T1_0 1 Tf 21.1 0 Td [(Comparative)-353(ef-)]TJ -22.814 -1.207 Td [(fectiveness)-331(and)-331(safety)-331(of)-331(statins)-331(as)-331(a)-331(class)-331(and)-331(of)-331(speci\223c)-331(statins)-331(for)]TJ T* [(primary)-412(prevention)-412(of)-412(cardiovascular)-412(disease:)-412(a)-412(systematic)-412(review,)]TJ T* [(meta-analysis,)-380(and)-380(network)-380(meta-analysis)-380(of)-380(randomized)-380(trials)-380(with)]TJ T* [(94,283)-275(participants.)-275(Am)-275(Heart)-275(J.)-275(2019;210:18-28.)-275([PMID:)-275(30716508])]TJ T* (doi:10.1016/j.ahj.2018.12.007)Tj T* (20.)Tj /T1_1 1 Tf 1.816 0 Td [(Downs)-455(JR,)-455(Clear\223eld)-455(M,)-455(Weis)-455(S,)-455(et)-455(al.)]TJ /T1_0 1 Tf 18.299 0 Td [(Primary)-455(prevention)-455(of)]TJ -20.115 -1.207 Td [(acute)-313(coronary)-313(events)-313(with)-313(lovastatin)-313(in)-313(men)-313(and)-313(women)-313(with)-313(aver-)]TJ T* [(age)-291(cholesterol)-291(levels:)-291(results)-291(of)-291(AFCAPS/TexCAPS.)-291(Air)-291(Force/Texas)]TJ T* [(Coronary)-348(Atherosclerosis)-348(Prevention)-348(Study.)-348(JAMA.)-348(1998;279:1615-)]TJ T* [(22.)-299([PMID:)-299(9613910])]TJ T* (21.)Tj /T1_1 1 Tf 1.66 0 Td [(Taylor)-299(F,)-299(Huffman)-299(MD,)-299(Macedo)-299(AF,)-299(et)-299(al.)]TJ /T1_0 1 Tf 18.565 0 Td [(Statins)-299(for)-299(the)-299(primary)]TJ -20.225 -1.207 Td [(prevention)-711(of)-711(cardiovascular)-711(disease.)-711(Cochrane)-711(Database)-711(Syst)]TJ T* [(Rev.)-674(2013:CD004816.)-674([PMID:)-674(23440795])-674(doi:10.1002/14651858)]TJ T* (.CD004816.pub5)Tj T* (22.)Tj /T1_1 1 Tf 1.719 0 Td [(Du)-358(H,)-358(Li)-358(X,)-358(Su)-358(N,)-358(et)-358(al.)]TJ /T1_0 1 Tf 10.706 0 Td [(Proprotein)-358(convertase)-358(subtilisin/kexin)-358(9)]TJ -12.425 -1.207 Td [(inhibitors)-322(in)-322(reducing)-322(cardiovascular)-322(outcomes:)-322(a)-322(systematic)-322(review)]TJ T* [(and)-454(meta-analysis.)-454(Heart.)-454(2019;105:1149-1159.)-454([PMID:)-454(30842207])]TJ T* (doi:10.1136/heartjnl-2019-314763)Tj T* (23.)Tj /T1_1 1 Tf 1.724 0 Td [(Baigent)-362(C,)-362(Keech)-362(A,)-362(Kearney)-362(PM,)-362(et)-362(al;)-362(Cholesterol)-362(Treatment)]TJ -1.724 -1.207 Td [(Trialists')-606(\(CTT\))-606(Collaborators.)]TJ /T1_0 1 Tf 13.994 0 Td [(Ef\223cacy)-606(and)-606(safety)-606(of)-606(cholesterol-)]TJ -13.994 -1.207 Td [(lowering)-370(treatment:)-370(prospective)-370(meta-analysis)-370(of)-370(data)-370(from)-370(90,056)]TJ T* [(participants)-515(in)-515(14)-515(randomised)-515(trials)-515(of)-515(statins.)-515(Lancet.)-515(2005;366:)]TJ T* [(1267-78.)-299([PMID:)-299(16214597])]TJ T* (24.)Tj /T1_1 1 Tf 1.695 0 Td [(Koskinas)-334(KC,)-334(Siontis)-334(GCM,)-334(Piccolo)-334(R,)-334(et)-334(al.)]TJ /T1_0 1 Tf 19.522 0 Td [(Effect)-334(of)-334(statins)-334(and)]TJ -21.217 -1.207 Td [(non-statin)-299(LDL-lowering)-299(medications)-299(on)-299(cardiovascular)-299(outcomes)-299(in)]TJ T* [(secondary)-582(prevention:)-582(a)-582(meta-analysis)-582(of)-582(randomized)-582(trials.)-582(E)20(u)20(r)]TJ -0.0398 Tc T* [(Heart)-356(J.)-356(2018;39:1172-1180.)-356([PMID:)-356(29069377])-356(doi:10.1093/eurheartj)]TJ T* (/ehx566)Tj -0.0195 Tc T* (25.)Tj /T1_1 1 Tf 1.82 0 Td [(Silva)-458(M,)-458(Matthews)-458(ML,)-458(Jarvis)-458(C,)-458(et)-458(al.)]TJ /T1_0 1 Tf 18.048 0 Td [(Meta-analysis)-458(of)-458(drug-)]TJ -19.868 -1.207 Td [(induced)-404(adverse)-404(events)-404(associated)-404(with)-404(intensive-dose)-404(statin)-404(ther-)]TJ T* [(apy.)-299(Clin)-299(Ther.)-299(2007;29:253-60.)-299([PMID:)-299(17472818])]TJ T* (26.)Tj /T1_1 1 Tf 1.66 0 Td [(Wang)-298(S,)-298(Cai)-298(R,)-298(Yuan)-298(Y,)-298(et)-298(al.)]TJ /T1_0 1 Tf 13.091 0 Td [(Association)-298(between)-298(reductions)-298(in)]TJ -14.75 -1.207 Td [(low-density)-257(lipoprotein)-257(cholesterol)-257(with)-257(statin)-257(therapy)-257(and)-257(the)-257(risk)-257(of)]TJ T* [(new-onset)-295(diabetes:)-295(a)-295(meta-analysis.)-295(Sci)-295(Rep.)-295(2017;7:39982.)-295([PMID:)]TJ T* [(28071756])-299(doi:10.1038/srep39982)]TJ T* (27.)Tj /T1_1 1 Tf 1.799 0 Td [(Zhan)-438(S,)-438(Tang)-438(M,)-438(Liu)-438(F,)-438(et)-438(al.)]TJ /T1_0 1 Tf 13.834 0 Td [(Ezetimibe)-438(for)-438(the)-438(prevention)-438(of)]TJ -15.633 -1.207 Td [(cardiovascular)-603(disease)-603(and)-603(all-cause)-603(mortality)-603(events.)-603(Cochrane)]TJ T* [(Database)-451(Syst)-451(Rev.)-451(2018;11:CD012502.)-451([PMID:)-451(30480766])-451(doi:10)]TJ T* (.1002/14651858.CD012502.pub2)Tj T* (28.)Tj /T1_1 1 Tf 1.665 0 Td [(Schmidt)-303(AF,)-303(Pearce)-303(LS,)-303(Wilkins)-303(JT,)-303(et)-303(al.)]TJ /T1_0 1 Tf 18.144 0 Td [(PCSK9)-303(monoclonal)-303(an-)]TJ -19.808 -1.207 Td [(tibodies)-279(for)-279(the)-279(primary)-279(and)-279(secondary)-279(prevention)-279(of)-279(cardiovascular)]TJ T* [(disease.)-501(Cochrane)-501(Database)-501(Syst)-501(Rev.)-501(2017;4:CD011748.)-501([PMID:)]TJ T* [(28453187])-299(doi:10.1002/14651858.CD011748.pub2)]TJ T* (29.)Tj /T1_1 1 Tf 0.0199 Tc 1.734 0 Td [(M)39(ora)-373(S,)-373(Chang)-373(CL,)-373(Moorthy)-373(MV,)-373(et)-373(al.)]TJ /T1_0 1 Tf 18.964 0 Td [(Association)-373(of)-373(non-)]TJ -20.698 -1.207 Td [(fasting)-325(vs)-325(fasting)-325(lipid)-325(levels)-325(with)-325(risk)-325(of)-325(major)-325(coronary)-325(events)]TJ -0.0398 Tc T* [(in)-331(the)-331(Anglo-Scandinavian)-331(Cardiac)-331(Outcomes)-331(Trial-lipid)-331(lowering)-331(arm.)]TJ 33 71.25 Td [(JAMA)-358(Intern)-358(Med.)-358(2019;179:898-905.)-358([PMID:)-358(31135812])-358(doi:10.1001)]TJ 0 -1.187 TD (/jamainternmed.2019.0392)Tj -0.0195 Tc T* (30.)Tj /T1_1 1 Tf 1.726 0 Td [(Angelow)-364(A,)-364(Schmidt)-364(CO,)-364(Do)]TJ 0.3448 Tc 12.694 0 Td [(\250)184(r)364(rM)364(,e)364(ta)364(l)364(.)]TJ /T1_0 1 Tf -0.0195 Tc [(Utility)-364(of)-364(repeat)-364(serum)]TJ -14.419 -1.187 Td [(cholesterol)-416(measurements)-416(for)-416(assessment)-416(of)-416(cardiovascular)-416(risk)-416(in)]TJ T* [(primary)-576(prevention.)-576(Eur)-576(J)-576(Prev)-576(Cardiol.)-576(2016;23:628-35.)-576([PMID:)]TJ T* [(26170419])-299(doi:10.1177/2047487315595583)]TJ T* (31.)Tj /T1_1 1 Tf 1.699 0 Td [(Perera)-337(R,)-337(McFadden)-337(E,)-337(McLellan)-337(J,)-337(et)-337(al.)]TJ /T1_0 1 Tf 18.572 0 Td [(Optimal)-337(strategies)-337(for)]TJ -20.271 -1.187 Td [(monitoring)-350(lipid)-350(levels)-350(in)-350(patients)-350(at)-350(risk)-350(or)-350(with)-350(cardiovascular)-350(dis-)]TJ T* [(ease:)-647(a)-647(systematic)-647(review)-647(with)-647(statistical)-647(and)-647(cost-effectiveness)]TJ T* [(modelling.)-565(Health)-565(Technol)-565(Assess.)-565(2015;19:1-401,)-565(vii-viii.)-565([PMID:)]TJ T* [(26680162])-299(doi:10.3310/hta191000)]TJ T* (32.)Tj /T1_1 1 Tf 1.807 0 Td [(Piercy)-445(KL,)-445(Troiano)-445(RP,)-445(Ballard)-445(RM,)-445(et)-445(al.)]TJ /T1_0 1 Tf 19.102 0 Td [(The)-445(physical)-445(activity)]TJ -20.909 -1.187 Td [(guidelines)-780(for)-780(Americans.)-780(JAMA.)-780(2018;320:2020-2028.)-780([PMID:)]TJ T* [(30418471])-299(doi:10.1001/jama.2018.14854)]TJ T* (33.)Tj /T1_1 1 Tf 1.709 0 Td [(Abell)-348(B,)-348(Glasziou)-348(P,)-348(Hoffmann)-348(T.)]TJ /T1_0 1 Tf 15.073 0 Td [(The)-348(contribution)-348(of)-348(individual)]TJ -16.782 -1.187 Td [(exercise)-454(training)-454(components)-454(to)-454(clinical)-454(outcomes)-454(in)-454(randomised)]TJ T* [(controlled)-465(trials)-465(of)-465(cardiac)-465(rehabilitation:)-465(a)-465(systematic)-465(review)-465(and)]TJ T* [(meta-regression.)-414(Sports)-414(Med)-414(Open.)-414(2017;3:19.)-414([PMID:)-414(28477308])]TJ T* (doi:10.1186/s40798-017-0086-z)Tj T* (34.)Tj /T1_1 1 Tf 1.726 0 Td [(Rees)-365(K,)-365(Takeda)-365(A,)-365(Martin)-365(N,)-365(et)-365(al.)]TJ /T1_0 1 Tf 15.848 0 Td [(Mediterranean-style)-365(diet)-365(for)]TJ -17.574 -1.187 Td [(the)-232(primary)-232(and)-232(secondary)-232(prevention)-232(of)-232(cardiovascular)-232(disease.)-232(Co-)]TJ T* [(chrane)-515(Database)-515(Syst)-515(Rev.)-515(2019;3:CD009825.)-515([PMID:)-515(30864165])]TJ T* (doi:10.1002/14651858.CD009825.pub3)Tj T* (35.)Tj /T1_1 1 Tf 1.633 0 Td [(Bhatt)-272(DL,)-272(Steg)-272(PG,)-272(Miller)-272(M,)-272(et)-272(al;)-272(REDUCE-IT)-272(Investigators.)]TJ /T1_0 1 Tf 26.496 0 Td (Car-)Tj -28.129 -1.187 Td [(diovascular)-298(risk)-298(reduction)-298(with)-298(icosapent)-298(ethyl)-298(for)-298(hypertriglyceride-)]TJ T* [(mia.)-293(N)-293(Engl)-293(J)-293(Med.)-293(2019;380:11-22.)-293([PMID:)-293(30415628])-293(doi:10.1056)]TJ T* (/NEJMoa1812792)Tj T* (36.)Tj /T1_1 1 Tf 1.81 0 Td [(Abdelhamid)-449(AS,)-449(Brown)-449(TJ,)-449(Brainard)-449(JS,)-449(et)-449(al.)]TJ /T1_0 1 Tf 21.637 0 Td [(Omega-3)-449(fatty)]TJ -23.447 -1.187 Td [(acids)-441(for)-441(the)-441(primary)-441(and)-441(secondary)-441(prevention)-441(of)-441(cardiovascular)]TJ T* [(disease.)-408(Cochrane)-408(Database)-408(Syst)-408(Rev.)-408(2018;11:CD003177.)-408([PMID:)]TJ T* [(30521670])-299(doi:10.1002/14651858.CD003177.pub4)]TJ T* (37.)Tj /T1_1 1 Tf 1.709 0 Td [(Keene)-348(D,)-348(Price)-348(C,)-348(Shun-Shin)-348(MJ,)-348(et)-348(al.)]TJ /T1_0 1 Tf 17.663 0 Td [(Effect)-348(on)-348(cardiovascular)]TJ -19.373 -1.187 Td [(risk)-377(of)-377(high)-377(density)-377(lipoprotein)-377(targeted)-377(drug)-377(treatments)-377(niacin,)-377(\223-)]TJ T* [(brates,)-283(and)-283(CETP)-283(inhibitors:)-283(meta-analysis)-283(of)-283(randomised)-283(controlled)]TJ T* [(trials)-630(including)-630(117,411)-630(patients.)-630(BMJ.)-630(2014;349:g4379.)-630([PMID:)]TJ T* [(25038074])-299(doi:10.1136/bmj.g4379)]TJ T* (38.)Tj /T1_1 1 Tf 1.703 0 Td [(Schandelmaier)-342(S,)-342(Briel)-342(M,)-342(Saccilotto)-342(R,)-342(et)-342(al.)]TJ /T1_0 1 Tf 20.255 0 Td [(Niacin)-342(for)-342(primary)]TJ -21.958 -1.187 Td [(and)-289(secondary)-289(prevention)-289(of)-289(cardiovascular)-289(events.)-289(Cochrane)-289(Data-)]TJ T* [(base)-474(Syst)-474(Rev.)-474(2017;6:CD009744.)-474([PMID:)-474(28616955])-474(doi:10.1002)]TJ T* (/14651858.CD009744.pub2)Tj T* (39.)Tj /T1_1 1 Tf 1.682 0 Td [(Kaur)-321(N,)-321(Pandey)-321(A,)-321(Negi)-321(H,)-321(et)-321(al.)]TJ /T1_0 1 Tf 14.848 0 Td [(Effect)-321(of)-321(HDL-raising)-321(drugs)-321(on)]TJ -16.53 -1.187 Td [(cardiovascular)-333(outcomes:)-333(a)-333(systematic)-333(review)-333(and)-333(meta-regression.)]TJ T* [(PLoS)-444(One.)-444(2014;9:e94585.)-444([PMID:)-444(24728455])-444(doi:10.1371/journal)]TJ T* (.pone.0094585)Tj T* (40.)Tj /T1_1 1 Tf 1.672 0 Td [(Jakob)-311(T,)-311(Nordmann)-311(AJ,)-311(Schandelmaier)-311(S,)-311(et)-311(al.)]TJ /T1_0 1 Tf 21.475 0 Td [(Fibrates)-311(for)-311(pri-)]TJ -23.147 -1.187 Td [(mary)-395(prevention)-395(of)-395(cardiovascular)-395(disease)-395(events.)-395(Cochrane)-395(Data-)]TJ T* [(base)-299(Syst)-299(Rev.)-299(2016;11:CD009753.)-299([PMID:)-299(27849333])]TJ T* (41.)Tj /T1_1 1 Tf 0.0199 Tc 1.703 0 Td [(S)39(hao)-341(K,)-341(Tang)-341(Y,)-341(Zhou)-341(D,)-341(et)-341(al.)]TJ /T1_0 1 Tf 14.934 0 Td [(Comparison)-341(of)-341(the)-341(safety)-341(of)]TJ -16.637 -1.187 Td [(statin)-535(monotherapy)-535(and)-535(coadministration)-535(with)-535(feno\223brate)-535(in)]TJ T* [(patients)-481(with)-481(mixed)-481(hyperlipidemia:)-481(a)-481(meta-analysis.)-481(Interna-)]TJ T* [(tional)-423(Journal)-423(of)-423(Clinical)-423(and)-423(Experimental)-423(Medicine.)-423(2016;9:)]TJ T* (5291-300.)Tj -0.0195 Tc T* (42.)Tj /T1_1 1 Tf 1.635 0 Td [(Murray)-274(AM,)-274(Hsu)-274(FC,)-274(Williamson)-274(JD,)-274(et)-274(al;)-274(Action)-274(to)-274(Control)-274(Car-)]TJ -1.635 -1.187 Td [(diovascular)-757(Risk)-757(in)-757(Diabetes)-757(Follow-On)-757(Memory)-757(in)-757(Diabetes)]TJ T* [(\(ACCORDION)-370(MIND\))-370(Investigators.)]TJ /T1_0 1 Tf 16.263 0 Td [(ACCORDION)-370(MIND:)-370(results)-370(of)]TJ -16.263 -1.187 Td [(the)-267(observational)-267(extension)-267(of)-267(the)-267(ACCORD)-267(MIND)-267(randomised)-267(trial.)]TJ T* [(Diabetologia.)-299(2017;60:69-80.)-299([PMID:)-299(27766347])]TJ T* (43.)Tj /T1_1 1 Tf 1.604 0 Td [(Ginsberg)-243(HN,)-243(Elam)-243(MB,)-243(Lovato)-243(LC,)-243(et)-243(al;)-243(ACCORD)-243(Study)-243(Group.)]TJ /T1_0 1 Tf -1.604 -1.187 Td [(Effects)-522(of)-522(combination)-522(lipid)-522(therapy)-522(in)-522(type)-522(2)-522(diabetes)-522(mellitus.)]TJ T* [(N)-439(Engl)-439(J)-439(Med.)-439(2010;362:1563-74.)-439([PMID:)-439(20228404])-439(doi:10.1056)]TJ T* (/NEJMoa1001282)Tj /CS0 cs 1 scn /T1_2 1 Tf 0 Tc 16 0 0 16 53.5 744.2472 Tm (C)Tj 11.5 0 0 11.5 63.8198 744.2472 Tm (LINICAL)Tj 16 0 0 16 111.2371 744.2472 Tm (G)Tj 11.5 0 0 11.5 122.6129 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k -0.0196 Tc 9 0 0 9 373.4 744.2472 Tm [(Updated)-324(VA/DoD)-324(2020)-324(Cholesterol)-324(Guidelines)]TJ /T1_3 1 Tf 0 Tc 7 0 0 7 53.5 35.7471 Tm (8)Tj /CS0 cs 1 scn /T1_2 1 Tf 1.203 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_4 1 Tf 65.769 0 Td (Annals.org)Tj 0 0 1 rg /GS1 gs /T1_5 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj264 0 obj<>endobj265 0 obj<>stream BT /CS0 cs 1 scn /GS0 gs /T1_0 1 Tf 11.5 0 0 11.5 53.5 712.2472 Tm (C)Tj 8.5 0 0 8.5 61.7231 712.2472 Tm (ONCLUSION)Tj 0 0 0 1 k /T1_1 1 Tf -0.0198 Tc 9.5 0 0 9.5 71.5 699.6676 Tm [(W)-20(e)-342(present)-342(a)-342(pragmatic,)-342(patient-centered)-342(approach)]TJ -1.895 -1.166 Td [(to)-286(managing)-286(lipid)-286(levels)-286(to)-286(reduce)-286(CVD)-286(risk,)-286(applying)-286(ev-)]TJ 0 -1.166 TD [(idence)-249(for)-249(treatment)-249(that)-249(is)-249(concordant)-249(with)-249(the)-249(risk)-249(in)-249(the)]TJ T* [(populations)-336(studied.)-336(Although)-336(our)-336(guideline)-336(is)-336(similar)-336(to)]TJ T* [(that)-240(of)-240(the)-240(American)-240(College)-240(of)-240(Cardiology)-240(and)-240(American)]TJ T* [(Heart)-395(Association)-395(\(7\),)-395(there)-395(are)-395(several)-395(important)-395(differ-)]TJ T* [(ences.)-332(First,)-332(we)-332(are)-332(less)-332(con\223dent)-332(that)-332(the)-332(trial)-332(data)-332(sup-)]TJ T* [(port)-589(lower)-589(LDL-C)-589(target)-589(levels)-589(and)-589(higher)-589(dosing)-589(of)]TJ T* [(statins,)-372(especially)-372(in)-372(primary)-372(prevention.)-372(Second,)-372(we)-372(ex-)]TJ T* [(tended)-301(the)-301(literature)-301(review)-301(through)-301(May)-301(2019.)-301(Third,)-301(al-)]TJ T* [(though)-360(we)-360(continue)-360(to)-360(support)-360(the)-360(use)-360(of)-360(calculators)-360(to)]TJ T* [(estimate)-333(CVD)-333(risk)-333(for)-333(primary)-333(prevention,)-333(we)-333(do)-333(not)-333(be-)]TJ T* [(lieve)-320(the)-320(evidence)-320(supports)-320(the)-320(routine)-320(use)-320(of)-320(additional)]TJ T* [(tests)-294(for)-294(risk)-294(prediction,)-294(even)-294(in)-294(intermediate-risk)-294(popula-)]TJ T* [(tions.)-275(Fourth,)-275(safety)-275(concerns)-275(\(particularly)-275(with)-275(higher)-275(sta-)]TJ T* [(tin)-317(doses)-317(and)-317(combination)-317(therapy\))-317(in\224uenced)-317(our)-317(phar-)]TJ T* [(macologic)-369(treatment)-369(recommendations,)-369(which)-369(start)-369(with)]TJ T* [(more)-405(conservative)-405(and)-405(safer)-405(moderate-dose)-405(statin)-405(ther-)]TJ T* [(apy)-238(for)-238(both)-238(primary)-238(and)-238(secondary)-238(prevention,)-238(reserving)]TJ T* [(upward)-425(titration)-425(for)-425(secondary)-425(prevention)-425(in)-425(higher-risk)]TJ T* [(patients)-362(on)-362(the)-362(basis)-362(of)-362(shared)-362(decision)-362(making)-362(and)-362(re-)]TJ T* [(current)-423(events.)-423(Fifth,)-423(we)-423(believe)-423(that)-423(the)-423(evidence)-423(sup-)]TJ 0 -1.165 TD [(ports)-325(a)-325(more)-325(assertive)-325(stance)-325(on)-325(aerobic)-325(activity,)-325(cardiac)]TJ T* [(rehabilitation,)-244(nutrition,)-244(and)-244(supplements.)-244(Sixth,)-244(we)-244(take)-244(a)]TJ T* [(stronger)-285(position)-285(on)-285(limiting)-285(the)-285(use)-285(of)-285(laboratory)-285(testing)]TJ T* [(to)-313(a)-313(more)-313(judicious,)-313(decision-oriented)-313(approach.)-313(Speci\223-)]TJ T* [(cally,)-624(we)-624(recommend)-624(nonfasting)-624(lipid)-624(pro\223les,)-624(which)]TJ T* [(should)-458(be)-458(repeated)-458(only)-458(every)-458(10)-458(years)-458(\(given)-458(limited)]TJ T* [(variability)-236(over)-236(time\),)-236(and)-236(not)-236(at)-236(all)-236(once)-236(a)-236(goal)-236(statin)-236(dose)]TJ T* [(is)-299(achieved.)]TJ 0 Tc 8.5 0 0 8.5 53.5 356.8835 Tm [(From)-445(Uniformed)-445(Services)-445(University)-445(of)-445(the)-445(Health)-445(Sciences,)]TJ 0 -1.243 TD [(Bethesda,)-343(Maryland)-343(\(P.G.O.,)-343(M.J.A.,)-343(B.E.N.\);)-343(U.S.)-343(Department)]TJ T* [(of)-371(Veterans)-371(Affairs)-371(Pharmacy)-371(Bene\223ts)-371(Management)-371(Services,)]TJ T* [(Scottsdale,)-366(Arizona)-366(\(C.K.\);)-366(South)-366(Texas)-366(Veterans)-366(Health)-366(Care)]TJ T* [(System)-459(and)-459(University)-459(of)-459(Texas)-459(Health)-459(Science)-459(Center,)-459(San)]TJ T* [(Antonio,)-308(Texas)-308(\(L.S.,)-308(J.R.D.\);)-308(Bay)-308(Pines)-308(VA)-308(Healthcare)-308(System,)]TJ T* [(Bay)-318(Pines,)-318(Florida)-318(\(A.B.\);)-318(New)-318(York)-318(University)-318(School)-318(of)-318(Med-)]TJ T* [(icine)-303(and)-303(VA)-303(New)-303(York)-303(Harbor)-303(Healthcare)-303(System,)-303(New)-303(York,)]TJ T* [(New)-281(York)-281(\(S.N.\);)-281(Duke)-281(University)-281(Medical)-281(Center)-281(and)-281(Durham)]TJ T* [(VA)-366(Medical)-366(Center,)-366(Durham,)-366(North)-366(Carolina)-366(\(M.P.D.\);)-366(Walter)]TJ T* [(Reed)-474(National)-474(Military)-474(Medical)-474(Center,)-474(Bethesda,)-474(Maryland)]TJ T* [(\(E.V.,)-315(L.T.\);)-315(Tibor)-315(Rubin)-315(VA)-315(Medical)-315(Center,)-315(Long)-315(Beach,)-315(Cali-)]TJ T* [(fornia)-435(\(J.B.\);)-435(Cincinnati)-435(VA)-435(Medical)-435(Center,)-435(Cincinnati,)-435(Ohio)]TJ T* [(\(A.L.\);)-596(and)-596(Walter)-596(Reed)-596(Military)-596(Medical)-596(Center)-596(and)-596(Uni-)]TJ T* [(formed)-360(Services)-360(University)-360(of)-360(the)-360(Health)-360(Sciences,)-360(Bethesda,)]TJ T* [(Maryland)-325(\(J.R.\).)]TJ /CS0 cs 1 scn /T1_2 1 Tf 8 0 0 8 53.5 170.7926 Tm (Disclaimer:)Tj 0 0 0 1 k /T1_1 1 Tf 8.5 0 0 8.5 99.7597 170.7926 Tm [(The)-310(views)-310(expressed)-310(here)-310(are)-310(of)-310(the)-310(authors,)-310(and)]TJ -5.442 -1.243 Td [(are)-325(not)-325(to)-325(be)-325(construed)-325(as)-325(those)-325(of)-325(the)-325(VA)-325(or)-325(DoD.)]TJ /CS0 cs 1 scn /T1_2 1 Tf 8 0 0 8 53.5 132.6563 Tm (Disclosures:)Tj 0 0 0 1 k /T1_1 1 Tf 8.5 0 0 8.5 104.1081 132.6563 Tm [(Authors)-441(have)-441(disclosed)-441(no)-441(con\224icts)-441(of)-441(interest.)]TJ -5.954 -1.243 Td [(Forms)-639(can)-639(be)-639(viewed)-639(at)-639(www.acponline.org)]TJ -0.0197 Tc 21.87 0 Td (/authors/icmje)Tj -21.87 -1.243 Td (/Con\224ictOfInterestForms.do?msNum=M20-4648.)Tj /CS0 cs 1 scn /T1_2 1 Tf 0 Tc 8 0 0 8 53.5 83.9517 Tm [(Corresponding)-528(Author:)]TJ 0 0 0 1 k /T1_1 1 Tf 8.5 0 0 8.5 150.0458 83.9517 Tm [(Patrick)-497(G.)-497(O\220Malley,)-497(MD,)-497(MPH,)-497(De-)]TJ -11.358 -1.243 Td [(partment)-490(of)-490(Medicine,)-490(Uniformed)-490(Services)-490(University,)-490(4301)]TJ T* [(Jones)-606(Bridge)-606(Road,)-606(Bethesda,)-606(MD)-606(20814;)-606(e-mail,)-606(patrick)]TJ T* (.omalley@usuhs.edu.)Tj 31.059 77.823 Td [(Current)-357(author)-357(addresses)-357(and)-357(author)-357(contributions)-357(are)-357(avail-)]TJ 0 -1.263 TD [(able)-325(at)-325(Annals.org.)]TJ /CS0 cs 1 scn /T1_0 1 Tf 10.5 0 0 10.5 317.5 667.2699 Tm (References)Tj 0 0 0 1 k /T1_1 1 Tf -0.0195 Tc 8 0 0 8 317.5 656.0312 Tm (1.)Tj /T1_3 1 Tf 1.124 0 Td [(Virani)-323(SS,)-323(Alonso)-323(A,)-323(Benjamin)-323(EJ,)-323(et)-323(al;)-323(American)-323(Heart)-323(Associa-)]TJ -1.124 -1.217 Td [(tion)-327(Council)-327(on)-327(Epidemiology)-327(and)-327(Prevention)-327(Statistics)-327(Committee)]TJ 0 -1.217 TD [(and)-684(Stroke)-684(Statistics)-684(Subcommittee.)]TJ /T1_1 1 Tf 17.826 0 Td [(Heart)-684(disease)-684(and)-684(stroke)]TJ -17.826 -1.217 Td [(statistics-2020)-421(update:)-421(a)-421(report)-421(from)-421(the)-421(American)-421(Heart)-421(Associa-)]TJ T* [(tion.)-604(Circulation.)-604(2020;141:e139-e596.)-604([PMID:)-604(31992061])-604(doi:10)]TJ T* (.1161/CIR.0000000000000757)Tj T* (2.)Tj /T1_3 1 Tf 1.09 0 Td [(Downs)-289(JR,)-289(O\220Malley)-289(PG.)]TJ /T1_1 1 Tf 11.094 0 Td [(Management)-289(of)-289(dyslipidemia)-289(for)-289(cardio-)]TJ -12.184 -1.217 Td [(vascular)-422(disease)-422(risk)-422(reduction:)-422(synopsis)-422(of)-422(the)-422(2014)-422(U.S.)-422(Depart-)]TJ T* [(ment)-448(of)-448(Veterans)-448(Affairs)-448(and)-448(U.S.)-448(Department)-448(of)-448(Defense)-448(clinical)]TJ T* [(practice)-869(guideline.)-869(Ann)-869(Intern)-869(Med.)-869(2015;163:291-7.)-869([PMID:)]TJ T* [(26099117])-299(doi:10.7326/M15-0840)]TJ T* (3.)Tj /T1_3 1 Tf 1.064 0 Td [(U.S.)-263(Department)-263(of)-263(Veterans)-263(Affairs,)-263(U.S.)-263(Department)-263(of)-263(Defense.)]TJ /T1_1 1 Tf -1.064 -1.217 Td [(Guideline)-659(for)-659(Guidelines.)-659(Accessed)-659(at)-659(www.healthquality.va.gov)]TJ T* [(/policy/index.asp)-299(on)-299(27)-299(August)-299(2020.)]TJ T* (4.)Tj /T1_3 1 Tf 1.162 0 Td [(Andrews)-361(JC,)-361(Schu)397(\250)-166(nemann)-361(HJ,)-361(Oxman)-361(AD,)-361(et)-361(al.)]TJ /T1_1 1 Tf 22.257 0 Td [(GRADE)-361(guide-)]TJ -23.419 -1.217 Td [(lines:)-288(15.)-288(Going)-288(from)-288(evidence)-288(to)-288(recommendation-determinants)-288(of)]TJ T* [(a)-279(recommendation's)-279(direction)-279(and)-279(strength.)-279(J)-279(Clin)-279(Epidemiol.)-279(2013;)]TJ T* [(66:726-35.)-299([PMID:)-299(23570745])-299(doi:10.1016/j.jclinepi.2013.02.003)]TJ T* (5.)Tj /T1_3 1 Tf 1.228 0 Td [(Newberry)-427(SJ,)-427(Ahmadzai)-427(N,)-427(Motala)-427(A,)-427(et)-427(al.)]TJ /T1_1 1 Tf 20.41 0 Td [(Methods)-427(Research)]TJ -21.639 -1.217 Td [(Report.)-379(Surveillance)-379(and)-379(Identi\223cation)-379(of)-379(Signals)-379(for)-379(Updating)-379(Sys-)]TJ T* [(tematic)-345(Reviews:)-345(Implementation)-345(and)-345(Early)-345(Experience.)-345(Agency)-345(for)]TJ T* [(Healthcare)-390(Research)-390(and)-390(Quality;)-390(2013.)-390(AHRQ)-390(publication)-390(no.)-390(13-)]TJ T* (EHC088-EF.)Tj T* (6.)Tj /T1_3 1 Tf 1.155 0 Td [(Guirguis-Blake)-354(J,)-354(Calonge)-354(N,)-354(Miller)-354(T,)-354(et)-354(al;)-354(U.S.)-354(Preventive)-354(Ser-)]TJ -1.155 -1.217 Td [(vices)-347(Task)-347(Force.)]TJ /T1_1 1 Tf 7.971 0 Td [(Current)-347(processes)-347(of)-347(the)-347(U.S.)-347(Preventive)-347(Services)]TJ -7.971 -1.217 Td [(Task)-649(Force:)-649(re\223ning)-649(evidence-based)-649(recommendation)-649(develop-)]TJ T* [(ment.)-299(Ann)-299(Intern)-299(Med.)-299(2007;147:117-22.)-299([PMID:)-299(17576998])]TJ T* (7.)Tj /T1_3 1 Tf 1.097 0 Td [(Grundy)-296(SM,)-296(Stone)-296(NJ,)-296(Bailey)-296(AL,)-296(et)-296(al.)]TJ /T1_1 1 Tf 17.352 0 Td [(2018)-296(AHA/ACC/AACVPR/)]TJ -18.448 -1.217 Td [(AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA)-408(guideline)-408(on)]TJ T* [(the)-474(management)-474(of)-474(blood)-474(cholesterol:)-474(a)-474(report)-474(of)-474(the)-474(American)]TJ T* [(College)-227(of)-227(Cardiology/American)-227(Heart)-227(Association)-227(task)-227(force)-227(on)-227(clin-)]TJ T* [(ical)-328(practice)-328(guidelines.)-328(Circulation.)-328(2019;139:e1082-e1143.)-328([PMID:)]TJ T* [(30586774])-299(doi:10.1161/CIR.0000000000000625)]TJ T* (8.)Tj /T1_3 1 Tf 1.094 0 Td [(National)-293(Institute)-293(for)-293(Health)-293(and)-293(Care)-293(Excellence.)]TJ /T1_1 1 Tf 22.209 0 Td [(The)-293(Guidelines)]TJ -23.303 -1.217 Td [(Manual.)-295(Process)-295(and)-295(Methods)-295(Guides)-295(No.)-295(6.)-295(Accessed)-295(at)-295(www.ncbi)]TJ T* [(.nlm.nih.gov/books/NBK395866)-299(on)-299(27)-299(August)-299(2020.)]TJ T* (9.)Tj /T1_3 1 Tf 1.123 0 Td [(Mart\232)235(\264)-4(nez)-322(Garc\232)235(\264)-4(a)-322(L,)-322(McFarlane)-322(E,)-322(Barnes)-322(S,)-322(et)-322(al.)]TJ /T1_1 1 Tf 21.505 0 Td [(Updated)-322(recom-)]TJ -22.629 -1.217 Td [(mendations:)-385(an)-385(assessment)-385(of)-385(NICE)-385(clinical)-385(guidelines.)-385(Implement)]TJ T* [(Sci.)-299(2014;9:72.)-299([PMID:)-299(24919856])-299(doi:10.1186/1748-5908-9-72)]TJ T* (10.)Tj /T1_3 1 Tf 1.61 0 Td [(Agency)-248(for)-248(Healthcare)-248(Research)-248(and)-248(Quality.)]TJ /T1_1 1 Tf 20.04 0 Td [(Methods)-248(Guide)-248(for)]TJ -21.649 -1.217 Td [(Effectiveness)-488(and)-488(Comparative)-488(Effectiveness)-488(Reviews.)-488(Agency)-488(for)]TJ T* [(Healthcare)-648(Research)-648(and)-648(Quality;)-648(2012.)-648(AHRQ)-648(publication)-648(no.)]TJ T* (10\(12\)-EHC063-EF.)Tj T* (11.)Tj /T1_3 1 Tf 1.673 0 Td [(Institute)-311(of)-311(Medicine.)]TJ /T1_1 1 Tf 9.698 0 Td [(Clinical)-311(Practice)-311(Guidelines)-311(We)-311(Can)-311(Trust.)]TJ -11.371 -1.217 Td [(National)-299(Academies)-299(Pr;)-299(2011.)]TJ T* (12.)Tj /T1_3 1 Tf 1.671 0 Td [(Atkins)-310(D,)-310(Best)-310(D,)-310(Briss)-310(PA,)-310(et)-310(al;)-310(GRADE)-310(Working)-310(Group.)]TJ /T1_1 1 Tf 25.781 0 Td (Grad-)Tj -27.452 -1.217 Td [(ing)-511(quality)-511(of)-511(evidence)-511(and)-511(strength)-511(of)-511(recommendations.)-511(BMJ.)]TJ T* [(2004;328:1490.)-299([PMID:)-299(15205295])]TJ T* (13.)Tj /T1_3 1 Tf 1.694 0 Td [(Andrews)-332(J,)-332(Guyatt)-332(G,)-332(Oxman)-332(AD,)-332(et)-332(al.)]TJ /T1_1 1 Tf 18.077 0 Td [(GRADE)-332(guidelines:)-332(14.)]TJ -19.771 -1.217 Td [(Going)-230(from)-230(evidence)-230(to)-230(recommendations:)-230(the)-230(signi\223cance)-230(and)-230(pre-)]TJ T* [(sentation)-432(of)-432(recommendations.)-432(J)-432(Clin)-432(Epidemiol.)-432(2013;66:719-25.)]TJ T* [([PMID:)-299(23312392])-299(doi:10.1016/j.jclinepi.2012.03.013)]TJ T* (14.)Tj /T1_3 1 Tf 1.605 0 Td [(Lloyd-Jones)-244(DM,)-244(Braun)-244(LT,)-244(Ndumele)-244(CE,)-244(et)-244(al.)]TJ /T1_1 1 Tf 20.562 0 Td [(Use)-244(of)-244(risk)-244(assess-)]TJ -22.167 -1.217 Td [(ment)-403(tools)-403(to)-403(guide)-403(decision-making)-403(in)-403(the)-403(primary)-403(prevention)-403(of)]TJ T* [(atherosclerotic)-543(cardiovascular)-543(disease:)-543(a)-543(special)-543(report)-543(from)-543(the)]TJ T* [(American)-308(Heart)-308(Association)-308(and)-308(American)-308(College)-308(of)-308(Cardiology.)-308(J)]TJ T* [(Am)-616(Coll)-616(Cardiol.)-616(2019;73:3153-3167.)-616([PMID:)-616(30423392])-616(doi:10)]TJ T* (.1016/j.jacc.2018.11.005)Tj T* (15.)Tj /T1_3 1 Tf 1.691 0 Td [(Lin)-329(JS,)-329(Evans)-329(CV,)-329(Johnson)-329(E,)-329(et)-329(al.)]TJ /T1_1 1 Tf 15.777 0 Td [(Nontraditional)-329(risk)-329(factors)-329(in)]TJ -17.468 -1.217 Td [(cardiovascular)-504(disease)-504(risk)-504(assessment:)-504(updated)-504(evidence)-504(report)]TJ T* [(and)-456(systematic)-456(review)-456(for)-456(the)-456(US)-456(Preventive)-456(Services)-456(Task)-456(Force.)]TJ T* [(JAMA.)-162(2018;320:281-297.)-162([PMID:)-162(29998301])-162(doi:10.1001/jama.2018)]TJ 0 -1.216 TD (.4242)Tj /T1_4 1 Tf 9 0 0 9 53.5 744.2472 Tm [(Updated)-300(VA/DoD)-300(2020)-300(Cholesterol)-300(Guidelines)]TJ /CS0 cs 1 scn 0 Tc 16 0 0 16 435.1302 744.2472 Tm (C)Tj 11.5 0 0 11.5 445.4501 744.2472 Tm (LINICAL)Tj 16 0 0 16 492.6486 744.2472 Tm (G)Tj 11.5 0 0 11.5 504.0244 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k /T1_5 1 Tf 7 0 0 7 53.5 35.7471 Tm (Annals.org)Tj /CS0 cs 1 scn /T1_4 1 Tf 42.296 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_6 1 Tf 29.221 0 Td (7)Tj 0 0 1 rg /GS1 gs /T1_7 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj266 0 obj<>endobj267 0 obj<>stream BT 0 0 0 1 k /GS0 gs /T1_0 1 Tf 9.5 0 0 9.5 53.5 713.2472 Tm [(6.)-254(Physical)-254(Activity:)-254(Increased)-254(Aerobic)-254(Exercise)]TJ 0 -1.21 TD [(for)-254(All)-254(and)-254(Cardiac)-254(Rehabilitation)-254(After)-254(a)-254(Recent)]TJ T* [(CVD)-254(Event)]TJ /T1_1 1 Tf 1.895 -1.21 Td [(Our)-327(rationale)-327(for)-327(including)-327(physical)-327(activity)-327(recom-)]TJ -1.895 -1.158 Td [(mendations)-366(in)-366(this)-366(dyslipidemia)-366(guideline)-366(is)-366(based)-366(on)]TJ 0 -1.158 TD [(the)-425(well-described)-425(effects)-425(of)-425(physical)-425(activity)-425(on)-425(both)]TJ T* [(lipid)-296(levels)-296(and)-296(CVD,)-296(as)-296(well)-296(as)-296(the)-296(reasonable)-296(hypoth-)]TJ T* [(esis)-297(that)-297(the)-297(bene\223t)-297(of)-297(physical)-297(activity)-297(on)-297(CVD)-297(may)-297(be)]TJ T* [(mediated)-325(by)-325(its)-325(effects)-325(on)-325(lipid)-325(levels.)]TJ 1.895 -1.158 Td [(On)-376(the)-376(basis)-376(of)-376(mostly)-376(observational)-376(evidence)-376(for)]TJ -1.895 -1.158 Td [(primary)-564(and)-564(secondary)-564(CVD)-564(prevention,)-564(we)-564(recom-)]TJ T* [(mend)-386(regular)-386(aerobic)-386(physical)-386(activity)-386(of)-386(any)-386(intensity)]TJ T* [(and)-255(duration.)-255(This)-255(is)-255(a)-255(weak)-255(recommendation)-255(based)-255(on)]TJ T* [(the)-610(observational)-610(nature)-610(of)-610(the)-610(data.)-610(Although)-610(the)]TJ T* [(widely)-256(propagated)-256(recommendations)-256(from)-256(the)]TJ /T1_2 1 Tf 21.648 0 Td (Physical)Tj -21.648 -1.158 Td [(Activity)-424(Guidelines)-424(for)-424(Americans)]TJ /T1_1 1 Tf 15.866 0 Td [(specify)-424(150)-424(minutes)]TJ -15.866 -1.158 Td [(of)-342(moderate-intensity)-342(or)-342(75)-342(minutes)-342(of)-342(vigorous)-342(physi-)]TJ T* [(cal)-289(activity)-289(per)-289(week)-289(\(32\),)-289(our)-289(systematic)-289(review)-289(discov-)]TJ T* [(ered)-390(only)-390(observational)-390(data)-390(supporting)-390(a)-390(graded)-390(as-)]TJ T* [(sociation)-558(between)-558(physical)-558(activity)-558(and)-558(reduction)-558(in)]TJ T* [(cardiovascular)-389(and)-389(all-cause)-389(mortality.)-389(The)-389(largest)-389(dif-)]TJ T* [(ference)-302(in)-302(risk)-302(was)-302(observed)-302(between)-302(persons)-302(who)-302(ex-)]TJ T* [(hibited)-286(sedentary)-286(behavior)-286(compared)-286(with)-286(those)-286(at)-286(the)]TJ T* [(lowest)-504(levels)-504(of)-504(regular)-504(physical)-504(activity.)-504(The)-504(lack)-504(of)]TJ T* [(RCT)-324(data)-324(limited)-324(our)-324(grading)-324(of)-324(this)-324(evidence)-324(to)-324(make)]TJ T* [(any)-317(further)-317(speci\223c)-317(recommendation.)-317(Thus,)-317(we)-317(believe)]TJ T* [(that)-326(recommending)-326(regular)-326(physical)-326(activity)-326(of)-326(any)-326(du-)]TJ T* [(ration)-408(and)-408(at)-408(any)-408(intensity)-408(is)-408(most)-408(consistent)-408(with)-408(the)]TJ T* [(available)-354(evidence.)-354(This)-354(broader)-354(recommendation)-354(has)]TJ T* [(implications)-401(for)-401(generalizability)-401(and)-401(feasibility,)-401(speci\223-)]TJ T* [(cally)-352(in)-352(patients)-352(who)-352(are)-352(elderly)-352(or)-352(have)-352(poor)-352(physical)]TJ T* (function.)Tj 1.895 -1.158 Td [(For)-478(secondary)-477(prevention)-477(in)-477(patients)-478(with)-477(recent)]TJ -1.895 -1.158 Td [(CVD)-645(events,)-645(we)-645(strongly)-645(recommend)-645(a)-645(structured,)]TJ T* [(exercise-based)-361(rehabilitation)-361(program,)-361(on)-361(the)-361(basis)-361(of)]TJ T* [(robust)-522(evidence)-522(of)-522(improvement)-522(in)-522(nonfatal)-522(MI)-522(and)]TJ T* [(both)-392(cardiovascular)-392(and)-392(all-cause)-392(mortality.)-392(A)-392(system-)]TJ T* [(atic)-415(review)-415(and)-415(meta-analysis)-415(of)-415(69)-415(mostly)-415(moderate-)]TJ T* [(quality)-295(clinical)-295(trials)-295(of)-295(cardiac)-295(rehabilitation)-295(reported)-295(a)]TJ T* [(26%)-421(relative)-421(risk)-421(reduction)-421(in)-421(cardiovascular)-421(mortality)]TJ -0.0198 Tc T* [(over)-298(a)-298(median)-298(of)-298(10)-298(years)-298(\(33\).)-298(Although)-298(the)-298(characteris-)]TJ T* [(tics)-427(of)-427(these)-427(programs)-427(were)-427(somewhat)-427(heterogeneous,)]TJ T* [(common)-296(elements)-296(included)-296(early)-296(initiation)-296(relative)-296(to)-296(the)]TJ T* [(event)-362(\(within)-362(2)-362(to)-362(8)-362(weeks\))-362(and)-362(the)-362(structured)-362(nature)-362(of)]TJ T* [(the)-299(exercise)-299(programs.)]TJ /T1_0 1 Tf 0 Tc 0 -2 TD [(7.)-254(Nutrition,)-254(Supplements,)-254(Niacin,)-254(and)-254(Fibrates:)]TJ 0 -1.21 TD [(Suggest)-254(a)-254(Mediterranean)-254(Diet)-254(for)-254(High-Risk)]TJ T* [(Patients,)-254(Limit)-254(Icosapent)-254(Ethyl)-254(to)-254(Secondary)]TJ T* [(Prevention,)-254(Avoid)-254(Supplements)-254(and)-254(Niacin,)-254(and)]TJ T* [(Avoid)-254(Adding)-254(Fibrates)-254(to)-254(Statin)-254(Therapy)]TJ /T1_1 1 Tf 1.895 -1.21 Td [(For)-534(primary)-534(and)-534(secondary)-534(CVD)-534(prevention,)-534(we)]TJ -1.895 -1.158 Td [(suggest)-444(a)-444(dietitian-led)-444(Mediterranean)-444(diet.)-444(A)-444(system-)]TJ 0 -1.158 TD [(atic)-310(review)-310(of)-310(30)-310(RCTs)-310(found)-310(only)-310(low-quality)-310(evidence)]TJ T* [(but)-354(did)-354(show)-354(that)-354(a)-354(Mediterranean)-354(diet)-354(reduced)-354(com-)]TJ T* [(posite)-355(events,)-355(stroke,)-355(MI,)-355(and)-355(both)-355(cardiovascular)-355(and)]TJ T* [(all-cause)-331(mortality.)-331(The)-331(bene\223t)-331(was)-331(limited)-331(to)-331(high-risk)]TJ T* [(primary)-355(prevention)-355(and)-355(secondary)-355(prevention)-355(popula-)]TJ T* [(tions)-627(\(34\).)-627(The)-627(Mediterranean)-627(diet)-627(includes)-627(a)-627(high)]TJ T* [(unsaturated\205saturated)-393(fat)-393(ratio,)-393(high)-393(proportion)-393(of)-393(ca-)]TJ T* [(loric)-372(intake)-372(from)-372(plant-based)-372(foods)-372(\(fruits,)-372(vegetables,)]TJ 27.789 69.579 Td [(nuts,)-398(legumes,)-398(and)-398(grains\),)-398(moderate)-398(consumption)-398(of)]TJ 0 -1.179 TD [(\223sh)-365(and)-365(low-fat)-365(dairy)-365(products,)-365(and)-365(low)-365(intake)-365(of)-365(lean)]TJ T* [(meat)-408(and)-408(red)-408(wine.)-408(Although)-408(it)-408(is)-408(reasonable)-408(to)-408(con-)]TJ T* [(sider)-313(other)-313(diets)-313(that)-313(comprise)-313(the)-313(same)-313(elements,)-313(the)]TJ T* [(only)-410(speci\223c)-410(diet)-410(studied)-410(in)-410(an)-410(RCT)-410(and)-410(powered)-410(for)]TJ T* [(CVD)-325(outcomes)-325(is)-325(the)-325(Mediterranean)-325(diet.)]TJ 1.895 -1.179 Td [(For)-313(primary)-313(CVD)-313(prevention,)-313(the)-313(evidence)-313(is)-313(insuf-)]TJ -1.895 -1.179 Td [(\223cient)-370(to)-370(recommend)-370(for)-370(or)-370(against)-370(icosapent)-370(ethyl)-370(in)]TJ T* [(patients)-280(who)-280(are)-280(receiving)-280(statins)-280(and)-280(have)-280(persistently)]TJ T* [(elevated)-469(fasting)-469(triglyceride)-469(levels.)-469(However,)-469(for)-469(sec-)]TJ T* [(ondary)-273(prevention,)-273(we)-273(suggest)-273(offering)-273(icosapent)-273(ethyl)]TJ T* [(to)-340(patients)-340(receiving)-340(statins)-340(who)-340(have)-340(fasting)-340(triglycer-)]TJ T* [(ide)-524(levels)-524(persistently)-524(greater)-524(than)-524(1.7)-524(mmol/L)-524(\(150)]TJ T* [(mg/dL\))-290(to)-290(reduce)-290(cardiovascular)-290(morbidity)-290(and)-290(mortal-)]TJ T* [(ity.)-553(These)-553(recommendations)-553(are)-553(based)-553(on)-553(a)-553(single,)]TJ T* [(large)-322(RCT)-322(\(35\).)-322(In)-322(that)-322(study,)-322(treatment)-322(wit)]TJ 0.322 Tc 19.598 0 Td [(h4go)322(f)]TJ 0 Tc (ico-)Tj -19.598 -1.179 Td [(sapent)-295(ethyl)-295(resulted)-295(in)-295(a)-295(25%)-295(reduction)-295(in)-295(the)-295(primary)]TJ T* [(end)-314(point,)-314(de\223ned)-314(as)-314(a)-314(combination)-314(of)-314(vascular)-314(death,)]TJ T* [(nonfatal)-293(MI,)-293(nonfatal)-293(stroke,)-293(coronary)-293(revascularization,)]TJ T* [(or)-273(unstable)-273(angina)-273(over)-273(5)-273(years.)-273(This)-273(effect)-273(was)-273(evident)]TJ T* [(only)-332(among)-332(patients)-332(with)-332(known)-332(CVD,)-332(who)-332(comprised)]TJ T* [(the)-376(majority)-376(of)-376(the)-376(study)-376(participants.)-376(The)-376(recommen-)]TJ T* [(dation)-252(was)-252(graded)-252(as)-252(weak)-252(because)-252(of)-252(a)-252(lack)-252(of)-252(corrob-)]TJ T* [(orating)-595(trials;)-595(the)-595(study's)-595(industry)-595(sponsorship;)-595(and)]TJ T* [(other)-248(idiosyncratic)-248(features)-248(of)-248(the)-248(trial,)-248(such)-248(as)-248(its)-248(use)-248(of)]TJ T* [(mineral)-325(oil)-325(as)-325(the)-325(placebo.)]TJ 1.895 -1.179 Td [(For)-473(primary)-473(or)-473(secondary)-473(prevention,)-473(we)-473(recom-)]TJ -1.895 -1.179 Td [(mend)-416(against)-416(the)-416(use)-416(of)-416(omega-3)-416(fatty)-416(acids)-416(as)-416(a)-416(di-)]TJ T* [(etary)-507(supplement)-507(to)-507(reduce)-507(CVD)-507(risk.)-507(The)-507(evidence)]TJ T* [(showed)-518(no)-518(effect)-518(of)-518(omega-3)-518(supplements)-518(\(ranging)]TJ T* [(from)-403(0.5)-403(to)-403(>5)-403(g/d\))-403(on)-403(cardiovascular)-403(mortality,)-403(com-)]TJ T* [(posite)-530(cardiovascular)-530(events,)-530(MI,)-530(stroke,)-530(or)-530(all-cause)]TJ T* [(mortality)-410(in)-410(studies)-410(ranging)-410(from)-410(12)-410(to)-410(72)-410(months.)-410(In)]TJ T* [(the)-451(RCTs)-451(evaluated,)-451(the)-451(results)-451(were)-451(inconclusive)-451(re-)]TJ T* [(garding)-297(the)-297(risk)-297(for)-297(adverse)-297(effects,)-297(including)-297(bleeding)]TJ T* [(and)-492(thrombosis,)-492(and)-492(the)-492(risk)-492(of)-492(bias)-492(was)-492(substantial)]TJ T* [(\(36\).)-684(Thus,)-684(the)-684(EBPWG)-684(decided)-684(to)-684(issue)-684(a)-684(\215weak)]TJ T* [(against\216)-325(recommendation.)]TJ 1.895 -1.179 Td [(Insuf\223cient)-500(evidence)-500(exists)-500(to)-500(recommend)-500(for)-500(or)]TJ -1.895 -1.179 Td [(against)-261(the)-261(use)-261(of)-261(\223ber,)-261(garlic,)-261(ginger,)-261(green)-261(tea,)-261(or)-261(red)]TJ T* [(yeast)-327(rice)-327(supplements)-327(to)-327(reduce)-327(CVD)-327(risk.)-327(No)-327(studies)]TJ T* [(evaluated)-347(the)-347(long-term)-347(effects)-347(of)-347(\223ber,)-347(garlic,)-347(ginger,)]TJ T* [(green)-323(tea,)-323(or)-323(red)-323(yeast)-323(rice)-323(supplements)-323(on)-323(CVD)-323(mor-)]TJ T* [(bidity)-360(or)-360(mortality.)-360(Instead,)-360(only)-360(the)-360(safety)-360(of)-360(these)-360(in-)]TJ T* [(terventions)-553(has)-553(been)-553(evaluated.)-553(Most)-553(of)-553(these)-553(sub-)]TJ T* [(stances)-293(were)-293(evaluated)-293(in)-293(their)-293(supplemental)-293(form,)-293(not)]TJ T* [(as)-368(they)-368(naturally)-368(occur)-368(in)-368(foods,)-368(where)-368(they)-368(may)-368(have)]TJ T* [(different)-325(effects.)]TJ 1.895 -1.179 Td [(We)-369(strongly)-369(recommend)-369(against)-369(the)-369(use)-369(of)-369(niacin)]TJ -1.895 -1.179 Td [(in)-355(prescription)-355(or)-355(supplement)-355(doses,)-355(alone)-355(or)-355(in)-355(com-)]TJ T* [(bination)-351(with)-351(statins,)-351(for)-351(primary)-351(or)-351(secondary)-351(preven-)]TJ T* [(tion)-410(because)-410(of)-410(increased)-410(adverse)-410(events)-410(and)-410(lack)-410(of)]TJ T* [(CVD)-325(risk)-325(reduction)-325(\(37\20539\).)]TJ 1.895 -1.179 Td [(We)-481(recommend)-481(against)-481(adding)-481(\223brates)-481(to)-481(statin)]TJ -1.895 -1.178 Td [(therapy)-319(for)-319(either)-319(primary)-319(or)-319(secondary)-319(prevention,)-319(on)]TJ 0 -1.178 TD [(the)-342(basis)-342(of)-342(evidence)-342(of)-342(adverse)-342(effects)-342(\(elevated)-342(liver)]TJ T* [(aminotransferase)-402(and)-402(creatinine)-402(levels)-402(and)-402(a)-402(possible)]TJ T* [(increase)-331(in)-331(CVD)-331(risk)-331(in)-331(women\))-331(and)-331(no)-331(known)-331(bene\223t.)]TJ T* [(However,)-380(because)-380(of)-380(the)-380(lack)-380(of)-380(robust)-380(evidence,)-380(this)]TJ T* [(recommendation)-325(was)-325(graded)-325(as)-325(weak)-325(\(37,)-325(40)-120(\205)-120(43\).)]TJ /CS0 cs 1 scn /T1_3 1 Tf 16 0 0 16 53.5 744.2472 Tm (C)Tj 11.5 0 0 11.5 63.8198 744.2472 Tm (LINICAL)Tj 16 0 0 16 111.2371 744.2472 Tm (G)Tj 11.5 0 0 11.5 122.6129 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k -0.0196 Tc 9 0 0 9 373.4 744.2472 Tm [(Updated)-324(VA/DoD)-324(2020)-324(Cholesterol)-324(Guidelines)]TJ /T1_4 1 Tf 0 Tc 7 0 0 7 53.5 35.7471 Tm (6)Tj /CS0 cs 1 scn /T1_3 1 Tf 1.224 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_5 1 Tf 65.748 0 Td (Annals.org)Tj 0 0 1 rg /GS1 gs /T1_6 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj268 0 obj<>endobj269 0 obj<>stream BT 0 0 0 1 k /GS0 gs /T1_0 1 Tf 9.5 0 0 9.5 53.5 713.2472 Tm [(than)-486(12%)-486(\(strong)-486(evidence\).)-486(These)-486(thresholds)-486(repre-)]TJ 0 -1.158 TD [(sent)-496(rationally)-496(de\223ned)-496(in\224ection)-496(points)-496(of)-496(increasing)]TJ T* [(risk)-333(and)-333(increasing)-333(congruency)-333(with)-333(clinical)-333(trial)-333(popu-)]TJ T* [(lations)-443(that)-443(derived)-442(a)-443(bene\223t)-443(from)-442(statin)-443(therapy.)-443(No)]TJ T* [(RCT)-335(directly)-335(compared)-335(high-dose)-335(with)-335(moderate-dose)]TJ T* [(statin)-378(therapy)-378(in)-378(primary)-378(prevention.)-378(Given)-378(the)-378(higher)]TJ T* [(risk)-344(for)-344(adverse)-344(effects)-344(with)-344(high-dose)-344(statin)-344(treatment)]TJ -0.0198 Tc T* [(and)-512(the)-512(absence)-512(of)-512(evidence)-512(for)-512(added)-512(bene\223t)-512(com-)]TJ T* [(pared)-356(with)-356(moderate)-356(doses,)-356(we)-356(believe)-356(the)-356(appropriate)]TJ T* [(goal)-468(dose)-468(for)-468(primary)-468(prevention)-468(should)-468(be)-468(moderate)]TJ T* [(\(same)-751(as)-751(moderate)-751(intensity\).)-751(We)-751(therefore)-751(recom-)]TJ T* [(mended)-382(against)-382(the)-382(use)-382(of)-382(high-dose)-382(\(or)-382(high-intensity\))]TJ T* [(statin)-299(therapy)-299(in)-299(primary)-299(prevention.)]TJ 0 Tc 1.895 -1.158 Td [(No)-405(clinical)-405(trial)-405(of)-405(nonstatin)-405(therapies)-405(has)-405(directly)]TJ -1.895 -1.158 Td [(proved)-457(a)-457(reduction)-457(in)-457(cardiovascular)-457(mortality)-457(in)-457(pri-)]TJ T* [(mary)-376(prevention)-376(populations.)-376(Nonstatin)-376(treatments)-376(in-)]TJ T* [(clude)-438(ezetimibe)-438(and)-438(proprotein)-438(convertase)-438(subtilisin/)]TJ T* [(kexin)-332(type)-332(9)-332(\(PCSK9\))-332(inhibitors.)-332(One)-332(systematic)-332(review)]TJ T* [(of)-242(PCSK9)-242(inhibitor)-242(trials)-242(showed)-242(that)-242(of)-242(the)-242(primary)-242(pre-)]TJ T* [(vention)-424(patients)-424(included)-424(in)-424(the)-424(studies)-424(\()]TJ /T1_1 1 Tf 19.453 0 Td (n)Tj /T1_0 1 Tf 1.001 0 Td [(>)-424(10)-260(000\),)]TJ -20.454 -1.158 Td [(none)-276(obtained)-276(a)-276(bene\223t)-276(in)-276(any)-276(cardiovascular)-276(outcome)]TJ T* [(\(22\).)-243(Given)-243(the)-243(uncertain)-243(safety)-243(of)-243(long-term)-243(use,)-243(lack)-243(of)]TJ T* [(evidence)-314(of)-314(bene\223t,)-314(and)-314(high)-314(cost)-314(of)-314(PCSK9)-314(inhibitors,)]TJ T* [(we)-417(strongly)-417(recommend)-417(against)-417(their)-417(use)-417(for)-417(primary)]TJ T* (prevention.)Tj /T1_2 1 Tf 0 -2.263 TD [(4.)-254(Secondary)-254(Prevention:)-254(Moderate)-254(Statin)-254(Doses)]TJ 0 -1.21 TD [(Initially,)-254(Then)-254(Stepped)-254(Intensi\223cation)-254(in)]TJ T* [(Higher-Risk)-254(Patients)]TJ /T1_0 1 Tf 1.895 -1.21 Td [(A)-573(large)-573(body)-573(of)-573(clinical)-573(trial)-573(evidence)-573(supports)]TJ -1.895 -1.158 Td [(moderate-dose)-348(statin)-348(therapy)-348(in)-348(secondary)-348(prevention)]TJ 0 -1.158 TD [(populations,)-460(with)-460(demonstrated)-460(reductions)-460(in)-460(cardio-)]TJ T* [(vascular)-443(and)-443(all-cause)-443(mortality)-443(over)-443(approximately)-443(5)]TJ T* [(years)-407(\(23,)-407(24\).)-407(The)-407(preponderance)-407(of)-407(evidence)-407(is)-407(de-)]TJ T* [(rived)-271(from)-271(trials)-271(of)-271(moderate)-271(statin)-271(doses,)-271(with)-271(very)-271(few)]TJ T* [(trials)-337(directly)-337(comparing)-337(the)-337(effectiveness)-337(of)-337(high-)-337(ver-)]TJ T* [(sus)-262(moderate-dose)-262(statin)-262(treatment.)-262(Given)-262(the)-262(substan-)]TJ T* [(tial)-365(bene\223t)-365(and)-365(limited)-365(harms,)-365(we)-365(believe)-365(that)-365(moder-)]TJ T* [(ate)-326(statin)-326(doses)-326(form)-326(the)-326(foundation)-326(of)-326(pharmacologic)]TJ T* [(treatment)-325(for)-325(secondary)-325(prevention.)]TJ 1.895 -1.158 Td [(Substantial)-253(evidence)-253(exists)-253(that)-253(high-)-253(versus)-253(low-)-253(or)]TJ -1.895 -1.158 Td [(moderate-dose)-504(statin)-504(therapy)-504(reduces)-504(cardiovascular)]TJ T* [(morbidity)-440(but)-440(not)-440(mortality)-440(\(25\).)-440(This)-440(evidence)-440(is)-440(de-)]TJ T* [(rived)-652(mostly)-652(from)-652(higher-risk)-652(secondary)-652(prevention)]TJ T* [(populations,)-303(such)-303(as)-303(those)-303(with)-303(recent)-303(MI)-303(or)-303(acute)-303(cor-)]TJ T* [(onary)-600(syndrome)-600(\(in)-600(the)-600(past)-600(12)-600(months\);)-600(recurrent)]TJ T* [(acute)-311(coronary)-311(syndrome,)-311(MI,)-311(or)-311(stroke;)-311(or)-311(established)]TJ T* [(CVD)-343(with)-343(additional)-343(major)-343(risk)-343(factors)-343(\(such)-343(as)-343(current)]TJ T* [(tobacco)-568(use,)-568(diabetes,)-568(peripheral)-568(artery)-568(disease,)-568(or)]TJ T* [(previous)-279(coronary)-279(artery)-279(bypass)-279(graft)-279(surgery)-279(or)-279(percu-)]TJ T* [(taneous)-600(coronary)-600(intervention\).)-600(Evidence)-600(also)-600(exists)]TJ T* [(that)-363(high-dose)-363(statin)-363(therapy)-363(is)-363(associated)-363(with)-363(higher)]TJ T* [(rates)-404(of)-404(adverse)-404(outcomes)-404(\(such)-404(as)-404(treatment)-404(discon-)]TJ T* [(tinuation,)-507(myopathy,)-507(and)-507(incident)-507(diabetes\))-507(\(25,)-507(26\).)]TJ T* [(We)-425(thus)-425(concluded)-425(that)-425(without)-425(a)-425(bene\223t)-425(in)-425(the)-425(pre-)]TJ T* [(de\223ned)-585(critical)-585(outcome)-585(of)-585(cardiovascular)-585(mortality,)]TJ T* [(but)-246(with)-246(an)-246(increased)-246(risk)-246(for)-246(adverse)-246(events,)-246(high-dose)]TJ T* [(statin)-371(therapy)-371(should)-371(be)-371(offered)-371(through)-371(shared)-371(deci-)]TJ T* [(sion)-309(making)-309(with)-309(patients,)-309(and)-309(preferentially)-309(to)-309(higher-)]TJ T* [(risk)-287(populations)-287(\(such)-287(as)-287(those)-287(with)-287(recurrent)-287(events)-287(or)]TJ T* [(those)-444(with)-444(known)-444(multivessel)-444(obstructive)-444(coronary)-444(or)]TJ 27.789 69.579 Td [(peripheral)-316(artery)-316(disease)-316(and)-316(active)-316(tobacco)-316(use)-316(or)-316(di-)]TJ 0 -1.159 TD [(abetes\),)-325(from)-325(which)-325(the)-325(evidence)-325(was)-325(derived.)]TJ 1.895 -1.159 Td [(For)-317(higher-risk)-317(patients,)-317(evidence)-317(supports)-317(the)-317(ad-)]TJ -1.895 -1.159 Td [(dition)-274(of)-274(ezetimibe)-274(or)-274(PCSK9)-274(inhibitors)-274(to)-274(moderate-)-274(or)]TJ T* [(high-dose)-393(statin)-393(therapy,)-393(with)-393(demonstrated)-393(improve-)]TJ T* [(ment)-340(in)-340(the)-340(important)-340(outcome)-340(of)-340(cardiovascular)-340(mor-)]TJ T* [(bidity)-351(but)-351(not)-351(in)-351(the)-351(critical)-351(outcome)-351(of)-351(cardiovascular)]TJ T* [(mortality)-323(\(27,)-323(28\).)-323(Because)-323(\215add-ons\216)-323(to)-323(high-dose)-323(sta-)]TJ T* [(tin)-374(therapy)-374(have)-374(not)-374(been)-374(compared)-374(directly,)-374(and)-374(the)]TJ T* [(decision)-422(to)-422(pursue)-422(such)-422(a)-422(strategy)-422(tends)-422(to)-422(be)-422(event)]TJ T* [(driven)-587(in)-587(higher-risk)-587(populations,)-587(we)-587(recommend)-587(a)]TJ T* [(stepwise)-379(approach)-379(to)-379(intensi\223cation)-379(based)-379(on)-379(relative)]TJ T* [(cost-effectiveness)-516(and)-516(safety)-516(as)-516(well)-516(as)-516(the)-516(patient's)]TJ T* [(event)-249(history)-249(and)-249(degree)-249(of)-249(atherosclerotic)-249(burden.)-249(Be-)]TJ T* [(cause)-247(of)-247(the)-247(high)-247(cost)-247(and)-247(uncertain)-247(long-term)-247(safety)-247(of)]TJ T* [(PCSK9)-376(inhibitors,)-376(we)-376(recommend)-376(that)-376(this)-376(medication)]TJ T* [(class)-325(be)-325(reserved)-325(as)-325(a)-325(last)-325(choice.)]TJ /T1_2 1 Tf 0 -2.264 TD [(5.)-254(Laboratory)-254(Testing:)-254(No)-254(Routine)-254(Fasting)-254(or)]TJ 0 -1.212 TD [(Monitoring)-254(Is)-254(Needed;)-254(Less)-254(Is)-254(More)]TJ /T1_0 1 Tf 1.895 -1.212 Td [(As)-431(in)-431(our)-431(2014)-431(guideline,)-431(we)-431(continue)-431(to)-431(recom-)]TJ -1.895 -1.159 Td [(mend)-405(the)-405(evaluation)-405(of)-405(nonfasting)-405(lipid)-405(levels)-405(for)-405(risk)]TJ 0 -1.159 TD [(assessment)-327(and)-327(monitoring,)-327(on)-327(the)-327(basis)-327(of)-327(further)-327(ev-)]TJ T* [(idence)-364(that)-364(fasting)-364(lipid)-364(levels)-364(add)-364(no)-364(clinical)-364(value)-364(to)]TJ T* [(risk)-248(prediction)-248(compared)-248(with)-248(nonfasting)-248(levels)-248(and)-248(are)]TJ T* [(considerably)-347(more)-347(burdensome)-347(in)-347(terms)-347(of)-347(patient)-347(in-)]TJ T* [(convenience)-325(and)-325(cost)-325(\(29\).)]TJ 1.895 -1.159 Td [(Because)-521(the)-521(focus)-521(on)-521(managing)-521(lipid)-521(levels)-521(has)]TJ -1.895 -1.159 Td [(evolved)-335(from)-335(cholesterol)-335(values)-335(themselves)-335(to)-335(therapy)]TJ T* [(based)-442(on)-442(CVD)-442(risk,)-442(the)-442(need)-442(for)-442(lipid)-442(testing)-442(should)]TJ T* [(diminish)-480(considerably.)-480(The)-480(calculation)-480(of)-480(CVD)-480(risk)-480(is)]TJ T* [(affected)-526(only)-526(minimally)-526(by)-526(lipid)-526(levels)-526(and)-526(depends)]TJ T* [(much)-445(more)-445(on)-445(other)-446(major)-446(risk)-445(factors,)-446(such)-446(as)-446(age;)]TJ T* [(sex;)-300(and)-300(the)-300(presence)-300(of)-300(hypertension,)-300(diabetes,)-300(or)-300(to-)]TJ T* [(bacco)-325(use.)]TJ 1.895 -1.159 Td [(In)-326(our)-326(systematic)-326(review,)-326(we)-326(found)-326(that)-326(lipid)-326(levels)]TJ -1.895 -1.159 Td [(vary)-355(little)-355(in)-355(a)-355(patient)-355(over)-355(time)-355(and)-355(that)-355(true)-355(variation)]TJ T* [(exceeds)-294(random)-294(variation)-294(only)-294(if)-294(testing)-294(is)-294(spaced)-294(by)-294(9)]TJ T* [(to)-327(10)-327(years)-327(\(30,)-327(31\).)-327(Thus,)-327(given)-327(the)-327(small)-327(contribution)]TJ T* [(of)-272(lipid)-272(values)-272(to)-272(calculating)-272(a)-272(cardiovascular)-272(risk)-272(score,)]TJ T* [(the)-499(focus)-499(on)-499(targeted)-499(dosing)-499(\(as)-499(opposed)-499(to)-499(target)]TJ T* [(cholesterol)-332(levels\),)-332(and)-332(the)-332(minimal)-332(within-patient)-332(vari-)]TJ T* [(ation)-329(over)-329(time,)-329(we)-329(recommend)-329(measuring)-329(lipid)-329(levels)]TJ T* [(no)-330(more)-330(than)-330(every)-330(10)-330(years.)-330(One)-330(can)-330(reliably)-330(use)-330(the)]TJ T* [(previously)-350(measured)-350(lipid)-350(value)-350(in)-350(assessing)-350(CVD)-350(risk.)]TJ T* [(We)-502(do)-502(not)-502(recommend)-502(rechecking)-502(lipid)-502(levels)-502(each)]TJ 0 -1.158 TD [(time)-364(CVD)-364(risk)-364(is)-364(assessed,)-364(because)-364(lipid)-364(levels)-364(remain)]TJ T* [(stable)-392(within)-392(persons)-392(over)-392(time)-392(and)-392(contribute)-392(only)-392(a)]TJ T* [(small)-298(amount)-298(to)-298(predicted)-298(risk)-298(relative)-298(to)-298(other)-298(factors.)]TJ T* [(Once)-388(moderate-dose)-388(statin)-388(therapy)-388(is)-388(prescribed)-388(\(the)]TJ T* [(therapeutic)-454(goal)-454(for)-454(managing)-454(lipid)-454(levels)-454(in)-454(primary)]TJ T* [(CVD)-455(prevention\),)-455(we)-455(see)-455(no)-455(rationale)-455(for)-455(monitoring)]TJ T* [(lipid)-325(levels)-325(thereafter.)]TJ 1.895 -1.158 Td [(We)-715(recognize)-715(that)-715(circumstances)-715(may)-715(exist)-715(in)]TJ -1.895 -1.158 Td [(which)-373(clinicians)-373(wish)-373(to)-373(measure)-373(lipid)-373(levels)-373(more)-373(fre-)]TJ T* [(quently,)-377(such)-377(as)-377(in)-377(assessing)-377(adherence)-377(to)-377(therapy)-377(or)]TJ T* [(for)-296(intensi\223cation)-296(strategies)-296(in)-296(secondary)-296(prevention)-296(to)]TJ T* [(avoid)-431(excessively)-431(low)-431(LDL-C)-431(levels.)-431(However,)-431(we)-431(rec-)]TJ T* [(ommend)-392(against)-392(routine)-392(lipid)-392(level)-392(testing)-392(for)-392(risk)-392(as-)]TJ T* [(sessment)-523(and)-523(monitoring,)-523(unless)-523(it)-523(is)-523(speci\223cally)-523(in-)]TJ T* [(tended)-325(to)-325(guide)-325(decision)-325(making.)]TJ /T1_3 1 Tf -0.0196 Tc 9 0 0 9 53.5 744.2472 Tm [(Updated)-300(VA/DoD)-300(2020)-300(Cholesterol)-300(Guidelines)]TJ /CS0 cs 1 scn 0 Tc 16 0 0 16 435.1302 744.2472 Tm (C)Tj 11.5 0 0 11.5 445.4501 744.2472 Tm (LINICAL)Tj 16 0 0 16 492.6486 744.2472 Tm (G)Tj 11.5 0 0 11.5 504.0244 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k /T1_4 1 Tf 7 0 0 7 53.5 35.7471 Tm (Annals.org)Tj /CS0 cs 1 scn /T1_3 1 Tf 42.264 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_5 1 Tf 29.221 0 Td (5)Tj 0 0 1 rg /GS1 gs /T1_6 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj270 0 obj<>endobj271 0 obj<>stream 0 0 0 0 k /GS0 gs 53.5 702.747 504 17 re f 0.048 0.003 0.019 0.016 k 53.5 651.747 504 26 re f 53.5 625.247 504 9 re f 53.5 598.747 504 17.5 re f 53.5 528.247 504 26 re f 53.5 493.247 504 9 re f 53.5 457.747 504 9 re f 53.5 397.247 504 34.5 re f 53.5 336.247 504 17.5 re f 53.5 309.747 504 17.5 re f 53.5 266.247 504 26 re f 53.5 231.247 504 17.5 re f 53.5 195.747 504 17.5 re f 53.5 151.247 504 9 re f 53.5 105.247 504 28.5 re f q 1 0 0 1 53.5 719.497 cm /CS0 CS 1 SCN 0.5 w 0 0 m 504 0 l S Q BT 0 0 0 1 k /T1_0 1 Tf 8.5 0 0 8.5 59.5 710.2472 Tm (Table.)Tj /T1_1 1 Tf 3.506 0 Td [(VA/DoD)-248(List)-248(of)-248(Recommendations)-248(for)-248(Managing)-248(Dyslipidemia)-248(to)-248(Reduce)-248(CVD)-248(Risk)]TJ ET q 1 0 0 1 53.5 704.497 cm /CS0 CS 1 SCN 0.5 w 0 0 m 504 0 l S Q q 1 0 0 1 53.5 689.122 cm 0.97 0.06 0.38 0.32 K 0.25 w 0 0 m 504 0 l S Q q 1 0 0 1 53.5 105.497 cm 0.97 0.06 0.38 0.32 K 0.5 w 0 0 m 504 0 l S Q BT /T1_2 1 Tf 7 0 0 7 59.5 693.2472 Tm [(Recommendation,)-250(by)-250(Topic)]TJ 60.726 0 Td (Strength)Tj -60.726 -1.929 Td [(Primary)-250(prevention:)-250(screening)-250(and)-250(assessment)-250(of)-250(CVD)-250(risk)]TJ /T1_3 1 Tf 1 -1.286 Td [(1.)-250(For)-250(primary)-250(prevention)-250(in)-250(patients)-250(aged)-250(>40)-250(y)-250(who)-250(are)-250(not)-250(receiving)-250(statins)-250(and)-250(have)-250(not)-250(developed)]TJ 2 -1.214 Td [(new)-250(CVD)-250(risk)-250(factors)-250(\(e.g.,)-250(diabetes,)-250(hypertension,)-250(tobacco)-250(use\),)-250(we)-250(suggest)-250(against)-250(offering)-250(a)]TJ 0 -1.214 TD [(CVD)-250(risk)-250(assessment)-250(more)-250(frequently)-250(than)-250(every)-250(5)-250(y.)]TJ 57.726 2.429 Td [(Weak)-250(against)]TJ -59.726 -3.714 Td [(2.)-250(For)-250(primary)-250(prevention)-250(in)-250(patients)-250(not)-250(receiving)-250(statins,)-250(we)-250(suggest)-250(against)-250(routinely)-250(ordering)-250(a)-250(lipid)]TJ 2 -1.214 Td [(panel)-250(more)-250(frequently)-250(than)-250(every)-250(10)-250(y.)]TJ 57.726 1.214 Td [(Weak)-250(against)]TJ -59.726 -2.5 Td [(3.)-250(For)-250(CVD)-250(risk)-250(assessment)-250(in)-250(primary)-250(prevention,)-250(we)-250(suggest)-250(using)-250(a)-250(10-y)-250(risk)-250(calculator.)]TJ 59.725 0 Td [(Weak)-250(for)]TJ -59.725 -1.286 Td [(4.)-250(We)-250(suggest)-250(against)-250(the)-250(routine)-250(use)-250(of)-250(CAC)-250(testing.)]TJ 59.726 0 Td [(Weak)-250(against)]TJ -59.726 -1.286 Td [(5.)-250(We)-250(suggest)-250(against)-250(the)-250(routine)-250(use)-250(of)-250(additional)-250(risk)-250(markers)-250(\(e.g.,)-250(high-sensitivity)-250(C-reactive)]TJ 2 -1.214 Td [(protein,)-250(ankle\205brachial)-250(index,)-250(CAC\))-250(when)-250(assessing)-250(CVD)-250(risk.)]TJ 57.726 1.214 Td [(Weak)-250(against)]TJ /T1_2 1 Tf -60.726 -3.786 Td [(Pharmacotherapy,)-250(supplements,)-250(and)-250(nutraceuticals)]TJ /T1_3 1 Tf 1 -1.286 Td [(Primary)-250(prevention)]TJ 1 -1.286 Td [(6.)-250(We)-250(recommend)-250(moderate-dose)-250(statin)-250(therapy)-250(for)-250(patients)-250(with)-250(a)-250(10-y)-250(CVD)-250(risk)-250(\00212%,)-250(an)-250(LDL-C)]TJ 1 -1.214 Td [(level)-250(\0024.9)-250(mmol/L)-250(\(\002190)-250(mg/dL\),)-250(or)-250(diabetes.)]TJ 57.726 1.214 Td [(Strong)-250(for)]TJ -58.726 -2.5 Td [(7.)-250(We)-250(suggest)-250(moderate-dose)-250(statin)-250(therapy)-250(for)-250(patients)-250(with)-250(a)-250(10-y)-250(CVD)-250(risk)-250(between)-250(6%)-250(and)-250(12%)]TJ 1 -1.214 Td [(after)-250(a)-250(discussion)-250(of)-250(the)-250(risks)-250(and)-250(bene\223ts)-250(and)-250(an)-250(exploration)-250(of)-250(the)-250(patient's)-250(values)-250(and)]TJ T* (preferences.)Tj 57.726 2.429 Td [(Weak)-250(for)]TJ -58.726 -3.714 Td [(8.)-250(For)-250(patients)-250(receiving)-250(moderate-dose)-250(statin)-250(therapy,)-250(we)-250(suggest)-250(against)-250(maximizing)-250(the)-250(statin)]TJ 1 -1.214 Td [(dose)-250(because)-250(of)-250(the)-250(lack)-250(of)-250(evidence)-250(proving)-250(added)-250(cardiovascular)-250(bene\223t)-250(and)-250(the)-250(risks)-250(of)-250(higher)]TJ T* [(statin)-250(doses.)]TJ 57.726 2.429 Td [(Weak)-250(against)]TJ -58.726 -3.714 Td [(9.)-250(Insuf\223cient)-250(evidence)-250(exists)-250(to)-250(recommend)-250(for)-250(or)-250(against)-250(using)-250(ezetimibe)-250(with)-250(or)-250(without)-250(statins.)]TJ 58.725 0 Td [(Neither)-250(for)-250(nor)-250(against)]TJ -58.725 -1.286 Td [(10.)-250(We)-250(recommend)-250(against)-250(offering)-250(PCSK9)-250(inhibitors)-250(because)-250(their)-250(long-term)-250(safety)-250(is)-250(unknown,)]TJ 1 -1.214 Td [(evidence)-250(for)-250(their)-250(bene\223t)-250(is)-250(inconclusive,)-250(and)-250(they)-250(are)-250(expensive.)]TJ 57.726 1.214 Td [(Strong)-250(against)]TJ -59.726 -2.5 Td [(Secondary)-250(prevention)]TJ 1 -1.286 Td [(11.)-250(We)-250(recommend)-250(using)-250(at)-250(least)-250(moderate)-250(statin)-250(doses.*)]TJ 58.726 0 Td [(Strong)-250(for)]TJ -58.726 -1.286 Td [(12.)-250(For)-250(higher-risk)-250(patients\201)-250(who)-250(are)-250(willing)-250(to)-250(intensify)-250(treatment,)-250(we)-250(suggest)-250(offering)-250(high-dose)]TJ 1 -1.214 Td [(statin)-250(therapy)-250(to)-250(reduce)-250(nonfatal)-250(cardiovascular)-250(events)-250(after)-250(discussing)-250(the)-250(risk)-250(of)-250(high)-250(statin)-250(doses)]TJ T* [(with)-250(the)-250(patient)-250(and)-250(exploring)-250(the)-250(patient's)-250(values)-250(and)-250(preferences.)]TJ 57.726 2.429 Td [(Weak)-250(for)]TJ -58.726 -3.714 Td [(13.)-250(For)-250(higher-risk)-250(patients\201)-250(who)-250(are)-250(willing)-250(to)-250(intensify)-250(treatment,)-250(we)-250(suggest)-250(adding)-250(ezetimibe)-250(to)]TJ 1 -1.214 Td [(either)-250(moderate-)-250(or)-250(high-dose)-250(statin)-250(therapy)-250(to)-250(reduce)-250(nonfatal)-250(cardiovascular)-250(events)-250(after)]TJ T* [(discussing)-250(the)-250(risk)-250(of)-250(high)-250(statin)-250(doses)-250(with)-250(the)-250(patient)-250(and)-250(exploring)-250(the)-250(patient's)-250(values)-250(and)]TJ T* (preferences.)Tj 57.726 3.643 Td [(Weak)-250(for)]TJ -58.726 -4.929 Td [(14.)-250(For)-250(higher-risk)-250(patients\201)-250(who)-250(are)-250(willing)-250(to)-250(intensify)-250(treatment,)-250(we)-250(suggest)-250(offering)-250(a)-250(PCSK9)]TJ 1 -1.214 Td [(inhibitor)-250(in)-250(addition)-250(to)-250(a)-250(maximally)-250(tolerated)-250(dose)-250(of)-250(a)-250(statin)-250(with)-250(ezetimibe)-250(to)-250(reduce)-250(nonfatal)]TJ T* [(cardiovascular)-250(events)-250(after)-250(discussing)-250(the)-250(uncertain)-250(long-term)-250(safety)-250(and)-250(additional)-250(bene\223ts)-250(with)]TJ T* [(the)-250(patient)-250(and)-250(exploring)-250(the)-250(patient's)-250(values)-250(and)-250(preferences.)]TJ 57.726 3.643 Td [(Weak)-250(for)]TJ -59.726 -4.929 Td [(Other)-250(medications,)-250(supplements,)-250(and)-250(nutraceuticals)]TJ 1 -1.286 Td [(15.)-250(For)-250(primary)-250(or)-250(secondary)-250(prevention,)-250(we)-250(recommend)-250(against)-250(using)-250(niacin)-250(\(either)-250(supplements)-250(or)]TJ 1 -1.214 Td [(prescription)-250(formulas\).)]TJ 57.726 1.214 Td [(Strong)-250(against)]TJ -58.726 -2.5 Td [(16.)-250(For)-250(primary)-250(or)-250(secondary)-250(prevention,)-250(we)-250(suggest)-250(against)-250(adding)-250(\223brates)-250(to)-250(statin)-250(therapy.)]TJ 58.725 0 Td [(Weak)-250(against)]TJ -58.725 -1.286 Td [(17.)-250(Insuf\223cient)-250(evidence)-250(exists)-250(to)-250(recommend)-250(for)-250(or)-250(against)-250(using)-250(bempedoic)-250(acid)-250(with)-250(or)-250(without)]TJ 1 -1.214 Td [(statins)-250(for)-250(either)-250(primary)-250(or)-250(secondary)-250(prevention.)]TJ 57.726 1.214 Td [(Neither)-250(for)-250(nor)-250(against)]TJ -58.726 -2.5 Td [(18.)-250(For)-250(primary)-250(prevention,)-250(insuf\223cient)-250(evidence)-250(exists)-250(to)-250(recommend)-250(for)-250(or)-250(against)-250(icosapent)-250(ethyl)]TJ 1 -1.214 Td [(for)-250(patients)-250(who)-250(are)-250(receiving)-250(statins)-250(and)-250(have)-250(persistently)-250(elevated)-250(fasting)-250(triglyceride)-250(levels.)]TJ 57.726 1.214 Td [(Neither)-250(for)-250(nor)-250(against)]TJ -58.726 -2.5 Td [(19.)-250(For)-250(secondary)-250(prevention,)-250(we)-250(suggest)-250(offering)-250(icosapent)-250(ethyl)-250(to)-250(patients)-250(who)-250(are)-250(receiving)]TJ 1 -1.214 Td [(statins)-250(and)-250(have)-250(persistently)-250(elevated)-250(fasting)-250(triglyceride)-250(levels)-250(>1.7)-250(mmol/L)-250(\(>150)-250(mg/dL\))-250(to)]TJ T* [(reduce)-250(cardiovascular)-250(morbidity)-250(and)-250(mortality.)]TJ 57.726 2.429 Td [(Weak)-250(for)]TJ -58.726 -3.714 Td [(20.)-250(For)-250(primary)-250(or)-250(secondary)-250(prevention,)-250(we)-250(suggest)-250(against)-250(omega-3)-250(fatty)-250(acids)-250(as)-250(a)-250(dietary)]TJ 1 -1.214 Td [(supplement)-250(to)-250(reduce)-250(CVD)-250(risk.)]TJ 57.726 1.214 Td [(Weak)-250(against)]TJ -58.726 -2.5 Td [(21.)-250(Insuf\223cient)-250(evidence)-250(exists)-250(to)-250(recommend)-250(for)-250(or)-250(against)-250(\223ber,)-250(garlic,)-250(ginger,)-250(green)-250(tea,)-250(or)-250(red)]TJ 1 -1.214 Td [(yeast)-250(rice)-250(supplements)-250(to)-250(reduce)-250(CVD)-250(risk.)]TJ 57.726 1.214 Td [(Neither)-250(for)-250(nor)-250(against)]TJ -59.726 -2.5 Td [(Monitoring)-250(and)-250(adherence)]TJ 1 -1.286 Td [(22.)-250(We)-250(suggest)-250(against)-250(the)-250(routine)-250(monitoring)-250(of)-250(lipid)-250(levels)-250(in)-250(patients)-250(receiving)-250(statins.)]TJ 58.725 0 Td [(Weak)-250(against)]TJ -0.0195 Tc -58.725 -1.286 Td [(2)-19(3)-19(.)-251(F)-19(or)-232(patients)-232(who)-232(cannot)-232(tolerate)-232(a)-232(statin,)-232(we)-232(suggest)-232(a)-232(washout)-232(period)-232(followed)-232(by)-232(a)-232(rechallenge)]TJ 1 -1.214 Td [(with)-230(the)-230(same)-230(or)-230(a)-230(different)-230(statin)-230(or)-230(a)-231(lower)-230(dose)-231(or,)-230(if)-230(that)-230(fails,)-230(a)-230(trial)-230(of)-230(intermittent)-230(\(nondaily\))-230(dosing.)]TJ 0 Tc 57.726 1.214 Td [(Weak)-250(for)]TJ -58.726 -2.5 Td [(24.)-250(We)-250(suggest)-250(offering)-250(intensi\223ed)-250(patient)-250(care)-250(\(e.g.,)-250(phone)-250(calls,)-250(e-mails,)-250(patient)-250(education,)-250(drug)]TJ 1 -1.214 Td [(regimen)-250(simpli\223cation\))-250(to)-250(improve)-250(adherence)-250(to)-250(lipid-lowering)-250(medications.)]TJ 57.726 1.214 Td [(Weak)-250(for)]TJ /T1_2 1 Tf -60.726 -3.786 Td [(Lifestyle)-250(interventions)]TJ /T1_3 1 Tf 1 -1.286 Td [(25.)-250(For)-250(primary)-250(and)-250(secondary)-250(prevention)-250(of)-250(CVD,)-250(we)-250(suggest)-250(a)-250(dietitian-led)-250(Mediterranean)-250(diet.)]TJ 59.725 0 Td [(Weak)-250(for)]TJ -59.725 -1.286 Td [(26.)-250(For)-250(primary)-250(and)-250(secondary)-250(prevention)-250(of)-250(CVD,)-250(we)-250(suggest)-250(regular)-250(aerobic)-250(physical)-250(activity)-250(of)-250(any)]TJ 2 -1.214 Td [(intensity)-250(and)-250(duration.)]TJ 57.726 1.214 Td [(Weak)-250(for)]TJ -59.726 -2.5 Td [(27.)-250(We)-250(recommend)-250(a)-250(structured,)-250(exercise-based)-250(cardiac)-250(rehabilitation)-250(program)-250(for)-250(patients)-250(with)]TJ 2 -1.214 Td [(recent)-250(coronary)-250(heart)-250(disease)-250(\(i.e.,)-250(MI,)-250(diagnosis)-250(of)-250(coronary)-250(artery)-250(disease,)-250(CABG)-250(surgery,)-250(or)-250(PCI\))]TJ T* [(to)-250(reduce)-250(cardiovascular)-250(morbidity)-250(and)-250(mortality.)]TJ 57.726 2.429 Td [(Strong)-250(for)]TJ 7.5 0 0 7.5 53.5 96.2472 Tm [(ACS)-290(=)-290(acute)-290(coronary)-290(syndrome;)-290(CABG)-290(=)-290(coronary)-290(artery)-290(bypass)-290(graft;)-290(CAC)-290(=)-290(coronary)-290(artery)-290(calcium;)-290(CVD)-290(=)-290(cardiovascular)-290(disease;)-290(DoD)-290(=)-290(U.S.)]TJ 0 -1.067 TD [(Department)-485(of)-485(Defense;)-485(LDL-C)-485(=)-485(low-density)-485(lipoprotein)-485(cholesterol;)-485(MI)-485(=)-485(myocardial)-485(infarction;)-485(PCI)-485(=)-485(percutaneous)-485(coronary)-485(intervention;)]TJ T* [(PCSK9)-325(=)-325(proprotein)-325(convertase)-325(subtilisin/kexin)-325(type)-325(9;)-325(VA)-325(=)-325(U.S.)-325(Department)-325(of)-325(Veterans)-325(Affairs.)]TJ T* [(*)-260(\215Moderate-dose\216)-325(statin)-325(therapy)-325(is)-325(equivalent)-325(to)-325(moderate-intensity)-325(therapy;)-325(\215high-dose\216)-325(statin)-325(therapy)-325(is)-325(equivalent)-325(to)-325(high-intensity)-325(therapy.)]TJ T* [(\201)-260(Higher-risk)-247(patients)-247(include)-247(those)-247(with)-247(an)-247(MI)-247(or)-247(ACS)-247(in)-247(the)-247(past)-247(12)-247(mo;)-247(recurrent)-247(ACS,)-247(MI,)-247(or)-247(stroke;)-247(or)-247(established)-247(CVD)-247(with)-247(additional)-247(risk)-247(factors)]TJ T* [(\(e.g.,)-325(currently)-325(smoking,)-325(diabetes,)-325(peripheral)-325(artery)-325(disease,)-325(or)-325(CABG/PCI\).)]TJ /CS0 cs 1 scn /T1_4 1 Tf 16 0 0 16 53.5 744.2472 Tm (C)Tj 11.5 0 0 11.5 63.8198 744.2472 Tm (LINICAL)Tj 16 0 0 16 111.2371 744.2472 Tm (G)Tj 11.5 0 0 11.5 122.6129 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k -0.0196 Tc 9 0 0 9 373.4 744.2472 Tm [(Updated)-324(VA/DoD)-324(2020)-324(Cholesterol)-324(Guidelines)]TJ /T1_5 1 Tf 0 Tc 7 0 0 7 53.5 35.7471 Tm (4)Tj /CS0 cs 1 scn /T1_4 1 Tf 1.214 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_6 1 Tf 65.758 0 Td (Annals.org)Tj 0 0 1 rg /GS1 gs /T1_7 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj272 0 obj<>endobj273 0 obj<>stream BT 0 0 0 1 k /GS0 gs /T1_0 1 Tf 9.5 0 0 9.5 53.5 713.2472 Tm [(the)-407(effectiveness)-407(of)-407(physical)-407(activity)-407(and)-407(dietary)-407(inter-)]TJ 0 -1.161 TD [(ventions)-325(\(including)-325(nutraceuticals\))-325(on)-325(CVD)-325(outcomes.)]TJ 1.895 -1.161 Td [(A)-374(systematic)-374(search)-374(of)-374(the)-374(peer-reviewed)-374(English-)]TJ -1.895 -1.161 Td [(language)-301(literature)-301(from)-301(1)-301(December)-301(2013)-301(through)-301(16)]TJ T* [(May)-364(2019)-364(was)-364(conducted)-364(to)-364(\223nd)-364(evidence)-364(relevant)-364(to)]TJ T* [(the)-420(KQs)-420(and)-420(focused)-420(on)-420(randomized)-420(controlled)-420(trials)]TJ T* [(\(RCTs\))-261(and)-261(systematic)-261(reviews)-261(and)-261(meta-analyses)-261(of)-261(fair)]TJ T* [(or)-416(better)-416(quality.)-416(Search)-416(methods)-416(and)-416(results)-416(are)-416(de-)]TJ T* [(tailed)-546(in)-546(the)-546(full)-546(guideline)-546(\(www.healthquality.va.gov)]TJ T* [(/guidelines/CD/lipids\).)-510(The)-510(guideline)-510(panel)-510(used)-510(the)]TJ T* [(GRADE)-656(\(Grading)-656(of)-656(Recommendations)-656(Assessment,)]TJ T* [(Development)-385(and)-385(Evaluation\))-385(method)-385(to)-385(rate)-385(the)-385(rec-)]TJ T* [(ommendations)-262(\(8)-120(\20513\),)-262(with)-262(the)-262(critical)-262(outcome)-262(of)-262(CVD)]TJ T* [(mortality)-297(as)-297(the)-297(primary)-297(factor)-297(in)-297(rating)-297(grade)-297(strength.)]TJ 1.895 -1.161 Td [(The)-404(draft)-404(guideline)-404(was)-404(sent)-404(to)-404(more)-404(than)-404(20)-404(ex-)]TJ -1.895 -1.161 Td [(pert)-306(reviewers)-306(both)-306(within)-306(and)-306(outside)-306(the)-306(federal)-306(sec-)]TJ T* [(tor.)-370(Comments)-370(were)-370(considered)-370(and)-370(incorporated)-370(ac-)]TJ T* [(cording)-529(to)-529(panel)-529(consensus)-529(into)-529(the)-529(\223nal)-529(guideline,)]TJ T* [(which)-298(the)-298(VA/DoD)-298(EBPWG)-298(approved)-298(on)-298(10)-298(June)-298(2020)]TJ T* [(and)-325(released)-325(on)-325(11)-325(June)-325(2020.)]TJ /CS0 cs 1 scn /T1_1 1 Tf 11.5 0 0 11.5 53.5 462.0653 Tm (R)Tj 8.5 0 0 8.5 62.6662 462.0653 Tm (ECOMMENDATIONS)Tj 0 0 0 1 k /T1_0 1 Tf -0.0198 Tc 9.5 0 0 9.5 71.5 449.5426 Tm [(T)-20(he)-313(guideline)-313(continues)-313(to)-313(focus)-313(on)-313(CVD)-313(risk)-313(reduc-)]TJ -1.895 -1.16 Td [(tion)-320(through)-320(management)-320(of)-320(lipid)-320(levels)-320(among)-320(persons)]TJ 0 -1.16 TD [(most)-322(likely)-322(to)-322(bene\223t.)-322(The)-322(primary)-322(critical)-322(outcome)-322(of)-322(in-)]TJ T* [(terest)-281(in)-281(grading)-281(the)-281(evidence)-281(was)-281(cardiovascular)-281(mortal-)]TJ T* [(ity,)-441(with)-441(cardiovascular)-441(morbidity)-441(considered)-441(an)-441(impor-)]TJ T* [(tant)-255(but)-255(less)-255(critical)-255(outcome)-255(by)-255(which)-255(to)-255(grade)-255(evidence.)]TJ T* (The)Tj /T1_2 1 Tf 1.932 0 Td (Table)Tj /T1_0 1 Tf 2.747 0 Td [(summarizes)-266(all)-266(27)-266(recommendations.)-266(Here,)-266(we)]TJ -4.679 -1.16 Td [(highlight)-414(the)-414(7)-414(areas)-414(most)-414(relevant)-414(to)-414(practice.)-414(The)-414(full)]TJ T* [(guideline)-515(report)-515(provides)-515(complete)-515(recommendations,)]TJ T* [(rationale,)-264(and)-264(supporting)-264(evidence)-264(\(www.healthquality.va)]TJ T* (.gov/guidelines/CD/lipids\).)Tj /T1_1 1 Tf 0 Tc 0 -2.266 TD [(1.)-254(Continue)-254(to)-254(Treat)-254(to)-254(Target)-254(Dose)-254(Not)-254(LDL-C)]TJ 0 -1.213 TD (Level)Tj /T1_0 1 Tf 1.895 -1.213 Td [(Our)-272(updated)-272(systematic)-272(review)-272(did)-272(not)-272(identify)-272(any)]TJ -1.895 -1.16 Td [(direct)-329(evidence)-329(to)-329(support)-329(a)-329(strategy)-329(of)-329(targeting)-329(cho-)]TJ 0 -1.16 TD [(lesterol)-354(levels)-354(to)-354(improve)-354(outcomes.)-354(Post)-354(hoc)-354(and)-354(ob-)]TJ T* [(servational)-446(studies)-446(have)-445(consistently)-445(shown)-445(a)-445(graded)]TJ T* [(association)-492(between)-492(LDL-C)-492(levels)-492(and)-492(cardiovascular)]TJ T* [(morbidity)-592(and)-592(mortality.)-592(However,)-592(studies)-592(have)-592(not)]TJ T* [(used)-458(an)-458(RCT)-458(design)-458(to)-458(directly)-458(compare)-458(LDL-C)-458(goal)]TJ T* [(strategies.)-395(Most)-395(trials)-395(have)-395(compared)-395(a)-395(speci\223c,)-395(\223xed)]TJ T* [(statin)-428(dose)-428(with)-428(placebo,)-428(and)-428(very)-428(few)-428(trials)-428(have)-428(di-)]TJ T* [(rectly)-325(compared)-325(relative)-325(doses)-325(of)-325(individual)-325(statins.)]TJ 1.895 -1.16 Td [(The)-472(EBPWG)-472(carefully)-472(considered)-472(whether)-472(to)-472(use)]TJ -1.895 -1.16 Td [(target)-330(levels)-330(for)-330(LDL-C)-330(but)-330(noted)-330(that)-330(the)-330(evidence)-330(re-)]TJ T* [(lating)-403(patient-oriented)-403(outcomes)-403(to)-403(LDL-C)-403(levels)-403(con-)]TJ T* [(sisted)-301(of)-301(trial)-301(comparisons)-301(between)-301(therapy)-301(intensities,)]TJ T* [(not)-250(LDL-C)-250(target)-250(levels.)-250(Because)-250(no)-250(study)-250(prospectively)]TJ T* [(evaluated)-434(LDL-C)-434(goals,)-434(the)-434(EBPWG)-434(decided)-434(to)-434(focus)]TJ T* [(on)-348(treatment)-348(intensity)-348(to)-348(match)-348(the)-348(evidence)-348(and)-348(sim-)]TJ T* [(plify)-325(point-of-care)-325(decision)-325(making.)]TJ 1.895 -1.16 Td [(Because)-440(of)-440(the)-440(lack)-440(of)-440(direct)-440(evidence)-440(of)-440(bene\223t)]TJ -1.895 -1.16 Td [(from)-295(using)-295(target)-295(LDL-C)-295(goals,)-295(we)-295(recommend)-295(the)-295(use)]TJ T* [(of)-383(target)-383(medication)-383(doses)-383(consistent)-383(with)-383(the)-383(clinical)]TJ T* [(trials,)-419(most)-419(of)-419(which)-419(used)-419(moderate)-419(statin)-419(doses.)-419(We)]TJ T* [(believe)-242(the)-242(use)-242(of)-242(LDL-C)-242(targets)-242(is)-242(more)-242(likely)-242(to)-242(lead)-242(to)]TJ 27.789 69.579 Td [(harm)-393(associated)-393(with)-393(higher)-393(statin)-393(doses)-393(or)-393(combina-)]TJ 0 -1.158 TD [(tion)-325(medical)-325(therapy,)-325(for)-325(which)-325(there)-325(is)-325(little)-325(evidence.)]TJ /T1_1 1 Tf 0 -1.658 TD [(2.)-254(Use)-254(of)-254(Additional)-254(Tests)-254(to)-254(Re\223ne)-254(Risk)]TJ 0 -1.21 TD [(Prediction:)-254(Evidence)-254(Is)-254(Still)-254(Insuf\223cient)]TJ /T1_0 1 Tf 1.895 -1.21 Td [(Despite)-311(their)-311(relative)-311(imprecision,)-311(current)-311(CVD)-311(risk)]TJ -1.895 -1.158 Td [(assessment)-323(tools)-323(remain)-323(the)-323(cornerstone)-323(for)-323(risk)-323(strati-)]TJ 0 -1.158 TD [(\223cation)-483(to)-483(direct)-483(risk)-483(reduction)-483(strategies)-483(\(14\).)-483(Much)]TJ T* [(effort)-283(has)-283(been)-283(made)-283(to)-283(improve)-283(these)-283(tools)-283(with)-283(addi-)]TJ T* [(tional)-441(testing,)-441(such)-441(as)-441(coronary)-441(artery)-441(calcium)-441(\(CAC\),)]TJ T* [(high-sensitivity)-628(C-reactive)-628(protein,)-628(ankle\205)-120(brachial)-628(in-)]TJ T* [(dex,)-312(and)-312(apolipoprotein)-312(evaluations.)-312(However,)-312(our)-312(up-)]TJ T* [(dated)-309(review)-309(of)-309(the)-309(literature)-309(on)-309(the)-309(added)-309(prognostic)]TJ T* [(value)-455(of)-455(these)-455(tests)-455(indicates)-455(that)-455(they)-455(are)-455(limited)-455(in)]TJ T* [(further)-507(re\223ning)-507(risk)-507(\(15,)-507(16\).)-507(Only)-507(CAC)-507(scoring)-507(pro-)]TJ T* [(vided)-283(a)-283(statistically)-283(signi\223cant)-283(net)-283(reclassi\223cation)-283(of)-283(risk)]TJ T* [(of)-408(at)-408(least)-408(modest)-408(magnitude,)-408(although)-408(its)-408(impact)-408(on)]TJ T* [(clinical)-366(outcomes)-366(is)-366(uncertain,)-366(even)-366(when)-366(it)-366(is)-366(applied)]TJ T* [(to)-582(intermediate-risk)-582(populations,)-582(who)-582(would)-582(bene\223t)]TJ T* [(most)-385(\(17\).)-385(Without)-385(prospective)-385(RCT)-385(evidence)-385(demon-)]TJ T* [(strating)-433(improvement)-433(in)-433(critical)-433(outcomes,)-433(we)-433(do)-433(not)]TJ T* [(believe)-321(the)-321(added)-321(cost)-321(and)-321(radiation)-321(risk)-321(of)-321(CAC)-321(scor-)]TJ T* [(ing)-378(can)-378(be)-378(justi\223ed)-378(in)-378(re\223ning)-378(risk)-378(assessment)-378(for)-378(pri-)]TJ T* [(mary)-401(prevention)-401(subpopulations)-401(\(18\).)-401(The)-401(decision)-401(to)]TJ T* [(pursue)-356(such)-356(testing)-356(should)-356(be)-356(shared)-356(with)-356(the)-356(patient)]TJ T* [(and)-402(include)-402(clear)-402(communication)-402(about)-402(the)-402(uncertain)]TJ T* [(bene\223ts)-268(and)-268(known)-268(harms,)-268(and)-268(the)-268(rationale)-268(for)-268(testing)]TJ T* [(should)-352(be)-352(apparent)-352(before)-352(it)-352(is)-352(carried)-352(out.)-352(For)-352(exam-)]TJ T* [(ple,)-358(these)-358(tests)-358(might)-358(be)-358(used)-358(in)-358(patients)-358(classi\223ed)-358(as)]TJ T* [(intermediate)-379(risk,)-379(for)-379(whom)-378(there)-379(is)-379(uncertainty)-379(about)]TJ T* [(treatment)-511(bene\223t)-511(or)-511(indifference)-511(about)-511(treatment.)-511(A)]TJ T* [(\215negative\216)-261(test)-261(result)-261(might)-261(lower)-261(the)-261(probability)-261(across)]TJ T* [(a)-356(threshold)-356(of)-356(\215no)-356(treatment,\216)-356(whereas)-356(a)-356(\215positive\216)-356(re-)]TJ T* [(sult)-366(might)-366(raise)-366(the)-366(probability)-366(across)-366(a)-366(\215treat\216)-366(thresh-)]TJ T* [(old.)-308(However,)-308(the)-308(rationale)-308(for)-308(the)-308(test)-308(should)-308(be)-308(clear)]TJ T* [(before)-339(it)-339(is)-339(performed.)-339(Routine)-339(CAC)-339(testing)-339(is)-339(not)-339(rec-)]TJ T* [(ommended,)-592(because)-592(no)-592(evidence)-592(exists)-592(that)-592(it)-592(im-)]TJ T* [(proves)-274(patient)-274(outcomes,)-274(it)-274(is)-274(costly,)-274(and)-274(it)-274(exposes)-274(pa-)]TJ T* [(tients)-325(to)-325(potentially)-325(harmful)-325(radiation.)]TJ /T1_1 1 Tf 0 -1.658 TD [(3.)-254(Primary)-254(Prevention:)-254(Moderate-Dose)-254(Statin)]TJ 0 -1.21 TD [(Therapy)-254(Is)-254(Still)-254(Emphasized;)-254(No)-254(to)-254(Proprotein)]TJ T* [(Convertase)-254(Subtilisin/Kexin)-254(Type)-254(9)-254(Inhibitors)]TJ /T1_0 1 Tf 1.895 -1.21 Td [(The)-290(updated)-290(evidence)-290(review)-290(on)-290(the)-290(role)-290(of)-290(statins)]TJ -1.895 -1.158 Td [(in)-454(primary)-454(prevention)-454(resulted)-454(in)-454(little)-454(change)-454(to)-454(the)]TJ 0 -1.158 TD [(previous)-526(guidelines.)-526(For)-526(patients)-526(with)-526(a)-526(10-year)-526(risk)]TJ T* [(greater)-415(than)-415(12%,)-415(clinical)-415(trials)-415(indicate)-415(that)-415(CVD)-415(risk)]TJ T* [(may)-290(be)-290(decreased)-290(by)-290(20%)-290(to)-290(30%)-290(with)-290(moderate-dose)]TJ T* [(statin)-305(therapy)-305(for)-305(5)-305(years)-305(\(19\).)-305(The)-305(rationale)-305(for)-305(using)-305(a)]TJ T* [(threshold)-349(of)-349(12%)-349(is)-349(that)-349(it)-349(most)-349(closely)-349(resembles)-349(that)]TJ T* [(of)-497(the)-497(clinical)-497(trial)-497(populations)-497(in)-497(which)-497(the)-497(bene\223ts)]TJ T* [(clearly)-276(outweighed)-276(the)-276(risks)-276(\(20,)-276(21\).)-276(A)-276(similar)-276(rationale)]TJ T* [(is)-282(used)-282(for)-282(the)-282(6%)-282(threshold;)-282(no)-282(clinical)-282(trial)-282(speci\223cally)]TJ T* [(addressed)-537(persons)-537(with)-537(a)-537(risk)-537(below)-537(this)-537(threshold.)]TJ T* [(Once)-393(a)-393(patient's)-393(10-year)-393(risk)-393(has)-393(been)-393(calculated,)-393(we)]TJ T* [(recommend)-726(shared)-726(decision)-726(making)-726(to)-726(determine)]TJ T* [(whether)-258(the)-258(potential)-258(bene\223ts)-258(of)-258(medications)-258(outweigh)]TJ T* [(the)-291(potential)-291(harms)-291(for)-291(that)-291(patient.)-291(This)-291(tradeoff)-291(varies)]TJ T* [(by)-372(level)-372(of)-372(10-year)-372(CVD)-372(risk)-372(because)-372(of)-372(differences)-372(in)]TJ T* [(the)-291(level)-292(of)-292(evidence)-291(of)-292(bene\223t)-291(weighed)-291(against)-291(a)-291(con-)]TJ T* [(stant)-284(risk)-284(for)-284(adverse)-284(events:)-284(less)-284(than)-284(6%)-284(\(no)-284(evidence)]TJ T* [(of)-369(bene\223t\),)-369(6%)-369(to)-369(12%)-369(\(limited)-369(evidence\),)-369(and)-369(greater)]TJ /T1_3 1 Tf -0.0196 Tc 9 0 0 9 53.5 744.2472 Tm [(Updated)-300(VA/DoD)-300(2020)-300(Cholesterol)-300(Guidelines)]TJ /CS0 cs 1 scn 0 Tc 16 0 0 16 435.1302 744.2472 Tm (C)Tj 11.5 0 0 11.5 445.4501 744.2472 Tm (LINICAL)Tj 16 0 0 16 492.6486 744.2472 Tm (G)Tj 11.5 0 0 11.5 504.0244 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k /T1_4 1 Tf 7 0 0 7 53.5 35.7471 Tm (Annals.org)Tj /CS0 cs 1 scn /T1_3 1 Tf 42.264 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_5 1 Tf 29.221 0 Td (3)Tj 0 0 1 rg /GS1 gs /T1_6 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj274 0 obj<>endobj275 0 obj<>stream 0 0 0 0 k /GS0 gs 53.5 701.747 504 17.5 re f q 1 0 0 1 53.5 719.497 cm /CS0 CS 1 SCN 0.5 w 0 0 m 504 0 l S Q BT 0 0 0 1 k /T1_0 1 Tf 9 0 0 8.5 59.5 709.7472 Tm (Figure.)Tj /T1_1 1 Tf 8.5 0 0 8.5 90.8771 709.7472 Tm [(Algorithm)-249(of)-249(the)-249(VA/DoD)-249(clinical)-249(practice)-249(guideline)-249(for)-249(managing)-249(dyslipidemia)-249(to)-249(reduce)-249(CVD)-249(risk.)]TJ ET q 1 0 0 1 53.5 703.997 cm /CS0 CS 1 SCN 0.5 w 0 0 m 504 0 l S Q /Document /MC0 BDC q 1 0 0 1 192.495 551.779 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 48.917 0 l S Q q 1 0 0 1 244.942 551.779 cm /GS1 gs 0 0 m -4.975 -2.032 l -3.795 0 l -4.975 2.033 l 0 0 l f Q q 1 0 0 1 160.618 547.012 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -11.97 l S Q q 1 0 0 1 160.618 531.512 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 160.618 577.281 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -15.165 l S Q q 1 0 0 1 160.618 558.586 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.795 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 243.41 583.552 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 68.954 0 l 68.954 -18.725 l S Q q 1 0 0 1 312.364 561.297 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 160.618 609.75 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -13.259 l S Q q 1 0 0 1 160.618 592.961 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 160.618 642.259 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -12.262 l S Q q 1 0 0 1 160.618 626.467 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 319.364 491.215 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -14.537 l S Q q 1 0 0 1 319.364 473.148 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.795 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 478.388 573.675 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -38.884 l S Q q 1 0 0 1 478.388 531.261 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 160.618 674.264 cm 0 0 0 1 K 0.5 w /GS1 gs 0 0 m 0 -11.287 l S Q q 1 0 0 1 160.618 659.447 cm /GS1 gs 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q 0.145 0.009 0.057 0.048 k /GS1 gs 261.328 602.061 269.527 29.274 re f 0 0 0 1 K 0.5 w 530.855 602.061 -269.527 29.274 re S 244.942 542.262 134.282 19.035 re f 379.224 542.262 -134.282 19.035 re S 245.222 484.436 134.283 19.035 re f 379.505 484.436 -134.283 19.035 re S 429.235 573.675 100.924 19.035 re f 530.159 573.675 -100.924 19.035 re S 423.833 512.226 109.109 19.035 re f 532.942 512.226 -109.109 19.035 re S q 1 0 0 1 198.052 671.48 cm 0 0 m 0 -1.096 -0.897 -1.993 -1.993 -1.993 c -72.875 -1.993 l -73.971 -1.993 -74.867 -1.096 -74.867 0 c -74.867 6.737 l -74.867 7.833 -73.971 8.73 -72.875 8.73 c -1.993 8.73 l -0.897 8.73 0 7.833 0 6.737 c 0 0 l f Q q 1 0 0 1 198.052 671.48 cm 0 0 m 0 -1.096 -0.897 -1.993 -1.993 -1.993 c -72.875 -1.993 l -73.971 -1.993 -74.867 -1.096 -74.867 0 c -74.867 6.737 l -74.867 7.833 -73.971 8.73 -72.875 8.73 c -1.993 8.73 l -0.897 8.73 0 7.833 0 6.737 c 0 0 l h S Q q 1 0 0 1 421.29 659.447 cm 0 0 m 0 -9.745 -30.397 -17.644 -67.893 -17.644 c -105.389 -17.644 -135.786 -9.745 -135.786 0 c -135.786 9.745 -105.389 17.645 -67.893 17.645 c -30.397 17.645 0 9.745 0 0 c f Q q 1 0 0 1 421.29 659.447 cm 0 0 m 0 -9.745 -30.397 -17.644 -67.893 -17.644 c -105.389 -17.644 -135.786 -9.745 -135.786 0 c -135.786 9.745 -105.389 17.645 -67.893 17.645 c -30.397 17.645 0 9.745 0 0 c h S Q q 1 0 0 1 87.594 649.678 cm 0 0 m 21.283 9.769 l 125.231 9.769 l 146.049 0 l 124.766 -9.768 l 20.818 -9.768 l 0 0 l f Q q 1 0 0 1 87.594 649.678 cm 0 0 m 21.283 9.769 l 125.231 9.769 l 146.049 0 l 124.766 -9.768 l 20.818 -9.768 l 0 0 l h S Q q 1 0 0 1 93.094 551.54 cm 0 0 m 21.283 7.046 l 114.231 7.046 l 135.049 0 l 113.766 -7.047 l 20.818 -7.047 l 0 0 l f Q q 1 0 0 1 93.094 551.54 cm 0 0 m 21.283 7.046 l 114.231 7.046 l 135.049 0 l 113.766 -7.047 l 20.818 -7.047 l 0 0 l h S Q q 1 0 0 1 87.594 616.699 cm 0 0 m 21.283 9.768 l 125.231 9.768 l 146.049 0 l 124.766 -9.768 l 20.818 -9.768 l 0 0 l f Q q 1 0 0 1 87.594 616.699 cm 0 0 m 21.283 9.768 l 125.231 9.768 l 146.049 0 l 124.766 -9.768 l 20.818 -9.768 l 0 0 l h S Q q 1 0 0 1 77.594 583.193 cm 0 0 m 21.283 9.768 l 145.231 9.768 l 166.049 0 l 144.766 -9.768 l 20.818 -9.768 l 0 0 l f Q q 1 0 0 1 77.594 583.193 cm 0 0 m 21.283 9.768 l 145.231 9.768 l 166.049 0 l 144.766 -9.768 l 20.818 -9.768 l 0 0 l h S Q q 1 0 0 1 77.594 521.743 cm 0 0 m 21.283 9.769 l 145.231 9.769 l 166.049 0 l 144.766 -9.768 l 20.818 -9.768 l 0 0 l f Q q 1 0 0 1 77.594 521.743 cm 0 0 m 21.283 9.769 l 145.231 9.769 l 166.049 0 l 144.766 -9.768 l 20.818 -9.768 l 0 0 l h S Q 198.743 384.171 240.201 88.977 re f q 1 0 0 1 438.944 384.171 cm 0 0 -240.201 88.977 re S Q q 1 0 0 1 233.643 649.777 cm 0 0 m 37.823 0 l 37.823 9.67 l 48.331 9.67 l S Q q 1 0 0 1 285.504 659.447 cm 0 0 0 1 k 0 0 m -4.974 -2.033 l -3.794 0 l -4.974 2.032 l 0 0 l f Q q 1 0 0 1 233.643 616.699 cm 0 0 m 24.155 0 l S Q q 1 0 0 1 261.328 616.699 cm 0 0 0 1 k 0 0 m -4.975 -2.033 l -3.794 0 l -4.975 2.032 l 0 0 l f Q q 1 0 0 1 379.224 551.779 cm 0 0 m 95.014 0 l S Q q 1 0 0 1 477.768 551.779 cm 0 0 0 1 k 0 0 m -4.975 -2.032 l -3.795 0 l -4.975 2.033 l 0 0 l f Q 474.29 307.997 -342.001 67.657 re S 132.35 362.135 341.879 13.519 re f 474.229 362.135 -341.879 13.519 re S BT 0 0 0 1 k /T1_2 1 Tf 7 0 0 7 123.1846 683.6493 Tm (1)Tj -2.889 -3.146 Td (2)Tj 26.441 1.525 Td (3)Tj -0.074 Tc -5.161 -2.665 Td [(Ye)-74(s)]TJ 0 Tc 5.887 1.126 Td (Discuss lack of evidence demonstrating)Tj 1.134 -1.2 Td (benefit and continue ongoing care)Tj -0.074 Tc -8.205 -4.684 Td [(Ye)-74(s)]TJ 0 Tc -13.519 1.624 Td (No)Tj 0 -4.857 TD (No)Tj 0.071 -4.55 Td (No)Tj -0.064 -4.311 Td (No)Tj 0.064 -4.915 Td (No)Tj -0.074 Tc 15.162 12.084 Td [(Ye)-74(s)]TJ -4.006 -4.572 Td [(Ye)-74(s)]TJ 2.842 -3.931 Td [(Ye)-74(s)]TJ 0 Tc -20.646 14.655 Td (4)Tj 22.623 0.689 Td (5)Tj -23.891 -5.317 Td (6)Tj 21.55 -4.633 Td (7)Tj -19.395 -0.382 Td (8)Tj -2.155 -3.678 Td (9)Tj 47.877 8.408 Td (10)Tj 0.176 -1.323 Td (If MI, ACS, or CABG/PCI in past)Tj 0.918 -1.2 Td (6 wk, refer for cardiac rehab)Tj -27.079 -3.288 Td (Recommend moderate-dose statin therapy)Tj 6.027 -1.2 Td (\(see Sidebar 3\))Tj -5.655 -7.061 Td (Recommend regular aerobic exercise and)Tj 1.751 -1.2 Td (smoking cessation \(if applicable\))Tj 25.383 5.17 Td (Recommend dietitian-led)Tj -1.827 -1.2 Td (Mediterranean diet for risk >12%)Tj -0.466 2.894 Td (11)Tj -25.516 -4.142 Td (12)Tj -6.64 -4.457 Td (13)Tj 0.572 -1.593 Td (Follow-up evaluation)Tj 0 -1.2 TD ( Primary prevention, no statin)Tj 0 -1.2 TD ( Lipid panel every 10 y \(nonfasting recommended\) )Tj 0 -1.2 TD ( Repeat risk evaluation in Box 1)Tj 0 -1.2 TD ( Every 2 y if 6% to 12%)Tj 0 -1.2 TD ( Every 5 y if <6%)Tj 0 -1.2 TD ( If risk factors change)Tj 0 -1.2 TD ( Secondary prevention: lipid panels as needed, only if patient is )Tj 0 -1.2 TD ( higher risk and willing to intensify treatment)Tj 0 -1.2 TD ( Once optimal therapy is received, no need to recheck lipid levels rou\tinely)Tj 8.811 33.463 Td (Recommend stepped intensification)Tj 0 -1.2 TD ( Maximize statin therapy or add ezetimibe)Tj 0 -1.2 TD ( Consider PCSK9 inhibitor only after maximizing statin therapy and add\ing ezetimibe)Tj -18.934 9.511 Td (Patient aged )Tj /T1_3 1 Tf (\001)Tj /T1_2 1 Tf -0.0001 Tc 0.0001 Tw (40 y)Tj 0 Tc 0 Tw -3.974 -3 Td (Does patient have HF with EF <35%,)Tj 1.445 -1.2 Td (ESKD, or life expectancy <5 y?)Tj -1.2 -3.511 Td [(Does patient have higher)55(-risk CVD?)]TJ 4.612 -1.2 Td (\(see Sidebar 2\))Tj -6.141 -3.583 Td (Does patient have CVD per Sidebar 1, DM,)Tj -0.208 -1.2 Td (or LDL-C level )Tj /T1_3 1 Tf (\001)Tj /T1_2 1 Tf (4.9 mmol/L \()Tj /T1_3 1 Tf (\001)Tj /T1_2 1 Tf (190 mg/dL\)?)Tj 2.252 -3.926 Td [(Is patient\222)74(s 10-y CVD risk >12%?)]TJ -0.729 -3.657 Td [(Is patient\222)74(s 10-y risk 6% to 12% and)]TJ 0.076 -1.2 Td (does patient prefer statin treatment?)Tj 4.312 -21.235 Td (Sidebar 1: CVD and Equivalents)Tj 0 -1.774 TD (MI or ACS)Tj 0 -1.2 TD (CABG/PCI)Tj T* (Stable CAD \(angina or equivalent\))Tj T* (Stroke/TIA)Tj T* [(P)55(AD \(claudication or AAA\))]TJ T* (Does not include asymptomatic incidental finding of atherosclerosis \(e.\g., CAC\))Tj ET 474.29 223.518 -342.001 84.479 re S 0.145 0.009 0.057 0.048 k 132.35 294.479 341.879 13.518 re f 474.229 294.479 -341.879 13.518 re S BT 0 0 0 1 k /T1_2 1 Tf 7 0 0 7 135.0029 299.1241 Tm (Sidebar 2: High-Risk CVD Patients)Tj 0 -1.773 TD (MI or ACS in past 12 mo or)Tj 0 -1.2 TD (Recurrent ACS, MI, or stroke, or)Tj T* [(Known CVD \(see Sidebar 1\) and any of the following: currently smoking,\ DM, CKD, P)55(AD, CABG/PCI)]TJ 0 -2.4 TD (Stepped intensification)Tj 0 -1.2 TD ( Maximize statin therapy or add ezetimibe)Tj 0 -1.2 TD ( If not already done, maximize statin therapy and add ezetimibe)Tj T* ( Consider PCSK9 inhibitor only after maximizing statin therapy and add\ing ezetimibe)Tj ET q 1 0 0 1 477.768 602.061 cm 0 0 m 0 -5.821 l S Q q 1 0 0 1 477.768 592.71 cm 0 0 m -2.033 4.975 l 0 3.794 l 2.032 4.975 l 0 0 l f Q q 1 0 0 1 243.643 521.743 cm 0 0 m 68.721 0 l 68.721 16.989 l S Q q 1 0 0 1 312.364 542.262 cm 0 0 m 2.032 -4.975 l 0 -3.795 l -2.032 -4.975 l 0 0 l f Q q 1 0 0 1 160.618 511.975 cm 0 0 m 0 -18.022 l 80.794 -18.022 l S Q q 1 0 0 1 244.942 493.953 cm 0 0 m -4.975 -2.032 l -3.795 0 l -4.975 2.033 l 0 0 l f Q q 1 0 0 1 478.388 511.975 cm 0 0 m 0 -18.022 l -95.352 -18.022 l S Q q 1 0 0 1 379.504 493.953 cm 0 0 m 4.975 2.033 l 3.795 0 l 4.975 -2.032 l 0 0 l f Q q 1 0 0 1 474.29 93.997 cm 0 0 -342.001 38.739 re S Q q 1 0 0 1 474.29 132.736 cm 0 0 -342.001 90.782 re S Q 0.145 0.009 0.057 0.048 k 132.35 210.001 341.879 13.517 re f 474.229 210.001 -341.879 13.517 re S 0 0 0 0.15 k 132.35 196.483 341.879 13.518 re f 474.229 196.483 -341.879 13.518 re S BT 0 0 0 1 k /T1_2 1 Tf 7 0 0 7 135.0029 214.6462 Tm (Sidebar 3: Drug Doses)Tj -0.0001 Tw 0 -1.931 TD (Generic Name)Tj 0 Tw 16.401 0.017 Td (Moderate Dose, )Tj /T1_4 1 Tf (mg)Tj /T1_2 1 Tf -0.0001 Tw 19.525 0 Td (High Dose, )Tj /T1_4 1 Tf 0 Tw (mg)Tj /T1_2 1 Tf -35.926 -1.911 Td (Atorvastatin)Tj 0 -1.2 TD (Rosuvastatin)Tj 0 -1.2 TD (Simvastatin)Tj 0 -1.2 TD (Pravastatin)Tj T* (Lovastatin)Tj T* (Fluvastatin)Tj 0 -1.2 TD (Pitavastatin)Tj 19.259 7.2 Td ( 10\22620)Tj 0.278 -1.2 Td ( 5\22610)Tj -0.278 -1.2 Td ( 20\22640)Tj 0 -1.2 TD ( 40\22680)Tj T* ( 40\22680)Tj -7.526 -1.2 Td ( 80 \(sustained release\) or 40 \(twice daily\))Tj 8.082 -1.2 Td ( 1\2264)Tj 18.053 7.2 Td (40\22680)Tj 0 -1.2 TD (20\22640)Tj 0.0001 Tc 0.446 -1.2 Td (N/A)Tj 0 -1.2 TD (N/A)Tj T* (N/A)Tj T* (N/A)Tj 0 -1.2 TD (N/A)Tj 0 Tc -38.314 -1.945 Td (In patients who are intolerant of statins: after washout \(e.g., 1 mo\),\ rechallenge with same or another statin)Tj 0 -1.2 TD ( rather than switching medication class.)Tj 0 -1.2 TD (Intensified patient care \(e.g., phone calls, e-mails, patient education\, drug regimen simplification\) may)Tj 0 -1.2 TD ( improve adherence to lipid-lowering medications.)Tj ET EMC q 1 0 0 1 53.5 87.497 cm /CS0 CS 1 SCN /GS0 gs 0 0 m 504 0 l S Q BT /GS0 gs /T1_5 1 Tf 7.5 0 0 7.5 53.5 78.7471 Tm [(Note)-274(that)-274(previously)-274(measured)-274(lipid)-274(levels)-274(may)-274(be)-274(used)-274(reliably)-274(in)-274(serial)-274(CVD)-274(risk)-274(assessments.)-274(We)-274(do)-274(not)-274(recommend)-274(rechecking)-274(lipid)-274(levels)-274(each)]TJ 0 -1.067 TD [(time)-339(CVD)-339(risk)-339(is)-339(assessed,)-339(because)-339(lipid)-339(levels)-339(remain)-339(stable)-339(within)-339(each)-339(patient)-339(over)-339(time)-339(and)-339(contribute)-339(little)-339(to)-339(predicted)-339(risk)-339(relative)-339(to)-339(other)]TJ T* (factors.)Tj /CS0 cs 1 scn /T1_6 1 Tf 16 0 0 16 53.5 744.2472 Tm (C)Tj 11.5 0 0 11.5 63.8198 744.2472 Tm (LINICAL)Tj 16 0 0 16 111.2371 744.2472 Tm (G)Tj 11.5 0 0 11.5 122.6129 744.2472 Tm (UIDELINE)Tj 0 0 0 1 k -0.0196 Tc 9 0 0 9 373.4 744.2472 Tm [(Updated)-324(VA/DoD)-324(2020)-324(Cholesterol)-324(Guidelines)]TJ /T1_7 1 Tf 0 Tc 7 0 0 7 53.5 35.7471 Tm (2)Tj /CS0 cs 1 scn /T1_6 1 Tf 1.172 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_8 1 Tf 65.8 0 Td (Annals.org)Tj 0 0 1 rg /GS2 gs /T1_9 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj276 0 obj<>endobj277 0 obj<>stream /CS0 cs 0.05 scn /CS0 CS 1 SCN 0.5 w /GS0 gs 557.75 100.997 -240.5 -49 re 317.25 100.997 m h B BT 0 0 0 1 k /T1_0 1 Tf -0.0199 Tc 20 0 0 20 53.5 706.7472 Tm [(Management)-175(of)-175(Dyslipidemia)-175(for)-175(Cardiovascular)-175(Disease)-175(Risk)]TJ 0 -1.1 TD [(Reduction:)-175(Synopsis)-175(of)-175(the)-175(2020)-175(Updated)-175(U.S.)-175(Department)-175(of)-175(Veterans)]TJ T* [(Affairs)-175(and)-175(U.S.)-175(Department)-175(of)-175(Defense)-175(Clinical)-175(Practice)-175(Guideline)]TJ /T1_1 1 Tf 0 Tc 8 0 0 8 53.5 646.7472 Tm [(Patrick)-250(G.)-250(O\220Malley,)-250(MD,)-250(MPH;)-250(Michael)-250(J.)-250(Arnold,)-250(MD;)-250(Cathy)-250(Kelley,)-250(PharmD;)-250(Lance)-250(Spacek,)-250(MD;)-250(Andrew)-250(Buelt,)-250(DO;)]TJ 0 -1.312 TD [(Sundar)-250(Natarajan,)-250(MD,)-250(MSc;)-250(Mark)-250(P.)-250(Donahue,)-250(MD;)-250(Elena)-250(Vagichev,)-250(PharmD;)-250(Jennifer)-250(Ballard-Hernandez,)-250(DNP,)-250(FNP-BC;)]TJ T* [(Amanda)-250(Logan,)-250(MPS,)-250(RDN,)-250(LD;)-250(Lauren)-250(Thomas,)-250(MS,)-250(RDN,)-250(LD;)-250(Joan)-250(Ritter,)-250(MD;)-250(Brian)-250(E.)-250(Neubauer,)-250(MD,)-250(MHPE;)]TJ T* [(and)-250(John)-250(R.)-250(Downs,)-250(MD)]TJ /CS0 cs 1 scn 8.5 0 0 8.5 53.5 593.2472 Tm (Description:)Tj 0 0 0 1 k /T1_2 1 Tf -0.0197 Tc 6.211 0 Td [(In)-269(June)-269(2020,)-269(the)-269(U.S.)-269(Department)-269(of)-269(Veterans)-269(Af-)]TJ -6.211 -1.273 Td [(fairs)-250(\(VA\))-250(and)-250(U.S.)-250(Department)-250(of)-250(Defense)-250(\(DoD\))-250(released)-250(a)-250(joint)]TJ 0 -1.273 TD [(update)-350(of)-350(their)-350(clinical)-350(practice)-350(guideline)-350(for)-350(managing)-350(dyslipi-)]TJ T* [(demia)-349(to)-349(reduce)-349(cardiovascular)-349(disease)-349(risk)-349(in)-349(adults.)-349(This)-349(syn-)]TJ T* [(opsis)-299(describes)-299(the)-299(major)-299(recommendations.)]TJ /CS0 cs 1 scn /T1_1 1 Tf -0.0398 Tc 0 -2.096 TD [(M)-40(ethods:)]TJ 0 0 0 1 k /T1_2 1 Tf 4.66 0 Td [(O)-20(n)-304(6)-304(August)-304(to)-304(9)-304(August)-304(2019,)-304(the)-304(VA/DoD)-304(Evidence-)]TJ -4.66 -1.273 Td (Based)Tj -0.0197 Tc 2.92 0 Td [(Practice)-296(Work)-296(Group)-296(\(EBPWG\))-296(convened)-296(a)-296(joint)-296(VA/DoD)]TJ -2.92 -1.273 Td [(guideline)-292(development)-292(effort)-292(that)-292(included)-292(clinical)-292(stakeholders)]TJ 0 -1.273 TD [(and)-278(conformed)-278(to)-278(the)-278(Institute)-278(of)-278(Medicine's)-278(tenets)-278(for)-278(trustwor-)]TJ T* [(thy)-360(clinical)-360(practice)-360(guidelines.)-360(The)-360(guideline)-360(panel)-360(developed)]TJ T* [(key)-327(questions,)-327(systematically)-327(searched)-327(and)-327(evaluated)-327(the)-327(litera-)]TJ T* [(ture)-389(\(English-language)-389(publications)-389(from)-389(1)-389(December)-389(2013)-389(to)]TJ 31.059 14.823 Td [(16)-312(May)-312(2019\),)-312(and)-312(developed)-312(27)-312(recommendations)-312(and)-312(a)-312(sim-)]TJ 0 -1.235 TD [(ple)-423(1-page)-423(algorithm.)-423(The)-423(recommendations)-423(were)-423(graded)-423(by)]TJ T* [(using)-431(the)-431(GRADE)-431(\(Grading)-431(of)-431(Recommendations)-431(Assessment,)]TJ T* [(Development)-299(and)-299(Evaluation\))-299(system.)]TJ /CS0 cs 1 scn /T1_1 1 Tf 0 Tc 0 -2.059 TD (Recommendations:)Tj 0 0 0 1 k /T1_2 1 Tf -0.0197 Tc 9.769 0 Td [(This)-371(synopsis)-371(summarizes)-371(key)-371(features)-371(of)]TJ -9.769 -1.235 Td [(the)-261(guideline)-261(in)-261(7)-261(crucial)-261(areas:)-261(targeting)-261(of)-261(statin)-261(dose)-261(\(not)-261(low-)]TJ 0 -1.235 TD [(density)-481(lipoprotein)-481(cholesterol)-481(goals\),)-481(additional)-481(tests)-481(for)-481(risk)]TJ T* [(prediction,)-410(primary)-410(and)-410(secondary)-410(prevention,)-410(laboratory)-410(test-)]TJ T* [(ing,)-299(physical)-299(activity,)-299(and)-299(nutrition.)]TJ /T1_3 1 Tf -0.0195 Tc 7 0 0 7 317.5 486.7472 Tm [(Ann)-240(Intern)-240(Med.)]TJ /T1_2 1 Tf 7.585 0 Td (doi:10.7326/M20-4648)Tj /T1_4 1 Tf 21.847 0 Td (Annals.org)Tj /T1_2 1 Tf -29.432 -1.429 Td [(For)-299(author,)-299(article,)-299(and)-299(disclosure)-299(information,)-299(see)-299(end)-299(of)-299(text.)]TJ 0 Tc 0 -1.357 TD [(This)-325(article)-325(was)-325(published)-325(at)-325(Annals.org)-325(on)-325(22)-325(September)-325(2020.)]TJ ET q 1 0 0 1 53.5 450.997 cm 0 0 0 1 K 0 0 m 504 0 l S Q BT /CS0 cs 1 scn /T1_1 1 Tf 25.9972 0 0 25.9972 53.5 414.2472 Tm (C)Tj 0 0 0 1 k /T1_2 1 Tf -0.0198 Tc 9.5 0 0 9.5 71.5941 425.2472 Tm [(a)-20(rdiovascular)-297(disease)-297(\(CVD\))-297(is)-297(a)-297(major)-297(cause)-297(of)-297(mor-)]TJ 0 -1.158 TD [(bidity)-298(and)-298(mortality)-298(in)-298(the)-298(United)-298(States)-298(and)-298(globally)]TJ -1.905 -1.158 Td [(\(1\).)-300(Reducing)-300(the)-300(burden)-300(of)-300(CVD)-300(is)-300(a)-300(priority)-300(area)-300(for)-300(the)]TJ T* [(U.S.)-278(Department)-278(of)-278(Veterans)-278(Affairs)-278(\(VA\))-278(and)-277(the)-277(U.S.)-278(De-)]TJ T* [(partment)-410(of)-410(Defense)-410(\(DoD\).)-410(In)-410(June)-410(2020,)-410(the)-410(VA/DoD)]TJ T* [(released)-302(an)-302(evidence-based)-302(update)-302(to)-302(their)-302(2014)-302(clinical)]TJ T* [(practice)-388(guideline)-388(for)-388(managing)-388(dyslipidemia)-388(to)-388(reduce)]TJ T* [(CVD)-278(risk)-278(\(www.healthquality.va.gov/guidelines/CD/lipids\))]TJ T* [(\(2\).)-284(This)-284(synopsis)-284(presents)-284(the)-284(guideline,)-284(which)-284(continues)]TJ T* [(to)-453(emphasize)-453(CVD)-453(risk)-453(management)-453(over)-453(a)-453(short-term)]TJ T* [(\(10-year\))-257(horizon)-257(with)-257(more)-257(conservative)-257(dosing)-257(of)-257(statins)]TJ T* [(in)-354(primary)-354(and)-354(stable)-354(secondary)-354(prevention,)-354(without)-354(tar-)]TJ T* [(geting)-355(low-density)-355(lipoprotein)-355(cholesterol)-355(\(LDL-C\))-355(goals.)]TJ T* [(We)-314(provide)-314(new)-314(recommendations)-314(for)-314(stepped)-314(intensi\223-)]TJ T* [(cation)-519(for)-519(secondary)-519(prevention)-519(in)-519(higher-risk)-519(patients)]TJ T* [(and)-541(a)-541(new)-541(emphasis)-541(on)-541(aerobic)-541(physical)-541(activity)-541(and)]TJ T* [(Mediterranean-style)-413(diets.)-413(The)]TJ /T1_5 1 Tf 14.039 0 Td (Figure)Tj /T1_2 1 Tf 3.27 0 Td [(outlines)-413(the)-413(algo-)]TJ -17.309 -1.158 Td [(rithm)-299(of)-299(these)-299(recommendations.)]TJ /CS0 cs 1 scn /T1_6 1 Tf 0 Tc 11.5 0 0 11.5 53.5 207.7471 Tm (G)Tj 8.5 0 0 8.5 62.7812 207.7471 Tm (UIDELINE)Tj 11.5 0 0 11.5 112.6684 207.7471 Tm (D)Tj 8.5 0 0 8.5 122.2602 207.7471 Tm (EVELOPMENT)Tj 11.5 0 0 11.5 190.4389 207.7471 Tm (P)Tj 8.5 0 0 8.5 198.501 207.7471 Tm (ROCESS)Tj 0 0 0 1 k /T1_2 1 Tf -0.0198 Tc 9.5 0 0 9.5 71.5 195.2472 Tm [(T)-20(o)-230(develop)-230(these)-230(recommendations,)-230(the)-230(VA/DoD)-230(fol-)]TJ -1.895 -1.158 Td [(lowed)-329(the)-329(method)-329(developed)-329(by)-329(the)-329(VA/DoD)-329(Evidence-)]TJ T* [(Based)-401(Practice)-401(Work)-401(Group)-401(\(EBPWG\))-401(\(3\),)-401(which)-401(follows)]TJ T* [(the)-311(standards)-311(described)-311(for)-311(trustworthy)-311(guidelines)-311(\(4)-120(\205)-120(6\).)]TJ T* [(The)-282(guideline)-282(project)-282(team)-282(completed)-282(con\224ict-of-interest)]TJ T* [(disclosure)-333(forms)-333(for)-333(relationships)-333(in)-333(the)-333(previous)-333(2)-333(years)]TJ T* [(and)-353(af\223rmed)-353(the)-353(disclosures)-353(verbally)-353(during)-353(the)-353(project.)]TJ T* [(Web-based)-590(surveillance)-590(\(such)-590(as)-590(through)-590(Centers)-590(for)]TJ T* [(Medicare)-481(&)-481(Medicaid)-481(Services)-481(open)-481(payments)-481(or)-481(Pro-)]TJ T* [(Publica\))-257(was)-257(used)-257(to)-257(screen)-257(for)-257(potential)-257(con\224icts)-257(of)-257(inter-)]TJ T* [(est)-324(among)-324(project)-324(team)-324(members,)-324(and)-324(action)-324(was)-324(taken)]TJ T* [(to)-299(mitigate)-299(identi\223ed)-299(con\224icts.)]TJ 0 Tc 1.895 -1.158 Td [(The)-257(EBPWG)-257(selected)-257(2)-257(guideline)-257(panel)-257(co-chairs,)-257(1)]TJ -1.895 -1.158 Td [(from)-410(the)-411(VA)-411(and)-411(1)-411(from)-410(the)-411(DoD.)-411(The)-411(co-chairs)-411(then)]TJ 27.789 39.263 Td [(selected)-306(a)-306(multidisciplinary)-306(panel)-306(that)-306(comprised)-306(prac-)]TJ T* [(ticing)-640(clinician)-640(stakeholders,)-640(including)-640(primary)-640(care)]TJ T* [(physicians)-265(\(family)-265(medicine)-265(and)-265(internal)-265(medicine\),)-265(car-)]TJ T* [(diologists,)-469(dietitians,)-469(pharmacists,)-469(nurse)-469(practitioners,)]TJ T* [(and)-385(physician)-385(assistants.)-385(The)-385(VA/DoD)-385(contracted)-385(with)]TJ T* [(The)-319(Lewin)-319(Group,)-319(a)-319(third)-319(party)-319(with)-319(expertise)-319(in)-319(devel-)]TJ T* [(oping)-290(clinical)-290(practice)-290(guidelines,)-290(to)-290(facilitate)-290(meetings)]TJ T* [(and)-532(develop)-532(key)-532(questions)-532(\(KQs\))-532(using)-532(the)-532(PICOTS)]TJ T* [(\(population,)-452(intervention,)-452(comparator,)-452(outcomes,)-452(tim-)]TJ T* [(ing)-566(of)-566(outcomes)-566(measurement,)-566(and)-566(setting\))-566(format.)]TJ T* [(\(For)-258(a)-258(list)-258(of)-258(EBPWG)-258(members,)-258(see)-258(the)]TJ /T1_5 1 Tf 17.832 0 Td (Appendix)Tj /T1_2 1 Tf [(,)-258(avail-)]TJ -17.832 -1.158 Td [(able)-325(at)-325(Annals.org.\))]TJ 1.895 -1.158 Td [(The)-435(guideline)-435(panel)-435(developed)-435(12)-435(KQs,)-435(many)-435(of)]TJ -1.895 -1.158 Td [(which)-412(are)-412(similar)-412(to)-412(questions)-412(that)-412(the)-412(American)-412(Col-)]TJ T* [(lege)-560(of)-560(Cardiology)-560(and)-560(American)-560(Heart)-560(Association)]TJ T* [(used)-283(in)-283(developing)-283(their)-283(guideline)-283(on)-283(cholesterol)-283(man-)]TJ T* [(agement)-770(\(7\),)-770(and)-770(concerned)-770(evidence)-770(supporting)]TJ T* [(LDL-C)-650(and)-650(non\205)-120(high-density)-650(lipoprotein)-650(cholesterol)]TJ T* [(levels)-367(as)-367(targets)-367(for)-367(treatment,)-367(treatment)-367(effectiveness)]TJ T* [(in)-417(reducing)-417(clinically)-417(important)-417(CVD)-417(events)-417(\(fatal)-417(and)]TJ T* [(nonfatal)-430(myocardial)-430(infarctions)-430([MIs])-430(and)-430(strokes,)-430(and)]TJ T* [(total)-321(mortality\),)-321(and)-321(adverse)-321(effects)-321(of)-321(each)-321(drug)-321(class.)]TJ T* [(Additional)-303(KQs)-303(addressed)-303(the)-303(timing)-303(and)-303(frequency)-303(of)]TJ T* [(CVD)-367(risk)-367(assessments)-367(and)-367(lipid)-367(level)-367(testing;)-367(the)-367(cost-)]TJ T* [(effectiveness)-315(of)-315(cholesterol-modifying)-315(drugs;)-315(the)-315(accu-)]TJ T* [(racy)-338(of)-338(risk)-338(assessments,)-338(as)-338(well)-338(as)-338(the)-338(added)-338(value)-338(of)]TJ T* [(additional)-344(risk-stratifying)-344(tests;)-344(the)-344(ef\223cacy)-344(of)-344(interven-)]TJ T* [(tions)-394(to)-394(enhance)-394(statin)-394(tolerance)-394(and)-394(adherence;)-394(and)]TJ /T1_4 1 Tf 0.632 -4.21 Td [(See)-333(also:)]TJ /T1_7 1 Tf 9 0 0 9 323.5 70.2471 Tm [(Editorial)-333(comment)-333(1)]TJ 0 -1.333 TD [(Related)-333(article)-333(2)]TJ /CS0 cs 1 scn /T1_8 1 Tf -0.0398 Tc 16 0 0 16 53.5 739.2472 Tm [(Annals)-293(of)-293(Internal)-293(Medicine)]TJ /T1_9 1 Tf 0 Tc 23 0 0 23 388.1325 739.2472 Tm (C)Tj -0.0277 Tc 16.5 0 0 16.5 402.5101 739.2472 Tm (LINICAL)Tj 0 Tc 23 0 0 23 467.975 739.2472 Tm (G)Tj -0.0277 Tc 16.5 0 0 16.5 483.8706 739.2472 Tm (UIDELINE)Tj 0 0 0 1 k /T1_4 1 Tf 0 Tc 7 0 0 7 53.5 35.7471 Tm (Annals.org)Tj /CS0 cs 1 scn /T1_9 1 Tf 42.364 0 Td [(Annals)-284(of)-284(Internal)-284(Medicine)]TJ 0 0 0 1 k /T1_10 1 Tf 29.221 0 Td (1)Tj 0 0 1 rg /GS1 gs /T1_11 11 Tf 1 0 0 1 460 16.5 Tm ( )Tj ET q 54 0 0 22.6125 98 16.5 cm /Im0 Do Q endstreamendobj278 0 obj<>endobjxref 0 2 0000000000 65535 f 0000289516 00000 n 19 1 0000290029 00000 n 27 1 0000290502 00000 n 31 1 0000290958 00000 n 35 1 0000291402 00000 n 39 1 0000291846 00000 n 52 1 0000292366 00000 n 56 1 0000292798 00000 n 65 1 0000293241 00000 n 69 1 0000293614 00000 n 72 1 0000297477 00000 n 261 18 0000298030 00000 n 0000304368 00000 n 0000304467 00000 n 0000319056 00000 n 0000319155 00000 n 0000333545 00000 n 0000333644 00000 n 0000346242 00000 n 0000346341 00000 n 0000358908 00000 n 0000359007 00000 n 0000372472 00000 n 0000372571 00000 n 0000385280 00000 n 0000385379 00000 n 0000397640 00000 n 0000397739 00000 n 0000409373 00000 n trailer <<6230F6FC29DB58479D1990E6C9ADA730>]/Prev 284134>> startxref 409472 %%EOF